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The complement system, part of innate immunity, provides a defence against 
invading pathogens and is composed of over 30 cooperating proteins. Strict 
regulation prevents damage to host cells by inappropriate activation. Decay 
accelerating factor (DAF) is a complement regulatory protein; its function is to 
accelerate the decay of activated complexes at key points in the proteolytic cascade 
that are central to a complement-mediated response. DAF is also involved in cell 
signalling and, ironically, has been exploited as a cellular ligand for a number of 
bacterial and viral pathogens. Widely expressed, DAF is membrane bound by a 
glycosylphosphatidylinositol (GPI) anchor. The GPI anchor is attached to a 
serine/threonine/proline (STP) rich 'stalk', followed by four end-to-end complement 
control protein (CCP) modules, of which the second, third and fourth are involved in 
complement regulation. The three-dimensional structures of DAF CCP modules 
(written DAF modules) have been solved and published in the following order: DAF3 4 
(by X-ray crystallography), DAF 23 (by NUR spectroscopy) and full DAF 1234 (by X-
ray crystallography). The overall' structure of modules two and three solved by both 
techniques are similar, with the exception of some loops, but significant differences 
were observed in the orientation and inferred flexibility between the modules. 
This thesis describes the reassignment of the original two- and three-dimensional 
NIMR data, acquisition of additional data sets and subsequent recalculation of the 
DAF23 solution structure. Additional 'data included the acquisition of three new sets 
of residual dipolar couplings (RDCs); these provide additional restraints for the 
structure calculation. The new resonance assignment highlighted both wrong and 
missing assignments in the original work. New structures of two conformers are 
presented. Their intermodular orientations are not congruent with the original 
solution structures, but are with the crystal structures; this observation is analysed 
and discussed. The dynamics of DAF23 are described using new ' 5N relaxation data 
and the model-free method of analysis. DAF 23 shows very limited intermodular 
movement, with consistent orientation. Key interface residues do not appear to be 
moving on timescales different to the rest of the modules. Conflicting interpretation 
of mutagenesis data is now resolved; key residues at the 2/3 interface are important 
in stabilizing structure, not solvent exposed and are directly involved in binding as 
thought in the previous study. 
This thesis also describes the purification of DAF fragments DAF 12 and DAF234, to a 
suitable quality for study by NMR spectroscopy. Use of a strong cation exchange 
column and a gradient elution provided the level of purification required. 
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RMSD Root mean square deviation 
S Seconds 
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1.1 The complement system 
1.1.1 Introduction and overview 
The complement system is an important part of the innate immune system that also 
contributes to acquired immunity. It consists of over 30 proteins that, following 
activation, work in unison to provide a defence against invading pathogens and to 
mediate clearance of immune complexes from the bloodstream. Complement was 
discovered over a century ago [29] as a component of blood plasma that possessed 
bactericidal properties and demonstrated species specific erythrocyte lysis. The 
multicomponent nature of the complement system was recognised some 20 years 
later [77]. 
Complement activation is stimulated by one (or a combination) of three pathways 
(figure 1. 1), following which specific protein-protein recognition events mediate an 
enzymatic cascade that rapidly targets cells for destruction. The main components of 
this cascade are 12 soluble plasma proteins; C  to C9, factor B, factor D and 
properdin. The terminal product of the enzymatic cascade is the membrane attack 
complex (MAC), which is able to penetrate target membranes, leading to cell lysis 
and death. The MAC is composed of activated components of terminal complement 
proteins; C5, C6, C7, C8 and a number of copies of C9. 
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The three pathways of activation are the classical pathway (CP), the alternative 
pathway (AP) and the lectin pathway. The classical pathway, so called because it was 
the first to be described [71], is activated predominantly by specific antigen 
recognition (however, it has been shown [329] that the classical pathway can also be 
activated by antibody-independent means, stimulated by substances such as 
components of damaged cells, bacterial lipopolysaccharide and nucleic acids). 
The AP, discovered in 1954 by Pillimer et al. [243], does not rely on specific 
recognition of molecules on the target surface by antibodies. The AP constantly 
operates in a "tick over" mode. It provides an efficient amplification loop for the 
proteolytic cascade [36, 156, 243]. Via this pathway, active products of complement 
are continually generated on all cells in the body, but at a low rate. These active 
products are deposited on target surfaces [232, 276]; subsequent amplification is 
prevented by regulators on all surfaces except those of foreign or target structures. 
The third pathway, the lectin pathway, discovered relatively recently [324], is also an 
antibody-independent route of complement activation on bacterial and other micro-
organisms. It is stimulated via association of bacterial polysaccharides with a 
complexed mannose binding lectin, MBL and two novel serine proteases (MBL-
associated serine proteases, MASP-1 and MASP-2). 
The three pathways of complement activation, the amplification cascade and 
formation of the MAC are shown diagrammatically in figure 1.1. 
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Figure 1.1: The complement system. All components and complexes are labelled, are representations only and are not drawn to scale. 
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1.1.2 Activation of complement 
Activation of the classical pathway starts with the large C  component of 
complement, which is composed of one Clq molecule associated non-covalently 
with two of each of Clr and Cis in a Ca 2 -dependent complex. Clq consists of six 
subunits, which converge at one end (to form a collagen-like tail) and diverge at the 
other, forming six globular heads [172, 248, 263]. In the presence of Ca 2 , Clr and 
Cis form an elongated Cls-Clr-Clr-Cls complex, which binds to Clq between the 
diverging strands [264, 2651 (figure 1.2). 
Figure 1.2: Diagram of C  qr2s2 complex. Diagram is representation only and not to scale. 
Polyvalent binding of C  q immune complex-bound IgG or 1gM antibody activates 
the C  complex via conformational changes that occur in Clq [239]. This 
conformational change activates Cir, which in turn activates Cis [264]. Cis in the 
activated complex is able to enzymatically cleave and activate the next component in 
the classical pathway, C4, to C4b. The small anaphylatoxin, C4a, is released, 
exposing a thioester in C4b, which gives C4b the capacity to bind covalently to 
membranes and other surfaces [64, 149]. Once attached to a membrane, C4b binds 
C2 in the presence of Mg 2 . Clq?s2 also cleaves C2: C2b is released and the 
enzymatically-active complex C4b2a is formed [206]. Enzymatic activity is located 
in the C2a component of this complex, C4b acts as a tether to the molecular surface. 
C4b2a is a C3 convertase; it cleaves C3, releasing its constituent components C3a, an 
anaphylatoxin, and C3b. Through a thioester, C3b also has the capacity to covalently 
bind the C4b fragment of the C4b2a complex [137, 328]; the result is formation of 
the C5 convertase, C4b2a3b. The C3b fragment of this complex binds C5 non- 
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covalently for subsequent cleavage by the enzymatically active C2a fragment. Two 
components are released; C5b and the small anaphylatoxin, C5a. C5b is the start of 
the terminal pathway leading to formation of the membrane attack complex. 
C3 is the most abundant of the complement components. It is essential in all 
pathways, and is the key component of the alternative pathway. In the AP, C3b (in 
the fluid phase or membrane-bound to an activating surface through a thioester) 
binds factor B (fB), which then becomes susceptible to cleavage by factor D (I)) that 
can only cleave C3b-attached fB [89]. Ba is released and a serine protease domain is 
exposed on Bb. The C3bBb complex formed is a C3 cleaving enzyme (i.e. the AP C3 
convertase). It cleaves C3 into its two components, C3a and C3b. C3b attaches to 
C3bBb, forming C3bBb3b, which binds and cleaves C5 to C5b, releasing C5a. 
C3bBb3b is therefore the C5 convertase of the AP. 
In biological fluids, C3 is continuously hydrolysed at a slow rate to form C3(H 20), a 
meta-stable molecule which has many of the characteristics of C3b and can attach fB 
in solution and render it susceptible to cleavage by ID [200, 230, 231, 261]. The Bb 
fragment of the resulting fluid phase complex C3(H20)Bb is able to cleave small 
amounts of C3, with subsequent deposition of C3b on adjacent surfaces [148]. This 
'tickover' phenomenon ensures that the AP is in a constant state of readiness and 
must be tightly regulated on self-cell surfaces. 
In the lectin pathway, mannose-binding lectin (MBL) binds mannose or N-acetyl 
glucosamine residues, which are abundant on bacteria cell walls. Surface bound 
complexes of MBL and MBL-associated serine proteases (MASP or MASP-2) 
activate C4 in a similar manner to the C  complex in the CP, providing a rapid, 
antibody-independent route to activating the CP on bacteria [108, 185, 332]. Other 
lectins have been shown to activate complement in this manner. Lectin triggered 
activation is a distinct complement activation pathway to specifically target 
carbohydrate residues expressed predominantly on bacteria [108]. 
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1.1.3 Terminal events 
The three activation pathways converge at the C3 and C5 convertases (figure 1.1); 
the cleavage of C5 to C5b being the final enzymatic step of the complement cascade. 
Following cleavage, C5b remains associated with the C3b components of the C5 
convertases. C6 binds non-covalently to the C3b-bound C5b fragment, exposing both 
a membrane binding site on C5b and a C7 binding site on C6 [245]. Binding of C7 
induces conformational changes in the C5b-7 complex, facilitating its release from 
the C3b component of the C5 convertase into the fluid phase. If a membrane is then 
encountered, the complex binds tightly, followed by association of C8 to the C7 
fragment of the complex. The complex then becomes deeply buried in the membrane 
and forms a small pore. The final component of complement, C9, binds to the C8 
fragment of the membrane-bound complex, upon which C9 undergoes a major 
conformational change, unfolds and traverses the membrane. This unfolding exposes 
another C9-binding site, this time on the attached C9. Up to 18 C9 molecules can 
bind, unfold and insert into the membrane, forming larger a pore, and facilitating cell 
lysis and death [340]. 
1.1.4 Other roles of complement 
In addition to mediating the targeting and killing of invading pathogens, another 
principal role of the complement system is solubilisation and clearance of immune 
complexes [286-288]. Immune complexes activate both the CP and AP and become 
coated in complement protein fragments (C3b, C4b etc.); this facilitates 
disaggregation and masks antigenic sites, which limits growth. C3b and C4b 
deposited on immune complex surfaces bind to another complement protein, 
complement receptor type 1 (CR1), which is a major erythrocyte receptor. CR1 
tethers the immune complex to the erythrocyte, and it is subsequently removed from 
circulation [58, 59]. 
Complement plays other physiologically and pathologically important roles. Release 
of the anaphylatoxins, C3a, C4a and C5a, initiates inflammation, which mediates 
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vasodilation and increased vascular permeability at sites of injury-or infection. 
Furthermore, complement makes an important contribution to the induction of 
antibody response [131, 237, 238], and through interactions with other components 
of the immune system, complement also plays a role in the development of acquired 
immunity [216]. Decay of surface-bound C3b is mediated by factor I, which, in the 
presence of an appropriate cofactor (factor H, CR1 or membrane cofactor protein, 
MCP) cleaves the molecule into inactive surface-bound fragments [98, 272]. This 
occurs in the order of C3b to iC3b (by release of small fragment C3f), iC3b to C3dg 
(by release of large fragment C3c) and finally C3dg to CM (by release of small 
fragment 0g). These surface-bound fragments, along with surface-bound C3b and 
C4b, influence immune response by association with the complement receptors CR1, 
CR2, CR3 and CR4 [86]. CR1, as stated previously, helps to clear immune 
complexes. CR2, expressed primarily on B cells, T cells and follicular dendritic cells 
[68, 168, 266, 271, 341], plays an important role in the presentation of antigens to 
specific B and T cells, and in the control of B-cell proliferation [338]. By interaction 
with C3dg and CM, CR2 can act synergistically with the B-cell antigen receptor in 
B-cell activation [74, 75]. Furthermore, C3dg- or CM-bearing immune complexes 
can bind to CR2, which then facilitates clearance. CR3 and CR4, expressed on 
phagocytes and myeloid cells, both bind to iC3b [204, 3611 and promote adhesive 
interactions of leukocytes with the vascular endothelium. They primarily function as 
adhesion molecules, mediating binding to the matrix and to C-opsonized' surfaces. 
Also, iC3b-coated immune complexes have a high affinity for the CR3 receptor on 
phagocytic cells of the liver and spleen, to where they are transported and degraded. 
1.2 Regulators of complement 
In order to protect host cells from destruction by non-discriminatory complement 
activation, each part of the complement system is tightly regulated. The proteolytic 
cascade, upon activation, has a propensity for rapid amplification resulting in a large 
Opsonization refers to deposition of complement activation products on target surfaces, causing the 
target to become more susceptible to the action of phagocytes. 
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and potentially harmful response. Unregulated activation would cause not only 
extensive local damage, but would also lead to consumption of complement proteins. 
Some degree of control is afforded by the inherent instability of the activated 
complexes, both within the activation pathways and on the fluid-phase precursor of 
the MAC. This limits the effects of complement to the vicinity of an activating site. 
The principal source of complement down-regulation and host cell protection, 
however, comes from at least 11 fluid-phase and membrane-bound regulatory 
proteins. Some of these proteins have other physiological functions, while others 
have the sole purpose of complement regulation. 
Complement regulation was first described in 1904 [198, 199], shortly after 
complement was discovered; it wasn't until the 1960s however, that characterisation 
of the components of regulation began. The main components of complement 
regulation are the fluid phase proteins: C  inhibitor (Clinh) [236], factor I-I (ff1) 
[357], factor I (11) [72, 143], C4-binding protein (C4BP) [78], S protein [134, 246] 
and clusterin [39, 40, 201]; and the membrane bound proteins: membrane cofactor 
protein (MCP) [177, 300], decay accelerating factor (DAF) [212, 213], complement 
receptor 1 (CR1) [73], homologous restriction factor (HRF) [292, 364], and CD59 
antigen (CD59) [57, 323]. 
The first regulatory protein is C  inh, which is a member of the serine protease 
family; this regulator inactivates the C  complex (Cl qr 2 s2) by removing C  r and C is 
[60, 61]. Factor I is also a serine protease; in the presence of a number of specific 
cofactors, fl cleaves C3b and C4b from the activation pathway convertases, 
rendering them inactive. These cofactors are other regulatory proteins; plasma 
proteins fl{ [229, 348, 356] and C4BP [207, 308], and membrane-bound proteins 
MCP [165, 166, 298] and CR1 [187, 188]. These proteins attach to the C3b or C4b of 
the convertase complexes and promote catalytic cleavage of that component by fl. 
FH binds 0b, C4BP primarily binds C4b, while MCP and CR1 are able to bind both 
C3b and M. This is summarised in table 1.1. 
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Factor I cofactor Fragment of convertase cofactor binds 
ff1 C3b 
C4BP C4b 
MCP C3b, C4b 
CR1 C3b, C4b 
Table 1.1: Table showing to which subunit(s) of the convertases each factor I cofactor binds. 
In addition to fl cofactor activity, ff1, C4BP and CR1 inactivate convertases in a 
second manner; decay acceleration. Convertases decay to their constituent 
components with a half-life of several minutes. Regulators with decay accelerating 
activity (DAA) bind to the convertases (via C3b or C4b in AP or CP respectively) 
and displace the enzymatic component of that convertase; C2a in CP and Bb in AP, 
shortening the half-life of the convertase to a matter of seconds. 
The final regulator of the activation pathway to be mentioned here is DAF, which is 
the topic of this thesis. DAF is a single-chain protein tethered to the membrane by a 
glycosylphosphatidylinositol (GPI) anchor. As the name suggests DAF has DAA. 
Widely expressed on many cell surfaces, it binds to and displaces the enzymatic 
components of both AP and CP convertases. DAF subsequently releases the 
components and is free to bind and accelerate decay of other convertases on the 
membrane. DAF is discussed further in subsequent sections. 
Formulation of the MAC in the terminal pathway of the complement system is - 
regulated by two fluid-phase proteins, S protein and clusterin, and two membrane-
bound proteins, HRF and CD59. Both S protein and clusterin are multifunctional 
serum proteins that bind tightly to the C5b-7 complex in the fluid phase, preventing 
the complex attaching to cell membranes [202, 247]. CD59 binds to C8 in the 
membrane bound C5b-8 complex, blocking attachment of C9 and inhibiting the 
formulation of the MAC on the cell surface [195, 269]. The significance of HRF is 
unproven [365]. In addition to these regulators, one further method helps to control 
MAC formation; if C8 binds C5b-7 in the fluid phase, the resulting complex does not 
form membrane-penetrating pores [63, 162, 210]. 
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1.2.1 Complement control protein (CCP) modules 
The regulators of complement activation (RCAs) are a subset of regulatory proteins 
that are encoded by a cluster of genes that lie on chromosome 1q32; the RCA cluster 
[111]. There are six members of the RCA identified in humans; CR1, CR2, fl-I, 
C4BP, DAF and MCP. All of these RCA proteins interact with an activation product 
of C3 and/or C4 [265]. 
RCAs share structural features, as well as gene linkage, in that they all consist of 
repeated protein domains, joined end-to-end like beads on a string, that share marked 
sequence similarity with one another. These domains are termed short consensus 
repeats (SCRs) or alternatively, complement control protein (CCP) modules. DAF 
and MCP each have four CCP modules, fH has 20, CR1 has 30 (in the most common 
form) and CR2 has 15 or 16. C4BP is also made up of CCPs, but in a more 
complicated fashion; in the most common isoform seven strands of eight joined CCP 
modules form a chains and one strand of three CCP modules form a 13  chain. All a 
and 13 chains are joined at one end so that C4BP resembles a spider, in that it has 
eight 'legs' (figure 1.3). 
Figure 1.3: Representation of C4131? in its most common form, with seven a chains (composed of 
eight CCP modules each) and one 13  chain (with three CCP modules). 
CCP modules have also been found in non-regulator complement proteins such as 
factor B and C2 (each with three repeats), C6 and C7 (each with two repeats), and 
Clr and Cis (also with two repeats each). Furthermore, CCP modules are not limited 
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to the complement system; they have also been found in the GABA B receptor, P2 
glycoprotein I, the 1L2 receptor, haptoglobin and the 3 subunit of clotting factor XIII, 
as well as many other proteins. 
Structurally, the CCP module is a compact globular domain consisting of 
approximately 60-70 amino acids, of which several are conserved. A hydrophobic 
core, containing a conserved tryptophan, is surrounded by fl-strands, with the 
carboxv- and amino-termini found at opposite ends of the module. The consensus 
sequence includes four invariant cysteines, which form two intradomain disulphide 
bridges in a I-Ill, II-IV pattern. Several proline, glycine, tyrosine, phenylalanine, 
isoleucine, leucine and valine residues are conserved or substituted with similar 
amino acids. CCP domains are joined end-to-end by short linker chains (from three 
to eight amino acids residues in length between the last cysteine of one module and 
the first of the next). Figure 1.4 shows a typical CCP module. 
Figure 1.4: Typical CCP module in cross-eyed stereo view. The structure shown is that of CR! 
module 16 [222]. The two disulphide bridges (1st to 3rd and 2nd to 4th cyste nes) are shown in 
yellow. The conserved tryptophan, found buried in a hydrophobic core, is shown in red. The 
secondary structure consists of fl-strands surrounding the hydrophobic core. 
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To date, there are 35 CCP modules, from 14 proteins, whose three-dimensional 
structures have been solved, 26 of which are from ten complement proteins. These 









CIr 1,2 2 30,31 
Cis 2 2 81 
MASP-2 1,2 2 82,96 
CR1 15, 16, 17 30 222,310 
CR2 1,2 15 260,327 
fl-I 5, 15, 16, 19, 20 20 9,10,101,117,218 
C4BP(a) 1,2 7 116 
DAF 1,2,3,4 4 178,345,360 
MCP 1,2 4 34 
VCP 1, 2, 3, 4 4 83, 84, 100, 203, 357 
2-GPI 1,2,3,4 4 21,295 
GABAB-R1a (rat) 2 2 18 
IL-2Rct. 1,2 2 267,317,353 
IL- l5Rcx 1 1 173 
Table 1.2: Experimentally solved CCP modules published to date. 132-GPI is apolipoprotein H. IL-2/- 
15Rcx is interleukin receptor ct-chain. GABA B is gamma-aminobutyric acid type B receptor, subunit 1. 
1.3 Decay accelerating factor (DAF) 
In 1969, Hoffman [105] described inhibition of complement by a substance from 
human erythrocytes with decay accelerating activity, subsequently showing that it 
accelerated the decay of the CP convertase [106]. This substance was distinguished 
from CR1 by its molecular weight and its inability to neutralise anti-CR1 antibodies' 
influence on activity. Nicholson-Weller was the first to purify and characterise DAF; 
firstly guinea pig DAF in 1981 [212], followed by human DAF in 1982 [213]. Since 
then much research has been undertaken on the structure and functions of DAF, both 
in complement and non-complement capacities. 
DAF is widely expressed and is present on most cells, including erythrocytes, 
leukocytes and endothelial cells [126, 214]. DAF is found in the urinary, 
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gastrointestinal and exocrine sytems [54, 113, 191], placenta [4, 107], spermatozoa 
[270], skin [284, 285], eye [147] and other locations. Soluble forms of DAF are also 
found in many biological fluids such as plasma, tears, saliva, synovial fluid and urine 
[191]. 
DAF accelerates the decay of the CP convertases, C4b2a and C4b2a3b, and the AP 
convertases, C3bBb and C3bBbC3b, its predominant target being the C3 convertases. 
The association constants of DAF for the C3 convertases, C4b2a and C3bBb, are 530 
nM and 910 nM' respectively, whereas those to uncomplexed C4b and C3b are 
0.45 nM' and 45 nM respectively [233]. This low affinity for the uncomplexed 
components (approximately 1000-fold and 20-fold reductions in comparison with 
DAF's affinity for the complexed convertases) allows DAF to be recycled, 
dissociating from components following decay, and then interacting with other 
convertase complexes on the membrane surface. Recent studies have provided 
further steps towards elucidation of the mechanism by which DAF dissociates the AP 
convertase [97, 112, 178]. It has been shown that DAF binds individual components 
of the convertase in the following order: Bb> C3b> fB [97]. DAFs method of 
regulation is in contrast and complimentary to those of fl-I, C413P and CR1, which 
bind C3b and C4b more strongly. 
DAF, predominantly a membrane-associated regulatory protein, has been shown to 
accelerate the decay of convertases present on the same cell surface [189] and not, 
extrinsically, on other targets. The proposed interaction point for DAF binding on 
factor B and C2a in the AP and CP convertases, respectively, is the a415 region of 
the von Willibrand factor type A domain [112, 142]. This region is critical for decay 
acceleration mediated by DAF, especially Y338 in Bb and its analogue, Y327, in 
C2a. A model of factor B type A domain [103] has also been docked onto a structure 
of DAF, providing further insight into DAF-convertase interactions [178]. 
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1.3.1 Primary structure of DAF 
The prmarv structure of DAF was revealed in 1987 [33, 190]. when the cDNA 
encoding DAF was cloned. It was shown that DAF contains four CCP modules 
(figure 1.5), joined end-to-end by short linkers (composed of three or four residues 
each). The CCP modules are followed by a sequence. approximately 70 amino acid 
residues long, rich in serine, threonine and proline residues (an STP region), which 
contains numerous sites for addition of 0-linked oligosaccharides and is heavily 
glycosylated in the mature protein [178, 2741. The result of this glycosylation is 
stiffening and elongation of the backbone of the STP region. The amino acid 
sequence of DAF is shown in figure 1.6. 
6 	 GPI 
anchor 
-V 
4 	3 	2 
STP region CCP modules 
Membrane  
Figure 1.5: Cartoon representation of DAF. The four CCP modules are shown in grey, their overall 
length is approximately 160 A [178]. Green moieties are 0-linked oligosaccharides, except for the N- 
linked oligosaccharide located at N61 between CCP modules one and two, also shown in green. 
1 	 11 	 21 	 31 	 41 
DGLPFDVPN AcIPALEGM FPTVITYK CFVK 	V1CLKO 
51 	 61 	 71 	SI 	 91 	-. 
SQWSDIEEFC 1P.SCEVP7RL NSAZLKOPYI TQIWFPVGTV VEYECR 
	
- 	 CCP3 
101 111 	11 	1 	131 	141 
REPSLZPKLT CLQLNKTA VEFCKY.Y2P NPOEIRNOQI DVPOGILFOA 
CCP4 
151 	161 	171 	131 	I 1191 
TIZFSCNTGY KLF1TSSFC LIZSVOWS DPLPEEW AFEQWNG 
201 	211 	221 	231 	241 
IIOMMHY13 YROZVI'YAC]4 KFMIOEHZ 1YNNDED EVVMGFFPECUZ  
SIP Region 
251 	261 	271 	281 	291 
G1(SLTSKVPP TVQKPTTV1JV PTFSFFSQ KTTKTTPN AQATRSTPV$ 
301 	 311 
R1'TIG1FHETT 1`11E3SOTTS
STP 
- 	 Region 
 1.6: Amino acid sequence of decay accelerating factor. CCP module one is comprised of 
residues Dl to C60, module two from C64 to C 124, module three from C129 to C186 and module 
four from Cl 91 to C249. The STP region extends from R250 to S319. 
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Following the STP region is a glycosyiphosphatidylinositol (GPI) anchor. The last 17 
amino acids in the STP region are essential for attachment of the GPI anchor [33]. 
The typical form of human DAF is 70 kDa (leukocyte form) or 65 kDa (erythrocyte 
form), the difference arising from the degree of glycosylation. Several atypical forms 
have been reported. DAF-A and DAF-B, smaller forms purified from human 
erythrocytes, are thought to be degradation products, neither having their GPI 
anchors. These forms are able to accelerate the decay of fluid-phase, but not cell-
bound, convertases [299]. Two more forms, DAF-Ul and DAF-U2, have been 
purified from human urine [208], a 100 kDa form (along with the 70 kfla form) has 
been reported in tears and a functional dimeric form (DAF-2) has been purified from 
human erythrocytes [127, 215], which appears to result from covalent linkage within 
the CCP modules of two DAF monomers. 
A representation of the predominant, 70 kDa, form is shown in figure 1.5. The STP 
stalk region, thought to be extended and stiffened by addition of 0-linked 
oligosaccharides to multiple serine and threonine residues, is thought to be 
approximately 180 A in length [178]. Although this region has been shown to 
contain no regulatory activity itself, it acts as a 'spacer' region, extending the CCP 
modules an appropriate distance from the cell membrane to enable them to bind and 
dissociate the convertases [55]. DAF remains functional following replacement of 
the STP region and GPI anchor by another domain of equivalent length. Deletion of 
this region, however, abolished function [55]. The presence of the GPI anchor 
appears to have additional importance; DAF has been shown to play a role in signal 
transduction and the GPI anchor is essential for triggering cell activation [307], as it 
is in other GPI-anchored molecules that have demonstrated cell-signalling and 
activation roles [37, 279, 306]. It has also been suggested that the GPI anchor gives 
DAF increased mobility in the plasma membrane. 
1.3.2 Interactions of DAF with convertases 
Selective deletion of CCP modules has enabled elucidation of the complement 
regulatory active sites of DAF [24, 55]. Regions required for regulation of the CP 
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convertase are located within CCP modules two and three. Regulation of the AP 
convertase requires residues spread over CCP modules two, three and four. 
Mutagenesis studies [141] have been carried out on human DAF in an attempt to 
elucidate the convertase binding sites on CCPs two, three and four. The following 
mutations significantly reduced or abolished decay acceleration of the classical 
pathway C3 convertase: R69A, R96A, R100A, RiOlI, K127A, F148A and L171A. 
These mutations had the same effect on decay acceleration of the AP convertase, as 
well as K126A, F169A, R206A and R212A. Further mutations have been performed 
but these, and the mutations described above, will be discussed further with regards 
to DAF structure in Chapter 8. 
1.3.3 Roles of DAF 
DAF plays a role in the protection of vascular wall from complement-mediated 
injury during acute or chronic inflammation; it has been shown that DAF may be up-
regulated by inflammatory cytokines for this purpose [3, 182, 1831. This, and other 
instances of tissue protection membrane-bound complement regulators, has lead to 
the exploration of therapeutic applications of these regulators. 
Complement regulators can influence the proliferative capacity of T cells and their 
ability to produce cytokines, influencing the outcome of a T-cell response to a given 
antigen [99, 125, 136, 167, 171, 180, 268, 275]. DAF, expressed in lipid rafts on T 
cells, modulates T-cell immunity by controlling T cell- and antigen presenting cell-
induced alternative pathway C3 activation during cognate interactions [99, 167]. The 
precise mechanism of this is yet to be elucidated, however studies have shown that T 
cells proliferate into an expanded number of effector cells in the absence of DAF and 
that the effects of DAF deficiency are abolished in the absence of factor D (critical 
for the formation of the C3 convertase in the alternative pathway). This indicates that 
under conditions of sustained C activation, such as tissue injury or chronic infection 
with a pathogen, DAF serves not only to protect against the destructive effects of 
CHAPTER 1: INTRODUCTION 
	
17 
complement, but also to decrease T-cell responsiveness in order to avoid 
immunopathy and autoimmunity. 
DAF is also involved in co-ordinating the innate immune system response to 
bacterial pathogens by enhancing natural killer cells activity [333]. 
1.3.4 Other ligands for DAF 
DAF has been studied extensively in non-complement capacities due to the 
observation of many non-complement interactions in which DAF takes part. 
Ironically DAF has been exploited as a cellular ligand for a number of bacterial and 
viral pathogens promoting cellular attachment prior to infection [158, 151]. Dr 
adhesins are bacterially expressed proteins, which are important virulence factors 
that allow colonization of the human urogenital tract by Esherichia coli. These 
adhesins include Dr- [220, 326, 347], X- [242] and Fl 845-adhesins [219]; and 
afimbrial adhesins Afa-I and Afa-III [87, 152, 219]. These uropathogenic strains of 
E. coli are associated with urinary tract infections and diarrhoea, particularly in 
children and pregnant women. Fimbriae of the adhesins bind CCP modules two and 
three of DAF (CCP three is essential) [297], which then facilitate the internalisation 
of these Dr adhesin-bearing E. coli. 
DAF is a receptor for a host of viruses: coxsackieviruses A21, Bi, B3 and B5 [301, 
302]; echoviruses 3, 6, 7, 11, 12, 13, 19, 21, 24, 29, 30 and 33 [14, 250, 354]; and 
enterovirus 70 [119]. These are all members of the enterovirus genus of the 
Picornaviridae; a family of small non-enveloped, positively stranded RNA viruses 
associated with a range of human diseases. Coxsackievirus B3 causes severe 
myocarditis, pancreatitis and meningitis in children. Coxsackievirus A21 is a 
causative agent of the common cold. Echoviruses that bind DAF cause conditions 
such as aseptic meningitis, exanthem, pleurodynia, pneumonia, encephalitis, 
haemorrhagic conjunctivitis (as does enterovirus 70), acute diarrhoea and severe 
generalized neonate infections. Most of these DAF-virus interactions are insufficient 
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to mediate cell infection, although conformational changes at the virion do occur. 
DAF appears to function as an initial receptor for these viruses, with subsequent 
internalisation requiring additional cell-surface components or proteins [249, 250]. 
Domain specificity for the majority of DAF-virus interactions have been mapped; all 
enteroviruses, except CAV21 and EN70 [120, 3021, appear to predominantly bind 
CCP module three with contributions from CCPs two and four, depending on the 
virus [41, 150, 251, 303]. CAV21 and EN70 are the exceptions as they require CCP 
one only for binding [120, 302]. Further studies to elucidate virus binding sites on 
DAF have been undertaken [251, 358], including quasi-atomic structural models of 
EV7-DAF and EV12-DAF complexes [17, 102, 241]. These studies show that 
different viruses that interact predominantly with the same domain of DAF may do 
so on different faces. 
HIV utilises the complement system in its strategy of infection in different ways 2 . 
DAF, along with MCP and CD59, has been reported to be hijacked by HIV, 
providing the viral surface with a protective coat. HIV makes numerous copies of 
itself in the active infection. Virions are created and bud off from the host cell taking 
host membrane proteins with them, including host DAF [181, 3131. DAF provides 
only partial protection however; it has been found that factor H is essential for HIV's 
resistance [244, 320]. 
Helicobacter pylori is a bacterium found in the mucus lining of the human stomach. 
The adherence of H pylori to gastric epithelial cells is critical for the induction of a 
persistent inflammatory response in the stomach; the largest risk factor for peptic 
ulcer disease, distal gastric adenocarcinoma and non-Hodgkins lymphoma of the 
stomach [197, 235]. Studies have shown that expression of DAF is increased with H. 
pylon-infected human gastric tissue compared with uninfected mucosa [15, 262, 
2801 and have suggested that aberrant expression of DAF precedes the development 
of gastric cancer [130]. One recent study showed that H. pylori binds avidly to cells 
expressing human DAF and that this is mediated by CCPs 1-4 and the 0- 
2  Good recent reviews are [315, 321, 320, 8]. 
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glycosylated SiP region [221]. These results suggest that H pylori induces up-
regulation of DAF in gastric epithelial cells and that DAF regulates the H pylon-
epithelial cell interactions relevant to pathogenesis. 
CD97 belongs to a family of seven-span transmembrane (TM7) receptors, which are 
predominantly expressed by cells of the immune system. The expression of CD97 is 
up-regulated on leukocytes early after inflammatory activation. It is speculated that 
CD97 may act as a surface receptor to transduce signals across cell membranes 
[186]. CD97 binds DAY (CCP-module one) as a cellular ligand [91, 92]. 
Characteristics of this protein-protein interaction have been studied; however, its 
physiological consequences are still poorly understood. Previous data has implied 
that it plays a role in cellular activation, migration and adhesion under inflammatory 
conditions. A role has been suggested in the pathogenesis of autoimmune diseases 
[90, 93]. Studies have also suggested that the CD97-DAF interaction may be 
involved in the inflammatory process, facilitating cell activation and migration 
through the blood brain barrier in multiple sclerosis [349]. A recent study found that 
the CD97-DAF interaction plays an essential role in the migration of neutrophilic 
granulocytes [155]. Another recent report suggests the CD97 interaction may 
participate in the development and invasion of gastric carcinomas [167]. Details of 
the CD97-DAF signalling pathway in cells are yet to be elucidated. 
DAF is broadly expressed in a wide range of malignant tumours, including 
colorectal, gastric, ovarian, thyroid and breast cancer. A lot of research is currently 
focussed on analysing the expression and function of DAF in carcinomas. 791Tgp72 
is an antigen from tumour cells that was originally described as a 72 kDa 
glycoprotein [255], which is over-expressed by a range of malignant tumours [67]. In 
a study by Spendlove et al. [314] this antigen was purified, characterised, cloned and 
sequenced. The sequence was shown to be identical to DAF. However, tumours do 
not solely express a single variant of DAF; different isoforms originating from 
different glycosylation patterns are expressed on tumoural surfaces. Recent studies 
have provided evidence of an essential role of DAF in cancer development and 
progression [170, 331]. The role of DAF in human malignancies has been recently 
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reviewed by Mikesch et al. [196]. Inhibition of complement-mediated attack and 
complement component deposition appears to be one of the main functions of 
tumour cell DAF expression. This means DAF might be a useful protein for tumour 
diagnosis and as a potential tumoural target for immunotherapeutic strategies. DAF's 
virus-binding capabilities have already been utilised successfully in treating tumours 
[2, 6, 302,304]. 
1.3.4.1 DAF and xenotransplantation 
Due to the central role that DAF plays in complement regulation, expression of 
human DAF in transgenic animals has been developed to help provide a potential 
source of organs for xenotransplantation [76, 176, 194]. A major problem in 
xenotransplantation is complement-mediated hyperacute rejection of the implanted 
organ. This problem can be circumvented by overexpression of human membrane-
bound complement regulators on endothelial cells of the transgenic animals. Human 
DAF, when expressed on transgenic organs, has been shown to suppress hyperacute 
rejection in xenografts [32, 290, 291]. 
1.4 Background to project 
Three experimentally derived structures of DAF, or its fragments, have been solved 
to date. The most recent, in 2004, was a crystal structure of all four CCP modules of 
DAF and their.linking sequences [178]. Prior to that, in 2003, two sets of module-
pairs from DAF were solved; modules three and four by X-ray crystallography [359] 
and modules two and three by NIvIR spectroscopy [345]. The overall structure of 
modules two and three between the structures solved by different methods were very 
similar, as would be expected, although there were some notable differences in loops 
(figure 1.7). 










Figure 1.7: A) Module two of closest-to-mean structure from original DAF 23 NMR solution structure 
ensemble [345] (shown in blue) overlaid on backbone heavy atoms of module two (C64 to Cl 24) of 
the X-ray crystal structures, taken from full DAF 1234 [178] (shown in rod). B) Module three of closest- 
to-mean structure from original DAF 23 NMR solution structure ensemble [345] (shown in blue) 
overlaid on backbone heavy atoms of module three (C 129 to Cl 86) of the X-ray crystal structures 
taken from full DAF 1234 [178] (shown in red). Regions highlighted are those which hold most 
differences between the structures. 
The most significant difference, however, was in the orientation between modules 
two and three, and the inferred flexibility at this intermodular interface. Whilst the 
NMR-derived solution structures suggested a very flexible junction, the crystal 
structure suggested a rigid junction. Moreover, in the crystal structure these modules 
are oriented differently to the orientation in any of the ensemble of 42 NMR-derived 
structures (figure 1.8). 
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Figure 1.8: DAF modules two and three overlaid on backbone heavy atoms of module two (C64 to 
CI 24). A) DAF 23 NIMR solution structures [345] (ensemble of 42, shown in blue) overlaid with 
modules two and three only of the X-ray crystal structures of DAF1234 [178] (eight models, shown in 
red). B) Rotated by 90 degrees. 
Key residues required for both CP and AP convertase dissociation include the linker 
residues between these modules, as well as other residues located close to the 
intermodular interface. In the NMR-denved structures, much of the linker side-
chains are solvent-exposed and were thought to contribute directly to convertase 
binding. Residues on opposite faces were implicated in binding; this led to the 
hypothesis that the larger convertases wrap around the smaller regulator during 
binding. In contrast, the linker lysine residues of the crystal structures are relatively 
buried and were thought to be acting indirectly by stabilizing the junction. Other key 
residues at this junction (namely F148 and L171) were thought, on the basis of the 
solution structures, to perform more structural roles at the interface. In the crystal 
structures these residues form part of an uncharged band located near the 
interdomain interface (see figures 1.9 and 1.10), and are thought to be directly 
involved in convertase binding rather than in a structural capacity. 
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Figure 1.10: Surface potential map of the closet-to-mean structure of the original NUR-derived 
solution-structure ensemble. Module three is oriented as well as possible to that of the crystal structure 
in figure 1.9. 
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In general, where protein molecules have been studied by both NMIR and X-ray 
based techniques, agreement between experimental structures has been excellent. 
However, occasionally, the crystal structure genuinely differs from the solution 
structure. This can sometimes be explained by variations in experimental conditions, 
or by crystal packing forces. Examples of other CCP modules whose structures have 
been solved by both techniques with conflicting results are VCP23 [100, 128, 2031 
and more recently, fl-I19,20 [101, 117]. The intermodular orientation of VCP23 in the 
NIvfR solution structures is in contrast to that in the crystal structure. Additionally, 
differences in the structure of module two are observed. In fl-I19,20, although the 
intermodular angles are similar there are noticeable regions of difference within each 
module. Furthermore, the structure of 2-GPI 23 has been solved by both X-ray 
crystallography and in solution by small angle X-ray scattering, with conflicting 
results with regards to the intermodular orientation [21, 94, 295]. 
It was considered in the case of DAF that, due to crystal packing forces and the 
conditions under which the protein was crystallised, the inter-domain junction may 
have been stabilised in a single conformation that is only one of several or many 
conformations available in solution. On the other hand, if crystal packing were a 
problem then it seems likely that more than one 2-3 orientation would have been 
observed in the three differently packed crystal structures of DAF modules one to 
four. Furthermore, the crystal structure's orientation did not agree with any of the 
solution structure orientations. It was also considered whether the presence of 
modules one and four in the molecule may play a role in the orientation of modules 
two and three with respect to one another. Previous quasi-atomic low resolution 
structures of DAF complexed with echoviruses provided further insight into the 
problem. A 16 A resolution model of DAF 1 234 complexed with echovirus type 7 
[102] determined by cryo-electron microscopy and a 16 A resolution model of 
DAF1234 complexed to echovirus type 12 [241], based on cryo-negative stain 
transmission electron microscopy and image reconstruction, provide functionally 
important views of DAF in complex with natural ligands. Although at lower 
resolution than either NMR or X-ray crystallography, these structures support 
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domain orientations of the 2-3 junction observed in the crystal structures, suggesting 
that these orientations are functionally relevant. 
The issue of which structure is closest to that found under physiological conditions is 
fundamental to interpretation of a wealth of mutagenesis data and therefore to 
understanding the mechanism of DAF. The validity and accuracy of the experimental 
NMR data and the issue of flexibility needed to be addressed. 
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1.5 Project aims 
The aims of this project were as follows: 
Chemical shift assignment, derivation of distance restraints and structure 
calculation were to be repeated in a non-biased way using the original raw NMR 
spectra, but taking advantage of different NMR-data processing and assignment 
programs. "Non-biased" means not referring to any of the original chemical shift 
assignments nor experimental structures (NMR or X-ray) during the process. 
Acquisition of new NIVIR data sets to aid assignment when required. 
Acquisition of new sets of residual dipolar couplings in order to provide more 
NMR-derived restraints for structure refinement. These are especially important 
since they provide long-range structural information. 
Analysis of the outcome of the refined structure calculations - comparison of 
these to both the original NMR-derived solution structures and the crystal 
structures. 
Acquisition of new sets of 15N relaxation data, and analysis and interpretation of 
these in terms of backbone dynamics, using the model-free method of analysis. 
• Purification of DAF12 and DAF234 samples to a suitable quality for use in NMR 
study. 
• Analyse DAF234 spectra to assess any changes that may result in the structure of 
modules two and three with the addition of module four. 
• Analyse DAF 1 2 spectra to assess any changes that may result in the structure of 
module two with the addition of module one. 
Chapter 2 
THEORY 
2.1 NMR Theory 
All nuclei possess a spin quantum number I, with any particular nucleus having only 
one value of I. Magnetic nuclei have an integer or half-integer value of! and non-
magnetic nuclei have I of zero. The value of the spin quantum number depends on 
mass and charge. Nuclei with even mass and even charge have I = 0 and so are non-
magnetic. Nuclei with odd charge and even mass have I = integer, and nuclei with 
odd mass have I = half integer, so both are magnetic. 
A nucleus has (21+1) degenerate energy levels, each of which have a second 
quantum number associated with them. This is the magnetic quantum number, m, 
and can take only the values I, 1- 1, 1-2.... etc. to —I. These quantum numbers only 
become meaningful when the nucleus is placed in a magnetic field, where the 
degeneracy of the (21+1) energy levels is removed and each level then corresponds to 
a different orientation of the nucleus in the magnetic field. The energy of each level 
is given by: 
E=_mt (-2'_)BO 	 (1) 
y is the gyromagnetic ratio of the nucleus, h is Planck's constant and B0 is the 
external magnetic field strength. The separation between energy levels is therefore: 
27 
CHAPTER 2: THEORY 	 28 
AE = —Amj 	 (2) 
With the selection rule that Ami = ±1: 
AE= 1 -JBo 	 (3) 
It can be seen from this equation that energy level separation depends on the nucleus 
(y) and the external field strength (B 0). Absorption of electromagnetic radiation of a 
frequency v, such that hv = AE, causes the nuclei to move from one level to an 
adjacent level. 




This frequency is known as the Larmor frequency and is also dependent on both the 
nucleus in question (y), and the strength of the external magnetic field (Bo). 
Protons have spin quantum number I = V2 and therefore have two energy levels in a 
magnetic field; these two energy states are shown in figure 2.1. 






Figure 2.1: Energy level diagram showing the non-degenerate energy levels of a proton that occur in 
the presence of an external, magnetic field. 
In the lower energy state, a, which corresponds to in = +'/ 2, the nuclear magnetic 
moment is parallel to the external magnetic field B0. The upper state, 8, corresponds 
to in = - Y2, where the nuclear magnetic moment is anti-parallel to the magnetic field. 
This magnetisation behaves much the same way a gyroscope does in a gravitational 
field. B0 generates a torque force on the magnetic moments causing them to precess 
about axis of B0 at an angular frequency of o = yB o radians per second (or v = 
7B0/27t Hertz). Precession (at Larmor frequency) of these two states is visualised in 
figure 2.2. 
m=+Y2 	 m=-',4 
Figure 2.2: Larmor precession of the aand fl energy states of a proton in a magnetic field 13 0 . 
These two energy states for protons are unequally populated and at thermal 
equilibrium are governed by a Boltzmann distribution: 
(6) 
Na 
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Na is the population of the lower energy state, Np the population of the higher energy 
state, k is the Boltzmann constant and T is temperature in Kelvin. The energy gap 
between the two levels is very small and so the populations are almost equal, - 
however there is a slight excess in the cc state (which is in = + Y2, parallel to the field 
and lower in energy, hence slightly higher population). So when the precessing 
magnetic moments are summed to provide a bulk magnetisation M along the z-axis, 
a net magnetisation is produced in the direction of the magnetic field. The vector 
diagram in figure 2.3 shows this. This bulk magnetisation is precessing at the Larmor 
frequency. 
BOT 
Figure 2.3: Vector diagram showing the bulk magnetic moment M, which is the summation of 
magnetic moments a in the direcion of the magnetic field. The precession of the bulk magnetisation is 
at Larmor frequency of'yuBo radians per second. 
This net magnetisation will remain aligned with the magnetic field unless the system 
is disturbed in some way. If magnetization can be moved away from its equilibrium 
position an NMR signal may be detected. This perturbation of the magnetisation 
from equilibrium is produced by a second magnetic field B 1 , which is perpendicular 
to B0 . The field is produced by a linearly oscillating magnetic field induced by 
radiofrequency coils wound perpendicular to B0, often defined as being on the x-axis. 
The linear field oscillation generated along the x-axis is equivalent to two counter-
rotating field vectors in the xy-plane, illustrated in figure 2.4. 
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Figure 2.4: Vector diagram of a pulse on the x-axis, oscillating in the xy-plane. Bi a refers to the vector 
rotating in an anti-clockwise direction and B ic refers to the vector rotating in the clockwise direction. 
For simplicity we will now work in the rotating frame, where we imagine our 
viewpoint moving at Larmor frequency in time with the precession of the spins. The 
z-axis remains in the field direction but the x- and y-axes rotate around the z-axis at a 
frequency of yBo radians per second. The angular component of M due to 130-induced 
precession becomes fixed in the rotating frame. The precession of spins around the 
z-axis is effectively no longer there, but net magnetization on the z-axis remains (its 
position is the same). x' and y' become the new axes; they are x- and y-axes rotating 
at Larmor frequency. Figure 2.5 illustrates this. 
B0 
y. 
Figure 2.5: Bulk magnetisation in the rotating frame. The x- and y-axes of the laboratory frame are 
now rotating at Larmor frequency and have become x' and y' respectively. Only the z component of 
the bulk magnetisation is seen. 
The excitation frequency is arranged to equal exactly that of the nuclear precession 
frequency so that: 
col = coo =yBo 	 (7) 
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The two counter-rotating field vectors now appear differently. If the frequency of B 1 
is tuned to be identical to the Larmor frequency, component Bi a moves at precisely 
the same rate of rotation as the nuclear spins as they undergo Larmor precession. 
This is the same rate as the rotating frame and hence Bia  appears stationary. Once 
this occurs this component of the oscillating field can interact strongly with the 
nuclear magnets. The other component (that now appears to be rotating at twice the 
Larmor frequency in the rotating frame) does interact with the nuclei but those 
interactions are time averaged to zero and can therefore be ignored. 
The bulk magnetisation M, just as it precesses about the field 130, also precesses 
about Bi a, with a much lower frequency, however, since the B1 field strength is much 
lower than that of B0. This angular frequency is yB 1 radians per second. The torque 
produced by the field B 1 interacting with the magnetisation M moves M towards the 
xy-plane (rotating in the yz-plane), remaining perpendicular to the B I field 
component (along the x-axis). The final position of the magnetisation will depend on 
the length of time the radiofrequency pulse is applied along B1. If Larmor precession 
frequency and pulse frequency are identical, following the pulse the bulk 
magnetisation would remain fixed in the xy-plane of the rotating plane (or rotating at 
frequency yBo radians per second in the laboratory frame). 
13 1 -induced magnetisation in the y' direction (rotating frame y-axis) is called 
'transverse magnetisation'. It is this magnetisation that the NMR spectrometer 
detects with the receiver coil, which lies along the x-axis. Magnetisation starts at 
equilibrium along the z-axis. Applying a B 1 field (by a radiofrequency pulse) causes 
the bulk magnetisation to precess about the x'-axis tipping the magnetisation towards 
the y'-axis. The rate of precession of M about B1 is given by (0 1 = -7B1 radians per 
second. As long as the oscillating B, field is kept going, the bulk sample 
magnetisation will continue to precess at a constant rate about B 1 . The maximum 
signal intensity detected at the receiver coil occurs when the magnetisation vector 
has rotated through 90° and lies along the y'-axis (in the xy-plane in the laboratory 
frame). Continued application of B 1  will lead to a 1800  rotation of M, so that it lies 
along the -z' direction with no component of M in the y' direction or xy-plane, 
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therefore no transverse magnetisation occurs, and no signal is detected. In order to 
achieve the 900  and 180° pulses, B 1 is switched on for very short and very carefully 
timed pulses. 
Once B 1 is turned off the magnetisation returns to equilibrium (i.e. returns to the z'-
axis), over a period of time, by relaxation processes. This relaxation time varies from 
one type of nucleus to another and also with chemical environment, but typically it is 
in the order of seconds. It is during this relaxation period that the NIvIR spectrum is 
recorded. In the rotating frame, M returns to equilibrium along the z'-axis by rotating 
about and remaining perpendicular to the x'-axis. Returning to the laboratory frame, 
M. returns to equilibrium along the z-axis by a gradually ascending spiral about the z-
axis at Larmor frequency. M will rotate around the z-axis many millions of times on 
its relaxation back to equilibrium. 
At any point during this precession the magnetisation can be described as two 
perpendicular components, one is defined as a cosine and the other as a sine wave, 
and so are ic/2 out of phase with each other (figure 2.6 and equation 8). 
Figure 2.6: Sine and cosine compoments of magnetisation M 1 after time t. 
M1 = Mjsin(&)t + Mjcos(a)t 	 (8) 
Both decay exponentially over time due to relaxation as the magnetisation returns to 
equilibrium. The receiver coil detects the decaying fluctuations of magnetisation in 
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the xy-plane and a corresponding decaying alternate current is recorded. A 





Figure 2.7: Sinusoidal 'free induction decay' (FID) of an NMR signal. 
The separation of peaks, represented by time t in figure 2.7, is the time taken for one 
revolution of M about the z-axis and is equal to the inverse of the Larmor frequency 
of that nucleus. This process is known as 'free induction decay' (FID); free of the 
influence of the radiofrequency field, induced in the coil and decaying back to 
equilibrium. If more than one type of magnetic nucleus is present in a sample, each 
type precesses with a different Larmor frequency at any given field strength. The 
detected current will therefore be the sum of the decaying sine waves of all 
magnetically different nuclei, each with a different frequency. 
The FID shows signal intensity (receiver current) as a function of time,f(t). To 
obtain the signal intensity as a function of frequency (and it is the frequency of the 
spins we are interested in) Fourier transformation is performed on the FID to change 
the time domain data into frequency domain data. The method of Fourier 
transformation is shown in equation 9, withf(w) being a function of frequency and 
f(t) a function of time. 
f(w) = Jf(t)e '1 5t 	 (9) 
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A schematic of Fourier transformation of an FID to an NMR spectrum is shown in 
figure 2.8. 
Fourier transform 
Free induction decay (time domain) 
 
NMR spectrum (frequency domain) 
Figure 2.8: Schematic of the Fourier transformation of FIDs (in the time domain) into an NMR 
spectrum (in the frequency domain). Individual signals can then be interpreted. 
The radiofrequency pulse and the receiver have different phases. The FID is a 
mixture of both cosine and sine components of a relaxation. In their pure forms they 
produce absorption and dispersion lines, respectively, following Fourier 
transformation. The spectrum can be manipulated to vary the proportion of cosine 
and sine components by phasing. In this way signals can be converted to a pure 
absorption mode (figure 2.9). 
1 N   
Absorption line 	Dispersion line 
(cosine wave) (sine wave) 
Figure 2.9: A) Absorption and B) dispersion lines. 
2.1.1 Chemical shift 
The resonance frequency of a nucleus not only depends on the external magnetic 
field strength, 130, but also on the chemical environment of that nucleus (its 
surroundings within a molecule). Otherwise all protons, for example, would have the 
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same resonance frequency and be indistinguishable by NMR. Each nucleus 
experiences a slightly different local field, Biocai,  due to this environment: 
	
Biocai = B0 - Bind .. d 	 (10) 
Binduced is a very small induced magnetic field caused by electrons circulating around 
the nucleus (and hence is dependent on electron density), this circulation being 
induced by the external magnetic field. B'nduced  is therefore proportional to the 
external magnetic field and the proportionality constant is termed the 'shielding 
constant', a. 
B induced = a B0 	 (11) 
Hence: 
Biocai = B0 (1_cr) 	 (12) 
Resonance frequency is therefore: 
V = YBiocai = yB0(l—a) 	 (13) 
2.ir 	2r 
-y is the gyromagnetic ratio of the nucleus in question. In order to overcome the field 
strength dependence of the resonance frequency, a ratio (equation 14) with a 
universally accepted standard molecule is used (for protons tetramethylsilane, TMS, 
is the standard). The resulting dimensionless number is now independent of B0 and 
depends only on the site of the nucleus in question in the molecule. 
yB 0 (1 - 
V 	 /2 - 1—a (14) 
VSTD 




The resulting number is almost exactly 1 and, for protons, varies only at the fifth and 
sixth decimal place (i.e. 1 .0000XX where X represents the varying numbers). 
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Convention is to subtract 1, then multiply by 106  to give the 'chemical shift' of a 
nucleus, 8, in parts per million (ppm). 
s=[_x__1J106 	 (15) 
VSTD 
2.1.2 Scalar coupling 
A coupling is an interaction between spins. Scalar coupling, also known as spin-spin 
coupling, refers to through-bond coupling between spins. This interaction between 
two spins, I and S, is mediated by the electrons surrounding the two spins. The 
nuclear spin, I, is coupled via the bonding electrons to the coupled nucleus, S. S 
experiences two slightly different environments (one due to the a state of I and one 
due to the 13  state of I) and resonates at two slightly different frequencies, the 
difference between which is J, the scalar coupling constant. In the same manner, I 
also experiences two environments as a result of coupling with S, and is split by the 
same J coupling. In the absence of spin-coupling, the NMR spectrum is composed of 
two singlets, which appear at two different Larmor frequencies if we assume I and S 
are magnetically inequivalent (figure 2.1OA). When scalar coupled, the resonance 





I 	 S 
Figure 2.10: A) NMR spectrum of nuclei I and S, which are not scalar coupled. B) NMR spectrum of 
nuclei I and S, which are scalar coupled and are therefore both split by a scalar coupling, J 15 , in Hertz. 
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The magnitude of J, which is independent of the applied magnetic field and is 
measured in Hz, depends on the number, and types, of bond through which the nuclei 
are coupled. Scalar coupling can be homonuclear or heteronuclear. Figure 2.11 
shows a diagram of typical magnitudes of XJ1  couplings in peptide chain, where x 
refers to the number of interceding bonds between coupled nuclei I and S. 
Hb 130 
H 	 0 	H'3 aCb 
<1 	
N 	
c 35 N '------' 1 15 Ca '- N 
V NCacN CV 
bNH -95 ..\ 
,Cb 	Ha 	IH 	 a 
Figure 2.11: Typical magnitudes of scalar couplings [368], Xj1 over x bonds between coupled nuclei 
I and S. within part of a peptide chain. All values are in Hertz. 
2.1.3 Relaxation 
As previously stated, after perturbation induced by NMR experiments, the 
magnetisation returns to equilibrium via relaxation pathways. There are two main 
ways by which the relaxation of a signal can occur; (1) longitudinal or 'spin-lattice' 
relaxation, which is caused by interaction with the surrounding environment (lattice) 
and is mostly governed by fluctuating dipole-dipole interactions produced by the 
rotation of molecules in solution, and (2) transverse or 'spin-spin' relaxation, which 
can be thought of as a reduction of measurable coherent signal in the xy-plane. 
2.1.3.1 Longitudinal relaxation time - T 1 
This relaxation time can be defined as the speed at which bulk magnetisation returns 
to equilibrium along the z-axis, following a radiofrequency pulse that moved it to a 
non-equilibrium state (e.g. the xy-plane or —z-axis): 
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Mz is the current magnetisation along the z-axis and M0 is the equilibrium 
magnetisation. A visual representation of this is shown in figure 2.12. 
A) 
B. 
B) C) BJ 
Figure 2.12: Visualisation of longitudinal relaxation process. A) Immediately after a 90'-pulse no bulk 
magnetisation exists along the z-axis, B) after time t some bulk magnetisation, Mz, begins to return to 
the z-axis and C) after time T bulk magnetisation is returned to equilibrium, so M z =M0 . 
Longitudinal relaxation is caused by processes that induce transitions between the 
spin states. During molecular tumbling the individual spins experience a constantly 
changing magnetic field, which is produced by nearby spins as a result of spatial 
anisotropy of the magnetic dipoles and the fact that each dipole does not change its 
orientation with respect to the external magnetic field (at least in the short term). 
When these local magnetic fields fluctuate at a frequency comparable to the 
frequency at which transitions between the spin states occur, energy can be dispersed 
and longitudinal relaxation takes place (i.e. spin transition and therefore population 
changes in the spin states). This process is local and acts on only one spin at a time. 
It follows that this relaxation is closely related to the speed at which the molecules 
are tumbling in solution, the global correlation time, t. 
2.1.3.2 Transverse relaxation time - 
As previously stated, transverse relaxation can be thought of as the reduction in 
measurable coherent signal in the xy-plane after a radiofrequency pulse, a result of 
the fluctuating magnetic fields of nearby spins changing temporarily, slightly altering 
the static magnetic field experienced by individual spins for short periods of time. 
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The transverse relaxation time is related to the magnetisation in the xy-plane by 
equation 17. 
dM = - MXY  (17) 
dt 	T2 
The relaxation mechanism leads to a loss of phase coherence within the net 










Figure 2.13: Visualisation of transverse relaxation process. A) Immediately after a 900  pulse the 
transverse magnetisation is aligned along the y-axis coherently. B) After time t the phase coherence of 
the transverse magnetisation decays - the spins start to spread out away from the y-axis. C) Many 
spins have become dephased in the xy-plane and the transverse magnetisation decays to zero. 
As spins do not change their position with respect to the z-axis during the course of 
transverse magnetisation, no energy is exchanged between the spins and the 
surrounding environment (lattice) in contrast with T 1 relaxation. 
2.1.4 Nuclear Overhauser enhancement 
Structure determination by NIMR spectroscopy relies on various restraints that can be 
derived from the NMR spectra. The most common method of deriving 
conformational information makes use of a phenomenon known as the nuclear 
Overhauser enhancement (NOE) effect, which occurs between dipole-dipole coupled 
spins, i.e. atoms that are in close proximity and therefore have an appreciable dipole-
dipole interaction. These spins are not scalar coupled (no spin-spin coupling). 
The two-spin system considered here is comprised of two spin-Va nuclei; by 
convention these spins are labelled I and S. I is the spin whose resonance is measured 
and S is the spin whose resonance is saturated. It is assumed that both spins are part 
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of a rigid molecule tumbling isotropically and that only dipole-dipole relaxation is 
appreciable. The energy diagram of such a spin system is shown in figure 2.14. 
c 
/ ES  
a/I ..........  . .... ............... ............. ..................WOIS 	______ fla 
Figure 2.14: Energy level diagram of a dipolar coupled two-spin system, IS. Four spin states are 
possible, with the I spin state written first and the S spin state second. Wi,, are the transition 
probabilities between the spin states. 
The W1, terms (where i = 0, 1 or 2 and x = I, S or IS) are described as transition 
probabilities and are, in effect, rate constants for each transition (effectively a 
measure of the "efficiency" of a transition). The W11 and Wis  transitions are single 
quantum transitions, where only the spin of I or S flips respectively. These transitions 
can be directly excited by a radiofrequency pulse and cause directly detectable NIMR 
signals. The other two transitions shown in figure 2.14 involve simultaneous spin 
flips of both spins; these are the double quantum transition (aa+-3I3)  with transition 
probability W2 15 and the zero quantum transition (a —*I3ct)  with transition 
probability W015. These transitions are central to the theory of NOE, as it is these 
'cross-relaxation' pathways that give rise to NOE enhancements by allowing 
saturation of the transitions of spin S to affect the intensity of I. These transitions 
cannot be directly excited by a radiofrequency pulse or cause directly detectable 
NIvIR signals. 
The intensity of I is governed by the population difference between its two spin 
states: a and fl. In figure 2.15 the two-spin system is shown with a total population 
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defined as N. The left hand side shows the system at equilibrium and the right hand 
side shows the system during saturation of the transitions of spin S (achieved by 
applying a weak radiofrequency pulse at the Larmor frequency of spin S), where the 
population difference of spin I over either W 11 transition is ('hN + '/2d) - ('hN—'/2d) = 
d. The saturation of S equalises and maintains the population difference over the Wi5 
transitions. 





+ d aa  
- 
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aa 
Figure 2.15: Two spin system energy levels and transitions at equilibrium (LHS) and during saturation 
of spin S (RHS). The total population is N in both diagrams. 
Following saturation of the transitions of spin S the intensity of dipole-dipole 
coupled spin I changes. This change in intensity, following perturbation of the spin 
system, is the NOE and occurs due to the cross-relaxation pathways, W21s and W 01 , 
which facilitate changes to the populations either side of the transitions and therefore 
the intensity of I. Relaxation via W21s increases the population of the aa state at the 
expense of the 8/i state and relaxation via the W0 15 transition increases the population 
of the 8a state at the expense of the a/i state. These mechanisms and the effects on 
populations are shown in figure 2.16. 
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Figure 2.16: Cross-relaxation pathways and population differences of the dipole-dipole coupled two- 
spin system, IS, after cross-relaxation via one of the pathways. 
So relaxation via the W215 pathway changes the population difference of I over both 
W11 transitions (population differences (N ap— Npp) and (Na,,—Npa)) to ('hN + '/2d) - 
('/4N— '/2d— e) = ('hN + '/2d + e) - ('/4N— '/2d) = d + e, meaning an increase in the 
intensity of I and a positive NOE. The W0i5  transition leads to a drop in intensity of I, 
the population difference incurred from this cross relaxation being d— e. The W215 
cross-relaxation pathway is prominent in small molecules and W01s in large 
molecules. 
The NOE enhancement, defined as fractional change in the intensity of I on 





y is the gyromagntic ratio of the nuclei, crjs is the cross-relaxation rate constant 
(equation 19) and p'  is the dipolar longitudinal relaxation rate constant (or auto-
relaxation rate constant) of spin I (equation 20). 
CIS =W21s - WoJs 	 (19) 
pi = Wojs + 2W1 1 + W21 	 (20) 
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The cross-relaxation constant relates to the rate of magnetisation transfer between 
spins I and S, which produces the observable NOE enhancement of the I signal when 
S is saturated, and is caused by fluctuating dipole-dipole interactions due to 
molecular motion. The extent to which the two spins can interact via their fluctuating 
magnetic fields depends on the distance between the two nuclei and the molecular 
tumbling. The rate of cross-relaxation between two protons can be more formally 
stated as [211]: 
o•1s = 
h 2 1uy4r( 	6 	
—1 
4O,r 2 r1 11+4wz 
(21) 
h is Planck's constant, 1u0 is the permeability of a vacuum, y is the gyromagnetic ratio 
of a proton, -cc is the correlation time of the molecule, coo is the Larmor frequency and 
ris is the internuclear distance. 
It can be seen from equation 21 that the cross-relaxation rate, and hence the NOE 
enhancement, is inversely proportional to the internuclear distance to the power of 
six. The closer in distance, the stronger the NOE enhancement will be; the maximum 
distance of detectable NOE enhancements being approximately 6 A apart. This 
distance related information provides the cornerstone for structure determination by 
NMR spectroscopy. A NOESY (Nuclear Overhauser Effect SpectroscopY) spectrum 
contains cross-peaks arising from NOE enhancements due to cross-relaxation 
between two nuclei. If the chemical shifts of the two nuclei in question are known, 
the two interacting nuclei and the distance between them (from NOE enhancement 
intensity) can be determined. With many such NOE-derived restraints a structure of 
the molecule in question can be generated. 
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2.1.5 NMR experiments - acquiring spectra 
This section is written to describe the basics of an NMR pulse sequence. Due to the 
complexity and diversity of pulse sequences used to acquire different spectra, only a 
simple schematic is presented, with an explanation of the stages involved. 
The general two-dimensional experiment consists of a set of experiments, which 
involves five stages; relaxation, a specific preparation sequence, an incremental 
evolution period (ti), a mixing step and then detection (acquisition) of the resulting 
signals. A basic schematic of a two-dimensional pulse sequence showing these five 
stages is shown in figure 2.17. 
Relaxation 	I 	Preparation  I 	Evolution 	I Mixing 
Time 
V " 	Acquisition 
t2 
Figure 2.17: Schematic of the stages of a basic two-dimensional pulse sequence. 
During the relaxation stage the system is at, or returning to, its equilibrium state. In 
the preparation period, the spin system is prepared for the evolution period in some 
manner. The simplest application during this period is a 7r/2 pulse (a 90 ° pulse 
along the x-axis). An example of a more complicated application is the INEPT 
(insensitive nuclei enhancement by polarisation transfer) pulse sequence, which 
allows transfer of magnetisation containing chemical shift information from protons 
to heteronuclei. Following this, in the evolution period, chemical shifts are allowed 
to evolve for time ti. The mixing period is when the effects of the evolution are 
transferred to the magnetisation that is finally detected. In homonuclear experiments, 
the magnetisation is moved to a new set of protons. In a heteronuclear experiment, 
the magnetisation is moved from carbon or nitrogen to proton in a reverse INEPT 
step. Either scalar interactions or NOE interactions facilitate this transfer, depending 
on the nature of the experiment. Finally, during the acquisition stage, the signals are 
detected by the spectrometer for time t2. This can be done in the presence of a 
CHAPTER 2: THEORY 
	
Eno 
decoupling pulse, where, for example, proton splitting of carbon or nitrogen signals 
(from scalar coupling) can be removed in that dimension. Fourier transform of a 
series of FIDs produces a two-dimensional spectrum. Three- and four-dimensional 
experiments are achieved by including additional evolution and mixing periods into 
pulse sequences. 
2.1.5.1 Water suppression 
Protein samples for NMR are often prepared in aqueous buffers. Water protons are 
present in such a high concentration compared to those of the sample that their signal 
dominates the spectrum (figure 2.18A) and signals of interest are difficult to detect, 
due to the limitations of the analogue-to-digital converter (figure 2.1813). 
 
 
Figure 2.18: A) DAF 23 'H NMR spectrum of a protein sample without water suppression, B) the same 
'H NMR spectrum magnified to show low resolution of signals of interest, C) 'H NMR spectrum of 
same protein sample with water suppression. All other parameters used in both experiments are the 
same. All spectra recorded and processed by this author. 
To avoid this, a water suppression technique is implemented into pulse sequences. 
Figure 2.18C shows the same samples spectrum with such a pulse sequence. The 
WATERGATE [366] technique is a good example of a water suppression technique; 
selective pulses are applied at the water resonance only at appropriate times in the 
sequence, irradiating the water signal. WATERGATE was used for water 
suppression in the majority of experiments in this study. 
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2.2 Residual dipolar couplings and the alignment tensor 
Dipole-dipole interactions, or dipolar couplings, between two nuclei can also be used 
to obtain both local and long range structural information. The magnitude of a 
dipolar coupling depends on the distance between the two interacting nuclei and the 
angle that the internuclear vector between those nuclei forms with the magnetic field, 
amongst other things. This angular dependence of the vector enables the position of 
the two interacting nuclei to be related to an arbitrary molecular coordinate system. 
In the solid state the internuclear vector is fixed in orientation, resulting in many 
strong dipole-dipole interactions. NMR signals are broadened and spectra become so 
complex it is impossible to obtain structural information at high resolution, except 
for very small molecules. In solution, dipole-dipole interactions average to zero as a 
result of the isotropic tumbling of the internuclear vector. It is possible to reintroduce 
dipolar couplings in solution by introducing a small degree of molecular order such 
that the molecule no longer tumbles isotropically. However, in order to acquire 
measurable dipolar couplings in macromolecules, this degree of order must be so 
small that the resultant couplings are scaled down by a factor of approximately 104 - 
105 relative to their static values. This is achieved by aligning only a small fraction of 
the molecules; this fraction is dependent on the both the media and the sample 
conditions. The resultant couplings are called residual dipolar couplings (RDC5). 3 
Some molecules exhibit anisotropic magnetic susceptibility and are aligned solely by 
the magnetic field. Tolman et al. were the first to measure dipole-dipole interactions 
in a macromolecule by studying one such protein [337]. In most cases, however, an 
alignment medium is required. Tjandra and Bax [335] were the first to use an 
alignment medium, a dilute lipid-bicelle system [277], to align a protein resulting in 
measurable RDCs. A variety of alignment media have been documented since then 
(table 2.1). 
A number of detailed reviews can be found in references [13, 27, 254]. 
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Media Reference 
Bicelles with paramagnetic ions  
Improved ether-linked bicelle systems [35, 225] 
Filamentous phage [50, 951 
Cetylpyridinium chloride (CPC1)/hexanol  
Cetylpyridinium bromide (CPBr)/hexanol [11] 
Polyethylene glycol/alkyl alcohol systems [273] 
Strain-induced alignment in strained gels [282, 343] 
Cellulose crystallites [80] 
Table 2.1. Alignment media used to acquire RDCs in proteins. 
In the current work a quasi-ternary surfactant/salt/alcohol system was employed. The 
use of this kind of system was first reported by Prosser et al. [259] in 1998 using 
cetylpyridinium chloride, sodium chloride and hexanol. A lamellar liquid crystalline 
(LLC) Helfrich phase of bilayers is formed. The interlamellar spacing is large 
enough to accommodate proteins molecules of a size suitable for study by NMR. In 
the CPC1/hexanol system stabilisation of the LLC phase requires high salt 
concentrations ( 200 mM NaCl), which can be problematic for protein NMR studies 
due to increased conductivity in the sample. In 2000, Barrientos et al. [111] reported 
an alternative system of cetylpyridinium bromide/sodium bromide/hexanol that is 
most stable at low salt concentrations (j- 25 mM NaBr). This system was used to 
align DAF23 to measure RDCs, due to this stability at low salt concentration, its 
suitable pH range and the possibility of sample recovery after alignment. 
Residual dipolar couplings (through-space couplings) manifest as an additive 
contribution to scalar couplings (through-bond couplings): Jobserved = Jscaiar + D res idual. 
RDCs are calculated by subtraction of Jscaiar  of an unaligned sample spectrum from 
(Jscaiar  + Dresidual) of an aligned sample spectrum. 
The Hamiltonian for an observed dipole-dipole (DD) contribution of coupling for a 
pair of heteronuclear spins I and S is given as: 
HDD = Du /j z sz (3  cos 2e_1)) 	 (22) 
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Where the angular brackets refer to the time or ensemble average, 8 is the angle 
between the internuclear vector of nuclei I and S and the magnetic field, and 	is 
the static dipolar coupling in SI units, which is equal to: 
Djx =-/(h/27r)flys/(47r'r1 ) 	 (23) 
p0 is the magnetic permeability of a vacuum, h is Planck's constant, Ix  is the 
gyromagnetic ratio of spin X and ris is the distance between nuclei I and S. The 
angular part of equation 22 can be expressed as a second rank Legendre function 
P2(x) = /(3x2-1) and the expression for dipolar splitting simplifies to equation 24. 
D's = DISw 	 (24)A\2  
The angle 0 between the internuclear vector and the magnetic field depends on the 
orientation of the internuclear vector with respect to the molecular coordinate system 
(an arbitrary axis of reference) as well as the orientation of the molecular coordinate 
system with respect to the magnetic field. If the molecule is rigid the orientation of 
the internuclear vector can be described by the angles between the vector and the x-, 
y- and z-axes of the coordinate system and the angles between the orientations of 
each of these axes and the static magnetic field. Figure 2.19 demonstrates each of 
these angles. 
B, 
Figure 2.19: Principle axes of the molecular coordinate system (x, y and z) with respect to the 
internuclear vector, IS, and the external magnetic field, B 0. The angles between each are defined. 
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Cosine 0 is the scalar product between the internuclear vector and a unit vector 
parallel to the magnetic field, so P2(cos 0) can be rewritten as: 
(P(cosO)) = f ((cosflcosa + cosflcosa + cosflcosa)2 ) - -- (25) 
It is then possible to simplify this and describe the average molecular orientation 
with respect to the magnetic field (i.e. the molecular coordinate system) by a 3 x 3 
Saupe order matrix, S: 
(P2 (cos9))= I Scosa,cosa3 	 (26) 
,,j={x,yz} 
S 1 = 1 (cos3cos3) 
- -- 
6, and is the Kronecker delta function. This 3 x 3 order 
matrix is traceless, as (COS /3) 2 +(cosfl)2  +(cosfl)2 = 1, and symmetric, as 
(cost), cosfl) = (cosfl cost),), and therefore has only five independent elements. If 
the structure is known the five independent elements of the matrix can generally be 
solved. A principal axis system in which the order matrix is diagonal can always be 
found, giving a molecular alignment tensor with three principle values: and 
where IS''I > JSyy j > IS''I by convention. The expression for the dipolar 
splitting can now be expressed in polar coordinates where 0= a, cos 0 = cosct7, 
cos a, = sin Ocos çb and cos ay  = sin 0sinq5to yield: 
DIs = AX . 	 e 
- 	
+ 'lSjn2 O cos 25] 	 (27) M ZZ 2 
	 2) 2 
0 and 0 are the polar angles defining the orientation of the internuclear vector with 
respect to the principle axis system and i = ($ - Syy)lSzz is the asymmetry parameter 
[13, 254]. S is the generalized order parameter (0 :5 S !~ 1) and has been introduced 
here to account for internal motions independent of the overall molecular tumbling. 
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If the structure of the molecule is known, five independent RDCs are sufficient to 
solve the five independent elements of the order matrix and completely define the 
alignment tensor. For macromolecules, many dipolar coupling are usually measured 
and the elements of the order matrix are best determined using singular value 
decomposition [175, 252]. 
2.2.1 Singular value decomposition 
Singular value decomposition (SVD) requires a set of linear equations of the form 
Ax = b to be solved. A column vector b of n RDC values is equal to matrix A, 
consisting of the direction cosines of the internuclear vectors, multiplied by column 
vector x which contains the five independent elements of the alignment tensor. The 
matrix A and the x and b vectors are defined in equation 28, where 	a1 , i.e. the 
angle the internuclear vector makes with the alignment tensor. 
cos 2  Ø,  
_COS 
2  Ø 	cos 2 
 0 1 —cos 2  q 2sq 	COS  . 2cosØ cosØ S D red 
2 Ø — cos 2 Ø cos 2—cosØcosØcosØ    ØCOS 2coscosØ D  d 2 osØcosØ S 
s xy = 
s xz 
cos 2  Ø —cos 2 q 	cos 2 
 on —cos 2  q 	2cosq$ 	cosØ 2 COS Ø cos 0" 2cosØ) cosØ S,, Dd 
(28) 
Dd is Dduced , which is the residual dipolar coupling divided by the static dipolar 
coupling. To determine the order matrix x, the inverse of matrix A must be found 
since x = A'Ax, so x = A-1 -b. Singular value decomposition is used to compute the 
pseudo inverse of matrix A = U.W.VT where U is an m x  m unitary/orthogonal 
matrix, W is a m x  n matrix with non-negative numbers on the diagonal and zeros on 
the off diagonal and VT  denotes the transpose of V, an n x  n unitary/orthogonal 
matrix. The pseudo inverse is A' = VW*UT where W is the transpose of W with 
every non-zero entry replaced by its reciprocal. 
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Experimental uncertainties are taken into account by solving for a randomly sampled 
Gaussian distribution of values of DduCed about the measured value with a spread 
depending on the estimated error. The distribution of solutions obtained from the 
procedure therefore reflects the degree of uncertainty in the order matrix elements as 
a consequence of errors in the data. 
Using SVD [175], the principle values of the alignment order matrix (eigenvalues) 
can be evaluated numerically and the axis directions (eigenvectors) corresponding to 
each eigenvalue can be plotted using a 'Sanson-Flamsteed projection' (a sinusoidal 




Figure 2.20: The Sanson-Flamsteed projection. The directions of the alignment tensor eigenvectors in 
the arbitrary Cartesian coordinate system can be mapped onto a two-dimensional Sanson-Flamsteed 
projection. The positions of the three dimensional axes x, y and z are highlighted on the projection. 
2.3 Relaxation and dynamics 
The relaxation mechanisms are intrinsically linked to the motion of molecules, as 
previously discussed in section 2.1.3. Therefore, the study of relaxation gives insight 
into dynamics, providing information on both overall molecular motion and internal 
CHAPTER 2: THEORY 
	
091 
mobility. In proteins, measuring 15N 14Iv1R relaxation data for each residue can begin 
to provide this insight. 
2.3.1 15N relaxation data 
The ' 5N T, and T2 relaxation times are most commonly quoted as relaxation rates R, 
and R2 , which are the inverses of T, and T2 respectively. Equations 29 and 30 show 
the relationship of the relaxation rates to the spectral density4, j(CO) [1]. 
R1 = [J(wH - 	 (29) 
    [4J(o)+J(N)]+ 
+R, 
R2 	[4J(o) + 	- N) + 3J(WN)+ 6J(WH)]+  	(30) 
d, defined as d - 	, relates to the dipole-dipole contribution of the 
- 
87r2 r' 
CONAO relaxation and c, defined as c = 	, relates to the chemical shift anisotropy 
(CSA) contribution of relaxation. pij  is the permeability of free space, h is Planck's 
constant, YN,H  are the gyromagnetic ratios of ' 5N and 'H, rNH = 1.02 A is the length of 
the N-H bond, aNand WH are the Larmor frequencies of ' 5N and 'F-I respectively, and 
zlo- = -172 ppm is the CSA of ' 5N (assuming an axially symmetric chemical shift 
tensor). The chemical exchange term, R ex , in equation 30, accounts for contributions 
to R2 from microsecond to millisecond timescale motion. In the case of protein 
motions it refers to intramolecular conformational changes that may be occurring at 
certain residues. 
"Spectral density functions, written J(w), are Fourier transformations of correlation functions 
converting time function into frequency function. Spectral density indicates the power available from 
the lattice(i.e. molecular motions) to bring about relaxation as a function of molecular tumbling rate 
(but it does not tell us how efficiently a given relaxation mechanism can use this power). 
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In addition to the 15N R, and R2 relaxation rates, the heteronuclear steady-state 
[l]5  NOE, can also be used as a measure of backbone dynamics on the 
nanosecond timescale. ['H] ' 5N NOE values reflect mainly the internal dynamics of 
amide N-H vectors. In this heteronuclear two-spin system the proton is saturated and 
the change in ' 5N intensity recorded. The decrease in the NOE between an amide ' 5N 
and it's directly bonded proton, following saturation of the proton, is a result of spin 
relaxation by dipolar coupling [121]. The steady-state NOE enhancement is given 
by: 
= [i— '] 
10 
'1 (31) 
10 is the equilibrium intensity of ' 5N and I is the intensity following saturation of the 
proton. Convention is to state the [ 1 H] 15N NOE as a simple ratio: 
NOE = 1+7= 	 (32) 
10 
The relationship of the heteronuclear NOE to the spectral density is given in equation 
33 [1]. 
NOE =+( d2rH [6J(wH N )J(WH  WN)] 	 (33) 4rR1 
2.3.2 Model-free formalism 
Model-free [163, 164] and 'extended' model-free [44] are methods used to extract 
information on the nature of internal motions of macromolecules in solution from 
relaxation data. The simplest way to describe internal dynamics is to specify a 
time scale and a spatial restriction of each bond vector. Model-free theory states that 
information on fast internal motions (i.e. picosecond to nanosecond) contained in 
relaxation data can be completely described by a generalised order parameter, S, and 
an effective correlation time, z,. The generalised order parameter is a measure of the 
degree of spatial restriction and takes values from 0 to 1 (with 1 being completely 
rigid). The effective correlation time is a measure of the rate of this motion. 
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The spectral density function, which determines the relaxation parameters, is given 
by: 
J(co) = 2f (cos o.t)C(t)dt 	 (34) 
w is Larmor frequency and t is time. C(t) is the correlation function, which describes 
the relaxation due to a dipole-dipole interaction between two nuclei, chemical shift 
anisotropy (CSA) relaxation (in the special case where the relevant tensors are 
axially symmetric), and quadrupolar relaxation. Relaxation due to quadrupolar 
interactions only apply when nuclei of a quadrupolar nature (e.g. deuterium) are 
present, hence in ' 5N- or ' 3C,' 5N-labelled proteins (and in this study) only dipole-
dipole interactions and CSA govern relaxation pathways. 
The total correlation function C(t) describes both the overall and internal motions, 
Co(t) and CI(t) respectively, and is set as: 
C(t) = Co(t)Cj(t) 
	
(35) 
The simplest approximation of the correlation function for internal motion is given 
by: 
C(t)=S2+(1 S)e-the 	 (36) 
A denotes an approximation. At time cx, all possible motions have occurred and all 
spatial positions occupied, so CI(t) can be equated with the general order parameter. 
The effective correlation time, t, ensures the integrals of C1(t) and C (t) are equal. 
S2 and te are defined in equations 37 and 38. 




=(1_S2)_f(C1(t)_S2)dt 	 (38) 
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For overall isotropic motion, the overall correlation function can be described as an 
exponential, dependent on time, t, and the macromolecular correlation time, Tm 
(equation 39). 
Co(t) = -- e" 	 (39) 
In the general case of overall anisotropic motion, the overall correlation function 
becomes complicated [360]: 
Co(t) = A je" + A2e + A3e' + A4e' + A5e' 	 (40) 
with A1 = 6m 2 n2 , A2 = 612 n2 , A3 = 612m', A4 = d - e and A 5 = d + e, where d = [3(l 4 + 
m 4 + n4) - 1J12, e = [8(31 + 6m2n2 - 1) + 8(3m4 + 612n2 - 1) + 8(3n4 + 612m2 - 1)J16 
and 8, = (D, - D)/(D2 - L 2) Y- . D is defined as '/3 the trace of the diffusion tensor, D = 
+ D + D), and L 2 = '/3(DXDY + DD + DYDZ). The time constants are defined 
asTI=(4D+D+D)', 
+ (D2 	 Z5  L 2) ")J' and V5 = [6(D - (D2- L)'12)]-'. 1, m and n are the direction cosines of 
the NH bond vector with respect to the diffusion axes x, y and z respectively. 
The spectral density becomes: 
J(a=
A1r1 
2] 	 (41) 
The five different correlation times, zj and coefficients, A, are defined above. When 
the overall motion is isotropic only A1 and rj apply (D = D = = D 0). When it is 
axially symmetric r1- T3 and A 1-A 3 apply (Dx = D) and when it's fully asymmetric all 
five correlation times and coefficients apply. 
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For the case of axially symmetric anisotropic diffusion, D D = D 1 and Dz = D11 
(D1 is Dperpendicular and Djj is Dparaiiei),  so equation 40 simplifies to: 
	
Co(t) = A JeT1 + A 2e' + A '3e 	 (42) 
A = (% 	, 	 4 cos  - osA 2 = 3(sin a)(ca), A  = Xsin  a, where a is the angle 
between the bond vector and the z-axis. The time constants become r'1 = (6D 1)', 
= (D11 + 5D j_) - ', r'3 = (4D11 + 2D J' 
In some cases the internal correlation function of a bond vector cannot be 
approximated by a single order parameter, but is better characterised by two order 
parameters Sj and S, which correspond to fast (ps-ns) and slow (ns <Tm) internal 
motions, respectively. This is the 'extended model-free approach' as described by 
Clore et al. [44]. Assuming the fast and slow motion correlation times are 
sufficiently different, the total general order parameter can be described as: 
S 2 =SS 
	
(43) 
The correlation time for very fast internal motions makes no significant contribution 
to NMR relaxation parameters, but the order parameter, Sf, does. Where motion 
exists on two timescales, as in the case of model 5 that includes two parameters S 
and S 2 , a simple motional model that can be used to visualise the meaning of these 
two parameters is diffusion within a cone for S? (fast ns motion) and a two-site jump 
model for S 2 (slow ns motion) [44]. Figure 2.21 illustrates this. 







Figure 2.21: Diffusion in cone and two-site jump models. The cone model for S f 2 gives S f = 
Y 2(cosO)(1+cos9) where e is the semi-angle of the cone about the average NH bind vector. The two- 
site jump model for S 2 gives S 2 = ( 1+3cos24))/4 where 4) is the angle between NH bond vectors for H 
at site 1 and site 2. 
When fitting R 2, a phenomenological exchange term Rex may be required to account 
for chemical exchange processes that may contribute to the decay of transverse 
magnetisation during the experiment used to measure R2 [19, 355]. 
For model-free formalism to provide meaningful results, the internal motions must 
be sufficiently faster than the overall motion and lie in the extreme narrowing limit 
(i << Vm). In the case of internal and overall motions being comparable, model-free 
is unable to separate the two and fails to provide a valid description of these motions 
[163, 164]. 
Chapter 3 
MATERIALS AND METHODS 
3.1 Protein Samples 
Samples of DAF were made by, and received from, Dr. Feng Lin 5 . Protein had been 
expressed in Pichia pastoris with a C-terminal hexa-His tag (which was not 
cleavable and remained) as described by Lin etal. [157]. ' 5N- and 13 C, 15N-labelled 
protein were produced by culturing DAF-transformed cells in minimal medium 
containing 0.2% (w/v) (' 5NH4)2 SO4 and 0.1% (w/v) ' 3 C-glucose (for ' 3C,' 5N 
labelling only), then induced in minimal medium containing 0.2% (w/v) ( 15NH4)2SO4 
and 0.5% (v/v) ' 3 C-methanol (for 13 C, 15N labelling only) for three days. Purification 
was by Ni2taffinity chromatography. Finally, samples were dialyzed into phosphate 
buffered saline (PBS, at pH 7) and concentrated. 
3.1.1 Protein samples for purification 
DAF 1 2 and DAF234 samples received from Dr. Lin that required further purification 
are shown in table 3.1. The only purification step carried out by Dr. Lin was a nickel-
affinity chromatography column. All DAF12 and DAF 234 samples were received in 
PBS at approximately pH 7. 
Department of Pathology, Case Western Reserve University, 2085 Adelbert Road #301, Cleaveland, 
Ohio, 44106, U.S.A. 
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Sample Labelling Approximate amount Date received 
DAF 12  1.5 mg 30/01/03 
DAF 1 2 None 2.5 mg 03/04/03 
DAF12 ' 5N,' 3C 0.5 mg 03/04/03 
DAF 12 None 3 mg 11/66/03 
DAF234 None 3.5 mg 03/04/03 
DAF234 ' 5N 3 mg 29/08/03 
DAF234  15N 5 mg 20/11/04 
Table 3.1: DAF 12 and DAF234 samples requiring further purification, their approximate amounts and 
dates they were received. 
3.1.2 Sample preparation 
3.1.2.1 Buffer exchange and sample concentration 
All buffer exchanges and concentration of protein samples (unlabelled, ' 5N-labelled 
and 13 C, ' 5N-labelled samples) were achieved using 5-ml Vivaspin concentrators 
(VIVASCIENCE) with a 5000 Da molecular weight cut off (MWCO) (occasionally 
10000 Da MWCO tubes were used). The concentrator membranes contain glycerol; 
this had to be washed out before use as glycerol NMR signals dominate spectra 
otherwise. In order to remove glycerol the concentrators were soaked, upside down, 
in double-distilled water for at least 24 hours, then rinsed through (via centrifugation) 
with at least three times concentrator-tube volume (5 ml) of double-distilled water in 
a Sorvall Legend RT centrifuge at 4000 g. 
Buffer exchange involved centrifugation of the sample to yield a suitable volume 
(depending on the concentration of the sample in question), then repeatedly filling 
the concentrator with the new buffer and centrifuging again to re-arrive at that 
volume. At least three repetitions were carried out, and in most cases five repetitions 
were used. 
3.1.2.2 NMR sample preparation 
For low amounts of sample Shigemi tubes (which allow a sample volume of 
approximately 350 il compared to the normal volume of 550 .tl) were used in order 
to maximise the protein concentration and hence the signal-to-noise of NMR spectra. 
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This was the case for DAF12 ( 15N-labelled) and DAF 12 (' 5N, 13 C-labelled). All except 
the first sample were buffer-exchanged into fresh PBS buffer in order to remove any 
small molecular weight impurities. 
To all samples (DAF23, DAF234 and DAF 12 samples) the following was added: 
• sodium azide (NaN3) to 0-01%  (wlv) 
• deuterated EDTA (Sigma) to 0.01 M 
• 1 p.1 P8215 Protease Inhibitor Cocktail (Sigma) 
• D20 to 10% (v/v) 
Sodium azide stops bacterial growth, EDTA complexes unwanted metal ions that 
may be present. Protease Inhibitor Cocktail is a mixture of protease inhibitors with a 
broad specificity for the inhibition of serine, cysteine, aspartic acid and metallo-
proteases. 10% (v/v) D 20 is required in order for the NMR spectrometers to be able 
to 'lock' the sample. 'Locking' involves the use of a reference NMR signal to 
maintain the necessary stability of the magnetic field, 130. Signal frequencies must 
remain constant for the duration of the experiment, which may be many hours. 
However, even with the most stable superconducting magnets, the magnetic field 
will change with time (due to small but significant factors such as electrical 
resistance in the solenoid, the temperature of the room or movement of metal objects 
near the magnet). The lock circuit compensates for these small changes using an 
NMR signal as a reference control circuit, in what is essentially a second continuous 
and automatic NMR experiment, detecting and compensating for drift in field. The 
reference nucleus is usually deuterium, as used in the current study. 
3.1.2.3 Liquid crystal media preparation 
The acquisition of residual dipolar couplings in NIvIR spectroscopy requires a weakly 
aligned sample. The media chosen to be most suitable and feasible given the 
facilities available, was the liquid crystal alignment medium based on a quasi-ternary 
surfactant system comprising of cetylpyridinium bromide (CPBr)Ihexanol and 
sodium bromide. Amphiphilic aggregates form a network of elongated wormlike 
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structures, which are suited for the molecular alignment of biomolecules. A suitable 
ratio of CPBr to hexanol for formation of the liquid crystals is 1:1.33 (wlw) [11]; 
concentration of between 4-6% (v/v) liquid crystal co-solvent is normal for the weak 
alignment required. The final co-solvent concentration often depends on the sample 
itself. A stock solution of 6.5% (v/v) of CPBr/hexanol (1:1.33 w/w) was prepared 
and diluted to a suitable concentration when required. 
A 1 .5-ml stock solution of 6.5% CPBr/hexanol (1:1.33 w/w) consisted of: 
• 0.0418 g cetylpyridinium bromide 
• 68 tiofhexanol 
.• 150 jil of 250 mM deuterated sodium bromide 'solution 
• 1102 .tl of 50 mM sodium acetate (0) buffer (pH 5.0) 
• 180t1ofD20 
Following addition to a 1.5-ml Eppendorf tube, theingredients were mixed until 
dissolved. Contents were heated on a 70 °C heating block for approximately 15 
minutes. Following this, the contents of the tube were centrifuged at 4000 g for 
approximately 2 minutes, or until clearance occurred. At this point the cosoivent 
appeared to have a bluish tinge. 
3.1.2.4 Liquid chromatography - electrospray ionisation - mass 
spectrometry (LC-ESI-MS) sample preparation 
LC-ESI-MS samples were made to approximately 20 jiM protein concentration in 
100 p1, and placed in glass mass spectrometry tubes in a 0.2 ml glass insert with 
Kim-Springs (legs used to hold the glass insert in place in the MS tube for sampling). 
Samples were salt-free. The LC system used was a Waters Alliance 2790 with a 
Jupiter C5 column. Column temperature was 25 °C. A gradient elution was 
employed; buffer A was water with 0.05% (w/w) formic acid and buffer B was 
acetonitrile with 0.05% (w/w) formic acid. Table 3.2 shows the gradient employed. 
Flow rate was 0.2 ml min- . 
Table 3.2: Gradient used for LC step of LC-MS. Flow rate of 0.2 ml min'. 
Time (mins) Buffer A % Buffer B % 
0.0 95 5 
5.0 95 5 
10.0 5 95 
12.0 5 95 
17.0 95 5 
19.0 95 5 
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The MS mlz mass range was 150 Da to 2,500 Da/charge and the cone voltage was 50 
V. 
3.1.2.5 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
In order to prepare a protein sample for SDS-PAGE, the following was added to a 
1.5-ml Eppendorf tube, mixed then heated on a 70 °C heating block for 2 minutes: 
5 p.1 of protein sample (protein concentrations varied from 0.09 mM to 0.33 mM) 
20 p.1 lx Laemmli (loading) buffer (New England Biolabs - 10 ml of 3x stock 
composition: 2.4 ml 1 M Tris-Cl pH 6.8, 3 ml 20% (w/v) SDS, 3 ml 100% 
glycerol, 1.6 ml -mercaptoethanol, 0.006 g Bromophenol blue) 
Protein separation was achieved using Bio-Rad Ready Gels (10 - 20% 
polyacrylamide-co-methylene-bis-acrylamide Tris-HC1 gel). Pre-stained, broad range 
protein molecular weight markers (New England Biolabs) were used to calibrate 
gels. Running buffer was made from a stock solution (1 Ox stock composition: 30.3 g 
Tris-base, 144 g glycine, 10 g SDS, made up to 1 litre with distilled water). To each 
well of the gel, 20 p.1 of protein molecular weight marker or sample plus loading 
buffer was dispensed. Gels were run at 200 V for 50 minutes on a Bio-Rad PowerPac 
1000. Staining was carried out using EZB1ueTM Coomassie Brilliant Blue G-250 gel 
staining reagent from Sigma. 
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3.2 Protein purification by ion exchange chromatography 
In this study liquid chromatography protein purification techniques were employed 
in an attempt to further purif' the available DAF 234 and DAF 12 samples; these were 
two different ion exchange techniques. 
Ion exchange chromatography separates biomolecules based on differences in their 
anionic or cationic charge characteristics. The choice of cationic or anionic exchange 
depends on the pH-stability of the sample. If the sample is stable on both sides of its 
p1, either method may be used. If it is only stable below its p1, a cation exchanger 
should be selected, whereas if it is more stable at higher pH, an anion exchanger is 
preferred. There are choices of 'weak' or 'strong' ion-exchange systems; this 
terminology refers to the extent of ionisation, not the strength of binding. Suiphonic 
groups and quartemary amines form strong ion exchangers (completely ionised over 
the pH range), all others are weak ion exchangers. 
This study used strong cation-exchange systems. Beginning with a strong ion 
exchanger enables development work to be performed over a broad pH range if 
required. Cation exchangers were used because modules of DAF are stable below 
their p1 values (DAF 12 and DAF234 theoretical p1 values are 5.85 and 6.77 
respectively, as calculated using the ProtParam tool at www.expasy.ch ). The first 
method of cation exchange chromatography to be explored was an SP Sepharose 
(Amersham Bioscience) column and a simple step-gradient method. SP Sepharose 
consists of macroporous, beaded, cross-linked agarose to which suiphonate groups (-
CH2S03) are attached, and is supplied in a suspension of 20% ethanol. After pouring 
approximately 2 ml of this slurry into an empty 10-ml Biorad plastic column, ten 
column volumes of starting buffer (50 mM sodium acetate buffer, pH 5, 1 mM 
NaN3) were flushed through the bed to remove ethanol. The DAF 234 sample, at a 
concentration of approximately 1 mg ml -1 (approximately 90 pM), was then added in 
2 ml of the same buffer, following which five column volumes of starting buffer 
were allowed to drain through the column under gravity and were subsequently 
collected in five aliquots of 10 ml. Five column volumes of the same buffer, but 
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containing 1 M sodium chloride, was then drained through the column under gravity 
and again collected in five aliquots of 10 ml. 
Purification using the SP Sepharose column was attempted with one, unlabelled, 
DAF234 sample. Some degree of purification was achieved, however this was not 
sufficient (see Chapter 7). A logical next step was to employ cation exchange but 
using a gradient elution. This involved an FPLC system with a MonoS column 
(model FIR 5/5, bed volume of 1 ml, Amersham Bioscience). The FPLC system used 
was a BioCAD 700E Perfusion Chromatography Workstation. MonoS is a strong 
cation exchanger composed of MonoBeads - a beaded hydrophilic polymer to which 
suiphonate groups are attached. The gradient employed for elution was created from 
50 mM sodium acetate buffer at pH 5 (buffer A) and 50 mM sodium acetate buffer at 
pH 5 containing 1 M sodium chloride (buffer B). The gradient used is shown in table 
3.3. Experiments were run at 25 °C, flow rate was 1 ml minute t , UV absorbance was 
monitored at 280 nm and 254 nm and 1 ml fractions were collected every minute. 
Buffers were filtered under suction through filter paper over a scinter-glass funnel, 
before application to columns. 
Volume of buffer (ml) % Buffer A % Buffer B 
0 100 0 
10 100 0 
45 0 100 
50 0 100 
50 100 0 
60 100 0 
Table 3.3: FPLC gradient employed for DAF 12 and DAF 234 purification. 
3.3 Chemical shift assignment of protein NMR spectra 
The term "assignment" in NMR refers to the process whereby each nucleus is 
assigned a chemical shift. Quite often, complete assignment cannot be achieved; 
however near-complete assignment often suffices for structural determination using 
NIMR data. Cross-peaks in multidimensional NUR spectra represent interactions 
between nuclei within the system under observation; the nuclei in question depend 
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on the NMR experiment. Each contributor is identified during the assignment 
process. Assignment is performed stepwise, using a set of multiple multidimensional 
NMR experiments, which are employed in a complementary fashion. 
Assignment is very difficult for large, unlabelled proteins that are not enriched with 
nitrogen-15 ( 15N) or carbon-13 ( 13C) (NMIR active isotopes). This is due to overlap 
and ambiguity of cross-peaks since only two dimensions, both proton, are normally 
accessible. Labelling proteins with ' 5N or both ' 5N and 13 C facilitates dispersion of 
cross-peaks in further dimensions thus creating extra frequency space. Furthermore, 
isotopic enrichment opens up the possibility of extra through-bond experiments that 
improve the speed and reliability of the assignment process. 
Experiments that were used for assignment are shown in table 3.4. 
Experiment Labelling required Experiment type 
'H-' 5N-HSQC 15N Through-bond 
CBCA(CO)NT-I 15N, 13 C Through-bond 
HNCACB ' 5N, ' 3C Through-bond 
HBHA(CO)NI-I 15N, 13C Through-bond 
HBHANH ' 5N, 13C Through-bond 
HNCO ' 5N, ' 3C Through-bond 
HN(CA)CO ' 5N, 13C Through-bond 
H(C)(CO)NH-TOCSY ' 5N, ' 3C Through-bond 
(H)C(CO)NH-TOCSY 15N, 13C Through-bond 
HCCH-TOCSY 15N, 13C Through-bond 
(HB)CB(CGCD)HD 13 C Through-bond 
(I-IB)CB(CGCDCE)HE 13C Through-bond 
Aromatic 'H-' 3 C-HSQC-TROSY ' 3C Through-bond 
'H- 15N-HSQC-NOESY ' 5N Through-space 
'H-' 3C-HSQC-NOESY ' 5N, 13C Through-space 
Table 3.4: NMR experiments employed in the assignment process. 
3.3.1 Basic NMR experiments 
3.3.1.1 Heteronuclear Single Quantum Coherence, HSQC 
In this experiment magnetisation, is transferred between covalently bonded 
heteronuclei, one of which is a proton. Magnetisation originates on the protons and is 
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transferred to the heavy atom where it is chemical-shift labelled by that heavy atom. 
This is because protons have a relatively high gyromagnetic ratio (26.75 x 107 rad T' 
S- ) compared to that of 13C or 'N (6.73 x 107  and -2.71 x 107  red T' s' 
respectively), meaning a larger proportion of protons contribute to net magnetisation 
compared to 13C or 15N. Following this the magnetisation is transferred back to the 
proton by a reverse INEPT step, for proton chemical-shift labelling and detection. 
The resulting two-dimensional spectrum correlates the 'H chemical shift to the 
chemical shift of the 15N or 13C to which it is attached. Figure 3.1 represents a 1 H-
15N-HSQC. For assignment of 15N-labelled proteins, the 'H-' 5N-HSQC is a 
fundamental starting point. Most residues will have a cross-peak corresponding to 
their backbone amide nitrogen and attached proton. Proline residues do not provide 
cross-peaks due to their lack of an amide proton. Any side-chain N-H groups will 
also produce cross-peaks. 
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Figure 3.1: Representation of a 'H-' 5N-HSQC. Each red dot (a cross-peak) represents an amide proton 
at its appropriate correlated proton and nitrogen chemical shift. F2 is the amide proton dimension. Fl 
is the indirectly detected second dimension; the nitrogen dimensioti 
3.3.1.2 TOtal Correlation SpectroscopY (TOCSY) 
TOCSY experiments allow magnetisation transfer to occur over up to five or six 
bonds, mediated by scalar interactions. This is done by a 'spin-lock' pulse sequence; 
magnetisation is brought down into the xy-plane by a 7r/2 pulse, then a new B, field 
is applied along the y-axis. The magnetisation becomes 'spin-locked' along the y-
axis and precesses around it at a frequency dependent on the B, field. During this 
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evolution time all coupled spins will have the same precession frequency, so they 
will be strongly coupled; the chemical shift difference will be much smaller than the 
scalar coupling between them and their transitions will be thoroughly mixed. The y-
axis B 1 field is removed and magnetisation returns to its familiar chemical shift, but 
will be labelled with the precession frequencies of all other spins in the same, 
connected spin system. In the spectrum generated, cross-peaks should be seen 
between all spins in a connected system. Further explanations of TOCSY 
experiments used in this study are discussed in subsequent sections. 
3.3.1.3 Nuclear Overhauser Enhancement SpectroscopY (NOESY) 
NOESY experiments perturb the system to promote cross-relaxation due to NOE 
enhancement between pairs of nuclei in close proximity (see section 2.1.3). A two-
dimensional 'H-'H-NOESY correlates protons close in space. With a ' 5N labelled 
protein, another dimension can be added; amide protons (dimension 1) at their 
attached ' 5N chemical shift (dimension 2) can be correlated to other protons 
(dimension 3) close in space. With 13 C, 15N-labelled proteins any carbon-attached 
proton (dimension 1) at its attached 13 C chemical shift (dimension 2) can be 
correlated to protons (dimension 3) close in space. 
3.3.2 13C,15N experiments 
Ideally a protein should be double labelled for NMR assignment and structure 
determination. Labelling with 15N allows one other dimension of chemical shift 
dispersion, which significantly reduces overlap and ambiguities. For a more 
complete and reliable assignment, labelling with ' 3C allows yet another dimension of 
chemical shift dispersion to be utilised and assignment becomes greatly simplified by 
the introduction of this extra dimension. 
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3.3.3 Backbone assignments with 13C, 15N spectra 
Backbone assignments using ' 3C,' 5N-labelled protein are achieved using pairs of 
complimentary experiments. In each of the experiments the first two dimensions are 
proton and nitrogen frequencies. The third dimension is 13 C, 'H or carbonyl 13C, 
13C0. In the resulting three-dimensional spectra, the third dimension is being added 
onto the two-dimensional 'H-' 5N-HSQC at right angles to the HSQC plane. This can 
be visualised as a three-dimensional cube and is represented below in figure 3.2. 
Each amide nitrogen and proton cross-peak seen in the 'H-' 5N-HSQC then has a 
'strip' of cross-peaks extending from that position in the third dimension, with each 
cross-peak in that strip correlated to the amide group ('strips' shown in blue in 
figure). When viewed from the top the stacked planes appear as the two-dimensional 
'H-' 5N-HSQC. The first of the pair of complimentary experiments correlates the 
specified ' 3 C, 'H or ' 3 C0 of the preceding (i-i) residue with the amide nitrogen and 
proton shift of the (i) residue. The second of the two experiments correlates the 
specified 13 C, 'H or 13 CO of both that residue (i) and of the preceding residue (i-i) 
with the amide group of residue (i). This allows sequential assignment, as will be 
further explained for each experiment type. 
3.3.3.1 HNCACB and CBCA(CO)NH experiments 
Here the third dimension is a ' 3C dimension. In the HNCACB experiment the 
chemical shifts of each amide group are correlated with the C a and Co chemical 
shifts of their own side-chain plus those of the preceding residue. So each "strip" 
(apart from that of glycine or a residue following a glycine or a proline) should 
contain four cross-peaks. In the CBCA(CO)NH experiment, the amide group 
chemical shifts are correlated with the Ca and Cp chemical shifts of the preceding 
residue only, so this "strip" should, in non-glycine residues, have two cross-peaks. A 
representation of this spectrum is shown in figure 3.2. 
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Figure 3.2: Representation of a CBCA(CO)NH three-dimensional spectrum. The stacked 15N -'H 
planes (at different indirectly detected 13C frequencies) viewed from the top appear as the two- 
dimensional 'H' 5N-HSQC, shown in red. An extracted 'HN- 13C plane is shown with three 'strips'. 
The Ca and Cp carbons from the proceeding residue give cross-peaks (shown in blue). 
The magnetisation transfer for each experiment is shown in figure 3.3A. When these 
two spectra are overlaid on each other, two peaks of the CBCA(CO)NH will coincide 
with two of the four peaks from the FINCACB. This exercise will show which Ca 
and Cp cross-peaks belong to the preceding residue (i-I); the Ca and C, cross-peaks 
of residue (i) in the I-INCACB can then be matched to appropriate cross-peaks in 
CBCA(CO)NH at another amide group shift. This is the next residue (i+l) in the 
chain. Figure 3.313 shows a representation of this. 
3.3.3.2 HBHANH and HBHA(CO)NH experiments 
These experiments are analogous to HNCACB and CBCA(CO)NH except the third 
dimension is a 'H dimension (indirectly detected) and cross-peaks occur at Ha and 
HD chemical shifts. Magnetisation starts on Ha and Hp protons, migrates to the 
attached carbon atoms and then continues on, as in the carbon experiments, to the 
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Figure 3.3: A) Magnetisation transfer pathways of CBCA(CO)NH and HNCACB experiments and B) 
a representation of the strips from each experiment at an amide group (i). 
Figure 3.4: A)Magnetisation transfer pathways of I-IBHA(CO)NH and HBHANH experiments and B) 
a representation of the 'strips' from each experiment at an amide group (i). 
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3.3.3.3 HNCO and HN(CA)CO experiments 
In these experiments the third dimension is carbonyl ' 3C. HNCO correlates the 
carbonyl 13 C chemical shift of a residue with the amide group of the preceding amide 
group. HIN(CA)CO correlates the amide group with the carbonyl carbon chemical 
shifts of the current residue and of the preceding residue. The magnetisation transfers 
and strips from the spectra are shown in figure 3.5. 
A) 	 B) 
	








Figure 3.5: A) Magnetisation transfer pathways of HNCO and HN(CA)CO experiments. B) 
Representation of strips' from each experiment showing each carbonyl carbon, C', at amide group (i). 
The experiments described in sections 3.3.3.1 to 3.3.3.3 can be used to sequentially 
assign the entire backbone of a protein. 
3.3.4 Side-chain assignment in 13C, 15N proteins 
Most side-chain assignments are found using three TOCSY experiments: 
(H)C(CO)NH-TOCSY 
• H(C) (CO)NH-TOCSY 
• HCCH-TOCSY 
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Each of these experiments contains a TOCSY mixing period in the pulse sequence. 
In (H)C(CO)NH-TOCSY the magnetisation starts on, and labels, the side-chain 
carbon atoms, moves through the carbonyl carbon and then onto the amide group of 
the next residue. In the H(C)(CO)NH-TOCSY experiment the magnetisation starts on 
and labels the side-chain protons, moves to the carbon atoms to which they are bound 
and continues as in the (H)C(CO)NH-TOCSY experiment. Again, these spectra may 
be broken into 'strips' in which these side-chain carbon and proton chemical shifts, 
respectively, are dispersed. A third dimension is, again, effectively being added onto 
the two-dimensional 'H- 15N-HSQC at right angles to the 'H- 15N-HSQC plane. A 
visual representation of an H(C)(CO)NH-TOCSY spectrum is shown in figure 3.6. 
'H 




Fire 3.6: Representation of a three-dimensional H(CXCO)NH-TOCSY spectrum. The stacked N - 
H planes (at different indirectly detected 'H frequencies) viewed from the top appear as the two- 
dimensional 'H-''N-HSQC spectrum, shown in red. An extracted 'H N-'H plane is shown with three 
'strips'. The side-chain protons from the preceeding residue give cross-peaks (shown in blue). 
The HCCH-TOCSY experiment differs from the above two experiments. It transfers 
magnetisation from protons to their attached carbons, on to other carbons in a 
TOCSY mixing period, and then back to proton. This experiment is not dependent 
on proximity of carbon atoms in that spin system to an amide group, hence valuable 
information is contained within the HCCH-TOCSY spectrum, allowing assignments 
for side-chain protons that can be hard to detect using other methods. As H, Hp, C 
and Cp chemical shifts (or at least some of this information) should be known for 
most residues from the backbone assignments, cross-peaks at these chemical shifts 
can be found within the HCCH-TOCSY. These cross-peaks can be used to proceed 
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stepwise, moving from a correlated proton chemical shift (for example a H 7 proton 
chemical shift correlated to a I-Ia proton chemical shift at the Cp chemical shift) to its 
attached carbon chemical shift (in this example, the C 7 chemical shift) by finding a 
symmetry related cross-peak (which will be a Hp proton correlated to H 7 chemical 
shift at the C7  chemical shift in the given example), and then from here to any further 
attached carbons. Visual representation of this is shown in figure 3.7. Symmetry 
related cross-peaks are located by moving through the carbon dimension (viewing 
two-dimensional 'H- 1 H planes at different carbon frequencies) to find a cross-peak at 
the symmetrical position, where the line of symmetry is the diagonal of the 1 H-'H 
plane. 





Figure 3.7: Representation of a three-dimensional HCCH-TOCSY spectrum. A) The HCCH-TOCSY 
with two example 'H-'H planes shown, one at the Cp frequency of a residue (plane 1) and one at the 
C. frequency of the same residue (plane 2). B) The two-dimensional 'H-'H plane at the Cp frequency 
(plane 1) with H 1 and H 2  shown on the diagonal at each corresponding frequency and the protons 
coupled to each (only the other H p proton and the I4 proton are shown here). C) The two-dimensional 
'H- 1 H plane at the C 7  frequency (plane 2) and correlated protons at the I-1 frequency. 
3.3.5 Aromatic assignment in 13C, 15N proteins 
Protons and carbons on the rings of histidine, phenylalanine, tyrosine and tryptophan 
residues are often very difficult to detect in the experiments discussed previously. 
Some specialised experiments have been designed to help assign these. These 
experiments are (HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE; two-dimensional 
experiments that correlate the Cp chemical shift of a residue with the HE or HE of its 
side-chain. Magnetisation is transferred from the Hp protons to their carbons and then 
on through the neighbouring carbons in the aromatic rings, then selectively 
transferred onto either Hs or H € ring protons. Providing the Cp chemical shift is 
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known for the residue in question, it should be possible to assign H 8 and H. Low 
dispersion of Cp chemical shifts can however provide problems, as can overlap in the 
proton dimension. 
An additional experiment that can also help is the aromatic 1 H-' 3 C-HSQC-TROSY. 
This correlates aromatic carbon shifts with their attached aromatic proton shifts. 
There are some characteristic regions, which aid in deciphering which protons are 
which. 
3.3.6 Assigning NOESY spectra 
With only a ' 5N-labelled sample, the 1 H- 15N-HSQC-NOESY becomes important for 
backbone assignment. However, because NOESY cross-peaks are produced by 
through-space interactions a significant number will be inter-residue cross-peaks and 
hence it would be preferable not to use NOESY spectra in chemical shift assignment 
of nuclei. With 13C, ' 5N-labelled samples, the use of NOESY spectra (both 'H-' 5N-
HSQC and 'H-' 3 C-HSQC) is unnecessary for the majority of chemical shift 
assignment. Using the experiments described in previous paragraphs assignment can 
be completed with a high degree of confidence prior to assignment of NOESY 
spectra. 
The NOESY spectra provide the basis for structure calculations. A 1 H- 13C-HSQC-
NOESY experiment correlates the shift of each carbon atom with those of attached 
proton atoms and, in the third dimension, to any proton less than 6 A away. It is these 
NOESY cross-peaks (or rather their assignments and intensities) that form the basis 
for calculating structure. Following chemical shift assignment, assignment of the 1 H-
' 5N-HSQC-NOESY and the 'H-' 3C-HSQC-NOESY spectra for structural purposes 
can begin. Note that assigning NOESY spectra of a double-labelled sample can 
confirm existing chemical shift assignments, may provide some missing assignments 
and resolve some ambiguously assigned nuclei. 
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NOESY cross-peaks can only be confidently assigned unambiguously by locating a 
symmetry-related cross-peak, i.e. the corresponding NOESY cross-peak from the 
interacting proton and its attached carbon. Cross-peaks that cannot be assigned 
exclusively to one NOE interaction are assigned only in their carbon and attached 
proton dimensions, and left unassigned in the indirect proton dimension (the 
dimension in which the chemical shift of the second contributors to the NOE 
interactions are detected). These are still useful in the structure calculation (see 
below). 
Another useful experiment is a 'H-' 3 C-HSQC-NOESY acquired where the protein is 
dissolved in a 100% D20 buffer. A proportion of the H a chemical shifts are normally 
located under the broad water signal in the H20 spectrum and their NOESY cross-
peaks are lost when water suppression is applied. By exchange of the H 20 buffer for 
an analogous D 20 buffer, the troublesome water peak is mostly avoided. When H 20 
is removed from the system the NOESY cross-peaks of the hidden H a protons are 
revealed and can be assigned. In addition to this, without the dominating water 
signal, the receiver coil of the spectrometer is able to detect weaker signals. This 
allows more NOEs to be assigned and hence more restraints to be used in structure 
calculations. 
3.4 NMR spectrometers 
Varian or Bruker 600 and 800 MHz spectrometers were used to acquire the spectra. 
All spectra of DAF23 , except for a newly acquired 'H- 13C-HSQC-NOESY, three two-
dimensional aromatic experiments and experiments used to acquire residual dipolar 
couplings, were acquired previously by Dr. Stanislava Uhrinova. The new 
HSQC-NOESY was acquired by this author using a Bruker Avarice 800 MHz 
spectrometer. The aromatic and RDC experiments were acquired by this author using 
a Bruker Avarice 600 MHz spectrometer with a cryoprobe. 
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3.5 NMR data processing and viewing 
3.5.1 AZARA, ANSIG and FELIX 
AZARA and FELIX are both software programs for off-line NMR data processing 
and spectral visualisation. Time-domain data is transformed to the frequency domain 
using mathematical algorithms. The advantages of FELIX are that data can be 
directly read from the spectrometer and the application of algorithms can be carried 
out within the program, with visualisation of the effects of each algorithm/function 
applied. AZARA requires a pre-written parameter file and script, which lists the 
desired algorithms and window functions to be applied. After using 'process', a 
program within AZARA that takes the parameter file, script and FID, and outputs a 
spectrum file and an associated spectrum parameter file, the spectrum can be loaded 
into 'plot 1' (for one-dimensional NMR spectra or a one-dimensional slice from two-
dimensional or three-dimensional spectra) or 'plot2' (for spectra with two or more 
dimensions), and via a graphic interface the spectrum can be viewed. For three-
dimensional spectra any number or two-dimensional planes can be loaded and 
viewed separately or simultaneously. However, any alterations to the window 
functions means adjusting the script, then reprocessing the data before reloading the 
spectra for viewing. 
FELIX can also be used for interactive assignment of spectra via a multi-windowed, 
menu-driven interface, where multiple spectra can be viewed simultaneously in one 
window. Three-dimensional spectra are viewed via tile and strip plots. 
AZARA does not possess assignment capabilities. Instead, after AZARA has been 
employed to process spectra, the spectrum files created can be loaded into ANSIG, a 
software program for display and assignment of multi-dimensional NTvIIR spectra. 
ANSIG also allows interactive assignment of spectra via a multi-windowed graphical 
interface. Again, spectra can be viewed simultaneously in one window. The 
advantage of ANSIG is the ability to 'scroll' through the dimension orthogonal to the 
two-dimensional plane being viewed (in the case of three-dimensional spectra). This 
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process is relatively quick and easy, allowing cross-peaks to be located easily. Also, 
the graphic interface allows for rapid zooming and moving of displayed regions. 
The main advantage of using the combination of AZARA and ANSIG is the ability 
to incorporate a maximum entropy processing step into the processing scripts, a 
facility not available within FELIX. 
3.5.2 Processing with AZARA 
AZARA software [20] (version 2.7, www.bio.cam.ac.uk/azara)  was used for 
reprocessing of existing NIvIR data and processing of the new data, this software was 
employed as it is the standard software used in this research group and allows the 
incorporation of the maximum entropy method of processing. Processing involves 
Fourier transformation of the acquired FIDs and application of various window 
functions. Each step is optimised to provide a spectrum with the highest possible 
resolution and signal. Appendix 2 (page 272) shows the procedure used for 
processing with AZARA and details commands used. 
3.5.3 Maximum Entropy Method (MEM) processing 
The maximum entropy method of processing was used in the current work to 
improve the digital resolution of poorly sampled dimensions in the multidimensional 
data sets (i.e. the indirectly detected dimensions that have a limited number of time 
domain points). The resolution is limited only by the intrinsic line-widths of the 
signals and the number of data points in a processed spectrum. The MEM randomly 
produces an extensive variety of spectra, reverse Fourier transforms each and then 
compares the back-calculated FIDs obtained to that of an actual data set. The 
majority provide no match, but where significant correlation is seen the spectrum is 
considered; the spectrum with the most closely matched FID is used. Should more 
than one spectrum produce the correct FID, then that with the least amount of 
information (hence maximum entropy) is used as it is less likely to contain 
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extraneous peaks [144]. Appendix 2 (page 272) shows the procedure employed for 
MEM processing with and details commands used. 
3.5.4 ANSIG 
AZARA software is able to carry out sophisticated processing of spectra; however it 
does not have assignment capabilities. ANSIG (version 3.3 was employed in this 
study) [138, 139] is a software program for viewing and assigning multidimensional 
spectra of biological macromolecules. Spectra are viewed as two-dimensional planes. 
However, in three- and four-dimensional spectra movement through the dimension 
orthogonal to those viewed is achieved using scroll bars. Many planes can be viewed 
at once if required. It is possible to have up to six graphics windows open at the same 
time, so that different planes and regions of different spectra can be viewed 
simultaneously. Contours can be computed 'on the fly' or loaded from pre-computed 
contour files, as was done in this study. Peaks were subsequently picked and 
assigned interactively. 
The input files required are a protein sequence file, a spectrum description file, a 
control file and an initialisation file. The sequence file specifies the residue names 
and number; residues must be defined in the dictionary file of ANSIG. The spectrum 
description file defines the spectra used in a project; the name of each spectrum, its 
dimensionality and experimental nucleus in each dimension. The initialisation file 
defines which graphics windows will be used for displays, as well as other set up 
information. The control file contains the names of all other files accessed by ANSIG 
at start up and during the session. Examples of each file are shown in Appendix 3 
(page 283). 
3.6 Residual Dipolar Couplings (RDCs) 
Three sets of RDCs were recorded on a sample of ' 3C,' 5N-labelled DAF 23 aligned in 
the quasi-ternary surfactant/alcohol/salt system, CPBr/n-hexanol!NaBr: I DNH, 'Dccc' 
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and 'DCUHU [7, 225, 226, 240]. Reference spectra were acquired prior to this using 
unaligned 13 C, 15N-labelled sample. Unaligned sample conditions were as follows: a 
ratio of 9:1 H20:1320, with a protein concentration of 0.7 mM (as determined by UV 
absorbance at 280 nm) in 50 mM d3-sodium acetate buffer (pH 5.0, 0.03% (w/v) 
NaN3 , 5 mM d12-EDTA) at a volume of 450 pl. The same 13C,' 5N-labelled sample 
was concentrated and added to 6.5% liquid crystalline medium, prepared as 
described in section 3.1.1.3. Aligned sample conditions were as follows: a ratio 9:1 
1120:1320, with a final protein concentration of approximately 0.56 mM 13C,' 5N 
DAF23 , approximately 5.0% (v/v) CPBrfhexanol!NaBr in 50 mM d3-sodium acetate 
buffer (pH 5.0, 0.03% (w/v) NaN3 , 5 mM d12-EDTA) at a volume of 560 tL. The 
residual quadrupolar splitting of D20 was 3.4 Hz, this is an acceptable splitting in 
partial alignment of proteins. All three experiments to measure RDCs were recorded 
under these conditions. 
NMR experiments used to obtain RDCs measure the one-bond scalar coupling 
constant, ' JNH, because the RDC is manifested as an addition to the scalar coupling. 
The simple way to do this would be to remove the decoupling proton pulse (nitrogen 
frequency labelling), however this would result in doubling of the cross-peaks within 
the same spectrum, which increases spectral overlap. The solution to this is to 
separate the two components of the I JNH doublet into two subspectra, as suggested by 
Ottiger etal. [225]. This method is called the IPAP editing scheme, IPAP refers to 
the fact that spectra, in which the doublets are alternatively in-phase (IP) and anti-
phase (AP), are collected then added to (to make 'IP+AP' spectra), or subtracted (to 
make 'IP-AP' spectra) from, each other to produce the relevant component of the 
doublet in one spectrum. This is shown in figure 3.8. 
A macro (available from the Bruker Library of AU programs for XWinNMIR, Bruker 
Biospin) was run that splits each spectrum into its IPAP subspectra: the IP+AP and 
the IP-AP spectra. This is done prior to Fourier transform processing. Subsequently 
each spectrum was processed using AZARA. Table 3.5 shows the parameters for 
each experiment and processed spectrum. 
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A)O 	B) 	 C) 	 D) 
Figure 3.8: A) In-phase doublet. B) Anti-phase doublet (dotted line indicates the cross-peak is 1800 
out of phase, therefore has a negative intensity). C) 'IP+AP" cross-peak (from added in-phase and 













Real data matrix after 
subspectra splitting and 
window functions 
IP+AP IP-AP 
NHN Unaligned 1024x848 199.3 48 512x4096 512x4096 
NT-IN Aligned 2048x640 150.4 64 1024x4096 1024x4096 
CuHa I Unaligned 2048x512 118.1 256 1024x2048 1024x2048 
CaHa Aligned 2048020 75.2 512 1024x1024 1024x1024 
CaC' Unaligned 2048x768 177.2 128 1024x4096 1024x4096 
CRC' Aligned 2048x512 120.3 288 1024x2048 1024x2048 
Fable 3.5: Acquisition and spectrum parameters of unaligned and aligned DAF 23 . 
All spectra were loaded into the program CCPN Analysis [350] and peaks picked 
(using the parabolic fit of Analysis to determine peak centres) and assigned. Two 
copies of the Analysis project file were made to accommodate peaks arising from a 
second minor conformer (see section 4.2.1 and 4.3); cross-peaks corresponding to the 
second conformer were picked and assigned in the second copy. Figure 3.9 shows an 
example of two IPAP subspectra overlaid. 
The coupling constants were determined as the difference between the ' 5N 
frequencies of the IP+AP and IP-AP cross-peaks of each peak pair in the ' 5N 
dimension (in Hz). The RDCs were calculated by subtraction of 'J (unaligned spectra 
scalar coupling constants) from '(J+D) (aligned spectra scalar plus dipolar coupling 
constants): 
ID = '(J+D) - 'J 	 (44) 
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In the case of 	coupling constants were scaled up by a factor of 1.5 in order to 
obtain the true value of the coupling. In the pulse sequence for this experiment, the 
incrementation of the time delay that samples the CaH< coupling is reduced by a 
factor of 1.5 in order to reduce potential relaxation losses due to the rapidly decaying 
Ca magnetisation. This results in coupling constants that are 0.667x their actual 
values. 
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Figure 3.9: Example of both subspectra of an IPAP experiment overlaid. The 'IP+AP' spectrum is 
shown in purple and the 'IP-AP' spectrum is shown in green. The example shown is measuring the 
DNH coupling. 
Errors in RDC were estimated using the approach of Kontaxis etal. [135], where an 
estimate of error is provided by the division of the line-width at half-peak height 
(LW,,) in the 15N dimension by the signal-to-noise (SN): 
LW 1 
AJ or 4(J + D) = 	 (45) 
SN 
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In each spectrum 30 noise peaks were picked in signal-free areas and the average 
noise calculated by averaging the 30 peak heights. All amide cross-peak heights were 
also averaged and this value was divided by the averaged noise value to give an 
estimated signal-to-noise ratio. 
For each subspectrum, the line-widths in ' 5N dimension at half peak height for 10 
randomly selected amide cross-peaks were averaged. Then, using these calculated 
values an error was estimated using equation 45. An approximation of the error for 
each subspectrum pair was calculated by: 
Error in for (J + D) = j(error in IP + AP spectrum)2 + (error in IP - AP spectrum)2 
(46) 
And then to determine the error in the dipolar couplings: 
Error in D = j(error in (J + D))2 - (error in J)2 	 (47) 
The errors were calculated as 1.4 Hz, 4.5 Hz and 8.5 Hz for 'DNH, 'D a ' and 
1 DCaHa respectively. This approximation of error provides a lower limit for the 
accuracy of the measurement, as other distortions can also contribute. 1.4 Hz was 
considered slightly low as a suitable error estimate in 'DNH and it was arbitrarily 
increased to 2 Hz. This would also have increased the relative contribution from the 
other RDC classes to the overall RDC energy term in the structure calculation, 
because the energy penalty for each restraint is divided by the square of the error 
estimate when using the harmonic implicit Saupe tensor alignment constraint (ISAC) 
potential (see section 3.7.6). This potential was employed in the implementation of 
RDCs in this study. The other two approximations of error were considered 
acceptable. 
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Three RDC tables, one for each coupling type, were exported from Analysis for each 
of the two conformers. These files were entered into one CNS-input table, which can 
be seen in Appendix 7 (page 305). 
3.7 Structure calculation 
The basis for structural determination of macromolecules using NMR is the 
transformation of NOE cross-peaks to distance restraints, i.e. distances between pairs 
of nuclei. This is why near-full assignment, firstly of the protein and secondly of the 
NOESY spectra, is required - more NOEs defined translate into more restraints for 
structural calculations, and therefore provides more accurately described structures. 
The first step towards structure calculation was integration by volume of all NOESY 
cross-peaks, whether fully assigned or not. The integration of cross-peak volume was 
not carried out over the entire cross-peak. This was because of possible cross-peak 
overlap and hence the possibility of introducing errors. A fixed area was prescribed 
surrounding the centre of a cross-peak for which the intensity is described; this area 
is the line-width at half-peak height in each dimension. The line-widths at half-peak 
height were entered into the ANSIG spectrum description file for each NOESY 
spectrum. Relative intensities of peaks were then derived from these 'boxes'. 
NOESY cross-peaks can be integrated within ANSIG and then a cross-peaks file 
exported. Using a script, the exported cross-peaks file was split into separate tables 
of chemical shift assignments - one for each experiment used. A priority is assigned 
to each spectrum that defines which chemical shift assignment was to be given 
higher priority when a resonance has been assigned in more than one spectrum. A 
complete table of chemical shifts for the protein is compiled from all spectra, when a 
resonance was assigned in more than one experiment, the higher priority spectrum 
assignment was used. Subsequently a master table was produced containing proton 
chemical shifts and the shifts of their attached heavy atoms. 
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A 'connect' script within AZARA was run for each NOESY spectrum. This script 
takes the NOESY cross-peaks table for that spectrum (complete with assignments 
and relative intensities) along with the master chemical shift table and outputs two 
tables for each spectrum. Figure 3.18 shows an example of a connect script. 
par.re 
put—shift . . /xpk/flX_Shifts .rdb 
put_crosspeak . . /xpk/cl3noesy.rdb 
lit—output 
tput_match match_cnoesy . rdb 
tput_nhlges cnoesy. tbl 
tput_crosspeak noinatch_cnoesy .rdb 
lumns 3 1 
luinns 2 
tenslty_dist 3.0 2.7 
tensity_dist 1.5 3.3 
tensity_dist 0.3 5.0 
tensity_dist 0.0 6.0 
Figure 3.10: Example connect script. 
The first output table contains unambiguous NOEs; i.e. those NOEs for which there 
was no uncertainty in assignment of either proton and no other obvious contributors. 
The script leaves these NOEs and their assignments unchanged. The second output 
table contains NOEs that are ambiguous, i.e. those that were not manually assigned 
in every dimension originally. These underwent automatic assignments. By finding 
chemical shift values from the table of assignments that fit, the script matches the 
unassigned dimensions to all the possible assignments [217] within an error bound 
on the chemical shifts. 
During this procedure, distance restraints for each NOE were calculated from the 
relative intensities. This was done using the last four lines of the connect script 
shown in figure 3.18, which show the lower bound of the relative intensities in the 
second column and the upper bound of the distance restraint (in A) in the third 
column. The strength of the NOE is inversely proportional to the distance, r, between 
the two interacting nuclei by a power of 6 (see section 2.1.3), i.e. 
NOE intensity cc 	 (48) 
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The intensity of each NOE allows each restraint to be assigned to a certain 
internuclear distance range/bracket. These distance ranges are shown in the table 3.6. 
Only upper bounds were used in the current work in order to help to reduce errors. It 
is possible in some cases that the intensity of an NOE may be reduced for a certain 
atom due to spin diffusion for example 6 . 
These distance ranges, rather than fixed distances, increase the degree of uncertainty 
when fitting the data to a structure, allowing many local structural possibilities. 
However, as a large number of restraints are used (thousands of NOEs), convergence 
can be achieved. A structure considered to be consistent with the experimental data is 
one that fits all of the restraints provided. 
Intensity Upper Distance Bound Term 
3.0> 2.7A Strong 
1.5-3.0 3.3A Medium 
0.3-1.5 5.OA Weak 
<0.3 6.OA Very Weak 
Table 3.6: Intensity ranges and upper distance bounds used for scaling NOESY cross-peak intensities 
to distances in the current work. 
3.7.1 Crystallography and NMR System (CNS) 
CNS [26] is a software suite developed for macromolecular structure determination 
by X-ray crystallography or solution NTVIR spectroscopy. CNS essentially requires 
three inputs: a force field, a molecular template file and experimental data. 
Spin diffusion is aT 1 phenomenon frequently observed in NMR of macromolecules. In the limit of 
'slow' motion, 'slow' meaning w; >> 1, the rate of transfer of spin energy between nuclei becomes 
much larger than the rate of transfer to the lattice and the NOE is no longer specific for proximal 
spins. In the extreme case, a homologous negative NOE will be seen throughout the whole spectrum; 
in practice spin diffusion is evident in the generation of three-spin effects (relayed NOE interactions). 
Consequently, there is no simple relationship between the magnitude of the NOE and the internuclear 
distance. 
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A force field is an empirically-derived definition of how atoms behave, making 
possible the production of a realistic, structure on the basis of experimental data. The 
force field includes bond lengths and angles, stereochemistry, steric interactions and 
electrostatics. In this work the PROLSQ force field was used. Information in this 
force field originates from high resolution X-ray crystallography [159]. The force 
field is described in parameter and topology files. Other information described in the 
parameter and topology files includes atoms present in each L-amino acid residue, 
their element type, atom "chemical type" (i.e. specifies what other atoms are bound 
to an atom of that type in that amino acid), charge on each atom, atoms that are 
bonded, where dihedral angles and improper angles exist, changes to amino acid 
residues when disulphide or peptide bonds are formed, typical bond lengths, angle 
values, improper angle values and dihedral angle values for the bonds that can be 
found within a protein, as well as the strength of any non-bonded (van der Waals) 
interactions that occur between various atom types within a protein. 
To make the molecular template file (MTF), the aforementioned parameter and 
topology files were used with a protein sequence file. Disulphide bridges known to 
exist in the structure were defined here. 
Experimental data is in the current study was NOE-derived distance restraints and 
residual dipolar couplings. 
These input files were fed into a script called a "wrapper" script. The wrapper script 
controls CNS structural calculations by feeding the input files into the correct CNS 
protocols 7 . 
An additional prochiral swapping protocol was employed in this work during the periods of 
simulated annealing. In cases where pairs of methylene protons on the same carbon atom have 
different chemical shifts, the previously random assignment was moved from one proton to the other 
and the energy of each possibility noted. The assignment that results in the lowest energy of each 
prochiral centre is then selected. 
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The starting point of NMR based structure calculation and refinement protocols are 
randomised strands of polypeptide chain (these strands can can be specified to start 
as extended or globular prior to calculation). Following initialisation, a constant high 
temperature restrained molecular dynamics annealing stage was carried out, followed 
by two slow-cooling simulated annealing stages implemented via restrained 
molecular dynamics. Finally a Powell minimisation stage was performed. 
Simulated annealing (SA) involves theoretically heating the protein and allowing it 
to cool slowly. The high temperature provides kinetic energy to the system and 
allows exploration of conformational space. Restrained molecular dynamics solve 
Newton's equations of motion within restraints imposed by bond lengths and bond 
angles. etc. A potential energy function for each atom is calculated and atoms are 
given masses and velocities (which are dependent on the temperature of the system 
providing kinetic energy in the SA protocol). From this, all forces are calculated and 
applied to the atoms and, at a specified time later, the position of each atom is noted. 
At various points during the SA protocol, periods of Powell energy minimisation are 
undertaken. This calculates the potential energy gradient on each atom then moves 
the atoms noting any changes to potential energy; these moves are accepted if 
potential energy drops. The restrained molecular dynamics process is repeated 
iteratively. Using this method it is possible to circumvent possible problems 
associated with structures becoming trapped in local energy minima, as opposed to 
the overall global minimum. 
The SA and Powell minimisation process was continued iteratively until no further 
drops in energy occured and it was therefore deemed that minimisation had been 
achieved in that particular trial. Three coordinate files were output; a random starting 
structure, a 'rrsa' structure (an intermediate structure) and a final minimised structure 
(the refined structure). Analysis of deviations from and violations of empirical and 
experimental restraints was undertaken on the final structure. This information was 
written to a violations file for that particular trial. Energy penalty summaries were 
written to header sections of the coordinate file corresponding to the particular trial. 
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The whole process was repeated 100 times using different initial velocities and 
random starting structures, which in general produces a different result. Obviously 
the more trials carried out the more likely it is that a subset of converged structures 
Will be obtained. Converged structures means structures at approximately the same 
low energy. The number of trials to be carried out was specified in the wrapper 
script. This number is limited only by the availability of CPU usage / computer time. 
Calculating 100 structures took approximately 4 hours over ten CPUs. 
3.7.2 Analysis of generated structures 
Calculation of structures using NMR restraints is achieved by minimizing the energy 
of a system, which contains a number of terms representing empirical knowledge of 
idealised structural elements (from the force field) and experimental measurements. 
Following generation of a round of structures, analysis of these structures was carried 
out to select those of lowest energy. These structures were to be used to influence the 
next round of structures. A low overall energy indicates the structure is likely to be 
relatively accurate, as it will have realistic covalent chemistry and good agreement 
with experimental data. The total energy of each generated structure was given as: 
Etota t = wEb00d + wxEang ie + wxEdjhedm l + WxEimproper + wEd + WXENMR 	(49) 
Bond refers to energy of covalent bonds, angle to bond angle, dihedral to dihedral 
angles, improper to improper angles, vdw to van der Waals interactions and NMR 
refers to the contributions from the experimental restraints. The w, terms are the 
respective weights on each energy term. 
The first terms in equation 49 are the empirical terms describing different 
contributions to the molecule as a function of its coordinates in space, followed by 
experimental terms obtained from closeness of fit of the restraints (ENMR). In the 
current work this term was initially provided by the fit of the NOE restraints alone, 
so was ENOE  for most of the calculations. Subsequently, during refinement in the 
final round of calculations, RDCs were used as additional experimental restraints 
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introducing an extra energy term, Eiu, in addition to the NOE energy term. Each 
energy term is weighted so as to provide more emphasis on the empirical or the 
experimental restraints. 
Deviation from the norm of bond lengths and angles are described by a simple 
harmonic (i.e.* quadratic) function. Deviations of dihedral and improper angles are 
described by a similar function. The van der Waals term contains only a repulsive 
force, proportional to r -12  (where r is the internuclear distance). 
The energy incurred by deviation from NOE-derived restraints can be calculated 
from: 
if D ~ U" 
ENOE [0 	
ifU<DJ 	
(50)  cc 1 
D is the actual distance between the nuclei in that structure and U the upper bound of 
the distance range assigned to that pair of nuclei on the basis of NOB intensity. So if 
the actual distance is beyond the bounds, an energy penalty is incurred, but if it is 
within the bounds, no energy is contributed. 
In the current work, where an NOE had been assigned to more than one set of 
contributors (during the automatic assignment process) an effective distance (refj-) 
was calculated and used to determine the energy for that restraint. This is known as 
sum averaging. reff is calculated as shown in equation 51, where ry is the distance in 
A between the atoms in each contributing pair. 
reff= (Er6) -116 	 (51) 
If a calculated structure has a large NOE energy term, it means many NOE restraints 
have been violated in that structure. In order to analyse restraints that were violated, 
a file was generated listing those violations for each structure exceeding a manually 
set violation threshold distance (0.3 A in the current work). Violations that 
persistently occur throughout all or most of the structures calculated probably 
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indicate a mis-assignment. These persistent violations were checked and 
reassignments were made when necessary. 
Following the first 'round' of structure calculations, structures were ranked 
according to NOE energy or total energy and plotted. The plots were inspected to 
assess convergence of energy values, and to look for an inflection point, or jump, 
corresponding to the boundaries between acceptable and unacceptable structures. An 
example of such a plot is shown in figure 3.19. 
The set of converged structures of low energy were then used to 'filter' and 'check' 
the NOE restraints (see sections 3.7.3 and 3.7.4), producing a new NOE restraints 
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Figure 3.11: Example of an energies plot. Total energy is represented by a green cross and NOE 
energy by a red circle. This plot is ranked on total energy. Here, an inflection point can be seen after 
29 structures. 
3.7.3 Filtering 
The intention (purpose) of "filtering" is to achieve the most accurate set of 
assignments for each ambiguous NOE, in terms of the contributions to its overall 
intensity that can be apportioned to each of the several different contributors. 
Filtering takes ambiguous NOE restraints and compares them to the converged, 
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lower energy structures selected as above. A threshold percentage contribution level 
was set manually, below which restraints were removed. Removal of weak and 
unlikely contributors means CNS will not attempt to accommodate them and thereby 
avoid consequent penalisation arising from the NOE energy term. 
As structures became more accurate over sequential rounds of structure calculations, 
the level of filtering after each round was lowered so as to remove a higher 
proportion of unlikely contributors. In this work 99% was used to filter on round 1 
(i.e. to remove any contributors that are contributing less than 1% to the NOE) and 
round 2 structures, 98% on round 3 structures, and 95% on round 4, 5 and 6 
structures. 
3.7.4 Checking 
"Checking" is a way of preventing inappropriate overemphasis on restraints that are 
erroneously present more than once in the list of NOEs. It compares restraints from 
each spectrum looking for duplication, such as might arise if a certain NOE 
interaction is represented in more than one NOESY spectrum. Intensities are 
compared between the duplicated restraints, and the higher intensity restraint is kept 
while the redundant, lower intensity, restraint is removed. A new file containing 
filtered and checked restraints is produced for use in the next round of structure 
calculations. 
The number of subsequent rounds undertaken depends on the degree of convergence 
of the potential energies of the structures. Once good convergence is achieved, i.e. 
the NOE and total energies for a number of structures are all low and very similar, 
and the restraints file is not significantly altered during the process of filtering and 
checking, it is deemed that the set of low energy structures are as accurate as 
possible. In the current work six rounds of filtering and checking were required, 
before a final round of structures were deemed suitable. 
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3.7.5 Water refinement in CNS 
Refinement in explicit water, where a fully non-bonded potential is used together 
with explicit solvent molecules thus mimicking the natural environment of a protein 
in solution, is commonly performed [161]. In this study, water refinement was 
carried out in CNS as a refinement stage on the final set of structures using scripts 
written by Aart Nederveen et al. [209], available at www.ebi.ac.uk/msd-
srv/docsfNlvllRlrecoordlscripts.html . These scripts are based on ARIA water 
refinement protocols [160, 161] with some modifications. The explicit water 
refinement consisted of the following steps: 
Immersion in a 7.0 A shell of water molecules and energy minimization. 
Slow heating from 100 K to 500 K with 200 molecular dynamics (MD) steps 
(3 fs) per temperature increment, with harmonic restraints on the protein 
heavy atoms that were slowly phased out during the heating stage. 
Refinement at 500 K with 2000 MD steps (time step 4 fs). 
Slow cooling from 500 K to 25 K in 25 K temperature steps with 200 MD 
steps (4 fs) per temperature increment. 
V. 	Final energy minimization (200 steps). 
The scaling of the force constants for bonds, angles, impropers and omega angles 
during the cooling stage had been modified slightly in these scripts with respect to 
the original protocol used in ARIA [160] to allow for the naturally occurring 
variations in these parameters, as described by Engh and Huber [69]. The non-
bonded interactions were calculated using an 8.5 A cut off with full van der Waals 
(Lennard-Jones) and electrostatic potentials that incorporated the OPLS non-bonded 
parameters implemented in the PARALLHDG5.3 force field [160]. 
Water refinement of the final round of structures was undertaken using this method, 
with three restraint files as input: hydrogen bonds, unambiguous NOEs and 
ambiguous NOEs that had been filtered and checked using round-6 structures. 
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3.7.6 Incorporation of RDCs into structure calculations 
Incorporation of RDCs into structure calculations in CNS can be achieved by several 
different methods [49, 192]. In the current study use was made of the TENSO 
module, which contains an implementation of the implicit Saupe tensor alignment 
constraint (ISAC) method [283]. The ISAC module is useful in that it does not 
require knowledge of the alignment tensor (refer to section 2.2 for a description of 
the alignment tensor). Instead it makes use of the fact that an RDC can be described 
by a function that is linear in five parameters representing the alignment tensor and 
non-linear parameters describing the internal degrees of freedom of the molecule 
(torsion angles etc. that define the structure). A linear least squares minimization of 
the alignment tensor is achieved by implicitly adjusting the alignment tensor 
parameters during a non-linear minimization of the structural parameters that 
represents the internuclear vector for each RDC, thereby eliminating the requirement 
of a pre-calculated alignment tensor, which may be difficult to obtain accurately 
from a limited distribution of RDCs. 
When refining structures using RDCs, the experimental restraints energy penalty, the 
ENMR term (see equation 49), becomes ENOE+EIWC. Using the ISAC module, EInDC is 
the least-squares energy penalty for dipolar couplings Di and given in equation 52: 
Epjc = X 2 (a, S) 	[Di  _s:7 2m (a)] 	 (52) 
Sm is the alignment order matrix in five-dimensional irreducible notation and T 2 '' (a) 
is a non-linear function in the internal coordinates cx describing the coupling i. 
Minimisation of this energy penalty gives the most accurate structures. In further 
chapters this energy penalty is referred to as ETENSO  or the 'tenso' energy. 
The TENS 0 module of CNS was implemented in the refinement script and used the 
previously calculated 'nsa' structures to refine employing both NOE and RDC 
restraints, as previously done and as protocol for implementation of this module into 
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CNS dictates. In all structure calculations the TENSO force constant was increased 
geometrically from 0.001 kcal (mol Hz 2)-1  to 1 kcal (mol Hz2) during the first 
cooling stage of refinement and fixed at the final value throughout the second 
cooling stage. An example of a TENSO refinement CNS script can be seen in 
Appendix 8 age 310). 
3.8 Measurement of 15N relaxation parameters 
Refer to sections 2.12 and 2.3 for theory and use of ' 5N relaxation parameters. 
3.8.1 15N Ti and T2 
The ' 5N relaxation times, T 1 and T2, were determined using sets of spectra based on 
the 1 H-' 5N-HSQC [121, 122], each of which is acquired with an increasing delay in 
the pulse sequence during which relaxation takes place. The intensities of amide 
cross-peaks decrease as longer relaxation delays are used, thus T1 and T2 can be 
calculated for each residue. T 1 spectra were collected with relaxation delays of 51.1, 
401.1, 601.1, 801.1, 951.1, 1101.1, 1201.1 and 1301.1 milliseconds. T2 spectra were 
collected with relaxation delays of 16.96, 33.92, 67.84, 101.76, 118.72, 135.68, 
152.64 and 169.60 milliseconds. T 1 and T2 spectra were acquired on both a Bruker 
600 MHz AVANCE NMR spectrometer and a Bruker 800 MHz AVANCE NMR 
spectrometer. 
Each set ofT1 or T2 spectra were loaded into the program CCPN Analysis [350]. 
Cross-peaks were picked and assigned in each spectrum. T 1 and T2 were calculated 
using the 'Rates Analysis' facility within Analysis by fitting the decaying cross-peak 
intensities over time to the following exponential: 
1(t) = I(0)e2 + I() 	 (53) 
1(0) is the cross-peak intensity at time zero, 1(t) is the cross-peak intensity at time t (t 
is the relaxation delay) and I(oo) is the non-zero limiting intensity as t -* co as a 
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consequence of pulse imperfections. In the case of overlapped cross-peaks where 
reliable intensities could not be obtained, calculation of Ti and T2 was not possible. 
For each T i or T2 calculation in Analysis the data was fitted to the exponential decay 
1000 times resulting in a fit error and an associated error in T 1 or T2. Figure 3.20 
shows the intensity decay for residue C 124 as an example. 
Ti 
Fitting Funchon: 	 A oxp(-Bx) • C 
Equation; 3688289Z,000000 cp(-0.0014715C) • 08284531250 Fit Error 4.1)21450 
Point a p fitted y delta 
50.100 3.429o-.07 3.4308+07 -15305.000 
401.100 2.0558+07 2.0459--07 74086.025 
3 601.150 1.5248+07 1.5288+07 -35005.000 
4 801.100 1.130e+07 1.1398+07 -18415.438 
5 950.100 9.0228+06 9.100o+06 -138175.025 
6 1101.101) 7.441a+0S 7.344e+06 90681.281 
7 1201.1011 6.4828+06 0.3458+08 137127.15€ 
8 1301.160 5.3828+06 5.4838+00 -130805.000 
Show Peek Next Set Close Help 
Figure 3.12: Fit of intensity decay for C 124 as calculated in Analysis with intensity (volume) on the y- 
axis and time delay on the x-axis. The experimental results are plotted in blue and the fitted results 
from the derived equation in red. 
3.8.2 Heteronuclear NOE 
An additional parameter used to provide information on the internal mobility of 
residues is the heteronuclear steady-state NOE ( 'H} 15N-NOE, refer to section 2.3.1 
and equations 31 and 32). Two 'H-' 5N-HSQC spectra were recorded, a reference 
spectrum and a saturated spectrum. The pulse sequence for the saturated spectrum 
started with a 5 second delay that contained 3 seconds of proton spin saturation. 
During saturation an NOE develops between the proton and the 15N and the intensity 
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of cross-peaks is decreased for each residue. The reference spectrum contained a 5-
second delay with no saturation. 
Each pair of spectra were loaded into Analysis and cross-peaks picked and assigned. 
The heteronuclear NOE values and associated errors were calculated within Analysis 
using the 'Heteronuclear NOE' facility. 
3.9 Model-free 
3.9.1 Modelfree input 
The amide spin relaxation data, i.e. ' 5N T1, T2 and heteronuclear NOE values, are 
required by Modeifree 4.15 as input, as are the spectrometer field strength for 
protons in MHz, the length of the amide bond (taken in this work to be 1.02 A), 
chemical shift anisotropy (taken in this work to be -172 ppm [5]), gyromagnetic ratio 
(-2.71 x iø 7  rad T s_ i [211]) and an estimate of global correlation time. Also 
required are upper and lower bounds for fitting of each parameter (i.e. the S 2 , 're  etc.). 
The overall correlation time for the molecule can be estimated from T 1/T2 ratios, 
provided that only motion distinctly faster than the overall tumbling is contributing 
to the ratios. Residues with a T1/T2 more than 1.5 times the standard deviation away 
from the mean value were excluded from calculations, as were all residues with 
heteronuclear NOEs less than 0.65, as they are likely to be highly flexible. A 
program called r2r1 tm, which is available from the Palmer group website [227], 
was then used to estimate overall correlation time, Tm, for the protein. 
3.9.2 Diffusion model 
Before model-free parameters could be fitted, the model of diffusion of the molecule 
had to be predicted. Parameters can be fit using an isotropic, axially symmetric 
anisotropic or fully anisotropic model. When a molecule tumbles anisotropically, the 
orientation of N-H bond vectors, with respect to the principal diffusion tensor, affect 
the relaxation data for that amide bond, therefore, anisotropic fitting requires an 
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accurate experimentally-derived structure. Many protein structures have anisotropic 
structures, i.e. they are not spherical, and are thus not likely to tumble as a sphere. 
CCP modules have dimensions of approximately 40 A x 15 A x 15 A [129, 310]; one 
would expect an extended structure of a double-module protein to tumble 
anisotropically. 
An estimation of the diffusion model and its tensors can also be determined from the 
relaxation data and the respective orientations of the N-H bonds within an 
experimentally-derived structure. A program called pdbinertia (also available 
from the Palmer group website [228]) was first used to calculate the principal 
moments of inertia from a PDB-format (protein database) file describing the atomic 
coordinates of the protein. This program outputs a new PDB file with the centre of 
mass located at the origin and the moments of inertia rotated to align with the 
Cartesian axes describing the coordinates. This PDB file is required for input, along 
with local correlation times calculated for each residue from T 1/T2 ratios (using 
r2rltm), into the program quadratic diffusion (also available from the 
Palmer group website [228]) which fits the data to the isotropic, axially symmetric 
and fully anisotropic diffusion models using the method of BrUschweiler et al. [28] 
and Lee et al. [153]. The correlation times were fit to the quadratic shown in 
equation 54 for each model, using linear least-squares fit. 
(6rJ' = eD 1 
	 (54) 
ej is the normalised internuclear vector of the ' 5N- 1 H pair, i. A sum of squared errors 
value, x2  was calculated for each fit and an F-test was carried out between isotropic 
and axially symmetric anisotropic fitting, and isotropic and fully anisotropic fitting to 
determine if the fit was statistically significant. 
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3.9.3 Model-free fitting 
Model-free interpretation (see section 2.3 in Chapter 2) of relaxation data was 
achieved by fitting internal motion spectral density function parameters to the 
relaxation data by least-squares regression using the program Modeifree 4.15 [179, 
227]. Two order parameters, S2  and S can be fitted to the data; if a distinction 
between fast and slow motion was made, S2  describes the slow motions and S 
describes the fast. S 2 is set to S2 x S and if no distinction between different 
timescales of motion was made then S2  was set to 1 and 2 = 	Two correlation 
times can be fitted; te is the fast timescale (ps-ns) motions correlation time and R ex is 
the contribution to T2 from slow timescale (ps-ms) motions (also called chemical 
exchange). 
There are five different dynamic models that can be fit to experimental relaxation 
data in turn: 
• Model 1: S2 - very fast motion (timescale less than 20 ps), y— 0 
• Model 2: S2 and z - Lipari and Szabo model-free 
• Model 3: S2 and Rex - model 1 with a chemical exchange contribution 
• Model 4: S2, i and Rex - model 2 with a chemical exchange contribution 
• Model 5: S, S2  and z = -r, - extended model-free 
Model 5 assumes a distinction between fast and slow timescales; that S2  is on a very 
fast time scale, less than 20 picoseconds, while S describes motion on a timescale 
that is hundreds of picoseconds. 'rein  model 5 therefore relates to S2  and is 
sometimes called 'r. 
An indication of the quality of the fit of any single model to the relaxation data for a 
given spin was tested using the sum of squared errors (SSE(i)), giving a x2  value, 
between the real data and relaxation, data back-calculated from the fitted internal 
motion parameters for that spin. The sum of squared errors, for a spin i, was 
calculated from equation 55. 
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R1, R2 y and NOEIJ are the relaxation values of the ith  spin and th  static magnetic 
field and Rh,, R2 and NOE,J are the back-calculated relaxation values from the fitted 
internal motion parameters. The a values are the errors associated with the relaxation 
data. N defines the number of spins in total and M the number of different magnetic 
field strengths used in acquiring the data [179, 227]. 
The protocol employed for model selection in the current study was the Bayesian 
Information Criterion (BIC) [294] protocol, which is based on frequentist techniques. 
BIC was introduced to model-free analysis in 2003 [56]. A recent study [38] of the 
predominantly-used protocol of model selection, via step-up hypothesis testing using 
x2  statistics and F-tests [179], found it was inefficient and suboptimal, often selecting 
oversimplified models and hence under-fitting parameters. The same study found 
model selection by BIC to be the optimal protocol. BIC protocol is also 
computationally more efficient. 
The basis of BIC is to achieve the best balance between bias (oversimplification) and 
variance (incorporation of experimental noise) by identifying the model that yields 
the smallest expected discrepancy. Expected discrepancy is the average discrepancy 
value of between the true data set and the result of fitting to a sample set. The true 
data set, in practice, is not available so expected discrepancy cannot be calculated, 
however, an estimation can be made using the sample data set. Such an estimation is 
called a criterion. 
BIC is given in equation 56, where k is the number of independent parameters in the 
model and D is the number of independent relaxation measurements. 
BIC= 2 +klnD 	 (56) 
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Using BIC all five models were compared simultaneously, and the model with the 
smallest criterion was selected as the best model. To discriminate between adequate 
and inadequate fitting of models to individual residues, the residual x2  value was 
compared to the (1 ..a) x  100% level, at confidence level a, of a distribution 
calculated by a series of 500 Monte Carlo simulations of the relaxation data. If the x2 
value'is less than the critical value, then the model adequately describes the data. The 
a level in this work was 0.05. If the selected model did not sufficiently describe the 
data and a different model had a criterion similar, that model was then selected and 
fit. If no similar criterion for a different model was available, or this second selected 
model did not sufficiently describe the data (x2> 
X2 (a)), it was decided that none of 
the models can sufficiently fit the data. 
Chapter 4 
REASSIGNMENT OF DAF23 
In early 2003 the solution structure of DAF 23 , solved by NIMR spectroscopy, was 
published by Uhrinova et al. [345] and the X-ray crystal structure of DAF34 was 
published by Williams et al. [359]. These structures were the first experimentally-
derived structures of DAF CCP modules to be solved; they had previously only been 
modelled by homology [140]. Module three of the X-ray structures and the NMR 
solution structures were similar, as would be expected. But they also exhibited some 
significant differences. The RIVISD values between the highest resolution structure of 
the crystal structures and the closest-to-mean structure of the NIvIR ensemble were: 
1.8 A over the backbone atoms of residues C129 to Cl 86 (first to last cysteine of 
module three) and 3.3 A over backbone and side-chain atoms of the same residues. 
Figure 4.1 shows an overlay of module three from these two structures. 
In early February 2004, the full X-ray structure of DAF modules one to four was 
published (hereafter referred to as DAF 1234) [178]. Module two of the X-ray 
structures and the INMR solution structures were, again, similar in overall fold, but 
also exhibited some differences. RMSD values between the highest resolution 
structure of the crystal structures and the closest-to-mean structure of the NMR 
structures were 1.9 A over the backbone atoms of residues C64 to C124 (first to last 
cysteine of module two) and 3.6 A over backbone and side-chain atoms of the same 
residues. Figure 4.2 shows an overlay of module two from these two structures. 
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Figure 4.1: Overlay of module three from the closest-to-mean DAFn NMR structure (from ensemble 
of 42 structures) shown in blue, with module three from the highest resolution DAF3 4 crystal 
structures, shown in red. Structures are overlaid on the backbone of residues C  29-El 88 in order to 
highlight the loops that appear different. The main difference is in the loop at the 213 interface, from 













Figure 4.2: Overlay of module two from the closest-to-mean DAF 23 NMR structure (from ensemble of 
42 structures) shown in blue, with module two from the highest resolution DAF 1234 crystal structures, 
shown in red. Structures are overlaid on the backbone of residues C64-K76, P86-E 102 and S 106- 
C124 to achieve the best fit. The main differences occur from P67 to F85, which contains the 
hypervariable loop from Q77 to P86, and in the loop from P103 to L105. Structures shown with N- 
terminus at the top. 
The intermodular junction is very poorly defined in the Uhrinova NMR structures, 
resulting in a large degree of inferred flexibility between the modules. In contrast, the 
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X-ray structures inferred that the 2-3 intermodular junction is rigid. This interface is 
consistent in all eight independent models found in the three differently packed 
crystal forms. In fact, only at the interface between modules one and two is any 
significant degree of difference in orientation observed amongst the eight models, 
and this is relatively small. The twist-, tilt- and skew-angles 1101 of the Uhrinova 
NMR structures and the crystal structures, and a diagram defining the angles, are 
shown in figure 4.3. Figure 4.4 shows the original ensemble of 42 structures 
submitted to the Protein Data Bank overlaid on each module, with equivalent from 
full DAF 1 234 . The RMSD over both modules two and three (from C64 to C 186) of 
the closest-to-mean crystal structure and DAF NMR structure was 4.1 A over 








Figure 4.3: A) Tilt-, twist- and skew-angles between modules two and three from the Ubrinova etal. 
NMR solution structures [345] (shown as blue circles) and the Lukacik et al. [178] crystal structures 
(shown as red circles). B) Definition of tilt-, twist- and skew-angles 110]: the small circles represent 
the centres of mass of each module and define the origin of the frame for the module. The z-axis 
points in the direction of the C terminus and is aligned with the principal component of the inertia 
tensor. The x-axis is perpendicular to the z-axis and points in the direction of the C a  of the conserved 
uyptophan residue in each module (Wl 17 for module two and WI 79 for module three). 
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Figure 4.4: Uhrinova et aL [345 1 NMR solution structures of DAF 23 (shown in blue) overlaid with 
modules two and three taken from the X-ray crystal structures of DAF 1234 (shown in red). A) Overlay 
of module two (from residue C64 to C 124) and the same overlay rotated by 900.  B) Overlay of 
module three (from residue C 129 to C 186) and the same overlay rotated by 900.  Structures shown 
with N-terminus at the top. 
The key interaction sites for both classical and alternative pathway convertases are 
located on residues situated at the junction between modules two and three [141] 
according to the results of mutagenesis studies. Uhrinova et al. [345] reached the 
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conclusion that these residues are sites of direct contact, because they are solvent-
exposed in the ensemble of the original solution structures. The conclusion reached 
by the crystallographers, on the other hand, was that these residues act indirectly by 
stabilizing the 2-3 junction and facilitating the correct conformation required for 
convertase binding [178]. The major differences between of the domain interfaces of 
the crystal and NIvIR-derived structures were worrying. 
Consequently, it was decided to re-evaluate the NIVIR data available for DAF23. The 
Uhrinova solution structure were calculated on the basis of data processed and 
assigned using an NMR software program called FELIX97 (MSI, Accelrys, San 
Diego, CA USA). It was decided to reprocess and reassign data using the NMR 
processing program AZARA and assignment program ANSIG, respectively. One of 
the main advantages of this would be the ability to use the maximum entropy method 
(MEM) to process indirect dimensions of each spectrum, in order to provide better 
defined spectra with better peak resolution. At this stage it was decided to reassign 
the DAF23 data with no reference or bias to the original assignments or structure 
itself. 
4.1 Processing spectra 
All NIvIR spectra were processed with the AZARA software by methods described in 
Chapter 3. All but the 1 H- 15N-HSQC, the 1 H- 15N-HSQC-NOESY and both 'flI-' 3C-
HSQC-NOESYs (one acquired in 1120 buffer and the other in D 20), were processed 
using maximum entropy method. This was to aid in resolving ambiguous 
assignments in highly populated areas. In spectra such as the CBCA(CO)NH and 
I-1NCACB (the backbone spectra) cross-peaks are, in general, fairly well resolved 
because only two or four peaks should reside in each strip. On the other hand, highly 
populated areas where amide frequencies are very similar or are overlaid did benefit 
from applying the MEM. It was in the TOCSY experiments, which produce crowded 
spectra, that the MEM provided maximum benefit, since overlapping side-chain 
cross-peaks are more easily resolved and identified. 
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Figure 4.5 shows an example of MEM processing. A plane has been extracted from a 
three-dimensional spectrum that was: A) processed using normal Fourier transform 
methods and B) part-processed using normal Fourier transform methods, but 
processed with the MEM in the two indirectly detected dimensions. 
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Figure 4.5: A) A 1 H-'H plane extracted from the 'H)"N-HSQC-NOESY of DAF 23 processed with 
Fourier tranform. B) The same plane with maximum entropy method processmg in the indirect 
dimensions. 
4.2 Chemical shift assignment of DAF 23 
Figure 4.6 shows the assigned 1H-' 5N-HSQC of DAF 23 . Assignment of all non-
proline backbone amide peaks in the 1H-' 5N-HSQC was achieved during backbone 
and side-chain atom assignment, which is presented in this section. 
4.2.1 Two conformers 
Due to the doubled resonances that are present in the NMR spectra for a number of 
residues in CCP module two, it is thought that two conformers of module two exist 
in solution that do not readily interconvert. Some of these have two separate sets of 
associated chemical shifts; others have doubled amide resonances only. Residues 
displaying any double cross-peaks are shown in red in the sequence of module two in 
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figure 4.7. The second conformer and the assignment of its resonances is described in 
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Figure 4.6: Assigned 'H-' 5N-HSQC of DAF23 . Folded cross-peaks are shown in orange. Horizontal 
axis is the 'H dimension and the vertical axis is the 'N dimension. Both axes show chemical shift in 
ppm. Doubled peaks corresponding to the minor conformer are labelled with the appropriate residue 
number plus 1000. 
61 	 71 	 81 	 91 
FRSCEVP1RL NSASLKQPYIIQNYFPVOTV VEYERPGYR 
101 	111 	 121 
REPSLSPKLT CLQNLKWSTA VEFCKK 
Figure 4.7: Sequence of module two. Residues with any doubled resonances are shown in red. 
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Those residues that have doubled amide cross-peaks, but appeared to have 
degenerate chemical shifts for the remainder of the residue, were F6 1, R62, T68, 
Y84, G88, L109, V121, F123 and the N 6 1-H1 group of Wi 17. Those residues that 
have two cross-peaks for each atom are P67, L75,180, T81, Q82, N83, V90 and V91. 
Residues before the first cysteine, C64, are ignored, as they are considered highly 
mobile because they are in an unstructured N-terminus. 
For convienience, during the assignment process, the conformer with the more 
intense 1 14- 15N-HSQC cross-peak was considered to be the major conformer 
(conformer one) and assigned normally. Residues within the conformer with weaker 
cross-peaks were numbered 1000 plus the sequence number (e.g. the minor 
conformer, or conformer two, cross-peaks of T68 were assigned with residue number 
T1068). 
4.2.2 Backbone assignment 
Backbone assignment was achieved using predominantly five spectra. These were: 
the 'H-' 5N-HSQC, and two complementary pairs of backbone experiments; the 
CBCA(CO)NFI with the HNCACB, and the HBHA(CO)NH with the HBHANI-L 
These assignments were then checked with an additional complementary pair of 
experiments; the HNCO and the HN(CA)CO. Refer to section 3.3.3 in Chapter 3 
The CBCA(CO)NH and HINCACB spectra were used to find sequential backbone 
assignments and link amide cross-peaks in the 'H- 15N-HSQC. A trail can be followed 
by matching the (i-i) C and Cp peaks in the CBCA(CO)NH with the (i) C and C 
peaks of the HNCACB spectrum at a different amide group resonance, and repeating 
this procedure for as many steps as possible. When this could not easily be achieved, 
or when assignment required confirmation, the analogous proton backbone spectra 
HBHA(CO)NFI and HBHANH were also used. This process provided sequential 
assignment. The residue type of some of these cross-peaks could be deciphered by 
inspection of the Ca and Cp carbon chemical shifts and the H a and Hp proton 
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chemical shifts. Comparison of segments of sequential assignments with the protein 
sequence allowed the majority of the amide peaks to be assigned to their residue 
number. Following this, the HNCO and HN(CA)CO were used to confirm sequential 
assignment, as well as to assign the carbonyl carbons of the backbone. 
The following figures (4.8A-M) show the Ca and Cp sequential assignment of DAF23 
using CBCA(CO)NH and HNCACB. For residues which cannot be connected via the 
backbone carbon experiments are shown connected via the proton backbone spectra 
(HBHANH and HBHA(CO)NH) in Appendix 4 (page 289). These are L70 to A73, 
Y79 to 180, E92 to E94, G98 to R100, K108 to Ti 10, G145 to L147, F148 to G149, 
S168 to F169 and W179 to S180. 
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Figure 48A: CBCA(CO)NH and HNCACB strips ( ' HN dimension on horizontal axis and 13C 
dimension on vertical axis, units in ppm) of residues F61 to V66. CBCA(CO)NH cross-peaks are 
shown in red and are (i-i) cross-peaks. FINCACB cross-peaks are shown in blue and are both i and (i- 
1) cross-peaks. Strips are shown joined by C and/or Cp cross-peaks. For all residues, except serine 








Figure 48B: Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and }{NCACB (blue cross-peaks) for residues T68 to Q77, with 
connecting backbone peaks shown. 
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Figure 4.8C: Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and HNCACB (blue cross-peaks) for residues Y79 to F85, with 
connecting backbone peaks shown. 
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Figure 4.813: Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and HNCACB (blue cross-peaks) for residues V87 to R96, with 
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Figure 4.8E: Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and HNCACB (blue cross-peaks) for residues G98 to El 02 and S104 to 
Li 05, with connecting backbone peaks shown. 
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Figure 4.8F: Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and HNCACB (blue cross-peaks) for residues K108 to SI 18, with 
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Figure 4.80: Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and HNCACB (blue cross-peaks) for residues SI 18 to C 129, with 
connecting backbone peaks shown. 
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Figure 4.8H: Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and FINCACB (blue cross-peaks) for residues G 13 3 to V 142, with 
connecting backbone peaks shown. 
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Figure 4.81: Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and HNCACB (blue cross-peaks) for residues G144 to F154, with 
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Figure 4,8J: Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and HNCACB (blue cross-peaks) for residues F 154 to G 164, with 
connecting backbone peaks shown. 
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Figure 4.8K: Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and HNCACB (blue cross-peaks) for residues U  b4 to U 114, WiLn 
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Figure 4.81, Strips from the carbon backbone experiments CBCA(CO)NH (red cross-peaks) and 1-INCACB (blue cross-peaks) for residues G174 to D181, with 
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Figure 4.8M: Strips from the carbon backbone experiments CBCA(UO)NH (red cross-peaks) and 
HNCACB (blue cross-peaks) for residues El 85 to HI 89 with connecting backbone peaks shown. 
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4.2.3 Extent of backbone assignment 
The extent of backbone assignment is shown in table 4.1. The number of amide N 
and H refer to all non-proline residues. 
Backbone Atom Current assignment Original assignment 
Number assigned Percentage Number assigned Percentage 
AniideN 116/fl6 100% 106/116 91% 
AmideH 116/116 100% 114/116 98% 
Ca 127/127 100% 121/127 95% 
Ha 127/127 100% 123/127 97% 
Carbonyl 13C 120/127 94.5% 0/127 0% 
Total I 	606/613 99% 464/613 76%] 
Table 4.1: Extent of DAF23backbone assignment in current and ongmai work. tul"du J.UU ygell 
protons refer only to non-proline groups. 
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In the current work, all backbone resonances have been assigned, with the exception 
of seven carbonyl-' 3C's; these were from the following residues: V66, Q77, E92, 
R96, P97, E102 and V142. Of these seven residues, five are followed by a proline, so 
only if the carbonyl appears in the HN(CA)CO can it be assigned. In these five cases 
a corresponding cross-peak is not seen in the HN(CA)CO. The remaining two are 
E92 and P97. At the amide shift of E92 there is a cross-peak in the HNCO (at the 
V91 carbonyl chemical shift), but no cross-peaks in the HN(CA)CO spectrum. At the 
amide shifts of Y93 and G98 there are neither HNCO nor I-IN(CA)CO cross-peaks. 
Two amide backbone assignments were made during the subsequent side-chain 
assignment process. These were Ni 31 and Li 83, both of which are sandwiched 
between two proline residues in the sequence. Therefore, their amide cross-peaks are 
present in the 'H- 15N-HSQC, but cannot be linked to other amide groups in the 
CBCA(CO)NHIRNCACB, HBHA(CO)NHJHBHANH and HNCO/HN(CA)CO 
experiments. We would expect to see the (i) Ca, C, H and Hp cross-peaks ofNl3i 
and L183 at the amide chemical shift of N131 and Li 83 (in the HNCACB and 
HBHANH spectra, respectively), along with the (i-i) Ca, C, H and Hp peaks of 
P130 and P182 (in the CBCA(CO)NH and HBHA(CO)NIH spectra, respectively); It 
was only later using TOCSY experiments for side-chain assignment that residue-type 
was determined for these previously unassigned 1 H- 15N-HSQC cross-peaks. In 
conjunction with assignment of proline peaks in the HCCH-TOCSY these chemical 
shifts were able to be matched and the amide cross-peaks assigned to these residues. 
These assignments are corroborated by NOE interactions. 
4.2.4 Additional and differing backbone assignments to original 
In the Ubrinova assignments (Biological Magnetic Resonance Data Bank deposition 
code 5506) a number of backbone assignments are missing; namely the amide 
nitrogen assignments of K76, Q77, V87, T89, Y93, Ni3i, Li7i, 1172, W 17 and 
L183. Amide proton assignments ofNi3l and L171 are also missing. As previously 
stated, assignment ofNl3i and L 18 was made difficult by the fact that they are 
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both sandwiched between prolines in the sequence. The 1 H- 15N-HSQC cross-peaks 
of the other amide groups that originally remained unassigned are overlapped with 
other cross-peaks in the 'H- 15N-HSQC (with the exception of Q77). Figure 4.9 shows 
the regions surrounding these cross-peaks in the originally acquired 'H- 15N-HSQC, 
and in a more recently acquired 'H- 15N-HSQC. This more recent spectrum contains 
more time domain points in the 'H-' 5N dimension and was acquired with an 
increased number of scans, giving a better resolution of cross-peaks. 
According to the current assignments, the cross-peak of K76 overlaps with that of 
L109 in the second, minor conformer. The L109 resonance from the major 
conformer now resolved from the cross-peak of F6 1, i.e what appeared to be only 
one amide cross-peak, assigned to F61, in the original 'H-' 5N-HSQC (see figure 
4.913), was in fact two cross-peaks: F61 and the first conformer peak of L109. This 
can be clearly seen in figure 4.9A. K76 was originally assigned as being overlapped 
with L109 in the 'H-' 5N-HSQC of the resonance assignment paper by Uhrinova etal. 
[344]. However, in the Biological Magnetic Resonance Data Bank (BMRB, [296]) 
submission, of the entire residue only the amide proton is assigned. Q77 precedes a 
proline in the sequence and as K76 was not assigned it would have been difficult to 
find this cross-peak. 
It was found that V87 and Wi 79 are overlapped with each other (figures 4.9C and 
4.913); their overlapped cross-peak was originally, and mistakenly, assigned as the 
amide cross-peak of V66. V66 is now reassigned elsewhere. Figure 4.8A shows the 
carbon backbone strips of E65 and V66, with the (i-i) C and Cp cross-peaks of E65 
from the CBCA(CO)N}{ experiment in the V66 strip. None of the originally assigned 
backbone and side-chain chemical shifts of V66 match the current backbone and 
side-chain assignments of V87 or W179, which is puzzling. 
The Y89 and 1172 resonances are both now shown to be partially overlapped with 
Si 76. The original cross-peak was large with what looked like a shoulder to the right 
hand side (figure 4.9F). This is now resolved into three peaks, which are assigned to 
the three amide cross-peaks of the aforementioned residues (figure 4.9E). 
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Figure 49: Recent (magenta) and Ubrinova (blue) 'H-' 5N-HSQC cross-peaks and their assignments. 
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The Y93 resonance (see figures 4.9G and 4.9H) is in a highly populated area of the 
'H- 15N-HSQC and is not an obvious cross-peak.Its backbone and side-chain cross-
peaks, however, could be seen at the corresponding amide nitrogen and proton 
chemical shifts in other backbone and TOCSY experiments. 
Finally, L171 is now shown to be overlapped with R136, as shown in figures 4.91 
and 4.9J. 
The C  that were not assigned in Uhrinova et al. study were from residues K76, 
Q77, F85, G88, R96, P130 and N131. The Hs that were not assigned were from 
residues K76, Q77, P130, L171 and P182. These assignments have all been made in 
the reprocessed spectra. 
The use of the maximum entropy method of processing aided the resolution of the 
strips of previously overlapped cross-peaks associated with the 'H- 15N-HSQC peaks; 
this made it possible to assign separate residues where it was previously assumed 
there was only one. In Uhrinova et al. backbone assignment carbon and proton 
assignments of some of these residues were made from the (i-i) cross-peaks in the 
strips of subsequent residues. From there side-chain assignments were probably 
made from TOCSY experiments. Some TOCSY and NOESY cross-peaks may 
previously have been wrongly assigned where overlapped peaks were not recognised 
as such. 
As well as missing assignments, poor spectral resolution led to backbone mis-
assignments, specifically amide cross-peaks that were originally assigned as S128 
and C129, which are now assigned as S180 and Dl 81. This resulted in subsequent 
side-chain mis-assignments. Note that S128 is a linker residue (located between the 
modules). Figure 4.10 depicts the proton backbone strips of K127, S128, C129, 
Wi 79, S180 and Dl 81 and shows that current assignments are correct and therefore 
previous assignments cannot be. 
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Figure 4.1O:HBHA(CO)NH and HBHAN}I strips for Kl27, S128,C129,W179,Sl8O and Dl8l. 
HBHA(CO)NH (i-I) cross-peaks are shown in green, }{BHANH (i) and (i-I) cross-peaks are shown in 
orange and pink. The Ha  of K 127 can be seen at the same chemical shift in the HBHA(CO)NH in the 
S128 strip and in the HBHANH in the K127 strip, but no H a  cross-peak is seen in this position in the 
W179 strip (as indicated by the dashed and crossed line). The (i-i) H a  cross-peak of S180 is at the 
same chemical shift as the (i) H in the WI 79 strip, however no (i) H cross-peak is seen at this 
chemical shift in the K 127 strip. 
To summarise, of the Ubrinova eral. assigned Ca atoms 11 differ from current 
assignments. These are the Ca assignments of V66, Y79, E92, E102, S106, S128, 
C129, S180, D181, P182 and L183. Of the Uhrinova et al. assigned Ha atoms, 13 
assignments differ significantly in chemical shift. These are the I-Li assignments of 
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4.2.5 Extent of side-chain assignment 
The majority of DAF23 side-chain nuclei were assigned in the current study, however 
a total of 144 side-chain resonances remain unassigned. Some atom-types 
consistently cannot be assigned. These are all six secondary amide atoms (N 11 , H1 11, 
H1 12, N12, H1 2 11 H122) of all seven arginine residues, N c and 	of all seven lysine 
residues, Hi's of all eight threonine residues and H 1 's of all five tyrosine residues. 
Also, Hr 's from 14 of the 16 serines cannot be assigned; only in S118 and S173 can 
the H assignment be made. Assignment of both were made in the HCCH-TOCSY, 
however only the H of S118 is seen in one NOESY spectrum. 
It is not unexpected that the side-chain amine groups of lysines and arginines, and the 
hydroxyl protons of serines and threonines, could not be assigned. These protons are 
often exposed to the solvent and therefore labile and exchangeable, and rarely 
detected in NMR. 
In addition, the Cr 's of all six asparagine and two aspartic acid residues and the C6's 
of all five glutamine and eight glutamic acid residues cannot be assigned. These 
carbons have no protons attached, so are unassignable with the spectra acquired. 
There are 40 further unassigned side-chain atoms (see table 4.2). Twenty of these 40 
unassigned nuclei are aromatic side-chain atoms; which are from phenylalanine 
residues. The remaining four are from the two tryptophan residues. The cross-peaks 
of these aromatic side-chain atoms may be overlapped and therefore be 
indistinguishable from other aromatic side-chain cross-peaks. 
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Residue 	Unassigned side-chain atoms 
F61 C61, H. C62, H62, C, H 
N71 N82, H621, H622 
K76 C8, H61, H62, C6 , H 1 , H62 
Y79 H131, H132 
N83 N62 
F85 C ,-, Hr  
P107 H71 , H72 
K116 C 6 
W117 
P143 H7 1, H72 
1152 C7 1, H7 11, H7 12 
F154 
F163 C(,H 
F169 C6 1, C62, C, H 
W179 C, C2 	- 	 - 
Table 4.2: Unassigned side-chain resonances in current DAFn assignment. 
4.2.6 Additional and differing side-chain assignments to original 
When this project was started, it was not expected that any chemical shift 
assignments would differ from to the Uhrinova et al. assignments. It has become 
apparent, however, that, many of the current assignments were different. In addition 
to differing assignments, a total of 235 new side-chain atom assignments (side-chains 
that were originally unassigned) have been made. The full extent of differing and 
additional assignments can be found in Appendix 6 (page 303) and a full chemical 
shift list can be found in Appendix 5 (page 293). Figure 4.11 shows a graph with the 




Figure 4.11: Bar chart showing the assigned percentage of assignable resonances in each residue. 
Current assignments are shown in black and original assignments shown in red. The thick black 
horizontal bars at the top of the diagram show where the modules are and the thin joining bar shows 
where the linker residues are. 
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4.2.7 Assignment of NOESY spectra 
Three NOESY spectra were used in this project. A lHbNHSQCNOESY  (hereafter 
referred to as 'H-' 5N-NOESY), a 'H-' 3 C-HSQC-NOESY (hereafter referred to as 
13C-NOESY) and a further 13 C-NOESY acquired using a sample that had been 
buffer-exchanged into D 20 buffer. Firstly, the 'H-'N-NOESY was assigned, as 
much as was possible by moving sequentially through each residue. The 1 H- 13C-
NOESY was then assigned, again moving through each residue in turn, using the 1 H-
15N-NOESY to help assign symmetry-related cross-peaks in the amide chemical shift 
region. Symmetry-related cross-peaks arise due to the same NOE interaction, as both 
contributors will experience an NOE enhancement from the other. These cross-peaks 
are symmetrical across the diagonal of the proton-proton planes, i.e. they are both 
found at the same two proton chemical shifts. Each will occur at a different carbon 
frequency (as each proton is attached to a different carbon). Cross-peaks that had an 
obvious symmetry-related cross-peak were unambiguously assigned, others were left 
as ambiguous. 
4.3 Second conformer 
As previously stated, the following residues have double resonances and are thought 
to correspond to a second conformer of module two: P67, T68, L75, 180, T81, Q82, 
N83, Y84, G88, V90, V91,1,109, V121, F123 and the N,-H1 group of Wi 17. The 
minor conformation of residues 180— Y84, labelled 11080 - Y1084, formed a 
continuous, second chain, as confirmed by C e 's, C's, He 's and Hp's chemical shifts 
from backbone experiments. The strips of connecting cross-peaks are shown in 
figure 4.12. 
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Figure 4.12: CBCA(CO)NH and HNCACB strips ('HN dimension on horizontal axis and 13C 
dimension on vertical axis, units in ppm) of second conformer cross-peaks residues Y79 to F85. 
CBCA(CO)NIH cross-peaks are shown in red and are (i-I) peaks, HNCACB cross-peaks are shown in 
blue and are both (i) and (i-I) cross-peaks. Strips are shown joined by Ca and/or Cp cross-peaks. For 
all residues, except serine and threonine residues, C is the cross-peak at higher ppm (lowest in strip). 
Neither the connecting backbone cross-peaks between Y79 and 180 (figure 4.8C) nor 
those between Y79 and 11080 (figure 4.12, above) could not be identified. It is 
thought that Y79 may be flexible and solvent exposed, because of the difficulty in 
assigning many of its corresponding cross-peaks in various spectra It is not known 
whether Y79 also gives rise to doubled cross-peaks. The connecting carbon 
backbone cross-peaks could not be found between N1083 and Y1084; however 
connecting backbone proton cross-peaks were detected. Figure 4.13 shows the 
connection of strips from HBHA(CO)NH and HBHANH experiments between I-Li in 
the HBHANH spectrum for N1083 and the HBHA(CO)NH Ha (1) in the strip from 
Y1084. Seen in the third strip are cross-peaks from N83 showing its connection to 
Y84, the cross-peaks of which are shown to the right of the Y1084 cross-peaks in the 
second strip. This region is shown to highlight the separate conformer cross-peaks of 
Y84 and Y1084, as they have very similar shifts. 
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Figure 4.13: HBHA(CO)NH and HBHANH strips ('HN dimension on horizontal axis and 'H 
dimension on vertical axis, units in ppm) of residues N1083, Y1084 and N83. HBHA(CO)NH (i-I) 
cross-peaks are shown in green, HBHANH (i) and (i-i) cross-peaks are shown in orange and pink. 
Strips are shown joined by Ha  cross-peaks. 
The doubled side-chain chemical shifts of residues in these regions were confirmed 
by inspection of the TOCSY spectra, in which they were assigned as fully as 
possible. NOESY cross-peaks were then assigned to the appropriate conformer, 
using the same residue numbering as used in backbone and side-chain assignments. 
During NOESY assignment some NOE interactions were observed within each 
conformer. These are shown, for each conformer, in table 4.3. 
Conformer One Conformer Two 
P67 Ha - WI 17H1 P1067Ha - W  1 I7H1 
L75H1 - I80Ha L1075H 	- I1080Ha 
L75H61-V91H L1075H-V1091H724 
L75H 	- P67H2 - 
L751-L51#-V91Hp - 
L75 -I&1# - V91Hi# L10751is# - V1091H7 1 
- V1O91H-LiIO9H 
V90H7 	- K1O8Hp1 VI O9OH2 - K1O8H# 
Table 4.3: NOESY cross-peaks observed within each conformer. 
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The fact that the minor conformer resonances have NOE interactions analogous to 
those of the major conformer supports the idea that module two of DAF23 exists in 
two conformations that are very similar. As was shown by structure calculation 
(Chapter 5), the corresponding sets of residues lie within strands that are close to one 
other within the respective conformers. 
In order to calculate the structures of both conformers following integration of 
NOESY spectra, two copies of the exported cross-peaks file from ANSIG were made 
and each one was edited. It was necessary to delete the NOESY cross-peaks that 
belonged to conformer one from the cross-peaks file for conformer two (except those 
that were assigned to degenerate resonances, see table 4.4). Following this, 
assignments of conformer two NOESY cross-peaks were changed back to conformer 
one numbering (i.e. T 106 was changed to T68) in order for them to be in the correct 
format for structure calculation. 
The intensities of NOESY cross-peaks from non-degenerate resonances (shown in 
table 4.4) were scaled to compensate for the population difference between the two 
forms. The scaling factor used for each conformer was the inverse of that 
conformer's relative intensity, as calculated on the basis of integrating the relevant 
'H- 15N-HSQC cross-peak [363]. The average ratio of the major form (conformer 
one) to the minor form (conformer two) was calculated to be 4:3. Hence, the scaling 
factor for conformer one NOE cross-peaks was 7/4 = 1.75 and for conformer two 7/3 
= 2.33. 




Degenerate reonances Unassigned 
P67 All  N 
T68 H11, N Ca, C, Cy2, Ha, H, H72 H7 1 
L75 All  
180 All  
T81 All  H7 1 
Q82 All  c6 
N83 All  C7 , N62 
Y84 H11, N Ca, C, C6, C6, Ha, H1 1 1-12, 1-16, H6 H1 
V90 All  
V91 All  
L109 H, N Ca, C, C7, C6 13  C62, Ha, H 1 , H 2, H73  H613 
H62 
Wi 17 N6 1, H6 1 H11 , N, Ca, C, C61, C63 C2, C12, 1-16 1 , H63 3  
H(2, _H1 2 
Cc3 , H 3 
V121 H11 , N Ca, C, C7 1, C72, H7 1 3  H72#  
F123 H, N Ca, C, C6, C6 , C, Ha, H, H6#3 H63 H 
Table 4.4: Table of residues that have doubled resonances and their degeneracy. 
4.4 Cisltrans proline conformations 
Proline is unique in that there is little difference in stability of its cis and trans forms. 
Most peptide bonds in proteins exist in trans geometry (in a ratio of approximately 
1000:1), but those involving proline (Xaa-Pro) may occur in either cis or trans 
configurations. Whilst the majority of these Xãa-Pro peptide bonds are in the trans 
conformation, the presence of the cis conformation is relatively common (an 
approximate ratio of 4:1). 
In NMR, NOE interactions from the proline residue to the preceding residue can be 
used to infer the configuration of the Xaa-Pro bond. If the trans configuration is 
present, medium to strong NOB interactions are seen between 1 -18's of the proline 
with Hn  and/or Ha of the preceding residue, Xaa (figure 4.14A, showing the 
interaction with H a of Xaa). If cis configuration is present, strong NOE interactions 
should be seen between the Ha of the proline and H11 and/or Ha of Xaa (figure 4.1413, 
showing the interaction with Ha of Xaa). 
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suggestion as to why two conformers are seen. Because the NOE interactions of the 
trans conformer of P86 are stronger (more intense), this was taken to be the major 
conformer and cis the minor conformer (named conformers one and two 
respectively). 
Alternatively, an indication of a cis Xaa-Pro configuration can be obtained from C 
and C. chemical shifts [293, 316, 339]. "Cp chemical shifts of cis Xaa-Pro are 
displaced upfield (to a smaller chemical shift value), while ' 3 C7 chemical shifts occur 
downfield (higher ppm value) compared to data for trans Xaa-Pro. There is, 
however, considerable overlap between the chemical shifts of both conformations. 
Recently, a method by which the chemical shift distance between Cp and C. can be 
reliably used as an indicator of cis or trans Xaa-Pro configuration has been noted 
[293]. For cis Xaa-Pro the range of chemical shift difference is 8.0— 12.5 ppm and 
for trans the range is 0 - 12.5 ppm. 
The (Cp - C 7) chemical shift difference for P78 is (34.0-23.7) = 10.3 ppm, which 
does not exclusively indicate cis Xaa-Pro; however, it supports the NOE evidence of 
that configuration. The (C - C 7) chemical shift difference of P86 is (32.6 —27.2) = 
5.4 ppm, which indicates a trans configuration. Assignment of P86 chemical shifts 
was difficult; C 7 and C8 of P86 could only be assigned with their attached protons in 
'H- 13 C-NOESY spectra. Second conformer cross-peaks were not found for any P86 
resonances, hence a the presence of a cis-Xaa-Pro configuration at F85-P86 could not 
be confirmed by 13 C chemical shift differences of Cp and C. of the second conformer. 
4.5 Hydrogen bonds 
DAF23 was re-suspended in D 20 buffer and 'H-' 5N-HSQCs recorded at different 
times (by Dr. Stanislava Ubrinova for original study). Amide protons undergo 
exchange with deuterium atoms and hence their amide cross-peaks in the 1 H 5N-
HSQC spectrum disappear. Protons that are involved in hydrogen bonds should have 
resonances that persist in the spectrum for longer. Once initial structure calculations 
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have been undertaken and some preliminary structures become available, potential 
hydrogen bonds can be examined. This was done with caution, any hydrogen bonds 
only being included when there was a good degree of certainty of their presence in 
terms of the proximity and orientation of potential hydrogen bond acceptors. 
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Figure 4.15: Overlay of 'H-' 5N-HSQC of DAF 23 in H20 buffer (in blue and yellow) with ' 5N-HSQC 
of sample in D20 buffer after 20 minutes (magenta). The cross-peak labelled 195E 151 T is the overlaid 
cross-peaks of T151 and E185. The peak labelled 1 39Q1091V is the overlaid cross-peaks of Q139 and 
the second conformer peak of V91, V1091. 
Five hydrogen bonds were inferred from the 1 H- 15N-HSQC spectra of DAF23 
acquired in D 20. Figure 4.15 compares the 'H- 15N-HSQC of DAF23 in H20 buffer 
with a 'H-' 5N-HSQC of DAF23 in D 20 buffer acquired 20 minutes after buffer 
exchanging. One of the remaining cross-peaks is the overlapping amide cross-peaks 
of T151 and E185. The amide group of T151, in all structures investigated, had no 
potential hydrogen-bond partners. On the other hand, El 85 did, making it the more 
likely candidate. The peak marked 139Q10911V corresponds to the overlapped 1 H-
15N-HSQC cross-peaks of Q139 and V1091 (i.e. the V91 amide cross-peak of the 
minor conformer). As a clear cross-peak remains at the V91 shift of the major 
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conformer, it can be fairly confidently assumed that this amide proton belongs to 
V91 of the minor conformer, as opposed to that of Q139. Also present are the amide 
proton cross-peaks of E94 and Y99 and the side-chain amide group of W179. 
Table 4.5 shows the hydrogen bond donors and acceptors used as input for CNS. 
Table 4.6 shows the hydrogen bonds used in structure calculation in the Ubrinova et 
al. work, the distance restraints between N and 0 of which are wrong and have most 






between H and 0 (A) 
Distance restraint 
between N and 0 (A) 
V91 NH L109 CO 1.95 ± 0.25 2.95 ± 0.25 
E94 NHn S74 CO 1.95 ± 0.25 2.95 ± 0.25 
Y99 NHn R96 CO 1.95 ± 0.25 2.95 ± 0.25 
W179 N6I-I1 P130 CO 1.95 ± 0.25 2.95 ± 0.25 
E185 NT-IA F163 CO 1.95 ± 0.25 2.95 ± 0.25 
Table 4.5: Hydrogen-bond donors and acceptors used in current structure calculations. Distances taken 






between H and 0 (A) 
(lower bound, upper 
bound) 
Distance restraint 
between N and 0 (A) 
(lower bound, upper 
bound) 
K76 NT-IA E92 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
V91 NHn L109 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
E94 NH,, S74 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
Y99 NHn R96 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
L109 NH V91 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
K125 NHn R100 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
Q139 NH,, S155 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
D141 NI-IA S153 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
1152 NHn S168 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
S155 NHn Q139 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
K161 NHn R187 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
F163 NHn E185 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
C170 NHn A150 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
R187 NHn K161 CO 1.88 (1.58, 2.30) 1.88 (1.58, 3.20) 
Table 4.6: Hydrogen-bond donors and acceptors used for structure calculation in Uhrinova etal. work. 
Chapter 5 
RECALCULATING THE SOLUTION STRUCTURE OF 
DAF23 
This chapter presents the calculation of both the major conformer (conformer one) 
and the minor conformer (conformer two) of DAF 23 , based on the reassigned original 
data with additional data sets. The method of RDC input and alignment tensor 
definition are also presented. The final ensembles of selected structures are shown. 
All structure calculation methods and protocols are defined in Chapter 3. 
5.1 Conformer one (major conformer) 
This section describes and presents the results of the calculation of DAF23 structures 
using restraints that correspond to the first (and major) conformer, which arises due 
to a cis conformation of P78 and a trans conformation of P86. NOB-derived distance 
restraints were generated from non-degenerate cross-peaks assigned to conformer 
one and degenerate cross-peaks, as described in Chapter 4. Section 5.2, below, 
describes and presents the results of the calculation of the second conformer, which 
arises due to a cis conformation of both P78 and P86. 
5.1.1 Structures calculated with NOE-derived restraints only 
Structures were initially calculated using only unambiguous NOB-derived distance 
restraints in round 1 (refer to section 3.7 for method and protocols of calculation); 11 
J39 
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structures out of 100 were judged to have converged (figure 5.1A). The converged 
set of structures were subsequently used to filter ambiguous restraints, and the 
resulting table of unambiguous and filtered ambiguous restraints (from which 
duplicate restraints had been removed) were used as the input restraints file in the 
second round of calculations. A total of 23 structures (out of 100) converged 
following this second round. Again, ambiguous restraints were filtered using the 
converged structures and any duplicated restraints removed. As before, the filtered 
ambiguous restraints along with the unambiguous restraints were used as input in a 
third round of calculations, but with inferred hydrogen bonds (see section 4.5) as 
additional input. A total of 23 converged structures (out of 100) from round 3 were 
used for filtering in round 4. Three further rounds of filtering and removal of 
duplicates ensued, with convergence of 20 structures in round 4, 25 in round 5 and 
25 in round 6. Figure 5.1 shows all convergence plots. 
Seven rounds were deemed sufficient as structures and filtered restraints files did not 
appear to be changing significantly at this stage. In the final round, a total of 2833 
NOE interactions (2149 unambiguous and 684 ambiguous), were used to calculate 
the final structures, resulting in 4062 restraints (table 5.1). A set of3l out of 100 
structures converged well, forming a clearly defined set (figure 5.1H). No violations 
above 0.5 A were found for this set of structures and only 5, inconsistent, violations 
above 0.3 A were observed. These final 31 structures were then subjected to a water-
refinement step in CNS, using as input the final unambiguous restraints table, 
ambiguous restraints filtered on the basis of round 6 structures and hydrogen bonds 
(i.e. the same set of restraints used in round 7). Figure 5.2 shows the ensemble of 
these 31 NOE-derived, water-refined structures. 
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Figure 5. 1: Energy plots for 100 structures calculated in A) round 1, B) round 2, C) round 3, D)round 
4, E) round 5, F) round 6, G) round 7 (final NOE-derived structures) and H) round 7 (RDC-refined 
structures). Energy (in kcal mol 4 ) is shown on the y-axes and structure number on the x-axes. 
Convergence cut-offs are shown by dotted lines except in round 7 plots where the low energy, 
converged set of structures is obvious. 
B) 
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No. of restraints Restraint type - No. of restraints Restraint type 
2449 Intraresidue 17 Intermodular 
770 Sequential 32 Module two - linker 
181 Medium range 20 Module three - linker 
662 Long range 169 Within the linker 
1987 Within module two 
1836 Within module three 
- 	
4O62intotal .. 
fable 5.1: Number and types 01 restraints used to cajcuiau wiiiuiiuci vu 
Figure 5.2: Ensemble of 31 NOE-derived structures after water-refinement. Shown overlaid on N, C 
and C atoms of A) module two (minus loops K76-F85 and E102-S106) and B) module three (minus 
loops V142-P146 and 1172-V 177). 
Over 90% of the q (phi) and W (psi) angles were found to be in the most favoured 
and additionally allowed regions of a Raniachandran map; however, the percent of 
angles in the disallowed region is rather high (table 5.2). 
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Region Percentage 
Most favoured 66.7% 
Additionally allowed 24.4% 
Generously allowed 4.5% 
Disallowed 4.3% 
Table 5.2: Ramachandran statistics for NOE-derived structures after water-refinement. 
5.1.2 Structure refinement with RDCs 
Round 7 structures were then refined with RDC-derived restraints. IDNH, 'Dcac' and 
1 DCaHa, measured as described in section 3.6, were used as input for the refinement 
step of the structure calculation protocol using the TENSO module of CNS [283]. 
TENSO contains an implementation of the Implicit Saupe tensor Alignment 
Constraint (ISAC) method and was discussed in section 3.7.6. 
RDCs measured for residues thought to be undergoing significant ps-ns timescale 
motion, determined on the basis of 600 MHz and 800 MHz ['H] ' 5N-NOE values 
below 0.65 (see figure 6.1 in Chapter 6, below), were excluded from the RDC 
refinement calculations as including these may introduce errors into the calculations. 
These residues were F6 1, R62, S63, T68, R69, Q77, Y84, Y93, S104, K108, L109, 
Qi 13, A120, V121, El22, El34, G145, S173 and H189. Also excluded were RDCs 
measured for residues possibly undergoing exchange on a ms-ps timescale, 
determined on the basis of the criterion of Tjandra et al. [334]: 
((T) 2 "2) ()-) >1.5xSDLHS 	 (57) 
T2 
T1 and T2 are the 15N longitudinal and transverse relaxation times respectively and 
SDLHS is the standard deviation of the left-hand-side of equation 57. Residues that fit 
this criterion are N71, S72, Q77, Q82, V87, G98, S104, L105, Li 12, Ti 19, G133, 
G144, G145 and L162. Other RDCs not included either correspond to cross-peaks 
that are too overlapped/unresolved, or to cross-peaks with shape such that it is not 
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possible to define an accurate cross-peak centre (inaccurate picking of a cross-peak 
centre would lead to errors in coupling measurements). 
5.1.2.1 Review of use of RDCs in Uhrinova et al. [345] structure 
calculations 
In the Uhrinova et al. study [345], a set of 'DNH RDCs were measured from an 
labelled sample aligned in cetylpyridinium bromide/hexanollNaBr. In that study, a 
total of 59 1 DNH RDCs had been used for structure refinement. Two alignment 
tensors, one describing each module, had been implemented into the CNS calculation 
using the 'DNH RDCs of each module for each alignment tensor. The use of two 
alignment tensors was based on several considerations. The structures that had been 
generated using NOE-derived distance restraints and H-bonds alone (i.e. no RDCs) 
had shown considerable variation in intermodular orientation (see figure 4.4 in 
Chapter 4). It was previously reported that significant flexibility in the linker 
between domains can result in different diffusion characteristics, and alignment 
tensors, for the two domains [79]. To determine whether the use of one, or two, 
alignment tensors was more appropriate, in the original work two separate sets of 
structures were therefore calculated using the RDC-derived restraints to refine the 
original NOE-based structures: one set with a single alignment tensor (set 'I AT', 59 
1 DNH RDCs), and a second set in which each module was assigned its own alignment 
tensor (set '2AT' using 28 'DNH RDCs for module two and 31 1 DNH for module 
three). The resulting CNS energy penalty terms were averaged for each converged 
ensemble; these are shown with backbone RMSD values in table 5.3. 
Ensemble ETOTAL ENOE ETENSO RMSDoveraii RMSDM2 RMSDM3 
'1AT' 1261.0 161.8 24.7 1.57 0.63 0.61 
'2AT' 1213.0 154.3 11.8 2.44 0.67 0.57 
Table 5.3: Original DAF23 energy penalties and RMSD values. The structures were overlaid on the 
backbone heavy atoms of the following residues: C64-L75 and P86-C124 for module two and C129- 
1140, L147-C156, Y160-C170 and Q178-C186 for module three. M2 and M3 denote modules two and 
three respectively. RMSD values are given in A, energy values are given kcal moE'. Data provided by 
Dr. Graeme Ball. 
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Uhrinova et al. [345] thus observed a significant energy increase with the use of a 
single alignment tensor for the whole molecule, with the 'tenso' energy doubling 
from 11.8 kcal mor' to 24.7 kcal mor 1 . A distribution of alignment tensors for each 
ensemble was calculated (by Uhrinova et al.) from the RDCs by singular value 
decomposition (SVD - section 2.2.2) using the program Orderten-SVD [175]. The 
alignment tensor distribution for the '1AT' set was calculated using all 59 DNH 
RDCs, with the ensemble of structures overlaid on both modules. For the '2AT' the 
distribution was calculated by overlaying the ensemble on each module in turn, and 
using only 'DNH RDCs from that module. The coordinate set used as a frame of 
reference was the lowest energy structure from the '1 AT' ensemble. The resulting 
distributions of alignment tensor eigenvectors are displayed using Sanson-Flamsteed 
projections in figure 5.3. These projections effectively show the penetration points of 
the x-, y- and z-principal axes of the alignment tensors calculated using SVD on the 
surface of a sphere (i.e. the axis direction). The size of each axis is reflected in the 
eigenvalues. 
The eigenvectors for the '2AT' set do not coincide well with those of the 'I AT' 
structures, and none are particularly well defined. The small size of the RDC dataset 
is likely to limit accuracy, especially amongst the '2AT' ensemble, in which only 
around 30 RDCs could be used as input for each module. The eigenvalues for each 
set were also calculated. These appear different, but lie within one standard deviation 
of each other (table 5.4). 
Set S ZZ S S, 
Original '1AT' 7.3(0.6) -6.7(0.6) -0.5(0.2) 0.85 (0.06) 
Original '2ATM2' 9.2(1.7) -8.5(1.6) -0.7(0.4) 0.84 (0.08) 
Original '2ATM3' 1 6.8 (1.3) 1 -6.0 (1.0) 1 -0.8 (1.1) 1 0.78 (0.21) 
Table 5.4: Average of distribution of original set of eigenvalues with standard deviations given in 
parentheses; S 11 values are shown x104. M2 and M3 denote module two and three respectively. i  is the 
asymmetry parameter. Based on original data provided by Dr. Graeme Ball and Dr. Krystyna Bromek. 
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Figure 5,3: Sanson-Flaxnsteed plots for original NMR structures of DAF 23  showing orientations of the 
alignment tensor eigenvectors. All sets were aligned using the lowest-energy structure of set '1 AT' as 
a coordinate set for frame of reference. A) Distribution of set 'I AT' eigenvectors: largest positive, 
largest negative and smallest eigenvalues shown in red, blue and green respectively. B) Distribution of 
set '2ATM2' and 2ATM3' eigenvectors. For set '2ATM2' largest positive, largest negative and smallest 
eigenvalues are shown in red, blue and green respectively. For set '2AT M3 ' largest positive, largest 
negative and smallest eigenvalues are shown in yellow, magenta and orange respectively. Based on 
original data provided by Dr. Graeme Ball. 
The distributions of alignment tensors did not appear to provide a definitive 
conclusion as to whether the use of one, or two, alignment tensors was more 
plausible. Therefore, the most significant difference resulting from implementation 
of two alignment tensors, compared to the use of a single alignment tensor, was the 
decrease in 'tenso' energy. 
5.1.2.2 Use of RDCs in new structure calculations 
A similar process was carried out using the new RDCs and the new structures 
generated in the current work. The NOE-denved structures (i.e. no RDCs) from the 
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current work (see figure 5.2) show a marked difference in the spread of the 
intermodular angles compared to the structures from the original work (see figure 
4.4), with a much better definition of the junction (presented in section 5.1.3 below). 
Subsequently, three sets of calculations were carried out as follows. One set of 
structures was calculated using a single alignment tensor and all of the RDCs 
('1AT L '). Another set of structures was calculated using two alignment tensors, 
one defining each module, and employing RDCs for each module as appropriate 
(linker-residue RDCs were not included) ('2AT'). Finally, a set of structures was 
calculated with a single tensor and using all of the RDCs except those from linker 
residues ('1ATNL'). This third calculation was performed in order to be able to 
directly compare the average 'tenso' energy term for the use of one or two alignment 
tensors (as otherwise, inclusion of extra RDCs in the single tensor calculation would 
affect the overall 'tenso' energy term). The results of this are summarised in table 
5.5. 
Set Cony. ETOTAL ENOE ETENSO RMSD RMSD RMSD 
M2 M3 M2&M3 
'1ATALL' 31 948.09 32.97 44.76 0.804 0.700 1.054 
(20.67) (4.45) (4.78)  
'1ATNL ' 29 916.35 32.33 35.62 0.865 0.695 1.092 
(28.51) (4.62) (4.19)  
'2AT' 29 918.19 33.44 34.23 0.863 0.733 1.626 
(32.31) (5.71) (4.43) 1 
Table 5.5: Table shows average energy penalties for each set of converged structures (in kcal mor'), 
standard deviations shown in brackets. RMSDs (in A) shown are from the structures overlaid on 
residues C64-C124 for module two, C129-C186 for module three and C64-C 186 for both modules. 
Cony, refers to the number of structures that converged out of 100 in that particular set. 
From this table, only the bottom two rows can be compared with one another 
directly, but the information for the 'I AT' structures calculated using all RDCs 
(named '1ATALL here) has been included for completeness. The main differences 
between the '2AT' and the 'I AT' structures are the root mean standard deviations 
(RMSDs) of the structure ensemble backbone overlay over the complete molecule. 
The '2AT' structures show a less defined intermodular junction. However, despite 
the seemingly large RMSD difference (from 1.054 A to 1.626 A), the spread of 
orientations in '2AT' is limited. This can be seen in figure 5.4 where the '2AT' 
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structures are shown overlaid on module two. Also shown are the '1 AT' structures 
and the '1 ATALL' structures in order to illustrate the differences. 
In comparing the energy terms for the '1 ATN set and the '2AT' set it can be seen 
that the differences are minimal. This suggests that using two alignment tensors has 
the same effect as using one alignment tensor and suggests that the two alignment 
tensors may be in fact very similar to each other and to the single alignment tensor. 
A) 
I 
Figure 5.4: Overlay of ensemble of A) 'IATALL' structures (31 of), B) 'IATNL' structures (29 of) and 
C) '2AT' structures (29 of). All structures are overlaid on module two on N, C a  and C of residues 
C64- L75, P86-RiOl and P107-C124. 
In order to investigate the distribution of alignment tensors for each ensemble SVD 
(using the Orderten-SVD program [175j) was again used. To put all the structures 
into the same coordinate frame, each set was first overlaid on the lowest energy 
structure of the '1 AT' set, which thus became the coordinate frame of reference. For 
the '1 AT' set, the 31 structures were overlaid over both modules (from the first 
cysteine to the last cysteine, C64-C186) and SVD was carried out using all 173 
RDCs. For the '2AT' set, the distribution of alignment tensors of module two was 
calculated using the ensemble of 29 structures overlaid on backbone atoms from the 
first cysteine to the last of module two (C64-C 124) and the 70 RDCs from module 
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two only. The alignment tensor of module three was calculated using the 29 
structures overlaid on the backbone from the first cysteine to the last of module three 
(C129-C186) and the 93 RDCs from module three only. Sanson-Flamsteed 




.......... .. . . ..... .. . ...... .. 	..... .... 
_I 
Figure 5.5: Sanson-Flamsteed plots of alignment tensor distributions for new structures of DAF23 
showing the orientation of the alignment tensor eigenvectors. All sets were aligned using the lowest 
energy structure of set '1 ATALL' as a coordinate frame of reference. A) Distribution of eigenvectors 
for set '1 ATALL': largest positive, largest negative and smallest eigenvalues shown in red, blue and 
green respectively. B) Distribution of eigenvectors for set '2ATe' and '2ATM3'. For set '2ATM2' 
largest positive, largest negative and smallest eigenvalues are shown in red, blue and green 
respectively. For set '2ATM3' largest positive, largest negative and smallest eigenvalues are shown in 
yellow, magenta and orange respectively. 
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The eigenvector distribution of the '1AT L ' set is relatively well defined, with clear 
areas of distribution for each eigenvector. Figure 5.513 shows the distribution of 
eigenvectors for each module's alignment tensor in the '2AT' set; the distributions in 
each case are less well defined. The difference is likely to at least partly result from 
the reduced sampling of RDCs when calculating over one module only. Eigenvectors 
for module three are better described than that of module two. Eigenvector 
orientations for each module coincide and have approximately the same coordinates 
as the orientations of the eigenvectors calculated for the '1 AT' set. This data 
suggests that both modules experience the same alignment. 
The eigenvalues of the alignment tensor distributions are summarised in table 5.6. 
Set S S S, 11 
'1AT L ' 8.25 (0.60) -6.15 (0.54) -2.09 (0.37) 0.49 (0.08) 
'2ATM2' 7.40 (0.84) -5.64 (0.84) -1.75 (0.55) 0.53 (0.14) 
'2ATM3' 9.17(l.2) -7.00 (1.3) -2.18 (0.52) 0.52 (0.13) 
Table 5.6: Alignment tensor eigenvalues of the three structure sets. S 1 values are shown x10 4 and are 
average values with standard deviation in brackets. M2 and M3 denote modules two and three 
respectively. rl is the asymmetry parameter. 
The averages of the eigenvalue distributions appear only slightly different, and agree 
within one standard deviation of each other. The spread of values is relatively good 
for the 'I AT' set, but is worse in the '2AT' set, particularly for module three. 
Overall, a relatively good agreement is found for the tensors of module two and three 
with the overall tensor of the molecule. From this data, and based on the 'tenso' 
energy term, it was reasoned that the use of one alignment tensor over both modules 
was justified. 
5.1.3 Final structures of DAF23 
Figure 5.1 H shows the energy plot of the 100 structures calculated by refining round 
7 structures with RDCs (using one alignment tensor). A good convergence of 31 
structures was observed (figures 5.6 and 5.7). There were a total of 11 NOE 
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A. The RMSD value for the final structures of DAF2-i from the first cysteine of 
module two to the last cysteine of module three (C64-C1 86) overlaid on the 
backbone N, C and C' atoms was 1.054 A. From the first to the last cysteine of 
module two the RMSD was 0.804 A (excluding loops K76-F85 and P103-L105 gave 
RMSD of 0.719 A) from the first to the last cysteine of module three the RMSD was 
0.700 A (excluding loops of P143-G145 and S173-S176 gave an RMSD of 0.628 A). 
Table 5.7 shows the Ramachandran statistics of the RDC-refined ensemble of 31 
structures. 
Figure 5.6: RDC-refincd final structures of DAF. A) Overlaid on N, C and C of residues C64-1,75, 
P86-E102, P106-C 124 (module two minus loops). B) Overlaid on N, C. and C of residues C 129- 
V142,114641 72 and V 177-C 186 (module three minus loops). 
Table 5.7: Rarnachandran statistics of ensemble of RDC-refined structures. 
Region Percentage 
Most favoured 47.4% 
FAdditionally allowed 42.0% 
enerously allowed 6.7% 
Disallowed 1 	3.9% 
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Figure 5.7: RDC-refined final structures of DAF 2 3 overlaid on N, C and C of residues C64-L75, 
P86-E102, P106-V142,1146-1172 and V177-C186 (both modules minus loops). 
5.2 Conformer two (minor conformer) 
The same method employed to calculate the structure of conformer one was used to 
calculate that of conformer two. Seven rounds of structure calculation, filtering and 
checking were carried out. in round 1, 13 structures converged (out of 100); these 
structures were subsequently used to filter ambiguous restraints. The resulting table 
of unambiguous and filtered ambiguous restraints (from which duplicate restraints 
had been removed) was used as the input restraints file in the second round of 
calculations. A total of 28 structures converged (out of 100) following this second 
round. Again, ambiguous restraints were filtered using the converged structures, and 
any duplicated restraints were removed. As before, the filtered ambiguous restraints 
along with the unambiguous restraints were used as input in a third round of 
calculations, but with inferred hydrogen bonds (see section 4.5) as additional input. 
A total of 19 converged structures from round 3 were used for filtering in round 4. 
Three further rounds of filtering and removal of duplicates ensued, with convergence 
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of 25 structures in round 4, 23 in round 5 and 26 in round 6 (figure 5.10). A final 25 
NOE-derived structures converged in round 7. A total of 2736 NOESY crosspeaks 
(2104 unambiguous and 632 ambiguous) were used to calculate these final 
structures, resulting in 3817 distances restraints (table 5.8). 
No. of restraints Restraint type - No. of restraints Restraint type 
2335 Intraresidue 17 Intermodular 
726 Sequential 32 Module two - linker 
168 Medium range 20 Module three - linker 
588 Long range 169 Within the linker 
1830 Within module two 
1749 Within module three 
3817 in total 
Table 5.8: Number and types of restraints used to calculatre conformer two structures. 
These structures were also refined using RDCs, employing the same method as was 
used for conformer one. Residues were excluded using the same criteria, as described 
in section 5.1.2. V91 'DNH and V90 'DC a Ha and 'D a ' could not be included because 
the second conformer cross-peak of V91 is overlapped with that Q139. A 
convergence of 21 structures out of 100 was obtained for the RDC-refined structures 
of conformer two; the energy plot of the 100 structures is shown in figure 5.8H. 
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Figure 5.8: Energy plots of 100 structures calculated in A) round 1, B) round 2, C) round 3, D) round 
4, E) round 5, F) round 6, G) round 7 (final NOE-derived structures) and H) round 7 (RDC-refined 
structures). Energy (in kcal mol') shown on vertical axes and structure number ranked according to 
total energy on horizontal axes. 
B) 
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Figure 5.9: Ensemble of conformer-two final structures. A) Overlaid on the backbone atoms of 
module two (excluding loops Q77-F85 and P103-L105). B) Overlaid on the backbone atoms of 
module three (excluding loops V142-P146 and 1172-V177). 
There were a total of 11 violations in the ensemble of final structures above 0.3 A, 
none of which were above 0.5 A. The ensemble is shown in figure 5.9. 
The RMSD of N, Ca and C' atoms over the backbone of modules two and three of 
conformer two (from C64 to C186) is 1.116 A and minus loops Q77-F85, P103-
L105,V1142-P146 and 1172-V177 is 1.014 A. Over module two residues only 
(backbone N, Ca and C' from C64 to C124) the RMSD is 0.933 A, minus loops Q77-
F85 and P103-L105 is 0.795 A. Over module three residues only (backbone N, Ca 
and C' from C129 to C186), RMSD is 0.669 A and minus loops V142-P146 and 
11 72-V177 is 0.615 A. Ramachandran statistics are shown in table 5.9. 
Table 5.9: Ramachandran statistics of ensemble of RDC-refined structures of conformer two. 
Region Percentage 
Most favoured 50.1% 
Additionally allowed 49.1% 
Generously allowed 7.0% 
Disallowed 3.7% 
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5.3 Comparison of conformers 
Residues with doubled resonances are located in strands that lie close together, in the 
upper half (with the exception of L75) of module two (when module three is 
described as being located below module two). Figure 5.10 shows these residues 
mapped onto the closest-to-mean structure from the ensemble of conformer two 
structures. 
Figure 5.10: Backbone atoms 'sticks' representation in cross-eyed stereo of module 2 from the 
closest-to-mean structure of the ensemble of conformer 2 structures. Residues with dual resonances 
are shown in cyan to highlight their positions in the structure. 
Figure 5.11 shows cartoon representations of the closest-to-mean structure of the 
ensemble of conformer one structures (green) and that of the ensemble of conformer 
two structures (magenta). The structures are overlaid on the backbone atoms of 
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module two, minus loops Y79 to F85 and P103 to L105. The conformations of the 
backbones are almost identical, with the obvious exception of the loop from Y79 to 
F85, the individual residues of which are labelled in the figure. 
Figure 5.11: Cartoon representation of module two from the closest-to-mean structure of conformer 
one (shown in green) and the closest-to-mean structure of conformer two (shown in magneta). 
Structures are overlaid on the backbone atoms of C64-P78, P86-E 102 and S 106-C 124. Residues 
between P78 and P86 are highlighted. 
Figure 5.12A show the ensemble of structures of both conformers overlaid on 
module two (minus the same loops). There are three notable regions of slightly 
different structure and/or position. The first, most prominent, region is the Y79 to 
F85 region as was also evident from figure 5.11. The second region of interest is 
from approximately L70 to S74; this loop adopts slightly different positions between 
the conformers. The third region that lies in two slightly different positions is C95 to 
L105. The differences in these latter two regions were not anticipated as their 
residues do not have any doubled resonances. These apparent differences may be 
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artefacts resulting from structure calculation; relaxation data does not indicate 
concerted movement of either of these regions (refer to Chapter 6). 
Figure 5.12: A) Module two overlays of conformer one (green) and conformer two (magenta), B) with 
residues P93-C95 cut out (between the black lines) in order to show residues L70 onwards. 
What is more surprising, as shown in figure 5.13, is a slight difference in 
intermodular orientation between the two conformers. Figure 5.1613 shows the two 
ensembles overlaid on the backbone atoms of module three (minus loops) confirming 
that the module-three structure is the same throughout, for both conformers, even in 
loop regions such as the one that occurs at the intermodular,  junction, L171 to Q178. 
It seems likely that the apparent minor shift in position of the C95 to L105 region 
arises due to the difference in orientation. Residues R96 to R100 have moved 
slightly towards module three. As will be shown in the subsequent section, these 
residues are involved in the 2-3 junction. The movement of these residues and also a 
shift in the position of residues L70 to S74, is most likely mediated by the change in 
intermodular orientation, shown in figure 5. 1213 above, which is likely to be an 
artefact of structure calculation. 
This apparent difference in intermodular orientations will be considered further in the 
discussion chapter (Chapter 8). 
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to-linker NOE-derived restraints were used in the final structure calculations. A 
summary of these interactions is shown in tables 5.10, 5.11 and 5.12. 
Linker - module two NOE-derived 
restraints 




K125-Y99 2 1 
K125-R100 2 1 
K125-R101 - 2 
K125-E102 - 3 
K125-L105 - 1 
K125-E122 - 1 
K125-C124 3 -. 
K126-G98 1 - 
K126-Y99 17 8 
K126-R100 1 1 
K127-G98 - 2 
K127-Y99 - 2 
K127-R100 - 9 
S128-R100 - 1 
Total 26 32 
Table 5.10: Summary table of module two-to-linker interactions used in structure calculations of both 
Uhrinova et al. and current work. 
Linker - module three NOE-derived 
restraints 




K126-L147 - 4 
K126-F148 - 4 
K127-F148 - 1 
K127-S176 2 4 
K127-V177 18 - 
S128-C129 2 - 
S1284146 - 2 
S128-L147 5 4 
S128-V177 - 1 
Total 27 20 
Table 5.11: Summary table of linker-to-module three interactions used in structure calculations of 
both Uhrinova et al. and current work. 
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Module two - module three NOE-derived 
restraints 




P97-1172 3 7 
G98-1172 2 4 
G98-V177 - 4 
Y99-F148 - 1 
Y99-1172 1 1 
Total 6 17 
lable -).12: SummarY moie oi mouw LWU-LULUUUUI  
of both Uhrinova et al. and current work. 
The key residues involved in contributing NOE-derived restraints that hold the 
modules together are the linker residues (K125-S128), P97, G98, Y99, R100, L147, 
F148. 1172 and V177. Figure 5.14 shows residues at the intermodular interface of the 
closest-to-mean structure of conformer one, with module two in blue, module three 










Figure 5.14: The intermodular junction of the closest-to-mean structure of conformer one. No protons 
are shown. Module two is shown in blue, linker residues in green and module three in red. Important 
residues are highlighted. 
K125 exhibits NOE interactions with residues from module two only. K126 and 
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contacts with module three; the only NOE interaction seen between S128 and 
module two are to the H1s of R100, whose side-chain sits down over the linker 
region, close to the side-chain of K127. The three lysines of the linker point in three 
distinctly different directions and are mostly buried. The side-chain of K! 27 sits 
between loops from modules two and three that exhibit NOEs with each other 
(residues P97-Y99 and 1172 / V177 respectively). The side-chain of K126 lies 
between Y99 and F 148, which also are in NOE range. 
Figure 5.15 shows residues at the intermodular junction from the closest-to-mean 
structure of conformer two. The linker residues take on similar distinct orientations 
as in conformer one. 
Figure 5.15: The intermodular junction of the closest-to-mean structure of conformer two (in a similar 
orientation to that of conformer one, as shown in figure 5.17). No protons are shown. Module two is 
shown in blue, linker residues in green and module three in red. Important residues are highlighted. 
A calculation of the buried suface area at the interface was performed, with the help 
Dinesh Soares (University of Edinburgh), on the closest-to-mean structure of the 
CHAPTER 5: RECALCULATING THE SOLUTION STRUCTURE OF DAF23 163 
conformer-one ensemble. This was done using the web server "GETAREA 1.1" 
(http://w" -w.scsb.utmb.edu/cgi-bin/get —a—forin.tcl). First, the surface area of the 
module pair (from S63 to R187) was calculated followed by the surface areas of each 
module in turn (S63 to K126 for module two and K127 to R187 for module three). 
The surface area that is buried at the interface was calculated as the surface area of 
the module pair minus the sum of the surface area of both individual modules. The 
buried surface at the interface of the above mentioned structure was estimated to be 
600.6 A2 . 
Figure 5.16 shows, for comparison, the intermodular junction from the closest-to-
mean structure of the Uhrinova et al. set of DAF structures [345]. The backbone of 
the linker residues is linear, with the side-chains more exposed and less buried in the 
junction. The K125 and K127 side-chains are oriented in the same direction as each 
other, that of K126 in the opposite direction. Contacts seen between the linker 
residues and the modules themselves appear to be different than in the current 
structure. Taken from reference [311], the estimated buried surface area of an 












Figure 5.16: The intermodular junction of the closest-to-mean structure of the Ubrinova el al. 
structures. No protons are shown. Module two is shown in blue, linker residues in green and module 
three in red. Important residues are highlighted. 
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5.5 Comparison.to X-ray crystal structures 
Figures 5.17 and 5.18 show overlays of the conformer-one ensemble (31 structures) 
and the conformer-two ensemble (21 structures) with the crystal structures, 
respectively. The structures are very similar. The inferred flexibility of the solution 
structure is much more limited than in the original work, and the intermodular 
orientations of the NMR-derived structures of both conformers now coincide with 
those of the crystal structures. 
Figure 5.19 shows the intermodular junction of the crystal structures. The positions 
of the linker residues are very similar to those of the new NMR-derived structures; 
the same distinct orientations of the side-chains are seen. Module residues found at 
the junction are also in similar positions as those from the new NMR structures. 
Refer to figures 5.14 and 5.15 for comparison with the junction of the new NMR 
structures (conformers one and two, respectively) and figure 5.18 for comparison 
with the junction of the original structures. Structures solved by both methods will be 
discussed further in Chapter 8. 
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180] 
Figure 5.17: New RDC-refined conformer-one structures (blue) and crystal structures (red). Overlaid 
on backbone heavy atoms from residue C64 to C186, minus Q77-F85, E102-L105, P143-0145 and 
1172-V177. 
IOU 
Figure 5.18: New RDC-refined conformer-two structures (blue) and crystal structures (red). Overlaid 
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Figure 5.19: Intermodular junction of the highest-resolution crystal structure. Linker residues are 
shown in green, those of module two in blue and those of module three in red. 
Figure 5.20 shows overlays of the crystal structures and the new NMR structures at 
the 2-3 junction. The crystal structures show the side-chain of K125 in a number of 




Figure 5.20: Intermodular junction (2-3) of A) all eight crystal structures of DAF 1234 overlaid on 
backbone heavy atoms and B) 25 structures from new NMR ensemble (conformer one) overlaid on 
linker residue backbone heavy atoms, modules are shown as lines to limit overcrowding the picture. 
Module two is shown in blue, module three in red and linker in green. No protons are shown. 
Also taken from reference [311], the estimated buried surface area at the 2-3 
interface of the highest-resolution crystal structure was 602.5 A2 . 
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5.5.1 'Back-calculation' of NOE interactions from crystal structures 
Using PDB files and the program X-PLOR [25], it is possible to 'back-calculate' 
NOE-derived distance restraints. X-PLOR is the precursor program to CNS and 
includes a relaxation matrix that allows the 'back-calculation' of 'spectra'. The 
output of this procedure is a text file listing pairs of protons that are close enough in 
space to participate in an NOE interaction. 'Spectra' were back-calculated for 
modules two and three taken from all eight crystal structure models of full DAF1234. 
Prior to back-calculation, protons were built onto the crystal structures using X-
PLOR. X-PLOR allows regions, between which NOE interactions are to be back-
calculated, to be specified. This specification was set to provide first, the 
intermodular NOEs, and then linker-to-module NOEs. 
Table 5.14 summarises the back-calculated strong NOEs (i.e. between protons less 
than 3.3 A apart) that arise between module two and module three in the eight crystal 
structure models. Appendix 9 (page 316) contains tables summarising those between 
the modules and the linker residues. These tables show how many of the models the 
interaction is detected in, and whether or not that interaction is observed in actual 
NOESY spectra (based on the current assignment). It was expected, due to the 
structural similarity between the current NMR structures and the crystal structures, 
that most of the back-calculated interactions would be observed in the experimental 
spectra. They also indicate whether these interactions were defined as restraints in 
the original study. Before this, table 5.13 shows a summary of the information within 
these tables, without reference to specific interactions or the number of models from 
which they arise. 
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Total In Interactions with In Interactions 
current unassigned atom Uhrinova with unassigned 
analysis (current work) et al. list atom (Uhrinova et 
al. work) 
Moduletwo - 14 5 4 4 4 
module three  
Module two- 93 15 22 3 21 
linker  (26 P)  
Module three 46 6 8 9 7 
- linker  (22 P)  
Table 5.13: Summary of information contained in tables 5.12 and Appendix 9. 'In' refers to whether 
that interaction is present in the experimental data. 'Interactions with unassigned atoms' refers to an 
interaction back-calculated from crystal structures involving an atom whose chemical shift has not 
been assigned, hence cannot be confirmed. Where the NOE interaction could possibly be represented 
by a NOESY cross-peak, but it is too overlapped for that restraint to be resolved, (P) is inserted. 
Back-calculated module No. of Seen in current Seen in Uhrinova et al. 
two - module three NOE models experimental NOESY experiment NOESY 
interaction  assignments assignments 
P97H1-I172Hy11 3 N N 
P97H1-I172H51# 1 Y Y 
P97H132-II72Hy11 7 Y N 
P97H2-I172H5 1# 3 Y Y 
G98Hn-F148H2 1 N N 
G98Hn-F148HcI 5 N N 
G98 Hn - 1172 HP 1 N N 
G98 Hal -1172HJ3 5 N N 
G98Ha1-V177Hy1# 7 Y N 
Y99H62-F148H61 8 Y N 
HTI  1 - - 
Y99Hi1-F148H82 1 - - 
Y99Hi-F148Hc1 1 - - 
Y99Hrj-F148Hc2 I 	1 I 	 - - 
Table 5.14: Table of back-calculated NOE interactions between the module two and module three 
from X-ray crystal structures of DAF 23 . Those shown are between protons less than 3.3 A apart (so 
should give rise to a strong NOE). Where one of the protons involved in the interaction has not been 
assigned, a dash is inserted. Where the NOE interaction could possibly be represented by a NOESY 
cross-peak, but it is too overlapped for that restraint to be resolved, (P) is inserted. 
Chapter 6 
RELAXATION AND DYNAMICS OF DAF23 
NMR is one of the most powerful experimental techniques for characterisation of 
protein dynamics [114, 123, 124, 223, 224]. Relaxation of NIVIR signals are primarily 
governed by dipole-dipole interactions and chemical shift anisotropy (refer to section 
2.3 in Chapter 2). In solution, the main processes behind this relaxation are Brownian 
motion of diffusion and local internal motions. When global tumbling and internal 
motions are uncorrelated, fitting relaxation data to the model-free models of 
dynamics can recover a significant amount of quantitative information on the internal 
dynamics of a protein [38, 44, 163, 164] and motions over a range of timescales can 
be probed at the atomic level. This chapter presents the NMR relaxation data 
obtained for DAF 23 and its interpretation in terms of the model-free method of 
analysis. The purpose of this work was to examine the possibilities of intermodular 
and intramodular motions, with a view to gaining further insight into DAFs 
convertase binding site and mode of action. 
61 Analysis of relaxation data 
Tables of 600 MHz and 800 MHz relaxation data are shown in Appendix 11 (page 
321). Plots of T I , T2, the TI/T2 ratio and ['H]' 5N NOB are shown in figure 6.1. T, 
and T2 relaxation times are field-dependent, T, increases with increasing magnetic 
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Residues quoted with 'low' and 'high' values for relaxation times are defined as 
those that have values greater than 1 .5x the standard deviation value away from the 
mean. 
ll II 	il llhi 	1111 ll iMll 
Residue number 
Figure 6.1: Relaxation data at 600 MHz (shown in black) and 800 MHz (shown in red). A) T 1 B) T2 
C) T 1/T2  and D) heteronuclear NOE. The x-axis shows residue number for all four plots. Filled 
squares in the appropriate colour show the relaxation data for conformer two residues, if data was 
available. The thick black horizontal bars at the top of each diagram show where the modules are and 
the thin joining bar shows where the linker residues are. 
The mean amide 15N Ti value for the module pair was 747.0 ± 75.6 ms for data 
acquired at 600 MHz and 989.0 ± 126.3 ms for data acquired at 800 MHz. Residues 
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with high T 1 were N71, Q77, T82, S104, L105, T110, G133, E134, V142, G144, 
G145 and G164. Residues with low T 1 values are V91, C95, G98, Al 50, G159, S174 
and the non-native H18 9. 
The mean amide ' 5N T2 value for the module pair was 86.2 ± 13.6 ms for data 
acquired at 600 MHz and 75.2 ± 14.0 ms for data acquired at 800 MHz. Residues 
with large T2 values were F61, R62, V66, L70, Y84, G88, Qi 13, V121, C156, N157, 
R187 and the non-native H189. Residues with low T2 values are N71, C64, S104, 
Li 12 and G144. 
The mean amide ' 5N T 1 /T2 ratio for the module pair was 8.88 ± 1.80 for data 
acquired at 600 MHz and 13.50 ± 3.00 for data acquired at 800 MHz. Residues with 
high ratio values were C64, N71, Q77, Q82, V87, S 104, L105, Li 12, G133, G144 
and G145. Residues with low ratio values were R62, G88, Qi 13, Li 15, V121, A150, 
N157, R187 and the non-native H189. 
Residues undergoing motion on a millisecond to microsecond timescale (so-called 
chemical exchange) can be determined on the basis of the criterion of Tjandra et al. 
[334], as defined in equation 57 (see section 5.1.2, page 143). Residues that fit this 
criterion are N71, S72, Q77, Q82, V87, SiO4, L105, Li 12, Ti 19, GI 33, G144, G145 
and Li62. These residues are mapped onto the closest-to-mean structure of 
conformer one, in red, in figure 6.2. 
The range of heteronuclear NOE values was from 0.482 (E122) to 0.820 (E92) and 
the mean was 0.702 ± 0.059. Most residues have fairly consistent values. Residues 
with values less than 0.65 (inferring that they are flexible) are: R62, S63, T68, R69, 
Y84, S104, L109, Qi 13, A120, V121, E122, G133, E134, G145, T166, S173 and 
Hi 89. This suggests that the N-H bond vectors of these residues are relatively 
mobile. These residues are mapped onto the closest-to-mean structure of conformer 
one, in blue, in figure 6.2. Residues that fit both the Tjandra criterion, and have low 
heteronuclear NOEs, are mapped in magenta. 
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The residues mapped onto the structure in figure 6.2 are considered to be undergoing 
internal motion different to the average motion of residues within the molecule. 
Many of these residues are in module two (on left), suggesting more internal motion 
within module two than module three. Many appear in loops. 
510 G144 
T119 












Figure 6.2: DAF23 closest-to-mean structure (conformer one). Residues shown in red have a larger 
than average T1/T2 ratio and those shown in blue have lower heteronuclear NOE values. Residues 
fitting both criteria are shown in magenta. 
The linker region showed average ' 5N T 1 , T2, T1/T2 and [ 1H]' 5N NOE values, as did 
other important areas at the intermodular junction; Y99-R100, L147 and 1172 
(relaxation data for F148 and V177 are not available due to overlap of their amide 
cross-peaks with those of other residues). This implies internal motion within the 
linker is on the same timescale as for the majority of residues within the module pair. 
The macromolecular overall correlation time at each field strength and for each 
module was calculated using the program r2  1_tm from the Palmer group website 
[228]. This uses the T1/T2 (or R2/R1) ratio of each residue that is not thought to be 
flexible (residues with NOEs higher than 0.65) or undergoing motion on a ms-is 
timescale, and outputs a local correlation time for each, the mean of these should 
give a reasonable estimate of the overall tumbling time of the molecule. Table 6.1 
shows the results of this calculation. 
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tm estimate / ms 
600 MHz 800 MHz 
Overall 8.96± 1.0 8.52± 1.2 
Module two 8.97± 1.2 8.65± 1.4 
Module three 1 8.95 ± 0.9 8.35 ± 1.0 
Table 6.1: Estimations of correlation times from R 2/R 1 data using the program r2rl_tm. 
The 600 MHz data gives consistent values for the overall correlation time of the 
whole molecule and those of each module. The 800 MHz data, however, although 
similar, suggests the tumbling of module three is slightly faster than that of module 
two, but the values are not significantly different. This is consistent with the two 
modules being tethered together such that they do not move much independently of 
one another. 
6.2 Diffusion 
T1 and T2 relaxation times can be used to determine the most suitable model of 
rotational diffusion for a molecule and to estimate its diffusion tensors (D i, D and 
D) (refer to section 2.3.2 in Chapter 2). Information on whether fitting the data to an 
anisotropic model gives a significant improvement over fitting to an isotropic model 
(where Dx = D = D) can also be calculated. When a molecule tumbles 
anisotropically, either axially symmetrically (where D x = D) or fully anisotropically 
(where D D 7' Di), the relaxation times become dependent on the angles the bond 
vectors make with the longest axis of diffusion. In order to fit model-free parameters 
correctly, the diffusion axis must be described (unless the relaxation data is fit locally 
to each residue). Note that an axially symmetric diffusion tensor can be prolate or 
oblate. In the prolate model D z is greater than D = D, and in the oblate model D = 
D is greater than D. 
The data was first 'trimmed'; any residues exhibiting motion different to the rest of 
the molecule were not included in fitting a diffusion model. Data from 600 MHz and 
800 MHz were fitted separately. Five different structures from the ensemble of 
conformer one structures were used to fit the data to the diffusion models; these were 
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the closest-to-mean structure, the second closest-to-mean structure, the lowest energy 
structure, the second lowest energy structure and a structure that was the fourth 
closest-to-mean and fifth lowest energy structure. 
In order to compare fitting to the isotropic model to fitting to the axially symmetric 
model and to the fully anisotropic model, the method of BrUschweiler et al. [28] and 
Lee et al. [153] was used. This is implemented in the program 
quadratic diffusion (also available from the Palmer group website) and fits the 
individual correlation times calculated (using r2rl_tm) for selected residues (i.e. 
the trimmed data set) to a quadratic function. The fitting of the above stated 
structures is summarised in table 6.2, which give the a value calculated for each 
case, where a is the (1-a) x  100% confidence level. A full table of results can be 
found in Appendix 10 (page 319). 













CTM 0.065 0.411 0.123 0.0457 0.199 0.197 
CTM2 0.005 0.251 0.301 0.0594 0.542 0.879 
LE 0.023 0.101 0.153 0.0325 0.610 0.656 
LE2 0.143 0.006 0.062 0.0328 0.122 0.114 
CTMLE 0.002 1 	0.350 0.031 0.0452 1 	0.116 0.081 
Table 6.2: Table of cc values from diffusion model fitting using quadrat ic_diffusion. cc is the (1- 
cc) x 100% confidence level. AS refers to axially symmetric anisotropy, CTM to closest-to-mean 
structure, CTM2 to the second closest-to-mean structure, LE to lowest energy structure, LE2 to the 
second lowest energy structure and CTMLE to the structure that is fourth closest-to-mean and fifth 
lowest in energy in the ensemble of conformer-one structures. 
When fitting with 600 MHz data or 800 MHz data, all five structures show a 
significant improvement in fitting the data (i.e. a lower value of a) to an axially 
symmetric diffusion tensor over an isotropic diffusion tensor (to less than a = 0.05 
for 600 MHz data and a = 0.06 for 800 MHz data, where a is the (1-a) x 100% 
confidence level). All structures except one (the second lowest energy structure) fit 
the prolate case over the oblate case. A further attempt to fit the data to a fully 
anisotropic diffusion tensor resulted in no statistically significant improvement in the 
fit of the data. 
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From these results, a prolate axially symmetric diffusion model is implied. This is 
certainly consistent with the oblong shape of the overall molecule. From the above 
fitting of a prolate axially symmetric diffusion model with 
quadratic diffusion, the diffusion tensor ratio D11/Di(where D11 = D and Di = 
DX  = Dr), averaged for all five structures fitted, was 1.284 ± 0.05 5. The angles 0 and 
4 were 21.8 ± 4.6 O  and 190.8 ± 108.9 O  respectively. Figure 6.3 shows a diagram of 
an axially symmetric diffusion tensor, and defines D11, Di and angles 0 and . 
FolF 
Figure 6.3: Representation of an axially symmetric diffusion tensor. D = D11 and D x = D = D. The 
oblong shape represents the molecule. z, y and x are polar coordinates. 0 and relate the diffusion 
tensor to these coordinates. 
6.3 Model-free 
The general theory of the model-free approach is outlined in Chapter 2 (section 
2.3.2) and the method used for fitting model-free parameters is given in Chapter 3 
(section 3.9). 
Model-free fitting of relaxation data, simultaneously from both 600 and 800 MHz 
NMR data, was performed using a prolate axially symmetric diffusion model and the 
closest-to-mean structure from the ensemble of conformer-one structures. The length 
of the amide bond was taken for this work to be 1.02 A, the chemical shift anisotropy 
was taken as -172 ppm [5] and YN  was taken as -2.71 x 
 107 rad T s'[211 ]. The mean 
of the global correlation times (calculated using r2rl_tm) and D11/Di(calculated 
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using quadratic_diffusion) at the two fields, for the closest-to-mean structure, 
were used in the input files for Modelfree. Because calculated 0 and 4' values were 
different at 600 MHz versus 800 MHz, a grid search (360 increments used for each 
angle) was performed in Modelfree prior to model selection in order to calculate 
more accurate angles. The resulting angles were calculated to be 19° and 56° for 0 
and 4) respectively. Model selection was performed using the BIC protocol (refer to 
section 3.9.3). Grid search was always used before x2  minimisation. Twenty 
increments were carried out in the grid search for each parameter, except te (and T, in 
model 5) where fifty increments were used because this parameter had a larger range 
of values. Search ranges were set to be between 0 and 1 for the order parameters, 0 
and 25 s 1 for Re,( in models 3 and 4, 0 and 2500 Ps for te in model 2, and 0 and 2500 
ps for Ts in model 5. Monte Carlo simulations were performed with Modelfree option 
'sim_type' set to 'pred'. After model selection had been completed and a final model 
input file made, Modelfree was performed using 8.845 and 1.295 as initial values of 
and Drat io  respectively, with a grid search between 8 and 10 forr c t and 1.0 and 2.0 
for D,-atjo using 50 increments each. 
Final parameters were 8.898 ns, 1.224, 19° and 56° for t, Dratjo, 0 and p respectively. 
Of the residues eligible for model-free analysis, relaxation data for 77 out of 107 
residues fit model-free parameters to SSE<0.95. Residues for which relaxation data 
did not fit model-free parameters to SSE<0.95, but did so below SSE<1 .00 were 
N71, Y79, Y84, G88, R96, E102, S104, Ti 10, Qi 13, Ni 14, Li 15, Si 18, Ti 19, 
V121, G138, G144, G145, T158, K161, F163 and C170. Residues whose relaxation 
data did not fit model-free parameters were V91, C129, G133, AlSO, C156, N157, 
G164, R187 and H189. An inability to provide sufficient fit to model-free parameters 
to relaxation data could indicate that intermediate timescale (ns-i.$) motion (which 
model-free is not designed to deal with) may be occurring. However, despite the lack 
of fit of these relatively few residues, data from the fitted model-free parameters can 
still be interpreted to infer a limited amount of information regarding their motions. 
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A table of the models selected and the fitted model-free parameters of each residue 
can be found in Appendix 11 (page 321). 
6.3.1.1 Models selected 
45 residues out of 107 were model 2 (S 2 and te), 32 were model 4 (52 te and R), 
while 30 were model 5 (S 2, S/ and r,). Thus all residues required a correlation time, 
almost a third required an exchange term and almost a third required both fast and 
slow order parameters. Figure 6.4 shows a chart of the model selected for each 
residue. 
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Figure 6.4: Chart of the model-free model selected for each residue. 
Models 4 and 5 are dominant for module two and model 2 tends to be dominant for 
module three. 
6.3.1.2 Order parameters 
The order parameter is a measure of the degree of spatial motion of a bond vector (in 
this case the N-H bond vector), where an order parameter of 0 means the bond vector 
has unrestricted motion (i.e. is completely flexible) and an order parameter of 1 
means the bond vector has completely restricted motion (i.e. is completely rigid). 
The S2  values of DAF23 are plotted against residue number in figure 6.5. Value of S 2 
ranged from 0.378 (R62) (or 0.580 (V121) if R62 is not included), to 0.956 (S73). 
Average S2  of all fitted residues is 0.813 ± 0.089. From the first to the last cysteine 
(C64 to C 186) average S 2 is 0.820 ± 0.078. From the first to last cysteine of module 
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two (CM to C 124) it is 0.8 15 ± 0.087 and from the first to last cysteme of module 
three (C129 to C186) it is 0.825 ± 0.069. It appears that N-H bond vectors of residues 
in module three are slightly more restricted that those of module two residues. 
Rc&ie 
Figure 6.5: S2 values of DAF23. S? values and S,2 values of residues fitted to model 5 (two order 
parameters - fast and slow timescales) are shown as red and blue circles respectively. The thick black 
horizontal bars at the top of the diagram show where the modules are and the thin joining bar shows 
where the linker residues are. 
The S2 values as a whole reveal varying degrees of motion as we move through each 
module. Residues with lower than average S 2 values (more than one standard 
deviations away from average) are R62, V66, L70, Y84, G88, S 104, L105, Ti 10, 
V121, G133, E134, G145, N157 and H189. Residues with the highest values (above 
0.90) of S2, suggesting rigidity, are C64, L72, S73, Y79,180, T89, R96, 098, RiOl, 
C124, C129, G138, L147, AlSO, 1152, S167 and S180 
Figure 6.6 shows S,2 and Sf for those residues requiring both fast and slow timescale 
order parameters (model 5). R62 exhibits rigidity on the fast timescale (ps) and 
flexibility on the slower timescale (ns-ps), as does Hi 89 but to a lesser degree. For 
many of these residues the fast and slow order parameters are comparable. Those that 
show slow timescale rigidity and more fast timescale motion (although still relatively 
limited) are V66, 168, L70, Y84, G88, E102 and Ti58. Those that show more fast 
timescale rigidity than slow timescale are V91, Li 15, E122, N137, CI 70, S173 and 
E188. 
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Figure 6.6: S (red) and S 2 (blue) values for residues of DAF 23 fitted to model 5. These are the two 
order parameters - fast and slow timescales respectively. The thick black horizontal bars at the top of 
the diagram show where the modules are and the thin joining bar shows where the linker residues are. 
6.3.1.3 Effective correlation times 
Correlation times have been plotted against residue number in figure 6.7. T. (models 
2 and 4) and; (model 5) are shown in black and red respectively. For the majority 
residues T. times are small. Effective correlation times are a measure of the rate of N-
H bond vector motion; for most fitted residues this rate of motion is fast (ps). 
However, residues R69, C95, R96, C124 and A150 have longer correlation times, all 
of which are model 2, with the exception of C124, which is model 4. These residues 
all show relatively high S2  values, suggesting limited movement at a slow rate. 









Figure 6.7: te (black) and ; (red) values for DAF 23 plotted against residue number. The thick black 
horizontal bars at the top of the diagram show where the modules are and the thin joining bar shows 
where the linker residues are. 
The range of; for residues fitted to model 5 is 418 Ps (E122) to 1695 ps (N157), 
with an average of 995 ± 342 ps. For these residues the timescale of motion is 
slower, like those residues mentioned above with longer T. values. The majority of 
V 
S 
CHAPTER 6: RELAXATION AND DYNAMICS OF DAF 23 	 180 
residues exhibiting slower rates of motion are within module two lying in varying 
positions within the module. Those in module three appear in more localised regions, 
i.e. S173 to S175 are the residues at the end of a loop, F154 and S155 are residues 
leading up to the loop from N157 to Y160 at the top of module three. 
These results indicate that N-H bond vectors of many residues in module three 
experience limited spatial movement at a fast (ps) rate (the exceptions are N13 7,  
A150, F154, S155, N157, T158, S163, C170, S173, G174, S175, E188 and H189). 
N-H bond vectors of anumber of residues in module two experience more spatial 
movement at a slower (ns) rate (specifically R62, S63, V66, T68, L70, 74, Y84, F85, 
G88,V91,E102,C111,Q113,L115,T118,A120,V121 and El22). This is shown in 
figure 6.8. 
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Figure 6.8: Effective correlation times mapped onto cross-eyed stereo view of conformer one closest- 
to-mean structure. Residues in grey do not have relaxation data and therefore no S 2 value available. 
6.3.1.4 Chemical exchange 
Out of 107 residues eligible for model-free fitting, 32 required a chemical exchange 
term in addition to the effective correlation time and the order parameter. Chemical 
exchange indicates slower motion on the microsecond to millisecond timescale. In 
this case all residues also have an effective correlation time (picoseconds to 
nanoseconds); therefore those with an exchange term appear to have two different 
models of motion occurring on different timescales. 
Chapter 7 
PURIFICATION OF DAF234 AND DAF12 
Samples of DAF 1 2 and DAF234 were received from our collaborators in Ohio' for 
structural studies using NMR spectroscopy. The intention was that these samples 
would be used for chemical shift assignment, structural calculation and binding 
studies. Spectra of DAF23 4 would help to provide insight into whether the addition of 
module four influences the structure of module three and/or the intermodular 
orientation of the 2-3 junction. For example, an 1 11- 15N-HSQC of DAF234 would 
provide information on any changes in residues in DAF23; differences in cross-peak 
positions are symptomatic of altered position or conformation. 
This chapter presents attempts to optimise sample conditions, in an attempt to obtain 
NMR spectra of useful quality, and, after failing to do so, the steps used in the 
subsequently devised purification protocols. This work has laid the groundwork for 
future efforts in this direction. 
The following sections are presented in the following order; unlabelled DAF12, ' 5N-
labelled DAF12, 13 C, 15N-labelled DAF12, unlabelled DAF234, ' 5N-labelled DAF234 
and, finally, further unlabelled DAF 12 work undertaken after a purification protocol 
Prof. Edward Medof and Dr. Feng Lin, Department of Pathology, Case Western Reserve University, 
2085 Adelbert Road #301, Cleaveland, Ohio, 44106, U.S.A. 
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had been devised (the work presented is not always in chronological order, but it set 
out in as logical a fashion as possible). 
7.1 DAF12 
This section shows results of initially screening four samples of DAF12 received from 
Ohio: two unlabelled samples (one and two), a ' 5N-labelled sample and a 
labelled sample. Figure 7.1 shows an SDS-PAGE gel of all DAF 12 samples. 
kDa 
1. Protein marker 
50 
37 	 2. Unlabelled 1 
8 	 3. Unlabelled 2 
4.'N labelled 
15.- 
10 	 . 13CN labelled 
—]. 	2 	3 	4 	5 
Figure 7.1: SDS-PAGE of all DAF 12 samples, lanes are marked in key. Refer to section 3.1.2.5 in 
methods chapter for details on preparation and conditions of experiment. 
7.1.1 Unlabelled DAF 12 
Two unlabelled samples of DAFI2 were received. SDS-PAGE shows broad bands 
above 15 kDa (lanes 2 and 3 in figure 7. 1), i.e. slightly higher mass than expected, 
with some smaller bands present corresponding to proteins with lower masses; these 
are likely to represent small quantities of degradation products. In order to obtain a 
more accurate mass, LC-ESI-MS was performed on both samples, using the 
protocols described in Chapter 3 (section 3.1.2.4). Single peaks were observed at UV 
absorbance of 280 nm in the LC chromatogram. From these, masses of 15,928 (± 
0.31) and 15,928 (± 4.99) Da were determined for the predominant species in 
samples one and two, respectively, compared to an expected mass of 15196 Da. In 
both samples, the presence of a number of other species, at low concentrations, was 
A)' 
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also suggested (figures 7.2A and B). The main peaks clearly correspond to the strong 
bands on the SDS-PAGE gel, which run at a position expected of a somewhat larger 
protein (-P20 kDa). 
Figure 7.2: Mass spectrum transforms of unlabelled DAF 12 samples one (A) and two (B) from LCMS. 
According to these results, each sample is approximately 732 Da greater in mass than 
the anticipated mass of the unlabelled protein. This could correspond to up to seven 
extra amino-acid residues, suggesting that additional residues may be attached to the 
N-terminus. Alternatively 0- or N-glycosylation might be occurring. The N-
glycosylation site between modules one and two (E61) remains in the protein, so it 
may be that N-linked sugar units are present instead. 
N-terminal sequencing was performed on sample one by Dr. Andrew Cronshaw 9 , 
using an Applied Biosystems Procise Sequencer. Nine cycles were acquired from a 
100 picomolar sample with a sampling rate of 4.0 Hz. Results gave a sequence 
believed to be EAEAEFDC with each cycle showing: 
1 1 	2 1 	3 1 	4 1 5 6 7 8 
E/G I AlL I El? I A/G I E F DIG I C 
Dr Andrew Cronshaw, University of Edinburgh, ICMB, Swann Building, Kings Buildings, 
Mayfield Road, Edinburgh, E119 3JJ. 
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This suggests that during expression in Pichia Pastoris, incomplete cleavage of the 
signal sequence occurred, leaving Glu-Ala-Glu-Ala (EAEA) at the N-terminus. This 
non-native sequence accounts for a molecular mass of approximately 400 Da only, 
leaving approximately 332 Da unaccounted for. In the LCMS of each sample, figure 
7.2A and B, it can be seen that smaller peaks at intervals of 162 Da (sample one) and 
161 Da (sample two) follow the predominant peak. It is likely that these are hexose 
(mass of 162 Da) sugar units (mannose, galactose etc) that are non-specifically 0-
linked to the protein. 
One-dimensional 'H NMR spectra were acquired of both samples following buffer 
exchange into fresh PBS (phosphate-buffered saline) at pH 7.0. These are shown in 
figure 7.3. 
10 	 8 	 6 4 
1H chemical shift / ppm 
Figure 7.3: 'H NMR spectra of unlabelled DAF 12  samples one (A) and two (B). Both were acquired 
with 128 scans. The higher signal-to-noise ratio in the spectrum of the second sample reflects the 
higher concentration. 
Both of these spectra show small signals in the 8 -0.5 to 0.5 ppm region suggesting 
folded protein is present in the sample. These correspond to methyl side-chain 
protons that have neighbouring aromatic side-chains - this indicates the presence of 
secondary and tertiary structural elements. However, the size of these signals is small 
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with respect to the large alkyl peaks in the 8 0 to 4 ppm region, which have low peak 
resolution (i.e. are ill-defined and have random-coil shifts). This implies lack of 
folding, although it is difficult to draw firm conclusions from I  spectra alone. 
Although it is hard to ascertain the degree of folding from 1D spectra alone, the lack 
of peak resolution and weak presence of folded protein proton peaks, suggest that 
these samples are partially unfolded, i.e. a portion of the total population of 
molecules present are not in a fully folded form, or one of the two domains is 
unfolded in a majority of molecules. 
7.1.2 15N-labelled DAF12 
The original sample concentration of ' 5N-labelled DAF 12 was approximately 0.27 
mM, however this concentration is likely to have become reduced due to losses 
sustained during buffer exchanges and other manipulations. 
SDS-PAGE (figure 7. 1A) shows a band of approximately the correct mass. Results 
from LC-ESI-MS show a predominant protein mass of approximately 16,115 Da 
(figure 7.4). This mass is, again, 732 Da in excess of the expected molecular weight, 
15,383 Da (unlabelled molecular weight was calculated - using the ProtParam tool at 
www.expasy.ch and labelled molecular weight was calculated manually from this 
assuming 100% labelling). As with the previous sample, some of this extra mass is 
likely to be due to additional residues (EAEA) at the N-terminus arising from non-
cleavage during expression. This however would only partially account for the extra 
molecular weight (approximately 400 Da). Alternatively, excess may originate from 
non-specifically, but covalently attached 0-linked sugars. Again, LCMS shows 
smaller peaks at an average interval of 162 Da following (and prior to) the 
predominant peak. As before, it is likely that these are hexose sugar units (mannose, 
galactose etc). The excess mass may, therefore, come from two 0-N-
acetylhexosamines (0-G1uNAc or 0-GalNAc, both approximately 203 Da in mass) 
and two hexose sugar units (approx 162 Da each), which would account for 730 Da. 
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terminal sequencing of that sample revealed excess EAEA at the N-terminus it is 
difficult to decipher these results. 
Figure 7.4: Mass spectrum transform of ' 5N-labelled DAF 12 . 
A 1 D 'H NMR spectrum of this sample, in its original conditions, was acquired, and 
is shown in figure 7.5A. The three large peaks at approximately 6 3.4 ppm, 6 3.5 
ppm and 6 3.6 ppm are glycerol peaks (impurities from the membrane of the 
Vivaspin concentrator tube) and the large peak at 6 2.6 ppm and its two satellites are 
from the ethanol present in the protease inhibitor cocktail used in this sample (these 
ethanol peaks disappear by the third buffer change - see figure 7.5C). This spectrum 
also show small signals in the 6 -0.5 to 0.5 ppm region (methyl side-chain protons 
region) suggesting folded protein is present in the sample. However, this spectrum, in 
general, shows a lack of peak definition. 
The DAF23 sample used in the previous NMR structure study was found to give best 
results in 50 mM NaOAc buffer at pH 5, which suggested that a lower pH may help. 
Titration from pH 7 to pH 6 resulted in the 1 D 'H spectrum in figure 7.513. This 
spectrum was acquired using 128 acquisitions so signals appear stronger. There does 
not appear to be a great deal of difference between the two spectra. A further pH 
change to 5, with a buffer change to 20 mM NaOAc (pH 5) was undertaken. The ID 
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1 H spectrum is shown in figure 7.5C. This in comparison to figure 7.5A shows only a 
small change; peaks are slightly broader and less well-defined. Some peaks 
consistent with structure are still present. The sample is much weaker as a result of 
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Figure 7.5: H NMR spectra of ' 5N-labelled DAF 12 : A) in PBS at pH 7 (acquired with 16 scans), B) in 
PBS at pH 6 (acquired with 128 scans), C) in 20 mM d 3-NaOAc at pH 5 (acquired with 128 scans). 
Original conditions were pH 7 in 150 mM phosphate buffered saline (PBS) at approximately 0.25 mM 
protein concentration. 
To further investigate the state of this protein sample, 2D 'H- 15N-HSQC spectra were 
also acquired at each pH. The degree of chemical shift dispersion of these cross-
peaks shows whether the protein has an ordered structure (i.e. is folded) or is 
disordered; a good separation and resolution of the cross-peaks indicates a well-
defined structure, while overlapping cross-peaks that are clumped together in a 
central, random-coil chemical shift region reflect the presence of unfolded material. 
Referring to figure 7.6A, which shows the 1 11- 15N-HSQC spectrum of the protein 
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sample in its initial conditions, a good spread of chemical shifts are observed with 
some cross-peaks shifted well away from random coil positions. Therefore, this 
sample contains some folded protein (i.e. in which at least one of the two modules is 
folded). However, a large amount of random coil is evident from the numerous peaks 
in the centre of the spectrum. The number of prominent, well-dispersed cross-peaks 
appears to be sufficient to account for all backbone amide protons, which suggests 
that some unfolded or partially folded protein molecules may exist in the sample, 
with the remainder fully folded, or that aggregation is occuring. Unfolding of one or 
both modules in some of the molecules is thus a possibility and this raises the 
question - is one module folded while the other is unfolded, and if so which module 
is the source of the problem? Another question is can this unfolding be rectified by 
changing buffer conditions? 
Figure 7.6B shows the 1 H- 15N-HSQC spectrum of the sample at pH 6. A loss of some 
amide peaks is observed and other cross-peaks start to appear (magenta 'folded-in" 0 
cross-peaks at approximately 5 6.9 and ö 7.4 ppm in 'H dimension and at 6 125 ppm 
in the 15N dimension). The large horizontal lines are artefacts due to poor water 
suppression during acquisition. Disappearance of cross-peaks in the well-resolved 
regions suggests increased protein unfolding. The HSQC spectrum of the sample in 
20 mM d3-NaOAc at pH 5 is shown in figure 7.6C; this shows a large extent of 
random coil signals, a loss of more cross-peaks and movement of some others. 
It seems clear, even allowing for the adventitious losses of protein arising from 
sample manipulation, that lowering the pH causes a deterioration in spectral quality 
that probably arose from a decrease in the extent of protein folding or an increase in 
oligomerisation. 
10  Folded-in refers to cross-peaks at a chemical shift outside of the sweep-width of the experiment, i.e. 
at chemical shifts lower or greater than the range covered; these peaks are therefore 'folded' into the 
spectrum and appear in the opposite phase to the rest of the cross-peaks. 
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Figure 7.6: 'H' 5N-HSQC spectra of 15N-labelled DAY 12  under different sample conditions: A) in PBS 
at pH 7 (acquired with 208 scans), B) in PBS at pH 6 (acquired with 208 scans) , C) in 20 mM d 3- 
NaOAc at pH 5 (acquired with 232 scans). 'H and ' 5N chemical shifts (in ppm) shown on horizontal 
and vertical axes respectively. All HSQCs have 2048 x 128 time domain points ('H x 15N dimensions 
respectively). Folded peaks are shown in magenta. Due to differences in sweep-width, the folded 
peaks at the top of spectrum A are not folded in in spectrum B; however, only one of these cross- 
peaks is now present (peak at bottom of spectrum). 
7.1.3 13C,16N-Iabelled DAF12 
The band on the SDS-PAGE (refer to figure 7. 1, lane 5) for this double-labelled 
DAF 1 2 sample is very weak (reflecting the small amount of available sample), and 
only minimal information concerning purity can be gained therefrom. The LC-ESI-
MS data shows two main peaks with broad bases composed of many smaller peaks in 
the transformed calculation (figure 7.7) indicating that it is likely that this sample has 
been degraded, i.e. the protein chain has been hydrolysed at multiple points. The two 
main peaks are at 9,570 Da and 13,000 Da highlighting the fact that no full chain 
protein appears to be present - i.e. there are no peaks in the 16,000 to 17,000 Da 
region. 
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Figure 7.7: Mass spectrometry transform of ' 3C, 5N-labelled DAF I2 . 
The 1D 'H NMR spectrum (figure 7.8) appears significantly different to that of the 
15N-labelled and the unlabelled samples, at the same pH and temperature and in the 
same buffer; signals in the methyl and aliphatic proton chemical shift regions (6 -0.5 
to 0.5 ppm and 6 0 to 4 ppm respectively) of the various spectra share very little 
resemblance to each other. The 13C-decoupled 'H- 15N-HSQC spectrum of the 
' 3C,' 5N-labelled sample shows more peaks spread out over this region but peaks are 
less resolved. The backbone amide proton chemical shift region also has some 
significant difference; there are three broad peaks at approximately 6 7.9, 8.1 and 8.3 
ppm that are more pronounced than the rest of this region and not seen in the ' SN-
labelled sample spectrum. 
._ 
H chemical shiFt / ppm 
Figure 7.8: 1D 1 H NMR spectrum of 13C, RN-labelled DAF 1 2 sample (acquired with 264 scans). 
CHAPTER 7: PURIFICATION OF DAF12 AND DAF 4 	 193 
The 'H-' 5N-HSQC spectrum (shown with the 'H-' 5N-HSQC of 'N-labelled DAF 1 2 
in figure 7.9 for comparison) also exhibits differences. In general, more peaks are 
seen, a lot of which are small and weak. This is most likely due to the protein 
fragments seen in the LC-MS results. Various components of the folded protein can 
be observed, but there are many additional signals. 
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Figure 7.9: 'H 5N-HSQC spectra of A)' 5N-labelled DAF, 2 sample (acquired with 264 scans) and B) 
13C, "N-labelled DAF 12  sample ( 13C-decoupled, acquired with 208 scans). 'H and ' 5N chemical shifts 
(in ppm) shown on horizontal and vertical axes respectively. Both HSQCs have 2048 x 128 time 
domain points ( 1 H x 15N dimensions respectively). 
This sample was therefore not considered fit to use for any further study. 
7.2 Unlabelled DAF 4 
SDS-PAGE of the initial (i.e. first to be received) unlabelled sample of DAF 4 
(figure 7.10) yields two main bands. One ran at approximately 25 kDa (somewhat 
larger than the expected 22 kDa), probably corresponding to full DAF234, and the 
second at approximately 15 kDa. A further faint band was observed at approximately 
6 kDa. The latter two bands could be degradation products representing two CCP 
modules and one CCP module, respectively. LC-ESI-MS of the main component 
(DAF 4) shows a molecular weight of 22,752 Da, this is 610 Da greater than the 
expected molecular weight for this protein. Again, it is likely that EAEA is present at 
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the N-terminus. This leaves approximately 210 Da unaccounted for. The mass 
spectrum transform (figure 7.1OB) shows a smaller peak at 22,551 Da, which would 
correspond to the loss of approximately 201 Da. This could be EA, or an attached 0-
N-acetylhexosamines (0-GIuNAc or 0-GaINAc, both 203 Da in mass). 
A) 1. Unlabelled DAF 4 
2. 15N labelled DAF2 34 
3. 1 N labelled DAF2 34 
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Figure 7.10: A) SDS-PAGE gel of DAF234  samples; both 15N labelled DAF 234 lanes are from the same 
sample (received 29/08/03). B) Mass spectrum transform of unlabelled DAF234 sample from LC-MS. 
A I D 'H NMR spectrum was acquired on this sample; this is shown in figure 7.11. 
The sample contains imidazole and glycerol (the large, sharp peaks at 6 7.2/7.9 ppm 
and 3.5 to 3.75 ppm respectively) because the buffer had not been exchanged after 
receiving the sample. The spectrum shows small peaks below 80.5 ppm indicating 
folded protein, and relatively well resolved peaks in the aliphatic and methyl proton 
chemical shift region (approximately 6 0 to 4 ppm). There are also small peaks in the 
fl-sheet ci-proton region (approximately 6 5.5 to 6.5 ppm). The good dispersion of 
peaks in this spectrum suggests the protein sample probably contains a substantial 
proportion of folded material. 
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Figure 7.11: 1 D 'H NMR spectrum of first unlabelled sample of DAF 234 in PBS at pH 7 (acquired 
with 264 scans). 
An NMR spectrum of 1 mg of the second sample of unlabelled DAF234 is shown in 
figure 7.12, in 50 mM deuterated sodium acetate buffer at pH 5 (as used for DAF 23 
samples). As in the first sample, and those of DAF 1 2, there is a group of large, 
overshadowing, peaks from approximately ö 3 to 4 ppm. These are likely to arise 
from sugars remaining in the sample following Pichia pastoris production and 
purifcation. It was thought that these unwanted sugars may have adverse effects on 
the proper folding because they had been observed in all the samples received up to 
that point. 
10 
chemical shift/ ppm 
Figure 7.12: 1D 'H NMR spectrum of unlabelled DAF 234 sample two (acquired with 128 scans), 
following buffer exchange into 50 mM d3-NaOAc buffer at pH 5. 
In an attempt to remove these unwanted sugars, 2 mg of the same sample (a total of 5 
mg was available) was applied to a column of SP Sepharose Fast Flow MonoBeads 
(see section 3.2 for method); this resulted in the spectrum shown in figure 7.13. A 
definite improvement was achieved; peaks have become sharper and more resolved, 
especially in the amide proton region (seen above 5 6 ppm). The sugar content is 
reduced; however some sugar peaks still appear to be present. 
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Figure 713: ID 'H NMR spectrum of unlabelled DAF 234 sample two following elution from an SP 
Sepharose column (acquired with 128 scans). 
In an attempt to remove all sugars, a further 1 mg of the sample was run on an FPLC 
MonoS column (Amersham Bioscience) over a salt gradient, using 50 mM sodium 
acetate at pH 5 (containing 0.01% TFA and I mM NaN3) as buffer. The method 
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Figure 7.14: FPLC chromatogram of unlabelled DAF 24 sample. Numbers (2 to 5) refer to the SDS- 
PAGE gel lanes in which the combined fractions of that peak were run (figure 7.16). UV absorbance 
at 254 nm is shown in red and at 280 nm in blue. AU is absorbance units. 
Fractions were collected (in 1 ml volumes). The ID 'H NMR spectrum of material 
collected and combined from the final large peak is shown in figure 7.15. This 
spectrum is a vast improvement on all previous samples, with much sharper and 
more resolved peaks. Virtually all the sugars have been removed. 
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Figure 7.15: 'H NMR spectrum of the combined fractions from the final large peak of the FPLC 
chromatogram (figure 7.14), following buffer exchange into 50 m d3-NaOAc buffer at pH 5 
(acquired with 128 scans). 
SDS-PAGE was run on the fractions collected from each peak (figure 7.16). The 
large initial peak appears to be degraded protein; it runs at a slightly lower mass on 
the gel. Material from peak three of the chromatogram was at too small a 
concentration to be observed on the gel. The species in peak four migrates on the gel 
to the same extent as the material in peak five; it is possible therefore that the smaller 
peaks (in fractions 20 to 30) correspond to degraded or misfolded protein, while the 
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Figure 7.16: SDS-PAGE gel of material from combined fractions of FPLC peaks (shown in figure 
7.14). The contents of each lane are given in the key and are indicated on the chromatogram itself. 
7.3 Further DAF 1 2 
Following the results obtained from DAF4, the method of purification using a 
MonoS column on an FPLC was applied to the unlabelled DAF 12 samples. The two 
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samples were combined before performing this purification step. Methods used were 
identical to those used for DAF4 purification. The resultant chromatogram is shown 
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Figure 7.17: FPLC chromatogram of unlabelled DAF 12 sample one. UV absorbance at 254 urn is 
shown in red and at 280 urn in blue. AU is absorbance units. 
Although 1 D 'H NMR spectra were acquired on combined fractions from each peak 
in the above chromatogram, due to the small amount of sample recovered, sufficient 
information could not be gained as to the condition of each sample. As a result no 
further action was taken with the first sample of unlabelled DAF 12 . The second 
sample, however, yielded higher quantities of protein in each peak (figure 7.18). As 
with the first sample, a sharp peak eluted at 30 ml. 
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Figure 7.18: FPLC chromatogram of unlabelled DAF 1 2 sample two. UV absorbance at 254 nm is 
shown in red and at 280 am in blue. AU is absorbance units. 
The fractions comprising this peak were combined and after buffer exchange into 50 
mM d3-NaOAc buffer at pH 5, a 1D 1 H NMR spectrum was acquired. As the first 
peak in the chromatogram, at approximately 7 ml, was reasonably sharp, the same 
procedure was undertaken for the combined fractions of this peak. Figure 7.19 shows 
the 1H NMR spectra of A) the original material, B) the material under the first signal 
of the chromatogram at approximately 7 ml and C) the material under the second 
signal of the chromatogram at approximately 30 ml (all in 50 mM d3-NaOAc buffer 
at pH 5). The best result was obtained for material from the second signal and the 
worst for the original sample; in the second sample, all contaminating sugars appear 
to have been removed and NMR signals of both the amide region and the side-chain 
proton region are sharp and resolved. It appears very likely that this sample is 
predominantly folded DAF 1 2. 
Unfortunately, the ''N-labelled DAF 12 sample was thought to be degraded, and at 
such a low concentration that purification by this method would not yield enough 
protein for any useful study in any case. Therefore no purification was attempted. 
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Figure 7.19: 1D 'H NMR spectra (all acquired with 128 scans) of DAF 12 sample two: A) in the 
condition it was received in, B) combined fractions from first large peak in FPLC chromatogram of 
second sample and C) combined fractions from under FPLC chromatogram peak at 30 ml. All 
samples are in 50 mM d3-NaOAc buffet at pH 5. 
7.4 15 N DAF234 
Figure 7.20 shows 'H-' 5N-HSQCs of the ' 5N-labelled DAF234 samples as they were 
received (following buffer exchanges into 50 mM d3-NaOAc buffer at pH 5). 
Although there is a good dispersion of many cross-peaks, indicating a high degree of 
folding in the sample, the centre of.the spectrum is still very crowded. This lack of 
peak resolution suggests there is also a fraction of unfolded or aggregated protein in 
the sample, rendering it unfit for structural study by NMR spectroscopy. The same 
method that was used to clean up the unlabelled DAF23 4 sample was applied to these 
two ' 5N-labelled samples. The two samples were combined and purified by FPLC in 
a single run. The chromatogram in figure 7.21 shows the results of this. 
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Figure 7.20: 'H-' 5N-HSQC spectra of "N-labelled samples of DAF 2 A) one (acquired with 32 scans) 
and B) two (acquired with 16 scans). 'H and 15N chemical shifts (in ppm) shown on horizontal and 
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Figure 7.21: FPLC chromatogram of "N-labelled DAF 234 sample. Numbers (3 to 8) refer to the SDS- 
PAGE gel lanes in which the combined fractions of that peak were run (figure 7.22). UV absorbance 
at 254 nm is shown in red and at 280 nra in blue. AU is absorbance units. 
Following an initial peak (labelled 3 in figure 7.21), there are five other definite 
peaks (labelled 4-8 in figure 7.21). The final peak, being the largest, was thought to 
contain fully folded protein. SDS-PAGE was run on the fractions collected from each 
peak; this is shown in figure 7.22. 
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Figure 7.22: SDS-PAGE gel of combined fractions from each peak seen in the FPLC chromatogram. 
Lane numbers for each peak are shown on the chromatogram in figure 7.21. 
The bands appear at approximately the same mass on the gel; this suggests that the 
smaller signals in the chromatogram were full, but misfolded, DAF234, or could 
possibly contain an EA artefact (from incomplete  cleavage of the signal sequence). 
Material from the large peak, in lane 8, contains material at lower mass; these are 
probably minor degradation products of one or two modules, which are detectable 
due to the high concentration of protein from this lane applied to the SDS-PAGE. 
Following buffer exchange into 50 mM deuterated sodium acetate buffer at pH 5, an 
'H)"N-HSQC of material from the fractions from the large signal was acquired. This 
is shown in figure 7.23. 
This appears to contain much less unfolded material than the original sample and 
would most likely be suitable for NMR spectroscopy. The number of amide cross-
peaks appears to be sufficient to account for all non-proline residues of DAF234 
(approximately 65 additional non side-chain amide cross-peaks); furthermore, overall 
dispersion is very good. Although the central region is slightly crowded, this is most 
likely due to the size and nature of the molecule; amide cross-peaks of DAF 23 are 
overlapped in this region in the 'H- 15N-HSQC of DAF, and it follows that addition 
of another CCP module will result in further overlap. However, given the high field 
spectrometers, cryoprobes and processing methods, such as maximum entropy 
processing, currently available, it is anticipated that this level of overlap would not 
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cause too much of a problem. Furthermore, the majority of module four amide cross-
peaks are likely to be dispersed, as was the case with DAF. 
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Figure 7.23: 'H-'N-HSQC of purified ' 5N-labelled DAF2 (acquired with 128 scans at 800 MHz). 'H 
and 15N chemical shifts (in ppm) shown on horizontal and vertical axes respectively. Spectrum has 
2048 x 128 time domain points ('H and ''N dimensions respectively). 
Figure 7.24 shows the 'H- 15N-HSQC of the above purified sample of DAF 4 (blue 
and light blue cross-peaks) overlaid with that of DAF 23 (green and orange cross-
peaks). This highlights cross-peaks belonging to modules two and three (although 
some are likely to have moved slightly with the addition of module four), and those 
of module four. 
DAF 4 is discussed further in Chapter 8. 
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Figure 7.24: 'H-' 5N-HSQC spectra of purified 15N-labelled DAF234 (blue and liht blue cross-peaks) 
overlaid with 'H- 15N-HSQC of DAF 23 (green and orange cross-peaks). 'H and 'N chemical shifts (in 
ppm) shown on horizontal and vertical axes respectively. Both samples are in 50 mM d3-NaOAc 




The advantages and disadvantages of NMR spectroscopy compared to X-ray 
crystallography for protein structure determination have been widely discussed 
elsewhere [23, 85, 154, 184, 325, 351]. Multiple domain proteins, which account for 
a sizeable fraction of the mammalian proteome [88, 330] and virtually all proteins of 
the complement system, represent a particular challenge to structural biology. It was 
therefore of some concern that two papers that dealt with the structure of the 
extracellular portion of DAF, published in 2003 [345] and 2004 [178], reached rather 
different conclusions. If the presence of module one and four (in the crystal 
structure) can really influence drastically the arrangements and flexibility of modules 
two and three (as observed in the solution structure of the 2-3 module pair), there 
could be important implications. The validity of the "dissect-and-rebuild" approach 
adopted by NMR spectroscopists for solving the structures of multiple domain 
proteins would be open to doubt. On the other hand, if crystal-packing forces could 
stabilise conformational populations of DAF that were poorly populated under 
physiologically relevant conditions, then the use of X-ray diffraction for this 
category of proteins could be regarded as potentially spurious. 
Thus, if either of the cases outlined in the previous paragraph could be proven, the 
consequences might be profound. There were several reasons, however, to suspect a 
more trivial explanation. A notorious problem in elongated structures in NMR is the 
reliance on short-range distance restraints derived from NOEs. While the number and 
205 
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degeneracy of NOEs in a globular protein are normally more than adequate to define 
the fold [43, 47, 66, 362], extended macromolecules are more problematic for NIvIR 
spectroscopy. The advent of RDCs to ameliorate these problems was greeted with 
great excitement [11, 12, 49, 50, 95, 132, 133, 253, 259, 278, 281, 335, 3371, but it 
has taken several years for the community to appreciate what data sets are required 
and how they should be implemented into structure calculations [16, 48, 49, 51, 174, 
175, 336, 352]. In the case of the published DAF23 structure, only one set of RDCs 
was available so the dependency on NOEs was high. Under these circumstances, the 
influence of some missed assignments or mis-assignments is very large. 
These issues formed the background to the current project. A step-wise procedure 
was therefore adopted with the aim of achieving the most reliable and accurate 
solution structure possible based on current NMR techniques and instrumentation. 
First, more powerful processing protocols were applied to new and existing data. 
Next, the protein was reassigned to ensure accuracy of the chemical shift table and 
avoid propagation of errors throughout the subsequent NOESY assignment. 
Subsequently, new sets of RDCs were collected and included in structure 
calculations based on the revised data sets. Finally, because flexibility within DAF 
could have a major significance for its function, a full study of backbone dynamics 
based on 15N relaxation measurements was carried out. Previous discussions of 
mutagenesis data were complicated by the differences between the two 
experimentally-derived three-dimensional structures. With a clear consensus now 
available, the existing mutations, and some new ones (ME Medof, personal 
communication) were reconsidered. 
The purpose of this chapter is to assemble the conclusions that were drawn from each 
component of the project. These will then be discussed with respect to the original 
project aims. They will also be considered in the context of the wider fields of 
complement and structural biology. 
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8.1 Differences in resonance assignments 
Several differences were observed, between the Uhrinova et al. study and the current 
work, in assignments of chemical shifts to nuclei. This discrepancy was not 
anticipated since modem methods for assignment exploit through-bond couplings in 
double-labelled protein samples; there is built-in redundancy and limited 
opportunities for error. Comments can, nonetheless, be made as to why there might 
have been mis-assignments in the previous work. The 15N-HSQC spectrum of 
DAF23 , the fundamental starting point for chemical shift assignment strategies, 
contained regions of severe overcrowding. In some cases, two peaks were fully 
overlapped. In addition to this, the spectrum of DAF 23 exhibited a number of 
doubled resonances resulting from the presence of two conformers in slow or very 
slow exchange (discussed below). Problems due to chemical shift degeneracy within 
the 15N-HSQC were compounded by overlap within the three-dimensional spectra. 
8.1.1 MEM-processing 
It may be that the use of the MEM, in the current work, for processing some 
dimensions within the three-dimensional spectra allowed misinterpretations 
stemming from crowding in the 15N-HSQC to be recognised and resolved. Certainly, 
the use of MEM facilitated a more complete assignment and this filling in of gaps in 
the previous assignment also contributed to the detection of errors. 
The MEM approach to image reconstruction has been used in a variety of fields. 
Details of MEM spectrum reconstruction of NMR spectra is described in references 
[104, 109, 318]. MEM seeks to extract as much information from a measurement as 
is justified by the data's signal-to-noise ratio [309]. The merits of this are the ability 
to estimate high-resolution spectra from limited data and to deconvolve spectra 
without enhancing the noise. Consequently, MEM is able to increase signal-to-noise 
and enhance resolution of NMR spectra simultaneously [110, 118, 319]. However, 
MEM improves the ratio between strong and weak peaks irrespective of whether 
they are signals or noise [65]. Therefore, this method does not enable signals to be 
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distinguished from noise and as a result false-positive peaks may be introduced. Of 
additional importance is the caveat that integrated areas or peak volumes are no 
longer proportional to the spectral components; careless application can result in 
peak distortion and render quantification almost impossible [289]. Furthermore, one 
of the major short-comings of the MEM is the computational demand. MEM could, 
in theory, be used on any dimension; however, due to this heavy computational 
demand it is more advantageous to use it on the indirectly-detected dimensions only, 
where data sampling is more limited than that of the directly detected dimension (i.e. 
there are less time-domain points used). This is a sensible compromise between CPU 
time and spectrum enhancement. 
MEM was used in this study to process the second and third dimensions (the 
indirectly-detected dimensions) of most three-dimensional spectra. It was not, 
however, applied to the NOESY spectra. This was to prevent the introduction of 
potential errors in NOE-derived distance restraints that could have derived from peak 
distortions, inaccurate integration of peak volumes and introduction of false-positive 
peaks. It was judged that the employment of MEM purely in a chemical shift 
assignment capacity was an optimal strategy. 
To properly quantify the advantages afforded by the use of MEM in terms of 
accuracy and completeness of chemical shift assignments, a comparison between 
assignments obtained by the same researcher with MEM versus Fourier transform 
would be required. But this would be time consuming and is not amongst the project 
aims. Instead, a comparison of the current MEM-based work with the previously 
performed full assignment of DAF23 (using Fourier-transformed data) provides a 
good indication. A summary of discrepancies in the assignments is presented in 
figure 8. 1, and the extents of assignment in both studies are compared in Appendix 6 
age 303). It should be remembered, however, that the introduction of errors at an 
early stage of the Uhrinova et al. DAF23 work (in analysis of the 'H- 15N-HSQCs) 
must have compounded subsequent errors and therefore this comparison is not a pure 
reflection of the relative merits of the two methods. One additional factor that may 
have played a part is the use of the HNCO and HN(CA)CO for carbonyl assignment 
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and to confirm backbone assignment, which do not appear to have been used in the 











Figure 8.1: Discrepancies in assignment: number of different atom assignments per residue between 
the Uhrinova et al. and the current study. The thick black horizontal bars at the top of the diagram 
show where the modules are and the thin joining bar shows where the linker residues are. 
8.2 Differences between structures 
The discrepancies between chemical shift assignment, and in the extent of chemical 
shift assignment, have a major effect on the respective lists of NOE-derived 
restraints. This effect contributed to the differences observed between the old and the 
new NMR-derived structures. For example there are many residues located at the 
interface that have differing assignments (see figure 8.1): K125 H; K126 C, Hi 
and Hi; K127 C, H 1 , 1­1 2, H, 1­18 1 , C, H 1 and H; S128 N, H C a, Ha and C; 
C129 N, H, C, Cp and H13; F148 Ha; Q178 Ha and Hp I . Those nuclei located at this 
interface region, with missing assignments in the Uhrinova et al. work, that have 
been assigned in the current study are: L171 N, H n  and Ha; 1172 N and H; and R96 
Ca . There are contributions from many of the previously misassigned atoms to many 
NOESY cross-peaks, including some between the linker residues and module 
residues, therefore these assignments have direct consequences on structure. 
Furthermore, the additional assignments have resulted in previously undefined NOE 
interactions being elucidated for use in structure calculations. 
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It is difficult to itemise the differences between the Uhrinova et al. and the new 
complete lists of NOE-derived distance restraints. This is due to the large total 
number of restraints used in each case as summarised in table 8.1. 



















Inferred H-bonds 14 5 5 
J-couplings (HNHa) 54 0 0 
Table 8.1: Table of restraints used for structure calculation in Uhrinova etal. and current work. 
One of the differences between restraints used in the Ubrinova et al. work and the 
current work is the deletion of J-couplings. These are the three-bond scalar coupling 
between HN and Ha that, using the Karplus equations, can be employed to restrain 
the phi (4)) angles of peptide bonds. Investigation of the protocol used in the previous 
work to extract the couplings from HNHA spectra revealed that this had been done 
incorrectly, yielding erroneous data. Subsequent attempts (in the current work) to 
analyse the same data using revised scripts provided a corrected list of J-couplings. 
However, incorporation of these into structure calculations resulted in numerous 
NOE violations. After further investigations, it was decided that the NOE data were 
reliable while the spectra used for measurements of J-couplings might have been 
collected incorrectly, or the scripts used for incorporation of the couplings into the 
calculations were in error. It was decided to abandon efforts to use J-couplings in this 
case. 
As stated in section 4.5, the hydrogen bonds were very stringently selected for input 
into current structure calculations, so as to avoid inappropriately restraining the 
molecule. The Uhrinova et al. calculation used 14 hydrogen-bond restraints (table 
4.6, page 138) only, three of which correspond to the hydrogen-bond restraints in the 
current structure calculations (table 4.5, page 138). In the present work only those 
amide cross-peaks that persisted for more than 20 minutes (compared to 12 minutes 
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in the Uhrinova et al. work) after buffer exchange were considered to be candidates 
for hydrogen-bond donors. 
8.3 Flexibility at the intermodular interface 
8.3.1 Comparison of the old and new solution structures of DAF23 
Tables 5.10 to 5.12 ages 160 and 16 1) are summarised lists of module-to-linker 
and module-to-module NOE interactions from the Uhrinova et al. study and the 
current study. The total number of module-to-linker NOE interactions for both 
modules are comparable between the two studies. However, the assigned NOB 
interactions themselves are different, and are seen between a greater number of 
residues than previously described. One can only assume this is a result of corrected 
assignment in the current study. Furthermore, in the Ubrinova et al. structural study 
there were six NOE interactions assigned between the modules. In the current study 
there are 17 NOE interactions between the modules. It is reasonable to conclude that, 
in the current study, these many NOE interactions, involving several residues, from 
both modules to the linker, and from module two to module three, represent the main 
cause of the stabilisation of the 2-3 junction in NOE- and hydrogen-bond-derived 
structures (prior to refinement with RDCs). Furthermore, the intermodular 
orientations of these DAF 23 structures are different to those of the Ubrinova et al. 
NIMIR-derived structures, but are similar to those of the X-ray crystal structures. This 
is discussed further below. 
8.3.2 Influence of the RDCs 
Three new sets of RDCs were employed in current structure calculations, detected in 
protein molecules that had been aligned using the same media as was used to align a 
sample in the Ubrinova et al. study. As well as a new 1 DNH data set, two further data 
sets were acquired: 1 D ac' and 1 13CaHcL . These additional restraints have allowed 
further refinement of the structures. Furthermore, the acquisition of additional data 
sets enabled the alignment tensor of DAF23 to be better defined, showing that the 
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Uhrinova et al. conclusion that each module has its own alignment tensor was 
incorrect. When a single alignment tensor was applied in that work, the RDC energy 
was double that obtained when separate tensors were applied (refer to table 5.3, page 
144). This seemed to be a valid argument for introduction of the second tensor. 
However the NOE-derived calculation was based on what are now considered an 
erroneous set of NOEs. Therefore conflicts between the RDCs and NOEs would have 
been likely. Such arte factual conflicts would inevitably be eased by the addition of a 
second tensor, which would explain the reduction in RDC energy. 
The use of SVD to calculate the alignment tensor distribution in the Uhrinova et al. 
structure calculations did not lead to significant conclusions. The eigenvectors of the 
alignment tensor (i.e. the directions of the axes of the tensor) could not be well 
defined due to the limited nature of the RDCs data set, and they were even less 
defined when applying two separate tensors. This is shown in the Sanson-Flamsteed 
plot (figure 5.3, page 146), where the distribution of eigenvectors was scattered. 
In the current work, the structures derived from NOEs and hydrogen bonds alone 
demonstrated a very limited range of intermodular orientations (figure 5.5, page 
149), due to the number of module-to-module and module-to-linker NOE 
interactions holding the modules in a particular conformation, as discussed above. 
Refinement using RDCs with one alignment tensor did not incur the large energy 
penalties observed in the Ubrinova et al. study (refer to table 5.3, page 144). In fact, 
upon inclusion of two alignment tensors instead of one, the alignments of each 
separate tensor were similar to that of the single overall tensor (figure 5.5, page 149). 
Thus, the current set of data shows the second tensor was unnecessary and only one 
alignment tensor across the entire molecule was needed to accommodate adequately 
both NOE and RDC data. 
Increasing the number of RDCs (i.e. in the current study) resulted in more defined 
areas of distribution of the eigenvectors of the alignment tensor in the Sanson-
Flamsteed plots. Furthermore, inclusion of two alignment tensors, one for each 
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module, did not change the orientation, or range of tilt-, twist- and skew-angles to a 




Figure 8.2: Tilt-, twist- and skew-angles of RDC-refined structures calculated with one alignment 
tensor (shown as red circles) and those of the RDC-refined structures calculated with two alignment 
tensors (shown as green crosses). 
The important implication of these results is that DAF23 does not experience a large 
amount of flexibility across the intermodular junction. This conclusion - which 
contradicts the previous study - is reinforced by the relaxation measurements (see 
below). Low flexibility between these domains is also consistent with the 
conservation of intermodular angles observed in different crystal forms of DAF1234 
[178]. 
The results of refinement of NOE-derived structures with RDCs are probably best 
summarised in the tilt-, twist- and skew-angles and the RMSDs of each ensemble of 
structures. All three angles are affected by this RDC-refinement. Figure 8.3 shows 
the angle distributions for the NOE-derived structure ensembles and the RDC-refined 
structure ensembles of both the major and the minor conformer. For the conformer-
one ensemble, the distribution of tilt- and twist-angles remains within the range of 
these angles observed for NOE-derived structures, but become more localised within 
the distribution. The skew angles of the RDC-refined conformer-one structures also 
become localised; however, some of the values lie outside the range of skew angles 
of the NOE-derived structures. A similar situation arises on RDC-refinement of 
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conformer-two structures. This localisation results from the structure calculations 








Figure 8.3: Tilt-, twist- and skew angles of NOE-only derived structures (shown as black circles) and 
RDC-refined structures (shown as red crosses) of A) conformer one and B) conformer two. 
8.3.3 Comparison of intermodular angles between conformers 
Tilt-, twist- and skew-angles of both conformers are similar. For the most part, the 
range of conformer-two angles lies within the range of conformer-one angles and 
only minor differences between the sets of orientations are observed (figure 8.4 
below shows the angles the RDC-refined structures of both conformers overlaid). On 
one hand, this could imply that the two conformers have slightly different 
intermodular angles and that this is revealed by the RDCs (and is masked to some 
degree in the absence of RDCs). On the other hand, differences in intermodular 
orientation between conformers are very limited and could simply represent the lack 
of precision in the structure calculations. This is discussed further in section 8.4. 




Figure 8.4: Tilt-, twist- and skew angles of the RDC-refined structures of the conformer-one ensemble 
(shown as green crosses) and the conformer-two ensemble (shown as magenta crosses). 
8.4 Why are there two conformers? 
In the Uhrinova et al. structural study of DAF23, the presence of two conformers was 
noted. The cross-peaks occurring due to the major form were scaled to compensate, 
while cross-peaks due to the minor form were ignored. In the current study it was 
decided not to discard the second conformer because doubling of many cross-peaks 
occurs and the ratio of the major form to the minor form appears to be approximately 
4:3. Whether the minor form would have a different structure to the major form was 
not known at the outset. But, as NOESY spectra were being assigned, it became clear 
that the minor form was slightly different in structure at some points within module 
two. Comparison of analogous sets of NOE interactions for the two forms (table 4.3, 
page 132) provided evidence of this. When initial structures were calculated, it 
became clear that residues that give rise to doubled cross-peaks lie close together in 
space within module two. The most prominent region of residues that had doubled 
cross-peaks was the strand from 180 to Y84. This strand is fairly exposed and is part 
of the hypervariable loop in module two. Evidence (in the form of NOE interactions) 
shows that P86, which is located just beyond this strand, can exist in either a cis or 
trans conformation. The cis conformation-associated NOESY cross-peaks appear 
slightly weaker and this therefore the minor conformer was judged to contain cis 
P86. P78 adopts a cis configuration only, with no NOE evidence to suggest the 
presence of a trans configuration. 
CHAPTER 8: DISCUSSION 
	
216 
The difference in the backbone structure of the 180 to Y84 strand, and other parts of 
module two can be ascribed to this cis/trans isomerisation. The propagation of small 
changes in 180 to Y84, via the C95 to L105 region that contacts module three, could 
result in the observed, very minor, alterations in the module-module orientation (see 
above), although the lack of chemical shift difference between conformers at the 
interface argues against any real differences in intermodular angles (as alluded to in 
section 8.3) 
8.5 Secondary structure 
The Ramachandran statistics of both the NOE-derived and RDC-refined structures 
contain a relatively high percentage of residues in the disallowed region (table 8.2) 
and is worse than was the case for the Uhrinova et al. ensemble of DAF23 structures. 
NOE-only Major Minor Uhrinova Crystal 
(major conformer conformer et al. structures 
conformer) final final structures 
structures structures  
No. in 31 31 21 42 8 
ensemble  
Most favoured 66.7% 47.4% 50.1 % 53.8% 85.3% 
Additionally 24.4% 42.0% 39.1 % 37.6% 14.6% 
allowed  
Generously 4.5% 6.7% 7.0% 6.9% 0.1% 
allowed  
Disallowed 4.3% 1 	3.9% 1 	3.8% 1.8% 1 	0.0% 
Table 8.2: Ramachandran statistics of each ensemble taken from S63 to R187 (i.e. one residue before 
the first and after the last cysteine). 
A reasonably high percentage of residues are in the most favoured and additionally 
allowed regions of the Ramachandran map. However, the percentage of residues in 
the most favoured region is rather low and in the disallowed rather high compared to 
other NMR-derived structures, such as those in references [22, 100], but comparable 
to others single and double CCP modules such as GABAB2, fR 19 ,20, C4BP 12 and 
CR! 16,17 [18, 101, 116, 310]. Though the percentage of residues in the most favoured 
region is higher in the NOE-derived structures, this is due to the water-refinement 
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stage, which could not be carried out with the RDC-refined structures (see section 
3.7.5). These poor values relate in part to extent of secondary structure, which, in 
both conformer ensembles, is not as high as would be expected. 
It would seem, therefore, that bond angles defined by the five inferred hydrogen 
bonds, the NOE-derived distance restraints and the RDC restraints, together with the 
force field employed by the calculation protocol, were insufficient to define the full 
extent of fl-strands presumed (from the crystal structure) to exist in DAF23. The 
secondary structure in the Uhrinova et al. structures, on the other hand, was much 
better defined. It is believed that the conservative use of hydrogen bonding 
constraints as input into CNS in the current project is a contributor to this difference. 
The reservationsof this author about including hydrogen bond restraints arose from a 
reluctance to run the risk of introducing unnecessary bias or errors into the protein 
fold of DAF23. Many of the hydrogen bonds described in the Uhrinova et al. 
structure calculations -may have indeed been correctly described, and the large NOE 
violations (two violations above 0.7 A are reported in Uhrinova et al. [345]) could 
have been observed a result of the correct hydrogen bonding conflicting with 
erroneous NOE-derived restraints in the structure calculations. On inspection of the 
crystal structures, all hydrogen bonds described by both in the current study and the 
Uhrinova et al. study are feasible, i.e. donors and acceptors described are close 
enough for hydrogen bonding. 
It is not known whether the relatively high numbers of residues found in disallowed 
regions of the Ramachandran map, approximately five residues per structure, arise as 
a result of erroneous NOEs, violated NOEs that fall below the threshold for 
inspection or a lack of definitive data. It is suggested that the use of further analytical 
methods, such as QUEEN [205], are applied as an evaluation / validation tool to 
identify possible sources of error. 
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8.6 Comparison to X-ray structures 
Table 8.3 summarises the RMSD values of the closest-to-mean structure of each 
conformer-ensemble with the highest-resolution crystal structure; also shown are the 
RMSD values of the closest-to-mean structure of the Uhrinova et al. NMR-derived 
structures with the highest-resolution crystal structure. 




Ubrinova et al. 
structures 
Two 1.514 A 1.809 A 1.947 A 
Two (minus loops) 1.443 A 1.460 A 1.654 A 
Three 1.662 A 1.258 A 1.676 A 
Three (minus loops) 1.339 A 1.090 A 1.435 A 
Two and three 2.039 A 1.794A 4.398 A 
Two and three (minus loops) 1.754 A 1.53 1 A 3.999 A 
Table 8.3: Table giving RMSDs of the highest-resolution crystal structure overlaid with the closest-to- 
mean structure of the conformer-one ensemble, the conformer-two ensemble and the Uhrinova et al. 
NMR-derived ensemble of structures. Loops are defined as K76-1785 and P103-L105 in module two 
and P143-G145 and L172-V177 in module three. 
The values in the table are of limited value, because only one structure (closest-to-
mean) out of the ensembles of 31 and 21 structures of the conformer-one and 
conformer-two ensembles, respectively, was selected for comparison. Nonetheless, 
the new structures canbe seen to more closely resemble the crystal structure at the 
level of individual modules, and in terms of module-module orientations. Module 
two of the major NMR-derived conformer (conformer-one) is more similar to 
module two of the X-ray structure than its counterpart in the minor conformer. This 
is to be expected since the crystal structure contains a trans P86 rather than a cis P86. 
One of the main differences between the crystal structure of modules two and three 
from full DAF 123 4 and the previously published NMR-derived DAF23 structures lies 
in the intermodular junction. The Uhrinova et al. NMR-derived structures implied an 
ill-defined, semi-flexible junction with a different set of intermodular orientations to 
those of the consistent, apparently rigid crystal structure, as discussed previously. 
Reassignment and recalculation of the NMR structures has resulted in a much more 
limited range of intermodular orientations. The tilt-, twist- and skew-angles of the 
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ensemble of RDC-refined major-conformer ensemble and minor-conformer 











Figure 8.5: Tilt-, twist- and skew-angles of A) the ensemble of new NIvIR conformer-one structures 
(shown as green crosses) with those of the crystal structure (shown as red circles) and B) the ensemble 
of new NMR conformer-two structures (shown as sky blue crosses) with those of the crystal structure. 
The orientations are highly similar for both sets of structures; however some of the 
NMR-derived structures (major conformer) show larger tilt angles than those of the 
crystal structures. It may be that the elongated forms of DAF modules one to four in 
DAF1234 that are packed against each other in the crystals have limited the angle to 
which modules two and three can tilt with respect to each other. 
There are two further differences; from F85 to T89 in module two and from P143 to 
G145 in module three. These are highlighted in figure 8.6. The loop from F85 to T89 
is located near the N-terminus of module two. The crystal structures are from full 
DAF 1 4 structures, hence module one was present; the lack of module one in DAF 23  
is most likely the reason for the slightly different structures of this loop. P143 to 
G145 in module three is an exposed loop and is flexible (see discussion of Dynamics 
below), From inspection of the coordinates, it is conceivable that crystal packing 
forces have retained this particular loop in one conformation. Also highlighted in 
figure 8.6 is the loop from L171 to Q178: this loop represents one of the main 
differences between the Uhrinova et al. NMR-derived structures and the crystal 
structures. In the Uhrinova et al. solution structures this loop bends back towards the 
module, with a different orientation and position compared to the crystal structures 
5 toTE 
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(refer to figure 4. 1. page 103). In the new structures, in both the major and the minor 
conformer, this loop is in approximately the same position and orientation as the 
same loop in the crystal structures. 
Figure 8.6: New RDC-refmed major-conformer structures (blue) and crystal structures (red). A) 
Overlaid on backbone heavy atoms of module two from residue C64 to Cl 24, minus loops Q77-F85 
and E102-L105. B) Overlaid on backbone heavy atoms of module three from residue C129 to Cl 86, 
minus loops P143-G145 and 1172-V177. 
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The buried nature of the side-chains of the linker lysines, and residues such as G98, 
Y99, part of the side-chain of R100 and F148 provide a hydrophobic core at the 
interface, stabilising the junction. The estimated buried surface area at the interface 
for the new NIvIR structures is 600.6 A2 (as calculated for the closest-to-mean major-
form structure), which is comparable to that calculated for the highest-resolution 
crystal structure (602.5 A2) [311]. For refererence, approximately 1400 to 1700 A2 
surface area is buried between in forming a typical antibody-antigen complex [367]. 
Despite the similarity in intermodular orientations between the new NMR structures 
and crystal structures, comparison of back-calculated NOE interactions from the 
crystal structures with experimental ones reveals some differences. The back-
calculated distances should correspond to strong NOEs (back-calculated NOEs 
corresponding to distance less than 3.3 A in over half of the eight models of the 
crystal structures were selected for this comparison). Many of the back-calculated 
module-to-linker NOE interactions have matching cross-peaks in the experimental 
NOESY spectra, as would be expected, but others had not been identified. In most 
cases these NOE interactions might have been present but could not be resolved due 
to cross-peak overlap or cross-peaks being situated very close to the 'H-'H diagonal 
in the 'H-'H plane. However, six back-calculated module-to-linker NOEs were 
definitely missing from the experimental NOESY spectra (table 8.4). Three back-
calculated intermodular NOEs are seen in the spectra; P97 H 2 - 1172 H 11 , G98 Ha i 
- V177 Hi# and Y99 H2 - F148 H1. However, there are two back-calculated 
intermodular interactions that are definitely not observed in the experimental spectra 
(table 8.4). 
Module two - Module three Module two - Linker Module three - Linker 
G98 H 	F148 H1 G98 Ha t 	K127 H2 K126 H 1 - F148 H 
G98Hai 1172H G98Ha2K127H52 K127HF148H1 
R100 H1 —K127 FI 1 
R100 H 1 —K127 H72 
Table 8.4: Table of back-calculated NOE interactions that are not seen in experimental NOESY 
spectra. 
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In the closest-to-mean major conformer structure, the distances of the interactions 
listed in table 8.4 are, with the exception of one, less than 6 A, indicating that they 
should have been at least a weak NOESY cross-peak detectable. Two of the 
distances should result in strong NOEs (i.e. they are less than 3.3 A), and another to a 
medium-to-strong NOB (just over 3.3 A). This suggests that, in solution, a limited 
degree of flexibility is present about a conformational "ground state" (probably close 
to that observed in the crystal structure), which may time-average some NOE 
interactions. Tilt-, twist- and skew-angles of both sets of structures support this, in 
that the intermodular orientations of the eight models of the crystal structure also 
vary to a small extent. 
8.7 Dynamics of DAF 23 
Study of backbone dynamics using ' 5N relaxation data can recover a significant 
amount of qualitative information on the internal dynamics of proteins. The model-
free method of analysis is a commonly used and powerful technique in revealing the 
nature of overall global tumbling and local internal motions. Significant insight can 
be gained from fitting relaxation data to the model-free models. Unfortunately, in 
depth understanding of protein internal dynamics is hindered by ambiguities in 
interpretation of relaxation data. Due to the limited number of measurements, 
intrinsically complicated internal motions have to be approximated by simple models 
that have only a few parameters. 
For successful fitting, the overall global tumbling of the molecule must be 
uncorrelated to internal motions. It must also be accurately described for the correct 
analysis of the internal motions. Furthermore, model-free analysis is insensitive to 
the presence of nanosecond timescale motions. In such cases the effective correlation 
time can be severely underestimated, and the general order parameter can be slightly 
overestimated. As a result the protein appears more rigid than it really is. However, 
both the order parameter and the effective correlation time can be accurately 
predicted when the presence of nanosecond motions is properly identified. 
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Protocols of model selection have a major effect on the information that can be 
reliably obtained. Unsuitable model selection results in an inappropriate set of 
parameters to be fitted, in turn resulting in flawed data. The commonly used protocol 
of step-up hypothesis testing has been shown to cause severe oversimplification and 
under-fitting [38, 561. The consequences of this are that the order parameter is 
overestimated and the correlation time is underestimated. The Baysian Information 
Criterion approach [56] has been shown to be more sensitive in detecting both fast 
(p s) and slow (ns) internal motions, and more effective in selecting appropriate 
models. This approach of model selection was used in the current study to reduce the 
introduction of errors into model-free analysis by inappropriate model fitting. 
Moreover, any motion the molecule experiences parallel to N-H bond vectors would 
not contribute to the relaxation of the ' 5N, since the bond is not reoriented by this 
motion. If 15N relaxation data is the only probe of dynamics employed, this motion 
would go unnoticed. A more complete description of dynamics would have been 
possible if experiments that monitor motions of both N-H and C" '-C' bond vectors 
had been combined. Unfortunately, due to time constraints, this was not possible for 
the current study. 
The two-domain nature of DAF 23 will, no doubt, have consequences on the global 
tumbling. Possible interdomain motion, even of a small magnitude, may influence 
results and fitting. Due to the complex nature of these motions, they are difficult to 
elucidate from simple, and limited, data. 
Therefore, model-free analysis does have its drawbacks. However, despite this, if 
these limitations are kept in mind during analysis, model-free still provides a unique 
insight into the internal flexibilities of the protein backbone. 
8.7.1 Module dynamics 
Figure 6.5 (page 178) shows general order parameter values calculated in Modelfree 
plotted for each residue, and figure 8.7 shows these values mapped onto the structure 
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of DAF23 with colour-coding. What the latter diagram reveals is concerted regions of 
motion. Residues that are coloured shades of orange and yellow experience spatial 
restriction of their N-H bond vectors (with those in yellow most restricted). Areas 
shaded red experience some spatial restriction (with S 2 values between 0.75 and 
0.80). Those shaded pink through purple to blue experience much less spatial 
restriction (purple and blue residues have S 2 values less than 0.65 and therefore have 
a reasonable degree of movement). 
12I 
( 
S173 	 -) 
G145 
- . ____'•\ 	144 
I 
N157 
5' values  
0.90 < 
0.85 - 0.90 
0.80 - 0.85 
I
0.7S - 0.80 
0.70 - 0.75 
0.65 - 0.70 
0.60 - 0.6S 
<0.60 
Figure 8.7: S 2 values mapped onto DAF 23 structure (closest-to-mean structure from conformer one 
ensemble) in cross-eyed stereo view. Residues in white do not have relaxation data and therefore no 
S2 value available. 
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As will be discussed subsequently, the 2-3 interface and the linker region are 
restricted in their movement, as is a lot of module three. One area of module three 
showing more flexibility is in the hypervariable loop, from residues V142 to G145 
(although data for P143 is not available). A lack of definition in the ensemble of 
NIvIIR structures (for both conformers) is observed in this loop, which, in the crystal 
structures is seen to be oriented in a slightly different way. The observed 52  values 
support the previous assumption that this loop is flexible. 
The loop of module three located at the 2-3 interface, from approximately Li 71 to 
V177 / Q178, demonstrates little flexibility, with most 52  values between 0.8 and 
0.85. The exception is S173 on an exposed part of the loop; this residue is not 
involved in the 2-3 junction. 
One further region that presents a higher level of motion when compared to the rest 
of module three, and in fact much of the molecule, is from approximately F 154 to 
T158. Ti58 is part of a loop that would be located at the 3-4 interface, were module 
four present. Whether the presence of module four would influence the flexibility of 
this loop and the chain extending to it (from F 154) is not currently known. Another 
pair of residues located close to this region of flexibility, which display less spatial 
restriction, is G133 and E134. These residues may be influenced by the movement of 
the F154 to T158 region. 
Module two, on the whole, appears to experience more flexibility within its 
backbone than module two. The most flexible of its residues is V121, although the 
region of Ti 19 to F123 shows lower levels of spatial restriction. Close to this region 
are residues E 10 to L105. This loop (with the exception of P103, for which data is 
not available), which appears exposed, can undergo some movement. Residues 
within the hypervariable loop (Q77, Q82, Y84, F85) also show less restriction of 
their backbone. This loop extends up towards the 1-2 interface, as does the region of 
Ti 10 to Qi13 and Li 15 / Ki 16, which also demonstrates a small degree of 
movement. Again this may be due to the lack of the normally attached neighbouring 
module (module one in this case). 
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8.7.2 Intermodular motion 
Strong experimental evidence, provided by calculated structures and the successful 
implementation of a single alignment tensor over both modules, now suggests that 
the intermodular junction experiences only a limited degree of flexibility. In addition, 
relaxation data and derived model-free data are also consistent with limited motion. 
T 1 /T2 ratios observed for the linker residues are all close to average values, as are the 
[ 1 H] 15N NOE values (figures 6.1C and 6.1D, page 170). None of the backbone amide 
groups of the linker residues appear to experience motion that is uncommon to the 
majority of residues located in the modules. The models selected for the linker 
residues from model-free fitting of the relaxation data were "model 2" for K126, 
K127 and S128 and "model 4" for K125. Model 2 is described by two parameters; 
the order parameter, S 2 , and an effective correlation time, 't e . Model 4 is model 2 
with an additional parameter; a chemical exchange term. This model selection 
implies uncomplicated motion of backbone residues at the intermodular junction. 
The average S2  values of residues present at the junction, both in the linker and from 
the loops of each module, for which data is available, i.e. R96, G98, Y99, R100, 
K125, K126, K127, S128, 1172, S176 and Q178, is 0.864 ± 0.044. For linker 
residues, S 2 values are relatively high, with K125 having the lowest value of 0.803. 
Thus these linker residues exhibit fast timescale (ps) motion comparable to that of 
relatively rigid regions throughout the protein (figure 8.7). Effective correlation 
times of interface residues (with the exception of G98) are all in the order of 
picoseconds, and range from 20 (Y99) to 52 (K127) picoseconds. G98 has an 
effective correlation time of 170 Ps. Of these residues, those that also require a 
chemical exchange term to be fitted are Y99, K125, 1172 and Q178. Overall, residues 
present at the intermodular interface show a limited degree of movement on the 
picosecond timescale and not much evidence for concerted motion on slower time 
scales. While it may be more mobile (lower S2  for Si 73), the S 173-Si 75 loop is not 
involved in the junction. 
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The linker residues are relatively buried in the current study. This can be seen in 
figures 5.14 and 5.15 (pages 161 and 162). This is consistent with the high order 
parameters (limited motion) observed for these residues. Contrastingly, in the 
Uhrinova et al. NMR structure, linker residues are relatively exposed at the module 
interface (figure 5.16, page 163). 
These results provide further evidence that modules two and three are fairly limited 
in the orientations they can take with respect to each other. The absence of some 
expected NOEs, however (see above), suggests they are unlikely to be completely 
rigid. Movement between the modules may be on a slow nanosecond timescale, but 
unfortunately, due to methodological limitations, measuring such complicated 
motion is not currently possible. 
8.8 Convertase binding 
The results of mutagenesis may now be discussed in the context of our knowledge of 
DAF23 structure and dynamics. Figure 8.8 shows a surface potential map of the 
closest-to-mean major conformer structure. 
According to mutagenesis, key residues that are essential for classical and alternative 
pathway regulation are R69, R96, R100, K127, F148 and L171, with F169 also 
contributing in the alternative pathway [141] (Kuttner-Köndo, ME Medof, personal 
communication). Each residue will be discussed in turn. 
R69 (seen in red in figure 8.9) has an exposed side-chain and does not appear to have 
a critical structural role. R69 contributes to the band of positive surface area on 
module two, located above the intermodular interface (figure 8.8). R69C and R69W, 
where arginine has been replaced by a polar residue and a similarly bulky residue 
respectively, both abolish CP activity implying that positive charge appears to be the 
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Figure 8.8: Surface-potential map of the closest-to-mean major conformer structure, provided by 
Dinesh Soares, created using GRASP. Residue numbers at positive and negative patches, as well as an 
important uncharged patch, have been mapped onto structure. 
R96 (seen in green in figure 8.9) is located very close to the junction and has an 
exposed guanidyl group, which also contributes to the positively charged patch 
above the interface on module two. R96L abolishes CP activity providing support to 
the argument that it is the positive charge of this residue that is most important for its 
functional contribution, not its long alkyl chain. 
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Figure 8.9: Positions of R69 (red) and R96 (green) (shown on closest-to-mean major form structure). 
A) Mapped onto surface. B) Surface hidden to show exposure of each residue. C) Positions of R69 
and R96 side-chains for all 31 structures of major-form ensemble. 
Figure 8.9 (A and B) shows both of these residues and their side-chain positions 
mapped onto the surface of DAF 23 and in 8.9C the positions of their side-chain in all 
31 structures of the major-form ensemble. R96 doesn't appear to contribute to the 
interface in any significant manner. This suggests that the positive charges of both 
R69 and R96 are their most significant features and provide a positively charged 
patch for binding. The order parameters of both of these residues are relatively high 
(0.904 for R69 and 0.923 for R96), suggesting their backbone N-H bond vectors 
undergo little motion. However, both residues have long effective correlation times 
(574 and 697 ps, respectively) suggesting any backbone motion experienced is 
slower than much of the backbone of the molecule. 
RI 00 is located on the opposite face to R69 and R96, and is shown in blue in figure 
8.10. RI 00, in the current solution structures, is half-buried and sits down over the 
interface, making many contacts with the linker residues (see NOE interactions in 
Appendix 9, page 316), contributing to the stability of the junction. R100A results in 
a reduction of 75% of CP activity and 88% of AP activity, whereas R1 OOC results in 
a slightly more modest loss of functional activity (63% reduction in CP activity and 
65% in AP activity). These data imply that R100 is involved in the stability of the 
junction and that a specific junction structure is required for both AP and CP activity. 
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Figure 8.10. A) Position of R 10 mapped onto surface and ifi R 10 side-chain positions within 
major-form ensemble of structures. 
According to mutagenesis studies, the three linker lysine residues are all important 
for function. These residues are mapped onto the major-conformer surface in figure 




Figure 8.11: Linker residues mapped onto major-confomer closest-to-mean structure. KI 25 shown in 
yellow, K126 in green, K127 in cyan and S128 shown for completeness in brown. 
K I 25A and KI 26A both result in a significant loss of activity in the alternative 
pathway (68% and 91% reductions, respectively). However, in the CP only a modest 
loss results from K1 25A (a reduction of 38% activity) and none from K1 26A. 
KI 26C abolishes AP activity but only reduces CP activity by approximately 40%. 
This implies that K1 26, which is mostly buried, is important due to its contribution to 
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stabilisation of the interface. Ki 25, though less buried. also contributes to this 
stabilisation. 
K127 is the most important of the linker residues (this lysine is also conserved in 
other functionally, equivalent CCP modules with decay accelerating activity), with 
K127A abolishing activity in both pathways. It is also the most buried of the linker 
residues, implying a major structural role. This is supported by the fact that the order 
parameter of K127 is the highest of the linker residues (0.90 ± 0.09). It lies on the 
opposite face to R69, R96 and K126, located just below RI 00. Following on from 
the hypothesis concerning the effect of R100 mutations, the most likely explanation 
of loss of activity following mutation to alanine is loss of critical junction structure. 
F148 is critical for function, since F148A renders DAF almost completely 
functionally inactive in both classical and alternative pathways. F148 is mostly 
buried within the hydrophobic core of the junction and is critical to junction 
structure; however, the aromatic ring experiences partial exposure (figure 8.12). 
While this exposed region ofFl48 contributes to a hydrophobic patch located on 
module three (consisting of F148, F1 69  and L171), mutation to alanine will disrupt 





Figure 8.12: A) Position of Fl 48 mapped onto surface of closest-to-mean maj or-conformer structure. 
B) Position of F 148's aromatic ring. 
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F 169 is critical for AP activity only. F 1 69A presents a relatively minor loss of CP 
regulatory activity (36% reduction), but abolishes AP regulatory activity. F169C also 
retains some CP regulatory activity (there is a 62% reduction), but again abolishes 
AP activity. This suggests that the hydrophobic nature of the aromatic ring is 
important in AP convertase binding. L171 A  has a substantial affect on regulatory 
activity in both pathways (abolishing AP activity and giving an 84% reduction in CP 
activity), The largely exposed side-chain of LI 71 is, therefore, important by virtue of 
its hydrophobic contribution to a convertase contact surface. The side-chains of F169 
and L171 lie next to each other on the surface of DAF (figure 8.13). 
A) t I l B) 	'-!V 
Figure 8.13: Fl 69 (orange) and L171 (yellow). A) Mapped onto the closest-to-mean major 
conformer structure. B) Side-chain positions in the ensemble of major-conformer structures (overlaid 
on the backbone of module three). 
When mapped onto the surface of the molecule R69, P.96, F148, F169 and L171 are 
all located on one face (figure 8.14). Only K126 of the linker residues is exposed on 
this face. When the electrostatic surface is viewed (figure 8.8) F148, F169, L171 and 
1172 form a large uncharged patch just below the junction. Above this patch on 
module two are the charged regions of R69 and R96. These regions are the proposed 
binding site for the CP and AP convertases. These results and conclusions are similar 
to those reached by the crystallographers [178]. 
One further mutation that holds relevance for convertase binding is D181, which is 
located just below LI 71 and F 169 (see figure 8.14), providing a small negatively 
charged area. D181A abolishes classical pathway activity and reduces alternative 
pathway activity by 86%. It is likely that this residue also contributes directly to the 
binding site for both convertases. 
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Figure 8.14: Important residues for convertase binding mapped onto surface of DAF 23 . 
8.8.1 Chemical exchange 
Figure 8.15 highlights (in red) residues that both require chemical exchange terms in 
the model-free analysis and also satisfy the Tjandra criteria for chemical exchange 
(refer to page 143). It has been reported that regions of CCP modules involved in 
protein-protein interactions exhibit j.ts - ms timescale motions [222], consistent with 
an induced fit mechanism for ligand binding. In the case of DAF, no such 
correlation could be found. Figure 8.15 also highlights (in magenta) the putative 
convertase binding site on DAF23 (R69, R96, F169, L171 and D181), and it is clear 
that there is no coincidence between the residues undergoing chemical exchange and 
residues, so far, implicated in functioa F169 and D181 do appear in the list of 
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residues that have a R term, but do not satisfy the Tjandra criteria. But given the 
very wide distribution of such residues over all faces of both modules, no correlation 















Figure 8.15: Residues indicated to be undergoing chemical exchange from model-free analysis and 
Tjandra criteria mapped onto closest-to-mean major conformer structure in red. Residues thought to 
be site of convertase binding shown in magenta. 
8.9 Consequences of the presence of module four 
Effective purification of DAF 234 samples was achieved using a strong cation 
exchanger. This procedure resulted in removal of sugars, which appeared to have a 
detrimental effect on the quality of the samples. Certainly, samples of a suitable 
standard for study by NMR were acquired only upon removal of these sugars, 
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suggesting excess sugars induced aggregation of protein molecules, or interfered 
with folding in some molecules. 
With a sample of a suitable quality for NMR, some conclusions can now be drawn 
on how the addition of module four effects modules two and three in solution. For 
the time being this, can only be attempted through inspection of the 'H-' 5N-HSQC of 
DAF234 . Figure 7.24 (page 204) shows an overlay of DAF 23 's 'H-' 5N-HSQC with 
that of DAF234. As many peaks as possible were assigned, assuming that those cross-
peaks that superimpose directly can be attributed to an equivalent residue, and that 
DAF23 cross-peaks close to similar cross-peaks in the DAF 234 spectrum, where there 
were no other nearby cross-peaks, can also be attributed to an equivalent residue. 
Approximately 65 extra non-side-chain cross-peaks were found, which is enough to 
account for module four. This indicates all three modules in DAF 234 are fully folded. 
8.9.1 Module two conformations in DAF234 
On inspection of the 1 H- 15N-HSQC of purified DAF 234 , it can be seen that amide 
cross-peaks assigned to both conformers are still present. Examples are shown in 
figure 8.16. This indicates that the two conformations of DAF module two are 
present in the triple module fragment as well as the double module. However, in full 
DAF 1234 the presence of module one may affect whether these two conformers occur. 
P86 is located at the 1-2 intermodular junction; it may be the lack of module one that 
has facilitated this cis/trans isomerisation. 
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Figure 8.16: 'H-'N-HSQC cross-peaks of DAF 23 (shown in green) and DAF (shown in blue). 
Conformer cross-peaks of A) Y84 / Y1084, Q82 /Q1082, and minor form cross-peak of 180 (11080), 
in both spectra, B) V91 (although V1091 is overlapped with Q139) and minor form cross-peak of N83 
(N1083) in both spectra, and C)T81 and T1081 in both spectra. 
8.9.2 Chemical shift differences in modules two and three 
Chemical shift perturbation of cross-peaks from modules two and three in the 
presence of module four were investigated in the DAF234 'H-' 5N-HSQC. Chemical 
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The results of this exercise are plotted for each residue (for which a cross-peak could 
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Figure 8.17: Chemical shift perturbation per residue, calculated according to reference [42]. 
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Most cross-peaks experience only minor shifts; however, these are minimal. Those 
that experience larger shifts have been mapped onto the DAF13 structure in figure 
8.18. An arbitrary cut-off value of 0.05 was chosen (shown as a dotted line in figure 
8.6). Residues whose cross-peaks have a perturbation value over 0.05 were S63, S72, 
C124, G138, S155, C156, T158, G159, Y160, K161, L161 R187 and E188. 
Figure 8.18 shows that it is in module three, at the C-terminus (where module four is 
added) that many shift differences occur, particularly in the region that is located at 
the 3-4 interface from S155 to L162. S155 to T158 have also been shown to have 
low S2  values (refer to figure 6.7) and therefore, some flexibility. These results 
corroborate one another. These shifts are to be expected, since the addition of 
another module at this terminus would no doubt affect the residues following the last 
cysteine of module three (i.e. R187 and E188) and the aforementioned loop at the 3-4 
interface. A loop that lies close to this region (1135 to G138) also experiences some 
shift differences, the largest being at G138, which is highlighted in figure 8.18. 
Figure S. 15: Residues experiencing chemical shill perturbation greater than 0.05 ppm shon in red 
and labelled. Residues experiencing chemical shift perturbation greater than 0.025 ppm shown in 
orange. Mapped onto closest-to-mean major-conformer structure. 
Three shift differences over 0.05 ppm are observed in module two residues; two 
close to the 2-3 interface. These two residues (S72 and C124) lie close to one another 
in the structure, however, no real conclusions can be drawn about this at present due 
to lack of data. Whether these shift differences result from minor structural changes 
cannot be concluded from this information. Overlays of these two residues 
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Figure 8.19: Amide cross-peaks of A) S72 and B) C124, from N-HSQCs of DAF 23 (green) and 
DAF234 (blue). 
With a suitable amount of labelled sample, confident assignment of the 1H-' 5N-
HSQC of DAF4 could be made. This could then be used for binding studies with 
suitable substrates that require all three modules of DAF 234 . 
8.10 Further work 
It would be recommended that further investigation into residues in disallowed 
regions of the Ramachandran plot be undertaken, in order to remove any further 
erroneous NOEs that may be contributing to this. Mother avenue to take in an 
attempt to improve secondary structure would be further investigation into hydrogen 
bonding within DAF23. NMR experiments have been developed that are able to give 
more insight into hydrogen bonding within proteins 11531. These experiments would 
give a much clearer insight and more accurate results than deuterium exchange 
experiments. 
Other methods of extracting dynamics information from NMR relaxation data are 
becoming more popular. SRLS (Slowly Relaxing Local Structure) analysis 11 342, 
304, 1931, which accounts rigorously for coupling between global and local N-H 
motions through a local ordering potential exerted by the protein structure at the N-H 
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bond, has been used in numerous studies and succeeds in areas that model-free 
analysis cannot deal with (i.e. correlated global and internal motion). Domain-
domain flexibilities have been investigated using this method; therefore, application 
of SRLS to DAF23 data is recommended. Two further different methods of relaxation 
data interpretation are RED (Reorientational Eigenmode Dynamics) [256, 257] and 
Brownian Dynamics [62]. Investigation of DAF23 dynamics using these methods 
would provide even more insight into 1) interdomain motion and 2) local motion, 
particularly for residues implicated in convertase binding. 
It would also be highly beneficial to acquire and analyse ' 3 C relaxation 
measurements. 
With respect to DAF234 and DAF 12 , further work would be production and 
purification of a suitable amount of 13 C, 15N-labelled protein and acquisition of 
spectra for chemical shift assignment. Once the backbone and the 'H-' 5N-HSQC and 
'H-' 3 C-HSQC spectra are assigned, titration experiments could be performed with a 
number of ligands in an attempt to further elucidate how DAF binds to its known 
substrates. With current assignment and analysis software [350] this process should 
certainly not take long. 
Chapter 9 
CONCLUSIONS 
This thesis has presented the new NMR-derived structures of two DAF 23 conformers. 
These new structures are not consistent with the Uhrinova et al. NIMR-solution 
structures. This is most likely due to erroneous and missing chemical shift 
assignments in the Ubrinova et al. study, which was presumably the result of the 
means of data processing employed and a more limited data set. New structures 
agree with module two and three of the previously described X-ray DAF 1234 crystal 
structures. There are examples of other instances such as this, where re-evaluation of 
experimental data of an originally published structure has been prompted by the 
publication of a corresponding structure [45, 46, 115, 145, 146, 346]. Misinterpreted 
NOE data have subsequently been found and erroneous structures have been 
corrected. One of these examples was of a similar situation, in than incorrect domain 
orientation was highlighted by crystal structure [45, 115], following which the NMR 
data was corrected [46]. These structures have stemmed from premier protein NMR 
groups, all involved in structure validation and refinement methodologies. 
Unfortunately, any experiment, and thus any structure model, will have errors 
associated with it. In this study, many errors have been located and corrected, and as 
a result, more appropriate structures produced. 
Current DAF 23 NMR structures mean that understanding of mutagenesis data based 
on experimentally-solved structures, with regards to binding of convertases to DAF, 
is now clearer and does not give rise to the previous conflicting interpretations. The 
main purpose of the linker lysines is likely to be in stabilizing the 2-3 junction, whilst 
240 
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other important residues (R69, R96, F148, F169 and L171) are likely to be direct 
sites of convertase binding. F148 is also critical in the stabilization of the junction. 
The advantages of NMR have been exploited in this work to provide an insight into 
global and internal dynamics of this molecule. This provided evidence of limited 
interdomain motion, which supports the aforementioned mutagenesis data 
interpretation. 
The addition of module four mainly has consequences (probably in minor structural 
perturbations) for residues proximal to the 3-4 interface, which would be expected. A 
suitable purification method has been achieved to enable suitable samples of DAF 234 
and DAF12 for further studies using NMR spectroscopy. 
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NMR ACQUISITION AND PROCESSING DETAILS 
Experiment Person Number of 
scans 
Time domain points 
(dimension) 
Real data matrix after 
window functions 
Real data matrix 
after MEM 
15N-HSQC SU 2 1024x 128 512x128 - 
CBCACONH SU 16 1024x128(C)x60(N) 512x128x64 512x256x128 
HNCACB SU 20 1024x128(C)x60(N) 512x128(C)x64(N) 512x256x128 
HBHACONH SU 16 910 x 76(N) x 192(H) 5 12x128(N)x256(H) 5 12x128(N)x256(H) 
HBHANH SU 24 918x80(N)x132(H) 512x128(N)x256(H) 512x256(N)x256(H) 
HNCO SU 4 1024x96(CO)x60(N) 512x128x64 512x128x128(N) 
HNCACO SU 96 1024x36(CO)x60(N) 512x64x64 512x128x128(N) 
H(CCO)NH-TOCSY SU 16 1024x192(H)x60(N) 512x256x64 - 512x512x128 
(H)C(CO)NFI-TOCSY SU 24 1024x128(C)x60(N) 1024x128x64 1 024x256x128 
HCCH-TOCSY SU 8 1024x192(H)x80(C) 1024x256x128 1024x512x256 
(HB)CB(CGCD)HD EB 256 2048x96 1024x128 1024x256 
(HB)CB(CGCDCE)HE EB 320 1024x96 512x128 512x256 
AROMATIC 13C-HSQC TROSY EB 8 2048x224 1024x256 - 
' 5N-HSQC-NOESY SU 8 1024x176(H)x112(N) 512x256x128 - 
13C-HSQC-NOESY EB 16 2048x192(H)x64(C) 2048x256x64 - 




NMR DATA PROCESSING 
The program 'process' within the AZARA software was used for the current work. 
'Process' requires a script for each spectrum that contains a section for each acquired 
dimension detailing the appropriate commands. Commands within scripts differ 
slightly between data collected on spectrometers supplied by the different 
manufacturers. 
The input to each script is an associated parameter file, which includes a link to the 
FID itself. This parameter file (usually given the name fid.par for Varian data and 
ser.ref for Bruker data) also includes information about each dimension of the 
spectrum. Examples are shown in the following section. 
The information required for each dimension is: number of points acquired, spectral 
width, spectral frequency, reference ppm, reference point and the nucleus observed in 
that dimension. The output of the processing script is the Fourier transformed 
spectrum along with a spectrum parameter file called spc.par. 
The scripts used to process NIMR data acquired using both Varian and Bruker 
spectrometers are detailed below. 
Varian data 
An example fid.par for Varian data is shown in figure 1. 
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freqHOppm is : 599807307. 425610 Hz 




varisn 2 3 
dim 1 
npts 1024 
sw 3515. 625 
sf 599810083 
refppm 4.627110 











Sw 1285. 016705 
sf 60.785270 
refppm 120. 990419 
refpt 65 ! 1+np/2 in ZF&FT spec 
nuc 15N 
Figure 1: Example fid.par for input into AZARA program 'process'. 
'int' tells 'process' that the data is integer. 
'varian' is required in the fid.par for data acquired on Varian spectrometers. The 
numbers refer to the ordering of the data. 'varian 2 3' is used for a 3-dimensional 
experiment where the data for each FID in the acquisition dimension is ordered as RR, 
IR, RI, II (R = real, I = imaginary). If the data was ordered RR, RI, IR, II then 'varian 
3 2' would be needed. 
'dim' refers to the dimension in question, 'npts' to number of points, 'Sw' to spectral 
width, 'sf' to spectral frequency, 'refppm' to the reference chemical shift in ppm, 
'refpt' to the reference point and 'nuc' to the observed nucleus. 
An example processing script for Varian data is shown in figure 2. 
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input fid.par 
ontpnt spc I  also produces spc.par 
interlace 3 
script con 1 coirsnands for dimension 
I 
complex 
conjugate takes complex 
conjugate 
cons 	16 _box reduce solvent signal 
sinsbell2 90 window function 
zerofill 1 !to next power of 2 
f ft !fast FT for complex 
data 
phase 69 0 !*start  with 	0 0 
reduce !discards any imaginary 
parts 
upper 512 ! change depending on 
data 








phase 90 -180 depends on f1180 - 









phase 0 -180 Idepends on f2180 - for 




base -trig 8 3 
end_script 
Figure 2: Example script for processing Varian data using the AZARA program 'process'. 
The meanings of commands used are as follows: 
• 'interlace 3' was used when the experiment involved sensitivity enhancement by 
interlacing the data (a method used for compression of data). '3' refers to which 
dimension of the acquired data requires interlacing. 
'complex' indicates to AZARA that the data is complex. 
'conjugate' informs AZARA that the complex conjugate of complex data should 
be used. The complex conjugate of a complex number is given by changing the 
sign of the imaginary part, i.e. z = a + bi becomes ZY = a— bi. 
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'cony—box <half-width>' convolves the data with a box function with the given 
<half width> and subtracts the results from the data. This is typically done on the 
acquisition FID before anything else in order to remove the water signal that 
occurs at zero frequency. 
'sinebe112 <angle>' multiplies the data by the sine function squared with the 
given <angle> (degrees) at point 1, and, if there are n (complex/real) points, with 
angle 180° at point n+1 (not point n). So 'sinebe112 90' multiplies the data by the 
square of a sine function which is 1 at point 1 and 0 at point n+1. It assists in 
removing "sinc wiggles"; during zerofilling (see below) a harsh step is created in 
the FID where the end of the signal has been truncated. The integration of such a 
step would produce a ((1/x) sin x) character giving rise to distortion at the base of 
each peak. In processing both dimensions, the FID was multiplied by a sinebell 
squared function that smoothed this step and therefore prevented this apodisation 
from occurring. 
'zerofill <n>' zerofihls the data so that its final size is 2 times the original size. It 
involves truncating the FID after it has relaxed to the extent that it contains no 
data that can be usefully interpreted from amongst the noise. The removed part of 
the FID is replaced with a series of zero intensity data points. This produces a 
higher effective sampling number and helps to increase the resolution of the 
processed spectrum. 
'fft' is a complex Fourier transform. The input data size doesn't have to be a 
power of 2, but the data is zero-padded if it is not. The time domain of the FID is 
changed into the frequency domain of the spectrum. 
'phase <phase 0> <phase 1>' phases complex data with the specified parameters 
<phase 0> and <phase 1>, both in degrees. It ensures data is entirely in cosine 
form (absorption line form) to avoid peak overlap, which can cause cancellation 
of signal. The phasing required is determined using AZARA. 
'reduce' transforms complex data to real data (by throwing out the imaginary 
part) for display purposes. 
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'upper <upper bound>' truncates data so that points above <upper bound> are 
discarded. This enables the user to remove any redundant parts of the spectrum. 
Analogous to this are 'lower <lower bound>' and 'range <lower bound> <upper 
bound>. For all of these commands the spectral width must also be modified 
accordingly. 
Bruker data 
For Bruker data, the parameter file analogous to fid.par is usually called ser.ref. An 
example of a ser.ref file is shown in figure 3.10. This is almost identical to the fid.par 
used with Varian data, except for the 'varian' command. The script for Bruker data is 
also very similar to that of Varian data but requires a few extra commands. An 

























Figure 3: Example ser.ref file for input into the AZARA program 'process'. 
Additional processing commands required for Bruker data are as follows: 
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'avance <DSPFVS> <DECIM>" 1 is added between any 'cony —box' and 
'sinebe112' command in the first dimension. This does the first part of the 
transform required for Bruker Avarice data with specified <DSPFVS>, <DECIM> 
and angle 180 degrees. The second part of the transformation 'avance_phase' (see 
below) is required in combination with this command. 
'avance_phase' does the second part of the transformation required for Bruker 
Avarice data. This is applied after 'fft' and before 'phase' commands in the same 
script as the first part of the transformation. 
'mask_ppmm' forms a ++-- multiplication needed to process some Bruker data. It 
multiplies points 3 and 4 of each set of four by —1. It must appear before the 
complex command in those dimensions requiring it. 
9.1.1 Other commands used in both types of data 
A number of additional commands can also be applied in order to improve the 
appearance spectra. Those used in this study for some spectra were as follows: 
'base_const <half width>' fits the baseline of a spectrum (not the FID) by first 
finding baseline points using a shifting window of half width and then fitting a 
constant to those baseline points. 
'basepoly <half width> <degrees>' fits the baseline of a spectrum (not the FID) 
by first finding baseline points using a shifting window of <half width> and then 
fitting a polynomial of degree (order) <degree>. 
11 As part of the Bruker digital filtering, there is an apparent delay at the start of the acquisition. The 
data must therefore be shifted left by a certain number of points then phase corrected. This command 
(avarice 12 24) informs the FID to remove the requisite number of points and also gives the magnitude 
of the phase to be perfomed. DECIM refers to the spectral width and DSPFVS refers to the Bruker. 
filtering version being used. 
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'base—trig <half width> <degrees>' fits the baseline of a spectrum (not the FID) 
as base_poly but using trig functions instead. This can only be used if the original 
data set contains the entire recorded spectral width. 
'scale2 <first point> <last point> <real value> <imaginary value>' multiplies 
each point between the first point and the last point (inclusive) of the data by 
(<real value> + i<imaginary>), note that it is complex multiplication. Values used 
were 'scale2 11 0.5 0', which multiplies the first (complex) point by 0.5. 
input ser.ref 
output spc 
script corn 1 
complex 
cony_box 32 
avance 12 16 
snebefl2 90 
zero fill 1 
f ft 
avance_phas e 







scale2 1 1 0.5 0.0 
conjugate 
srnebe112 90 
zero fill 1 
fft 
phase 0 0 
reduce 
end_script 





zero fill 1 
f ft 
phase 90 -180 
reduce 
end_script 
script corn 1 
has e_poly 8 0 
end—script 
Figure 9.1: Example of a script for processing Bruker NMR data using AZARA program 'process'. 
If water suppression in a particular spectrum was especially bad the following section 
of script (figure 4) was added after the first dimension commands and 'cony —box' and 









Figure 4: Alternative water suppression script. The command 'iffin' does an inverse Fourier transform, 
so that the 'cony-box' command is applied to the time-domain data. 
Maximum Entropy Method (MEM) processing 
Processing a three-dimensional spectrum with the MEM takes a great deal of CPU 
time. To find suitable parameters required for MEM processing the three-dimensional 
spectrum was part-processed (where only the directly detected dimension is fully 
processed), then a two-dimensional plane was extracted from the two indirect 
dimensions and MEM processed. The MEM processing parameters could be 
optimized for this two-dimensional spectrum without requiring a large amount of 
CPU time. Once suitable parameters were achieved the MEM was applied to the 
whole spectrum. 
To part-process, all commands that apply to the indirect dimensions were edited out 
of a copy of the original processing script, except the 'complex' and 'conjugate' 
commands. A part-processed plane cuffing across the indirect dimensions (a '2 3' 
plane) was extracted using the AZARA program 'extract', which outputs the plane 
and an associated parameter file. An example of an 'extract script' is shown in figure 
5. 
input m. spc par 
output plane341 part processed plane 
extract 1:341 
Figure 5: Example of an 'extract' script for AZARA program 'extract'. 
The initial MEM process script (example shown in figure 6) input file is the part- 
processed plane spectrum parameter file (which contains a link to the spectrum itself). 
WEI 
input planell7L par 
output memll7l 
maxert2 corn 1 2 
iter 20 
noise 600 
log M. log 








phase 90 -180 
end inaxent 
Figure 6: Example of a maximum entropy processing script used in AZARA program 'process'. 
The commands of a MEM processing script are as follows: 
'maxent2_com <dim 1> <dim 2>' specifies MEM processing. The '2' indicates 
how many dimensions are to undergo processing. 
• 'iter <maximum number>' dictates the maximum number of iterative cycles 
allowed in the attempt to reach convergence, i.e. the number of iterations the 
algorithm will use on one slice of data before "giving up". 
'noise <noise level>' gives the noise level on the input data (not the spectrum). 
Experimentation with this number is recommended. The following calculation of 
noise is often used as a starting point. 
Noise = 
Std. dev. of background noise 
,J(No. complex points in dimension 1) * (No. complex points in dimension 2) 
+1000 
'log <log file>' enables information provided by the algorithm to be written to a 
log file for every iteration of every data slice. This enables convergence of all data 
slices to be checked (i.e. whether correct processing of that data slice has occured. 
'rate <relative step size>' gives the relative rate at which the algorithm takes step 
sizes. A smaller rate often helps if the algorithm is not converging. 
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Necessary commands for each dimension in the script file are shown below. 
'dim <dimension>' starts the section for the given dimension. Dimensions are 
relative to the slice not the entire file. 
'npts <number of points>' gives the size of the spectrum (the output from the 
maximum entropy algorithm) in this dimension. Any 2" number can be used. 
Often double the number of points from the zerofilled, processed spectrum is used 
here. 
• 'complex' to indicate the data is complex. 
• 	'ih 	<h1l 	hQ.1 >' 	fh, ,-1f 
Once the two-dimensional slice had been MEM processed to suitable quality and the 
algorithm converged for this data slice, MEM processing was applied to the whole 
spectrum by adding the MEM script to the end of the script used to part-process the 
entire spectrum (from which the plane was extracted). At this point the command line 
'maxent2 corn 12' required changing to 'maxent2_com 2 3' to indicate the correct 
dimensions to be MEM processed. 'Convergence' of the algorithm in all data slices in 
the spectrum was checked after processing. 
Contours 
'Contours' is another program in the AZARA software. It computes a contour file 
describing peaks within a spectrum for use in viewing and assignment software such 
as ANSIG [138, 139] (see below). For two-dimensional spectra, one contour file 
describes all peaks but in three-dimensional spectra, two contour files are required. A 
contour file represents a set of two-dimensional planes, with each plane describing a 
different frequency in a third, orthogonal dimension. Each plane is described at 
multiple levels above the spectrum baseline, hence describing the contours of each 
plane. For a complete description of three-dimensional data, a second set of contour 
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planes viewed from an orthogonal angle is required. An example of a contour script is 
shown in figure 3.15 
irput. spcper.ref 
o=puz 12.cnt 
dims 1 2 
levels 90000 -90000 
levels 125999 -125999 
levels 176399 -176399 
levels 246959 -246959 
levels 345743 -345743 
levels 484041 -484041 
levels 677658 -677658 
levels 948721 -948721 
levels 1328210 -1328210 
levels 1859494 -18599494 
Figure 9.2: Levels script for contouring using the AZARA program 'contours'. 
The input for contours is the spectrum parameter file (containing a link to the FID), 
the output is the contour file. Commands are as follows: 
'dims <dimi of plane> <dim2 of plane>' describes the appropriate dimensions to 
be contoured. 
'levels <levels to contour>' describe each level from an appointed base level up 
at which contours should be created. 
In this work eight levels were used with the multiplier between levels set at 1.4. 
Optional commands that could be included define specific ppm or point ranges, but 
these were not used in the current study. 
Information on commands detailed in Appendix 2 is taken from the AZARA html 
documentation (www.bio.ca.ac.uk/azara/azara —docs/azara.html). 
APPENDIX 3 
EXAMPLE ANSIG SET-UP FILES 
Example of ANSIG control file 
control 
{ANSIGDIR} 	/usr/local/ansig/ansig3 .3 
{lib} 	{ANSIGDIR}/lib/ 
local lib) 	{ANSIGDIR} /locallib/ 
{data} 	/usr/people/eveb/NMR/DAF23/ 
(my lib) /usr/people/eveb/ANSIG/lib/ 
help dir 	(ANSIGDIR) /doc/ 
dictionary {lib}amino acids l5N 130. dic 
grtranslate 	{ lib}amino acids. tm 
sequence 	daf23nme.seq 
spectra daf23nme . spd 
crosspeaks 	daf23nnie.crp 





general; three variants 
general 
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Example of ANSIG spectrum description file 
ppm range 13C -10.0 150.0 
ppm range 15N 90.0 150.0 
ppm range lH -5.0 15.0 
ppm_range 13CO 160.0 190.0 
SPECTRUM 1 
spectrum 2D n-hsqc 
expnucleus Fl 15N 
experiment lj 
temperature 310.0 pH 5.0 
contour—file (data )/hsqc 8000. fid/spc. cnt 
matrix file 
parameter file {data} /hsqc 8000. fid/spc . par. ref 
aliased Fl 
linewidth Fl 0.3 F2 0.03 
noise—level 90000.0 




spectrum 3D cl3noesy 
expnucleus F2 1H 
expnucleus Fl 13C 
expnucleus F2 1FI 
experiment Fl F2 lj 
equivalent n-hsqc 




parameter_file (data } /cl3noesy_eve/spc. par. ref 
aliased El 
linewidth Fl 1.45 F2 0.16 F3 0.045 
noise level 3000000.0 
contour base +1 - 150000.0 1.4 8 
end _matrix _file 
end—spectrum 
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Example of ANSIG initialization file 
Initialization file ANSIG v3.3 
program parameters setup 
set graphics separator 
set graphics translate on 
set backup 25 
set diagonal 0.05 
set tolerance lii 0.02 
no assignment label separator 
switch on assignment label translate 
switch on crosspeak file backup 
avoid extracting diagonal peaks 
NOS intensity classes and distances 
noe class veryweak 0.0 0.1 
noe class weak 	0.1 0.8 
noe class medium 0.8 1.5 
noe class strong 	1.5 50.0 
noe distance veryweak 4.0 2.2 2.0 
noe distance weak 	4.0 2.2 1.0 
noe distance medium 3.0 1.2 0.3 
noe distance strong 	2.5 0.7 0.2 
set correction off 
macro definitions 
macro loadsp 
variable sp ?spectrum? 
Gr_update (false) 
graphics crosspeaks $sp 
graphics connections $sp 




compile (lib}clear_cont. al 
macro clear cont 
clear cont () 
graphics toggle 
end—macro 








compile (lib} jump symmetry. al 
macro jump sym 
jump_symmetry () 
end—macro 
reasonable values; should be checked 
map classes to distance restraints 
no distance corrections added 
download everything but contours 
in the current spectrum area 
clear contours for all viewed 
spectra in current window 
toggle on all spectra 
make copy of crosspeak at symmetry-
related position 
interactive move of crosspeak 
with connections or assignments 
jump to symmetry related part of 
spectrum in another window 
compile {lib}show_ss.al 	 show crosspeaks data for given seq 
macro show_ss 




I Show possible assignments 
macro ass nuc 
	 for corresponding cp's 
ass _nuc (?crosspeak?) 
end—macro 
--------------- ---- Brian's macros 
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compile { lib}cp_unalias . al 
macro cpunalias 
cp_unalias (?crosspeak?, ?direction?) 
end—macro 
compile (my lib)3d N.al 
macro show_XHN 
show XHN (?crosspeak_?, ?window?, false, false) 
end—macro 
macro showXHNr 
show_XHN (?crosspeak?, ?window_?, true, false) 
end—macro 
macro show_XHN_f 
show_XHN (?crosspeak?, ?window_?, false, true) 
end—macro 
macro click XHN 
click XHN () 
end macro 
macro show NHN 
show NHN (?crosspeak?, 3) 
end—macro 
macro showHCXf 
show_HCX (?crosspeak_?, ?window?, false, true) 
end—macro 
macro show CX 
show_CX (?crosspeak?, 3) 
end—macro 
compile (my lib)shift match. al 
macro Closeln HF? 
CloseInHFl (?crosspeak?, ?spectrum?) 
end—macro 
macro Close in C 
close _in_C (?crosspeak?, ?spectrum?) 
end—macro 
macro Close _in_CO 













copy ass (?fromcrosspeak?, ?tocrosspeak?) 
end macro 
compile lib/del duplicatesnd. al  





!cacb program interface 
compile (my lib)cacb.al  
macro type_prob 
variable crash type prob() 
if $crash stop 




variable crash seq prob)) 
if $crash stop 
SYSTEM seq_prob cacb seq seq_prob.in 
variable crash 
end macro 
* * * * * * * ** ******** * * *** *** * * *** ** * ** **** * **** 
* ** * *** ** ** ** *** * * **** ********** ** ****** ** ** 
Rasmus Fogh Macros, 
For crosspeak assignment. These should not be changed. 
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compile (local lib}rhf assign.al  
macro ass dims 
List and Assign dimensions one by one 
set clobber true 	 Allow overwriting of symbols 
rhf_assign(?crosspeak_?, 0) 
set clobber false 	 Disallow overwriting of symbols 
end—macro 
macro ass Jcorr 
List and Assign a pair of dimensions for coupled nuclei 
set clobber true 	 Allow overwriting of symbols 
rhf_assign(?crosspeak_?, 1) 
set clobber false 	 Disilow overwriting of symbols 
end macro 
***************** *************************** 
******* ***** * **** **** * ** ***** ** *** ** * ******* 
Peak find and fitting stuff 
variable data file data file 
variable interactive yes 
macro interactive 
variable interactive ?Interactive? 
end—macro 
compile (my lib)peak_find.al 
macro peak_find 
variable sp ?Spectrum? 
variable crash peak find(sp) 
if $crash stop 






graphics menu setup 
graphics menu show ss 
graphics menu cpmove 
graphics menu cpunalias 
graphics menu peak_find 
graphics menu interactive 
graphics menu show XHN 
graphics menu show_HCX 
graphics menu seq_c 
graphics menu Close _in_c 
graphics menu closelnHFl 
graphics menu propagate 
graphics menu iii 
graphics menu iimli 
graphics menu copy—ass 
graphics menu ass Jcorr 
graphics menu ass_dims 
graphics menu ass nuc 
graphics menu delduplic 
open graphics windows at explicit positions 
window 1 
graphics window 0.666 0.417 0.997 1.0 
graphics plane 15N 1H 
graphics contours ri-hsqc 
graphics crosspeaks n-hsqc 
graphics assignments n-hsqc 
graphics color crosspeaks n-hsqc 0.8 1.0 1.0 
graphics toggle 15N-NOESY 
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graphics contours 15N-NOESY 
graphics crosspeaks 15N-NOESY 
graphics assignments 15N-NOESY 
graphics toggle cbcaconh 
graphics contours cbcaconh 
graphics crosspeaks cbcaconh 
graphics assignments cbcaconh 
graphics toggle hbhanh 
graphics contours hbhanh 
graphics crosspeaks hbhanh 
graphics assignments hbhanh 
graphics toggle hbhaconh 
graphics contours hbhaconh 
graphics crosspeaks hbhaconh 
graphics assignments hbhaconh 
!window 2 
graphics window 0.005 0.250 0.329 1.0 
graphics plane 13C 1H 
graphics view cl3noesy Fl F2 
graphics view d2onoesy Fl F2 
graphics toggle cbcaconh 
graphics contours cbcaconh 
graphics crosspeaks cbcaconh 
graphics assignments cbcaconh 
graphics toggle cl3noesy 
graphics contours cl3noesy 
graphics crosspeaks cl3noesy 
graphics assignments cl3noesy 
graphics toggle d2onoesy 
graphics contours d2onoesy 
graphics crosspeaks d2onoesy 
graphics assignments d2onoesy 
graphics toggle hcchtocsy 
graphics contours hcchtocsy 
graphics crosspeaks hcchtocsy 
graphics assignments hcchtocsy 
window 3 
graphics window 0.334 0.250 0.657 1.0 
graphics plane 13C lH 
graphics attach Fl 2 Fl 
graphics view cl3noesy Fl F2 
graphics view d2onoesy Fl F2 
graphics attach F2 1 F2 
graphics toggle hcchtocsy 
graphics contours hcchtocsy 
graphics crosspeaks hcchtocsy 
graphics assignments hcchtocsy 
graphics toggle cl3noesy 
graphics contours cl3noesy 
graphics crosspeaks cl3noesy 
graphics assignments cl3noesy 
APPENDIX 4 
OTHER BACKBONE STRIPS 
Strips from the proton backbone experiments HBHA(CO)NH (green cross-peaks) and HBHANH (yellow cross-peaks) with connecting 
backbone peaks shown for residues: 
L70toA73 
Y79 to 180 
See below 






C) Strips from the carbonyl carbon backbone experiments HNCO (brown cross-peaks) and HN(CA)CO (blue cross-peaks) for residues Y79 to 
180, with connecting backbone peaks shown. 
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APPENDIX 5 
CHEMICAL SHIFT LIST 
61 Phe 64 Cys HN 6.52 0.03 
N 121.2 0.2 N 122.4 0.0 CA 63.0 0.1 
HN 8.08 0.02 RN 8.80 0.02 HA 3.74 0.00 
CA 57.4 0.1 CA 61.4 0.0 Co 173.8 0.0 
HA 4.71 0.01 HA 4.37 0.01 CB 69.9 0.0 
CO 175.5 0.0 Co 175.7 0.0 HR 3.58 0.01 
CB 39.5 0.1 CB 43.1 0.1 CG2 21.8 0.1 
HB1 3.19 0.01 ff81 2.34 0.01 HG1 - 
H82 2.99 0.01 HB2 2.90 0.01 RG24t 1.08 0.00 
CD# 131.4 0.3 
HD# 7.22 0.01 65 Glu 69 Arg 
CE1 - N 121.0 0.0 N 129.0 0.0 
HE1 - HN 8.74 0.01 HN 8.51 0.01 
CE2 - CA 56.1 0.1 CA 56.5 0.1 
HE2 - HA 4.55 0.01 HA 4.39 0.01 
CZ - Co 174.8 0.0 Co 175.1 0.0 
HZ - CB 31.0 0.2 CB 30.2 0.1 
HB1 2.37 0.01 HB# 1.76 0.01 
62 Arg FIB2 2.12 0.01 CG 27.6 0.1 
N 123.6 0.2 CG 36.5 0.2 HG1 1.69 0.00 
RN 8.24 0.04 HG1 2.60 0.01 HG2 1.58 0.01 
CA 56.0 0.2 HG2 2.45 0.01 CD 43.3 0.0 
HA 4.39 0.01 CD - HD# 3.19 0.00 
CO 174.5 0.0 NE 127.5 0.0 
CB 31.0 0.1 66 Val HE 7.24 0.00 
HB1 1.82 0.01 N 117.4 0.1 NH1 - 
HB2 1.74 0.01 HN 7.95 0.01 HH11 - 
CG 27.6 0.1 CA 61.7 0.0 HH12 - 
HG1 1.58 0.01 HA 3.98 0.01 NH2 - 
HG2 1.68 0.01 CO - HH21 - 
CD 43.4 0.0 CB 31.6 0.1 HH22 - 
HD# 3.21 0.01 RB 2.10 0.00 
NE 127.8 0.0 CG1 21.0 0.1 70 Leu 
HE 7.12 0.00 HG14t 1.15 0.01 N 127.1 0.0 
NH1 - CG2 20.7 0.0 RN 8.90 0.01 
HH11 - HG2# 1.13 0.01 CA 53.2 0.0 
HH12 - HA 4.58 0.01 
NH2 - 67 Pro CO 176.8 0.0 
HH21 - N - CS 44.0 0.1 
HH22 - CA 62.8 0.0 HB1 1.58 0.01 
HB# - HA 2.78 0.01 HB2 1.40 0.01 
CO 175.2 0.0 CG 26.9 0.0 
63 Ser CS 31.6 0.1 HG 1.23 0.01 
N 115.3 0.1 HB1 1.27 0.01 CD1 23.1 0.1 
HN 7.93 0.01 HB2 0.76 0.01 HD1# 0.45 0.01 
CA 55.9 0.1 CG 27.1 0.1 CD2 25.8 0.2 
HA 4.74 0.01 HG1 1.09 0.01 HD2# 0.07 0.01 
CO 174.8 0.0 HG2 0.44 0.01 
CS 66.1 0.1 CD 50.3 0.1 71 Asn 
HB1 3.46 0.01 HD1 3.00 0.01 N 121.1 0.1 
HB2 3.54 0.01 HD2 2.78 0.01 RN 9.54 0.01 
HG - CA 55.4 0.0 
68 Thr HA 4.42 0.01 
N 114.8 0.1 CO 176.4 0.0 
CA 57.6 0.1 CO 174.4 0.0 
CB 38.7 0.1 HA 2.68 0.01 CS 24.9 0.2 
HB1 2.71 0.01 CO 173.6 0.0 HB# 1.23 0.01 
HB2 2.67 0.00 CS 65.5 0.0 
CG - HB1 3.17 0.00 74 Ser 
ND2 - HB2 3.13 0.00 N 115.3 0.0 
HD21 - HG - RN 9.32 0.01 
HD22 - HB# 3.16 0.01 CA 56.6 0.1 
HB* 2.69 0.01 HA 4.79 0.01 
73 Ala CO 173.3 0.0 
N 121.9 0.0 CS 65.8 0.0 
72 Ser HN 6.72 0.01 HB1 3.76 0.01 
N 111.1 0.1 CA 51.7 0.1 HB2 3.71 0.00 
HN 8.16 0.01 HA 5.10 0.01 HG - 
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HD1 7.43 0.00 CD# 133.1 0.1 
CD2 133.2 0.0 HD# 7.05 0.01 
HD2 7.40 0.00 CE# 118.0 0.0 
CE1 119.3 0.0 HE# 6.73 0.00 
HE1 7.07 0.01 RH - 
CE2 118.7 0.0 
HE2 7.04 0.00 85 Phe 
HR - N 124.2 0.0 
RN 8.75 0.01 
80 lie CA 54.2 0.2 
N 114.8 0.0 HA 4.79 0.01 
HN 7.36 0.01 CO - 
CA 63.0 0.1 CD 41.3 0.1 
HA 3.98 0.01 HB# 2.88 0.01 
CO 175.3 0.0 CD# 132.7 0.1 
CB 38.3 0.1 HD# 7.23 0.01 
HR 1.63 0.01 CE# 130.7 0.2 
CG1 29.6 0.1 HE# 7.23 0.01 
HG11 1.47 0.01 CZ - 
HG12 1.22 0.01 HZ - 
CG2 17.5 0.2 
HG2# 0.84 0.02 86 Pro 
CD1 13.8 0.1 N - 
HD1# 0.98 0.00 CA 62.0 0.1 
HA 4.58 0.01 
81 Thr CO - 
N 109.6 0.0 CD 32.6 0.1 
RN 7.45 0.01 HB1 2.24 0.01 
CA 61.1 0.1 HB2 1.88 0.01 
HA 4.55 0.01 CG 27.2 0.2 
CO 174.2 0.0 HG# 1.76 0.01 
CD 69.0 0.1 CD 49.7 0.2 
HR 4.54 0.00 HD1 3.4 .6 0.01 
CG2 22.3 0.0 HD2 2.43 0.01 
HG1 - 
HG2# 1.19 0.01 87 Val 
N 122.5 0.0 
82 Gin RN 8.34 0.01 
N 123.8 0.0 CA 65.6 0.1 
HN 7.40 0.05 HA 3.17 0.01 
CA 56.2 0.0 CO 176.8 0.0 
HA 4.24 0.01 CB 31.7 0.1 
CO 175.0 0.0 HE 1.75 0.01 
CD 30.2 0.1 CG1 22.9 0.2 
HB1 2.21 0.10 HG1# 0.90 0.01 
HB2 1.87 0.01 CG2 21.0 0.1 
CG 33.8 0.2, HG2# 0.76 0.01 
HG1 2.36 0.01 
HG2 1.97 0.01 
CD - 88 Gly 
NE2 108.8 0.1 N 116.4 0.0 
HE21 7.12 0.01 RN 8.98 0.02 
HE22 6.61 0.01 CA 44.3 0.1 
HAl 4.39 0.01 
83 Asn HA2 3.45 0.01 
N 117.7 0.1 CO 174.6 0.0 
RN 8.42 0.01 
CA 53.2 0.0 89 Thr 
HA 4.86 0.01 N 118.0 0.1 
CO 173.5 0.0 RN 8.04 0.02 
CB 40.3 0.1 CA 65.6 0.1 
HE1 2.77 0.01 HA 4.07 0.02 
HB2 2.68 0.01 CO 172.3 0.0 
CG - CB 69.7 0.1 
ND2 - RB 4.03 0.01 
HD21 7.40 0.00 CG2 22.8 0.1 
HD22 6.74 0.00 HG1 - 
HG2# 1.56 0.01 
84 Tyr 
N 120.6 0.0 90 Val 
RN 6.90 0.01 N 127.0 0.0 
CA 56.8 0.0 RN 8.21 0.01 
HA 4.81 0.01 CA 60.7 0.1 
CO 173.4 0.0 HA 5.22 0.01 
CB 40.2 0.1 CO 176.6 0.0 
HB1 2.87 0.01 CB 34.2 0.2 
HB2 2.77 0.01 HB 1.91 0.00 
75 	Leu 
N 126.4 	.1 
RN 	8.62 .02 
CA 55.7 	.1 
HA 	3.61 .01 
CO 176.7 	.0 
CB 	43.4 .1 
HB# 1.37 	.01 
CG 	26.4 .1 
HG 1.36 	.00 
CD1 	25.0 .1 
HD1# 0.42 	.01 
CD2 	23.1 .2 
HD2# -0.03 	.01 
76 	Lys 
N 121.0 	.1 
HN 	8.16 .01 
CA 56.3 	.1 
HA 	4.30 .01 
CO 178.3 	.0 
CB 	34.2 .2 
HB1 2.09 	.00 
HB2 	1.57 .07 
CG 26.4 	.1 
HG# 	1.45 .01 
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CG1 21.1 0.2 CB 29.0 0.1 
HG1# 1.03 0.01 HB1 1.60 0.01 101 Arg 
CG2 22.1 0.2 1182 1.12 0.01 N 124.8 0.0 
HG2# 0.84 0.01 CG 29.6 0.0 HN 8.85 0.01 
HG# 1.87 0.01 CA 56.2 0.0 
91 Val CD 43.0 0.0 HA 4.60 0.01 
N 117.8 0.0 HD1 3.13 0.00 CO 176.8 0.0 
HN 8.68 0.01 HD2 2.95 0.01 CB 30.5 0.1 
CA 58.3 0.1 NE 127.1 0.0 HB1 1.95 0.01 
HA 3.43 0.01 HE 6.35 0.01 HB2 1.69 0.01 
CO 172.9 0.0 NH1 - CG 27.7 0.0 
CS 33.7 0.2 HH11 - HG# 1.59 0.01 
HB 1.07 0.01 HH12 - CD 42.4 0.1 
CG1 21.7 0.0 NH2 - HD# 3.32 0.01 
HG1# 0.61 0.01 HH21 - NE 85.2 0.0 
CG2 18.4 0.2 HH22 - HE 7.32 0.00 
HG2# 0.12 0.01 NH1 - 
97 Pro HH11 - 
92 Glu N - HH12 - 
N 118.7 0.1 CA 64.2 0.0 NH2 - 
HN 5.54 0.00 HA 4.29 0.01 HH21 - 
CA 54.4 0.2 CO - HH22 - 
HA 5.01 0.01 CB 31.7 0.1 
CO - HB1 2.27 0.01 102 Glu 
CS 34.3 0.1 HB2 1.73 0.01 N 127.1 0.1 
HB1 1.74 0.01 CG 28.3 0.0 RN 8.46 0.01 
HB2 1.92 0.00 HG1 2.13 0.00 CA 52.8 0.1 
CG 37.0 0.1 HG2 1.98 0.01 HA 4.98 0.01 
HG1 2.07 0.01 CD 50.3 0.1 CO - 
HG2 2.22 0.00 HD1 3.83 0.01 CS 30.4 0.1 
CD - HD2 3.54 0.01 1-181 2.16 0.01 
HB2 1.92 0.01 
98 Gly CG 36.2 0.1 
93 Tyr N 111.0 0.1 HG1 2.32 0.00 
N 122.8 0.0 HN 8.29 0.01 HG2 2.16 0.01 
HN 8.20 0.01 CA 44.0 0.1 CD - 
CA 57.0 0.1 HAl 2.98 0.01 
HA 5.01 0.01 HA2 2.24 0.01 103 Pro 
CO 174.7 0.0 CO 171.6 0.0 N - 
CB 42.9 0.0 CA 65.2 0.0 
HB1 2.75 0.01 99 Tyr HA 4.24 0.01 
HB2 2.62 0.01 N 117.1 0.1 CO 177.1 0.0 
CD# 131.9 0.1 HN 8.03 0.01 CB 32.5 0.2 
HD# 6.56 0.01 CA 56.8 0.1 HB1 2.37 0.01 
CE# 118.1 0.1 HA 5.04 0.01 HB2 2.04 0.01 
HE# 6.42 0.01 CO 174.5 0.0 CG 27.5 0.0 
HH - CB 41.1 0.1 HG1 2.10 0.01 
HB1 3.36 0.01 HG2 1.98 0.01 
94 Glu HB2 2.56 0.01 CD 51.7 0.1 
N 116.8 0.0 CD# 133.0 0.2 HD1 4.09 0.01 
RN 9.36 0.01 HD# 6.60 0.01 HD2 3.89 0.01 
CA 53.5 0.1 CE# 117.7 0.2 
HA 4.82 0.01 HE# 6.70 0.01 104 Ser 
CO 175.3 0.0 HH - N 111.5 0.1 
CB 33.1 0.1 HN 8.25 0.01 
HB1 2.08 0.00 100 Arg CA 59.6 0.1 
HB2 1.90 0.01 N 118.0 0.0 HA 4.31 0.01 
CG 34.8 0.2 RN 9.86 0.00 CO 173.8 0.0 
HG# 2.21 0.00 CA 53.3 0.1 CS 63.4 0.1 
CD - HA 4.91 0.01 HB1 4.04 0.01 
CO 175.5 0.0 1-182 3.90 0.01 
95 Cys CB 33.6 0.1 HG - 
N 120.0 0.1 HB1 1.87 0.01 
RN 8.91 0.01 H52 1.68 0.01 105 Leu 
CA 53.6 0.0 CG 25.7 0.2 N 122.8 0.1 
HA 4.98 0.01 HG# 1.56 0.01 HN 7.71 0.01 
CO 176.0 0.0 CD 43.5 0.1 CA 53.3 0.0 
CB 36.6 0.1 HD# 3.14 0.01 HA 4.76 0.01 
RB-i 3.09 0.01 NE 128.1 0.0 CO 175.6 0.0 
H82 2.67 0.01 HE 7.21 0.00 CB 44.4 0.2 
NH1 - HB1 1.73 0.01 
96 Arg HH11 - HB2 1.43 0.01 
N 124.1 0.0 HH12 - CG 27.1 0.1 
HN 7.92 0.01 NH2 - HG 1.59 0.01 
CA 55.7 0.1 HH21 - CD1 23.0 0.1 
HA 4.44 0.01 HH22 - HD1# 0.89 0.01 
CO - CD2 25.8 0.1 
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HD2# 0.84 0.00 CA 55.4 0.1 CG 25.0 
HA 3.73 0.01 HG1 1.27 
106 Ser CO 174.0 0.0 HG2 1.23 
N 117.7 0.0 CB 38.1 0.2 CD 28.6 
RN 8.41 0.01 HEl 2.36 0.01 HD1 1.66 
CA 54.7 0.0 HB2 1.44 0.01 HD2 1.60 
HA 4.70 0.01 CE - 
CO 174.1 0.0 112 Leu HE1 2.97 
CD 64.3 0.1 N 133.1 0.0 HE2 2.94 
1481 3.86 0.01 RN 8.49 0.01 NZ - 
HB2 3.76 0.01 CA 54.9 0.0 HZ# - 
HG - HA 4.38 0.01 
CO 177.6 0.1 117 Trp 
107 Pro CB 42.3 0.1 N 120.6 
N - HB1 2.37 0.01 HN 7.99 
CA 61.4 0.1 HB2 1.43 0.01 CA 57.0 
HA 2.69 0.01 CG 26.3 0.0 HA 4.92 
CO 173.6 0.0 HG 1.86 0.01 CO 178.4 
CB 29.7 0.2 CD1 25.6 0.0 CB 31.1 
HB1 2.22 0.01 HD1# 0.79 0.00 HB1 3.40 
HB2 0.91 0.01 CD2 21.7 0.0 HB2 2.94 
CG 27.1 0.0 HD2# 0.77 0.00 CD1 126.5 
HG1 - HD1 7.22 
HG2 - 113 Gin NE1 130.9 
CD 49.8 0.2 N 116.4 0.0 HE1 9.95 
HD1 3.73 0.01 HN 8.29 0.00 CE3 120.7 
HD2 3.54 0.01 CA 58.5 0.1 HE3 7.18 
HA 3.92 0.01 CZ2 113.4 
108 Lys CO 175.3 0.0 HZ2 6.68 
N 119.2 0.0 CB 28.3 0.1 CZ3 - 
HN 7.27 0.01 HB# 2.07 0.01 HZ3 - 
CA 54.9 0.0 CG 33.5 0.1 CH2 122.8 
HA 5.30 0.01 HG# 2.40 0.01 HH2 6.92 
CO 175.6 0.1 CD - 
CB 36.4 0.2 NE2 111.6 0.0 118 Ser 
HBi 1.37 0.01 HE21 7.44 0.01 N 117.7 
HB2 1.60 0.01 HE22 6.78 0.00 RN 9.06 
CG 25.8 0.2 CA 59.0 
HG1 1.04 0.01 114 Asn HA 4.34 
HG2 0.84 0.01 N 114.9 0.0 CO 172.4 
CD 29.6 0.0 RN 7.67 0.00 CD 63.9 
HD# 1.46 0.01 CA 52.3 0.0 HE1 4.47 
CE 42.2 0.0 HA 4.49 0.01 HB2 1.40 
HE# 2.77 0.01 CO 174.7 0.0 HG 4.10 
NZ - CB 36.4 0.1 
HZ# - HB1 3.11 0.01 119 Thr 
109 Leu HB2 2.63 0.01 N 114.9 
N 120.9 0.2 CG - RN 8.06 
RN 8.09 0.04 ND2 107.6 0.0 CA 64.2 
CA 54.0 0.1 HD21 6.58 0.01 HA 3.95 
HA 4.61 0.01 HD22 7.20 0.01 CO 174.5 
CO 175.3 0.0 CB 69.6 
CB 47.3 0.0 115 Leu HE 4.01 
HB1 1.81 0.01 N 114.2 0.0 CG2 21.8 
HB2 1.38 0.01 HN 8.44 0.01 HG1 - 
CG 27.7 0.2 CA 56.2 0.1 HG2# 1.24 
HG 1.63 0.01 HA 3.75 0.01 
CD1 23.7 0.1 CO 175.6 0.0 120 Ala 
HD1 0.87 0.01 CB 36.9 0.1 N 130.9 
CD2 25.8 0.2 HB1 2.02 0.01 HN 8.53 
HD2# 0.77 0.01 HB2 1.46 0.01 CA 51.9 
CG 27.1 0.2 HA 4.42 
110 Thr HG 1.31 0.01 CO 176.9 
N 116.8 0.0 CD1 25.6 0.1 CB 19.8 
HN 8.65 0.01 HD1# 0.83 0.01 HB# 1.27 
CA 61.5 0.0 CD2 23.0 0.1 
HA 5.48 0.01 HD2# 0.52 0.01 121 Val 
CO 173.4 0.0 N 116.4 
CB 71.6 0.1 116 Lys 	- HN 7.17 
HE 3.75 0.01 N 118.3 0.0 CA 59.6 
CG2 21.1 0.0 HN 7.06 0.01 HA 4.32 
HG1 - CA 53.5 0.0 CO 175.0 
HG2# 1.03 0.01 HA 4.41 0.01 CB 33.5 
CO 175.1 0.0 HB 2.16 
iii Cys CD 34.6 0.1 CG1 19.7 
N 127.5 0.1 HB1 1.79 0.01 HG1# 0.91 
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HG2# 0.91 0.00 HE1 3.00 0.00 HA 4.11 
HE2 2.83 0.01 Co 175.8 
122 Glu NZ - CD 32.0 
N 120.9 0.0 HZ# - HB1 1.63 
HN 8.21 0.01 HB2 1.43 
CA 55.8 0.1 127 Lys CG 27.0 
HA 4.08 0.01 N 121.2 0.0 HG1 1.88 
CO 175.8 0.0 RN 8.43 0.01 HG2 1.54 
CB 27.7 0.1 CA 57.0 0.1 CD 50.9 
HB1 1.98 0.01 HA 4.01 0.01 HD1 4.04 
HB2 1.73 0.01 CO 174.6 0.0 HD2 3.99 
CG 35.6 0.1 CB 35.0 0.1 
HG1 2.29 0.01 HB1 1.69 0.01 133 Gly 
HG2 2.14 0.01 HB2 1.23 0.01 N 105.0 
CD - CG 20.5 0.2 HN 7.68 
HG# 0.46 0.01 CA 44.5 
123 Phe CD 30.3 0.0 HAl 4.13 
N 119.2 0.1 HD1 1.51 0.01 HA2 3.56 
RN 6.84 0.02 HD2 1.20 0.01 CO 171.8 
CA 58.1 0.1 CE 42.2 0.1 
HA 4.41 0.01 HE1 2.86 0.00 134 G1u 
CO 175.1 0.0 HE2 2.77 0.01 N 119.5 
CB 39.1 0.2 NZ - HN 7.79 
HB1 2.79 0.01 HZ# - CA 54.9 
H82 2.72 0.01 HA 4.37 
CD# 133.0 0.3 128 Ser CO 174.4 
HD# 7.01 0.01 N 113.1 0.0 CB 32.9 
CE# 131.0 0.2 RN 8.29 0.01 HB1 1.89 
HE# 6.74 0.01 CA 57.3 0.1 HB2 1.77 
CZ 129.8 0.1 HA 4.64 0.01 CG 35.4 
HZ 6.42 0.01 CO 175.8 0.0 HG# 2.08 
CB 65.4 0.1 CD - 
124 Cys HB1 3.67 0.00 
N 119.9 0.1 HB2 3.49 0.01 135 lie 
RN 7.68 0.00 HG - N 122.0 
CA 55.3 0.1 HN 8.68 
HA 5.45 0.01 129 Cys CA 59.8 
CO 172.5 0.0 N 125.6 0.0 HA 4.05 
CB 45.6 0.0 RN 8.68 0.01 CO 176.3 
HB1 2.80 0.01 CA 62.0 0.1 CB 40.9 
HB2 2.72 0.01 HA 4.25 0.01 RB 1.23 
CO 171.8 0.0 CG1 27.4 
125 Lys CB 39.5 0.1 HG11 1.26 
N 121.6 0.0 HB1 2.49 0.01 HG12 0.57 
HR 9.35 0.01 HB2 1.99 0.01 CG2 17.8 
CA 54.1 0.1 HG2# 0.61 
HA 4.81 0.01 130 Pro CD1 14.1 
CO 176.0 0.0 N - HD1# 0.46 
CB 36.2 0.1 CA 62.4 0.1 
HB1 1.95 0.01 HA 4.51 0.01 136 Arg 
H82 1.59 0.01 CO - N 130.0 
CG 25.0 0.1 CB 32.3 0.1 HR 8.50 
HG1 1.46 0.01 HB1 2.43 0.00 CA 57.5 
HG2 1.38 0.01 HB2 1.98 0.01 HA 3.98 
CD 29.3 0.1 CG 28.0 0.1 CO 177.4 
HD# 1.71 0.01 HG1 2.24 0.00 CD 29.1 
CE 42.3 0.0 HG2 2.14 0.01 HB1 1.69 
HE# 3.01 0.00 CD 50.3 0.1 HB2 1.66 
NZ - HD1 3.66 0.01 CG 27.0 
HZ# - HD2 3.16 0.00 HG1 1.62 
HG2 1.58 
126 Lys 131 Asn CD 43.2 
N 123.3 0.0 N 122.1 0.0 HD# 3.18 
HN 8.93 0.01 HN 8.64 0.01 NE 85.0 
CA 58.9 0.0 CA 52.5 0.1 HE 7.14 
HA 3.53 0.01 HA 4.62 0.01 NH1 - 
CO 177.2 0.0 CO - HH11 - 
CD 35.1 0.2 CB 38.7 0.3 HH12 - 
HB1 1.79 0.00 HB# 2.80 0.00 NH2 - 
HB2 1.70 0.01 CG - HH21 - 
CG 28.3 0.0 ND2 113.5 0.2 HH22 - 
HG1 1.57 0.02 HD21 7.69 0.01 
HG2 0.80 0.01 HD22 7.04 0.01 137 Asn 
CD 30.2 0.2 N 118.4 
HD1 1.92 0.01 132 Pro HN 9.02 
HD2 1.62 0.01 N - CA 56.0 
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CO 172.6 0.0 CO 178.0 0.0 RN 8.80 0.01 
CB 36.2 0.1 CB 32.1 0.1 CA 44.2 0.0 
HB1 2.29 0.01 HB1 2.26 0.01 HAl 3.90 0.02 
HB2 1.31 0.01 HB2 1.96 0.01 HA2 3.17 0.01 
CG - CG 27.0 0.1 CO 174.3 0.0 
ND2 116.6 0.0 HG1 - 
HD21 7.44 0.21 HG2 - 150 Ala 
HD22 6.79 0.19 CD 50.9 0.0 N 124.5 0.0 
HD1 3.95 0.00 HN 8.43 0.01 
138 Gly HD2 3.39 0.01 CA 52.7 0.0 
N 104.5 0.0 HA 4.34 0.01 
HN 7.55 0.01 144 Gly CO 176.6 0.0 
CA 46.3 0.1 N 109.5 0.0 CB 21.6 0.1 
HAl 4.38 0.01 RN 9.09 0.01 HB# 1.45 0.01 
HA2 4.04 0.00 CA 45.7 0.1 
CO 172.1 0.0 HAl 4.63 0.01 151 Thr 
HA2 3.55 0.01 N 114.3 0.0 
139 Gln CO 175.3 0.0 RN 8.08 0.01 
N 118.3 0.0 CA 61.5 0.0 
HR 8.73 0.01 145 Gly HA 5.35 0.01 
CA 54.9 0.0 N 108.9 0.1 CO 174.7 0.0 
HA 4.72 0.01 HN 7.74 0.01 CB 71.3 0.2 
CO 173.7 0.0 CA 44.8 0.1 RB 3.82 0.00 
CB 33.3 0.1 HAl 4.19 0.01 CG2 21.0 0.0 
HB1 1.93 0.00 HA2 3.84 0.01 HG1 - 
HE2 1.76 0.01 CO 172.3 0.0 HG2# 1.03 0.00 
CG 33.5 0.1 
HG# 2.16 0.00 146 Ile 152 Ile 
CD - N 109.0 0.1 N 122.3 0.0 
NE2 112.7 0.0 HN 8.09 0.00 HR 8.87 0.01 
HE21 7.57 0.01 CA 60.6 0.1 CA 59.7 0.1 
HE22 6.61 0.01 HA 4.77 0.01 HA 4.89 0.01 
CO 173.6 0.0 CO 173.6 0.0 
140 Ile CB 38.9 0.1 CB 40.2 0.1 
N 122.0 0.0 HB 2.49 0.01 RB 1.51 0.01 
RN 8.32 0.01 CG1 25.6 0.0 CG1 - 
CA 60.5 0.1 HG11 1.33 0.01 HGll - 
HA 4.66 0.01 HG12 0.96 0.00 HG12 - 
CO 175.1 0.0 CG2 18.3 0.1 CG2 19.8 0.1 
CE 39.8 0.2 HG2# 0.97 0.01 RG2# 0.82 0.00 
HE 1.67 0.00 CD1 14.0 0.3 CD1 11.7 0.0 
CG1 27.0 0.1 HD1# 0.90 0.01 HD1# -0.40 0.01 
HG11 1.68 0.01 
HG12 0.90 0.01 147 Leu 153 Ser 
CG2 17.7 0.1 N 117.6 0.1 N 114.1 0.1 
HG2# 0.64 0.01 HN 7.66 0.01 HN 8.04 0.01 
CD1 15.1 0.2 CA 53.9 0.1 CA 57.0 0.1 
HD1# 0.64 0.01 HA 4.61 0.02 HA 4.56 0.01 
CO 176.0 0.0 CO 172.5 0.0 
141 Asp CB 43.1 0.2 CE 66.0 0.1 
N 130.2 0.0 HB1 1.68 0.01 HB# 3.69 0.01 
RN 9.32 0.01 HB2 1.34 0.01 HG - 
CA 53.8 0.1 CG 27.0 0.1 
HA 4.82 0.01 HG 1.77 0.01 154 Phe 
CO 174.5 0.0 CD1 26.1 0.2 N 121.9 0.0 
CB 42.3 0.0 HD1# 0.92 0.00 RN 7.83 0.00 
HE1 2.57 0.01 CD2 22.3 0.1 CA 54.4 0.1 
HE2 2.43 0.01 HD2# 0.72 0.01 HA 5.56 0.01 
CG - CO 174.7 0.0 
148 Phe CB 43.4 0.1 
142 Val N 117.4 0.0 HB1 2.86 0.01 
N 123.4 0.1 HN 8.09 0.01 HE2 2.62 0.01 
RN 8.31 0.01 CA 58.8 0.0 HB# - 
CA 58.7 0.1 HA 3.85 0.00 CD# 132.5 0.2 
HA 4.68 0.01 CO 175.1 0.0 HD# 7.01 0.01 
CO - CB 40.2 0.0 CE# 129.8 0.2 
CE 31.7 0.1 HE1 3.07 0.01 HE# 6.64 0.01 
RB 2.15 0.00 HE2 2.34 0.01 CZ - 
CG1 22.4 0.1 CD# 131.1 0.2 HZ - 
HG1# 0.84 0.01 HD# 6.73 0.01 
CG2 20.4 0.2 CE# 131.9 0.0 155 Ser 
HG2# 0.80 0.01 HE# 7.36 0.01 N 113.7 0.0 
CZ 130.0 0.0 RN 8.46 0.01 
143 Pro HZ 7.31 0.00 CA 57.6 0.0 
N - HA 4.56 0.01 
CA 64.7 0.1 149 Gly CO 172.5 0.0 
HA 4.49 0.01 N 118.4 0.0 CD 65.7 0.1 
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HB# 3.85 0.01 CE 42.2 
HG - HE1 2.68 
HE2 2.63 
156 Cys NZ - 
N 116.4 0.0 HZ# - 
HN 8.69 0.00 
CA 53.2 0.0 162 Leu 
HA 5.35 0.01 N 129.3 
CO 174.4 0.0 HN 8.18 
CB 41.4 0.1 CA 57.3 
HB1 3.03 0.01 HA 4.64 
HB2 2.47 0.01 CO 176.7 
CB 43.7 
157 Asfl RB# 1.52 
N 122.4 0.0 CG 28.4 
RN 8.72 0.01 HG 1.22 
CA 52.5 0.0 CD1 26.4 
HA 4.62 0.01 HD1# 0.73 
CO 174.5 0.0 CD2 25.7 
CB 38.3 0.1 HD2# 0.55 
HB1 3.02 0.01 
HB2 2.46 0.01 163 Phe 
CG - N 128.8 
ND2 109.1 0.0 RN 9.51 
HD21 6.82 0.01 CA 58.1 
HD22 7.56 0.01 HA 4.64 
CO 174.1 
158 Thr CB 40.9 
N 115.8 0.0 HB1 2.95 
RN 8.35 0.01 HB2 2.89 
CA 64.9 0.1 CD# 131.9 
HA 4.07 0.01 HD# 7.29 
CO 175.2 0.0 CE# 130.9 
CB 69.1 0.1 HE# 7.25 
RB 4.04 0.01 CZ - 
CG2 21.8 0.1 HZ - 
HG1 - 
HG2# 1.28 0.00 164 Gly 
N 114.6 
159 Gly RN 8.31 
N 114.9 0.0 CA 43.4 
RN 8.94 0.01 HAl 4.59 
CA 44.7 0.0 HA2 3.63 
HAl 4.20 0.01 CO 172.0 
HA2 3.48 0.00 
CO 173.2 0.0 165 Ser 
N 118.5 
160 Tyr RN 8.78 
N 119.3 0.1 CA 58.8 
HN 8.24 0.01 HA 4.54 
CA 57.1 0.1 CO 173.4 
HA 4.81 0.02 CB 64.2 
CO 173.9 0.1 HB1 4.20 
CB 41.3 0.1 HB2 3.88 
R131 3.26 0.01 HG - 
RB2 2.44 0.02 
CD# 132.6 0.0 166 Thr 
RD# 6.69 0.01 N 108.8 
CE# 118.0 0.0 RN 8.25 
RE# 6.72 0.01 CA 62.9 
RH - HA 4.44 
CO 175.1 
161 LYS CB 69.6 
N 123.6 0.0 RB 4.56 
RN 9.37 0.01 CG2 23.1 
CA 54.5 0.0 HG1 - 
HA 4.53 0.01 RG2# 1.33 
CO 174.1 0.0 
CB 36.3 0.0 
RB1 1.66 0.02 167 Ser 
H82 1.39 0.01 N 115.8 
CG 25.2 0.2 RN 7.85 
HG1 1.17 0.01 CA 57.2 
HG2 0.92 0.01 HA 4.55 
CD 29.0 0.0 CO 172.0 
RD1 1.36 0.01 CB 66.1 
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CB 63.3 0.1 HE3 7.47 0.01 185 Glu 
RB# 3.44 0.01 CZ2 113.4 0.1 N 114.2 0.1 
HG 4.72 0.00 HZ2 7.26 0.01 HN 8.11 0.01 
CZ3 - CA 54.4 0.1 
174 Gly HZ3 6.92 0.01 HA 4.53 0.00 
N 119.0 0.0 CH2 - CO 175.3 0.0 
RN 9.03 0.01 HH2 6.90 0.02 CO 33.9 0.2 
CA 47.1 0.2 HB# - HB1 2.02 0.00 
HAl 4.04 0.01 HB2 1.91 0.01 
RA2 3.64 0.01 180 Ser CG 36.4 0.2 
CO 174.6 0.0 N 121.5 0.0 HG1 2.32 0.01 
RN 10.02 0.00 HG2 2.19 0.01 
175 Ser CA 61.0 0.2 CD - 
N 122.4 0.0 HA 4.07 0.01 
RN 8.82 0.01 CO 174.5 0.0 186 Cys 
CA 58.2 0.1 CB 63.5 0.0 N 122.6 0.0 
HA 4.51 0.00 HB1 3.93 0.00 RN 9.00 0.00 
CO 173.9 0.0 HB2 3.79 0.00 CA 53.9 0.1 
CB 63.7 0.2 HG - HA 5.40 0.01 
HB1 4.02 0.00 CO 174.4 0.0 
HB2 3.89 0.01 CO 40.3 0.2 
HG - 181 Asp HB1 2.84 0.01 
N 121.8 0.1 HB2 2.52 0.01 
176 Ser RN 8.08 0.01 
N 118.3 0.1 CA 51.6 0.1 187 Arg 
HN 8.03 0.00 HA 5.44 0.00 N 124.1 0.0 
CA 56.3 0.0 CO 173.4 0.0 RN 9.22 0.01 
HA 4.62 0.01 CB 43.1 0.0 CA 55.0 0.1 
CO 173.8 0.0 HB# 2.74 0.01 HA 4.87 0.01 
CB 65.0 0.1 CG - CO 176.3 0.0 
RB1 3.88 0.00 CB 33.0 0.1 
HB2 3.81 0.00 182 Pro HB1 1.89 0.01 
HG - N - RB2 1.82 0.00 
CA 61.6 0.0 CG 27.7 0.1 
177 Val HA 4.57 0.01 RG1 1.62 0.01 
N 117.3 0.1 CO - HG2 1.50 0.01 
RN 8.07 0.01 CB 32.4 0.1 CD 43.1 0.2 
CA 59.6 0.1 RB1 2.27 0.01 HD1 2.86 0.01 
HA 5.05 0.01 RB2 1.96 0.01 HD2 2.45 0.01 
CO 174.5 0.0 CG 27.0 0.1 NE 126.4 0.0 
CB 33.4 0.1 HG1 2.07 0.00 HE 6.89 0.00 
RB 1.89 0.01 HG2 1.96 0.01 NH1 - 
CG1 22.8 0.2 CD 50.9 0.0 HR11 - 
HG1# 0.48 0.01 HD1 3.91 0.01 HH12 - 
CG2 20.3 0.2 HD2 3.79 0.01 NH2 - 
HG2# 0.45 0.01 RH21 - 
183 Leu RH22 - 
178 Gin N 119.6 0.0 
N 121.0 0.0 RN 7.95 0.01 188 Giu 
RN 9.00 0.01 CA 53.0 0.1 N 126.2 0.0 
CA 54.1 0.1 HA 3.49 0.01 RN 9.17 0.01 
HA 4.35 0.01 CO - CA 58.0 0.1 
CO - CE 40.8 0.1 HA 3.57 0.01 
CB 33.0 0.1 HB1 1.44 0.01 CO - 
RB1 2.21 0.01 HB2 1.00 0.01 CB 29.8 0.2 
H02 2.09 0.01 CG 27.1 0.2 HB# 1.81 0.01 
CG 33.0 0.0 HG 1.48 0.01 CG 36.3 0.1 
HG# 1.81 0.01 CD1 25.2 0.2 HG1 2.06 0.11 
CD - HD1# 0.69 0.01 HG2 2.00 0.01 
NE2 111.7 0.0 CD2 23.7 0.1 CD - 
HE21 7.40 0.01 HD2# 0.37 0.01 
HE22 6.71 0.01 189 His 
184 Pro N 124.1 0.0 
179 Trp N - RN 8.23 0.01 
N 122.7 0.0 CA 62.1 0.1 CA - 
RN 8.35 0.01 HA 4.73 0.01 HA 4.58 0.01 
CA 57.0 0.1 Co 173.8 0.0 CO - 
HA 5.01 0.01 CB 33.6 0.2 CB 31.0 0.0 
CO 179.5 0.0 HB1 2.23 0.00 HB1 2.85 0.01 
CB 29.7 0.1 HB2 1.64 0.01 HB2 2.80 0.00 
HB1 3.61 0.01 CG 26.3 0.0 ND1 - 
RB2 2.92 0.01 HG1 1.78 0.00 RD1 - 
CD1 126.4 0.2 HG2 1.05 0.01 CD2 - 
RD1 7.36 0.01 CD 48.9 0.0 HD2 - 
NE1 128.0 0.0 HD1 2.56 0.01 CE1 - 
HE1 10.60 0.00 HD2 2.03 0.00 HE1 - 
CE3 121.3 0.1 NE2 - 
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HE2 - HB2 0.76 0.00 HE21 7.50 0.01 
CG - HE22 - 
1061 Phe RG1 - 
N 121.8 0.1 HG2 0.46 0.00 1083 Asn 
RN 8.19 0.01 CD 50.3 0.1 N 119.3 0.0 
CA 57.3 0.1 HD1 3.08 0.01 HN 8.43 0.01 
HA 4.71 0.00 HD2 2.83 0.01 CA 53.2 0.1 
CO 175.5 0.0 HA 4.82 0.01 
CB 39.6 0.1 1068 Thr CO 173.4 0.0 
HB1 3.17 0.00 N 114.7 0.0 CB 40.3 0.1 
RB2 2.98 0.00 HN 6.44 0.00 RB1 2.77 0.01 
CD1 - CA - HB2 2.67 0.01 
HD1 - HA 3.75 0.01 CG - 
CD2 - CO 173.8 0.0 ND2 - 
HD2 - CB 69.8 0.0 HD21 - 
CE1 - HB 3.56 0.00 HD22 - 
HE1 - CG2 - 
CE2 - RG1 - 
HE2 - HG2# - 1084 Tyr 
CZ - N 120.7 0.0 
HZ - 1075 Leu HN 7.04 0.00 
N 126.2 0.0 CA 56.8 0.1 
1062 Arg RN 8.56 0.03 HA 4.81 0.01 
N 123.9 0.0 CA 55.6 0.1 CO 173.4 0.0 
RN 8.35 0.00 HA 3.58 0.01 CB 40.1 0.0 
CA - CO - HB1 2.85 0.04 
HA 4.38 0.00 CD - HB2 2.77 0.01 
CO - HB# 1.37 0.01 CD1 - 
CB - CG - HD1 - 
1481 - HG 1.36 0.00 CD2 - 
H32 - CD1 25.0 0.0 HD2 - 
CG - HD1# 0.45 0.00 CE1 - 
HG1 - CD2 23.1 0.1 HE1 - 
HG2 - HD2# -0.03 0.01 CE2 - 
CD - RE2 - 
HD1 - 1080 lie HH - 
HD2 - N 118.4 0.0 
NE - HN 7.46 0.01 1090 Val 
HE - CA 64.2 0.1 N 126.6 0.0 
NH1 - HA 3.93 0.01 RN 8.28 0.01 
HH11 - CO 176.8 0.0 CA 60.7 0.1 
HH12 - CB 38.5 0.1 HA 5.27 0.01 
NH2 - RB 1.95 0.01 CO 176.7 0.0 
HH21 - CG1 28.5 0.2 CD 34.3 0.1 
HH22 - HG11 1.55 0.01 RB 1.92 0.01 
HG12 1.29 0.01 CG1 - 
2062 Arg CG2 17.7 0.2 HG1# 1.03 0.01 
N 124.1 0.0 HG2# 0.96 0.01 CG2 22.3 0.2 
RN 8.45 0.00 CD1 13.7 0.2 HG2# 0.85 0.01 
CA - HD1# 0.91 0.01 
HA - 1091 Val 
CO - 1081 Thr N 118.3 0.1 
CD - N 108.4 0.0 RN 8.71 0.01 
HB1 - RN 7.55 0.01 CA 58.7 0.2 
HB2 - CA 61.3 0.2 HA 3.67 0.01 
CG - HA 4.38 0.01 CO - 
RG1 - CO 174.3 0.0 CB 33.8 0.2 
RG2 - CB 68.8 0.0 RB 0.97 0.01 
CD - RB 4.28 0.84 CG1 21.7 0.0 
RD1 - CG2 22.0 0.0 HG1# 0.59 0.00 
HD2 - RG1 - CG2 18.3 0.1 
NE - RG2# 1.18 0.00 HG2# 0.11 0.01 
RE - 
NH1 - 1082 Gin 1109 Leu 
Hull - N 123.3 0.1 N 121.0 0.0 
HH12 - RN 7.17 0.01 RN 8.17 0.01 
NH2 - CA 56.4 0.1 CA - 
HR21 - HA 4.16 0.01 RA - 
HR22 - CO 174.9 0.0 CO - 
CB 29.5 0.1 CD - 
1067 Pro RB1 2.14 0.00 HB1 - 
N - HB2 1.96 0.00 RB2 - 
CA 62.9 0.0 CG 33.7 0.1 CG - 
HA 2.74 0.01 HG1 2.24 0.01 HG - 
CO - HG2 1.86 0.01 CD1 - 
CB - CD - RD1# - 
1481 1.29 0.00 NE2 112.2 0.0 CD2 - 
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HD2# - CG2 - HOl 	- 
HG2# - HB2 2.72 	0.00 
1121 Val CG# - CD1 	- 
N 116.6 0.0 HG# 0.91 0.00 HD1 - 
HN 7.21 0.01 CD2 	- 
CA - 1123 Phe HD2 - 
HA 4.31 0.00 N 119.1 0.1 CE1 	- 
CO - HN 6.86 0.02 HE1 - 
CB 33.4 0.0 CA 58.0 0.0 CE2 	- 
HB 2.16 0.00 HA 4.41 0.01 HE2 - 
CG1 - CO - CZ 	- 








Differently assigned atoms Extra atoms assigned in current work Extra atoms 
assigned in 
Uhrinova et al. work 
61 Ha Cd#,Hd#  
62 Hbl, Hb2, Hgl Cg, Ne, He  
65 Hbl Hgl,Hg2  
66 N, Hn, Ca, Ha,Cb, Hb, CgI, 
Hgl#, Cg2, Hg2#  
67 Hg2, Hd2 Cd  
69 Hb2 Cg, Hg I, Hg2, Cd, Ne, He  
70  Cg  
71  Hd21,Hd22 
72 Hbl  
74 Hb2  
75 Hb2 Hg  
76  N, Ca, Ha, Cb, Hbl, Hb2, Cg, Hg 
77 Hn, Cg N, Ca, Ha, Cb, Hbl, Hb2, Hgl, Hg2, 
Ne2,_He21  
78  Hgl,Hg2,Hdl  
79 Ca, Ha, Cb Cdl, Cd2, Cel, Ce2 Hbl,Hb2 
82  Cg, Hgl, Hg2, Ne2, He21, He22  
83  Hd21,Hd22  
84 Hn Cd#, Hd#, Ce#  
85 Ha, Hb2, He# Ca, Cb, Cd#, Ce#  
86 Ha, Cb, Hdl, Hd2 Hbl, Hb2, Cg, Cd, Hg 
87  N  
88  Ca  
89 Hn N 
91 Cgl  
92 Ca Hbl, Hb2, Cg. Hg I, Hg2  
93 Hd#, Ce#, He# N, Cd#  
94  Hgl  
96 Hbl Ca, Cb, Hb2, Cg, Cd, Hdl, Hd2, Hg#, 
Ne He  
97 Cg Hbl, Hb2, Hg I, Hg2, Hdl, Hd2  
99  Cd#, Ce#  
100 Cg Hg2, Ne, He  
101 Hg2 Hd2,Ne, He Hhll, Hh12, Hh21, 
Hh22 
102 Ca, Cg Hbl,Hgl,Hg2  
103 Hd2 Hgl,Hg2,Hdl  
105 Cg, Cdl,Cd2  
106 Ca  
107 Cg, Cd  Hgl, H22 
108 Hbl, Hb2, Cg, Hg I, Hg2, Cd, Ce, 
Hd#,_He#  
109 N, Hn, Hb2, Hg  
112 Cg,Cd2 Hg  
113 Hb# Cg, Ne2, He2 1, He22, Hg#  
114  Nd2  
116 Hbl,Cg, Hd2 Cd, He2 Ce 
117 Cdl, He3, Hh2 Nel, Ce3, Ch2 Hz3 
118 Ha, Hbl,Hb2 Hg  
119 Ha,Cg2  
121 N,Hn  
123 Cd#, Hd#, He# Cz, Ce#, He2  
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125 Hg2  
126 Cb, Hb1, He! Cg, Hg!, Hg2, Cd, Hd2, Ce  
127 Cb, Hbl, Hb2, Hg, Hdl, Ce, 
He!,_He2  
Cg, Hg2, Cd, Hd2 
128 N, Hn, Ca, Ha, Cb  
129 N, Hn, Ca, Cb, Hb2  
130 Cd, Hd!, Hd2 Ca, Ha, Cb, Hbl, Hb2, Cg, Hgl, Hg2  
131 Ha N, Hn, Ca, Cb, Hb#, Nd2, Hd21, 
Hd22  
132 Hbl, Hb2, Cg, Hg!, Hg2, Hd2 Hg2  
134 HgJ Cg  
135 Hb,Hg12  
136 Cg, Hgl, Hg2, Hd2 Hb2, Cd, Ne, He  
137 Hd22 Nd2  
139 Cb, Hb2, Hg# Cg, Hg2, Ne2, He21, He22  
140 Cg!,Hgll,Hg12  
142 N 
143  Hg! 
146  Hg12  
147 Cb, Hb!, Hb2 N, Cg, Hg  
148 Ha Cz, Hz, Cd#, Ce#, He#  
152 Cd!  Cgl,Hg!1,Hg12 
154 Cd#, Ce#  Cz, Hz 
155  Hb2  
157 Hd21 Nd2  
160  Cd#,Ce#  
161 Hb2, Hgl, Hdl, Hd2 Hb2, Hg2, Cd, Ce, He I, He2  
162 Hb2 Hg  
163  Cd#, Ce#, He#  
166 Ha, Hbl,Hb2  
169 He# Cd#,He2  
170 Hb2  
171 Cb N, Hn, Ha, Hb#, Cg, Hg, Cdl, HdI#, 
Cd2,_Hd2#  
172  N  
173  Hb2,Hg  
178 Ha, Hbl Cg, Hg, Ne2, He2!  
179 Cb, Cd!, He3, Hz3 N, Nel Cz3 
180 N, Hn, Ca, Cb Hbl, Hb2  
181 N, Hn, Ca, Cb, Hb# Hb2  
182 Ca, Cb Ha, Hb!, Hb2, Cg, Hg!, Hg2, Cd, 
Hdl,_Hd2  
183 N, Hn, Ca, Ha, Cb, Hbl, Cdl, 
Hd!#, Cd2, Hd2#  
N, Hb2, Cg, Hg 
184 Ha, Hbl, Cd, Hdl, Hd2 Hg!, Hg2  
185  Cg  
187  Hg2, Ne, He  
188 Hg!  
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APPENDIX 7 
RESIDUAL DIPOLAR COUPLINGS CNS INPUT 
This appendix shows the list of residual dipolar couplings used for refinement of 
structures. This list was the input for the TENSO module of CNS: the residue and 
bond are specified first, then the dipolar coupling value, followed by the error. 
Conformer one 
assign (resid 64 and name CA) (resid 64 and name C) 7.281 8.465 
assign (resid 64 and name CA) (resid 64 and name HA) -0.879 4.460 
assign (resid 65 and name CA) (resid 65 and name C) -11.116 8.465 
assign (resid 65 and name CA) (resid 65 and name HA) -3.751 4.460 
assign (resid 65 and name N) (resid 65 and name HN) -7.665 2.000 
assign (resid 66 and name N) (resid 66 and name HN) -4.896 2.000 
assign (resid 67 and name CA) (resid 67 and name C) 19.205 8.465 
assign (resid 67 and name CA) (resid 67 and name HA) 2.632 4.460 
assign (resid 73 and name CA) (resid 73 and name C) -8.842 8.465 
assign (resid 73 and name CA) (resid 73 and name HA) -2.259 4.460 
assign (resid 73 and name N) (resid 73 and name HN) -3.519 2.000 
assign (resid 74 and name CA) (resid 74 and name C) 6.750 8.465 
assign (resid 74 and name N) (resid 74 and name HN) -4.913 2.000 
assign (resid 75 and name N) (resid 75 and name HN) -4.531 2.000 
assign (resid 76 and name CA) (resid 76 and name C) -6.526 8.465 
assign (resid 78 and name CA) (resid 78 and name C) -12.873 8.465 
assign (resid 78 and name CA) (resid 78 and name HA) 6.667 4.460 
assign (resid 79 and name CA) (resid 79 and name C) -12.090 8.465 
assign (resid 79 and name N) (resid 79 and name HN) -4.853 2.000 
assign (resid 80 and name CA) (resid 80 and name C) -18.348 8.465 
assign (resid 80 and name CA) (resid 80 and name HA) -4.048 4.460 
assign (resid 80 and name N) (resid 80 and name HN) -3.335 2.000 
assign (resid 81 and name CA) (resid 81 and name C) 10.582 8.465 
assign (resid 81 and name CA) (resid 81 and name HA) -0.530 4.460 
assign (resid 85 and name N) (resid 85 and name HN) -4.261 2.000 
assign (resid 88 and name N) (resid 88 and name HN) 1.503 2.000 
assign (resid 89 and name CA) (resid 89 and name C) -12.094 8.465 
assign (resid 89 and name CA) (resid 89 and name HA) 2.071 4.460 
assign (resid 89 and name N) (resid 89 and name HN) -5.992 2.000 
assign (resid 90 and name CA) (resid 90 and name C) -5.724 8.465 
assign (resid 90 and name N) (resid 90 and name HN) -3.133 2.000 
assign (resid 91 and name CA) (resid 91 and name C) -10.482 8.465 
assign (resid 91 and name N) (resid 91 and name HN) -3.102 2.000 
assign (resid 92 and name N) (resid 92 and name HN) -8.351 2.000 
assign (resid 94 and name N) (resid 94 and name HN) -4.658 2.000 
assign (resid 96 and name N) (resid 96 and name HN) -6.430 2.000 
assign (resid 100 and name CA) (resid 100 and name C) 13.643 8.465 
assign (resid 100 and name CA) (resid 100 and name HA) -9.366 4.460 
assign (resid 100 and name N) (resid 100 and name HN) -5.979 2.000 
assign (resid 101 and name CA) (resid 101 and name C) -14.685 8.465 
assign (resid 101 and name CA) (resid 101 and name HA) -0.874 4.460 
assign (resid 101 and name N) (resid 101 and name HN) -4.598 2.000 
assign (resid 102 and name N) (resid 102 and name HN) -2.095 2.000 
assign (resid 103 and name CA) (resid 103 and name C) 0.380 8.465 
assign (resid 103 and name CA) (resid 103 and name HA) -2.018 4.460 
assign (resid 107 and name CA) (resid 107 and name C) 1.518 8.465 
assign (resid 107 and name CA) (resid 107 and name HA) -2.155 4.460 
assign (resid 110 and name CA) (resid 110 and name C) 2.332 8.465 
assign (resid 110 and name CA) (resid 110 and name HA) -4.867 4.460 
assign (resid 110 and name N) (resid 110 and name HN) -7.811 2.000 
assign (resid 111 and name CA) (resid 111 and name C) 15.090 8.465 
assign (resid 111 and name CA) (resid 111 and name HA) 0.605 4.460 
assign (resid 111 and name N) (resid 111 and name HN) -4.629 2.000 
assign (resid 114 and name CA) (resid 114 and name C) -0.502 8.465 
assign (resid 114 and name N) (resid 114 and name HN) 0.848 2.000 
assign (resid 115 and name CA) (resid 115 and name C) 17.798 8.465 
assign (resid 115 and name CA) (resid 115 and name HA) -1.881 4.460 
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assign (resid 115 and name N) (resid 115 and name HN) -2.140 2.000 
assign (resid 116 and name CA) (resid 116 and name C) -0.139 8.465 
assign (resid 116 and name CA) (resid 116 and name HA) -0.899 4.460 
assign (resid 116 and name N) (resid 116 and name MN) 2.162 2.000 
assign (resid 117 and name CA) (resid 117 and name C) -11.329 8.465 
assign (resid 117 and name N) (resid 117 and name HN) 3.457 2.000 
assign (resid 118 and name CA) (resid 118 and name C) 14.458 8.465 
assign (resid 118 and name N) (resid 118 and name MN) -3.037 2.000 
assign (resid 123 and name CA) (resid 123 and name C) 15.510 8.465 
assign (resid 123 and name CA) (resid 123 and name HA) -4.017 4.460 
assign (resid 123 and name N) (resid 123 and name HN) -1.998 2.000 
assign (resid 124 and name CA) (resid 124 and name C) -2.907 8.465 
assign (resid 124 and name N) (resid 124 and name HN) -4.511 2.000 
assign (resid 125 and name CA) (resid 125 and name C) -8.934 8.465 
assign (resid 125 and name CA) (resid 125 and name HA) -8.728 4.460 
assign (resid 125 and name N) (resid 125 and name HN) -3.980 2.000 
assign (resid 126 and name CA) (resid 126 and name C) -23.956 8.465 
assign (resid 126 and name CA) (resid 126 and name HA) -1.516 4.460 
assign (resid 126 and name N) (resid 126 and name HN) -4.668 2.000 
assign (resid 127 and name CA) (resid 127 and name C) -2.085 8.465 
assign (resid 127 and name CA) (resid 127 and name HA) -4.641 4.460 
assign (resid 127 and name N) (resid 127 and name MN) -9.812 2.000 
assign (resid 128 and name N) (resid 128 and name MN) -1.692 2.000 
assign (resid 129 and name N) (resid 129 and name MN) -4.645 2.000 
assign (resid 130 and name CA) (resid 130 and name C) -4.159 8.465 
assign (resid 130 and name CA) (resid 130 and name HA) 3.520 4.460 
assign (resid 131 and name N) (resid 131 and name MN) -2.277 2.000 
assign (resid 132 and name CA) (resid 132 and name C) 15.604 8.465 
assign (resid 132 and name CA) (resid 132 and name HA) -7.212 4.460 
assign (resid 135 and name N) (resid 135 and name MN) -4.303 2.000 
assign (resid 136 and name CA) (resid 136 and name C) 3.124 8.465 
assign (resid 136 and name CA) (resid 136 and name HA) -4.599 4.460 
assign (resid 137 and name CA) (resid 137 and name C) 0.057 8.465 
assign (resid 137 and name CA) (resid 137 and name HA) -9.979 4.460 
assign (resid 137 and name N) (resid 137 and name MN) -5.549 2.000 
assign (resid 138 and name N) (resid 138 and name MN) -0.612 2.000 
assign (resid 140 and name CA) (resid 140 and name C) 11.866 8.465 
assign (resid 140 and name CA) (resid 140 and name HA) -12.979 4.460 
assign (resid 140 and name N) (resid 140 and name HN) -7.637 2.000 
assign (resid 141 and name N) (resid 141 and name MN) -6.446 2.000 
assign (resid 142 and name N) (resid 142 and name MN) -7.500 2.000 
assign (resid 143 and name CA) (resid 143 and name C) 12.779 8.465 
assign (resid 143 and name CA) (resid 143 and name HA) -6.247 4.460 
assign (resid 146 and name CA) (resid 146 and name C) -18.593 8.465 
assign (resid 146 and name CA) (resid 146 and name HA) 2.075 4.460 
assign (resid 146 and name N) (resid 146 and name HN) 2.715 2.000 
assign (resid 147 and name N) (resid 147 and name MN) -5.152 2.000 
assign (resid 149 and name CA) (resid 149 and name C) -8.881 8.465 
assign (resid 150 and name N) (resid 150 and name MN) -1.902 2.000 
assign (resid 152 and name N) (resid 152 and name MN) -5.578 2.000 
assign (resid 154 and name CA) (resid 154 and name C) -5.779 8.465 
assign (resid 154 and name N) (resid 154 and name HN) -7.935 2.000 
assign (resid 155 and name CA) (resid 155 and mane C) -3.151 8.465 
assign (resid 155 and name CA) (resid 155 and name HA) 7.685 4.460 
assign (resid 155 and name N) (resid 155 and name MN) -4.258 2.000 
assign (resid 156 and name CA) (resid 156 and name C) -11.316 8.465 
assign (resid 156 and name CA) (resid 156 and name HA) -2.013 4.460 
assign (resid 156 and name N) (resid 156 and name MN) -3.328 2.000 
assign (resid 157 and name CA) (resid 157 and name C) 21.108 8.465 
assign (resid 157 and name CA) (resid 157 and name HA) 1.449 4.460 
assign (resid 157 and name N) (resid 157 and name MN) -4.864 2.000 
assign (resid 158 and name CA) (resid 158 and name C) 1.408 8.465 
assign (resid 158 and name CA) (resid 158 and name HA) -12.377 4.460 
assign (resid 158 and name N) (resid 158 and name MN) -1.138 2.000 
assign (resid 159 and name CA) (resid 159 and name C) 6.780 8.465 
assign (resid 159 and name N) (resid 159 and name MN) -6.183 2.000 
assign (resid 160 and name CA) (resid 160 and name C) 0.464 8.465 
assign (resid 160 and name CA) (resid 160 and name HA) 3.388 4.460 
assign (resid 160 and name N) (resid 160 and name MN) 3.786 2.000 
assign (resid 161 and name CA) (resid 161 and name HA) -4.999 4.460 
assign (resid 161 and name N) (resid 161 and name MN) -1.899 2.000 
assign (resid 163 and name CA) (resid 163 and name C) -2.491 8.465 
assign (resid 163 and name CA) (resid 163 and name HA) -5.171 4.460 
assign (resid 163 and name N) (resid 163 and name MN) -5.210 2.000 
assign (resid 164 and name N) (resid 164 and name MN) -1.368 2.000 
assign (resid 165 and name CA) (resid 165 and name C) -5.320 8.465 
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assign (resid 165 and name CA) (resid 165 and name HA) -2.654 4.460 
assign (resid 166 and name CA) (resid 166 and name C) 24.730 8.465 
assign (resid 166 and name CA) (resid 166 and name HA) -5.018 4.460 
assign (resid 166 and name N) (resid 166 and name RN) -7.552 2.000 
assign (resid 167 and name CA) (resid 167 and name C) -1.177 8.465 
assign (resid 167 and name CA) (resid 167 and name HA) -7.786 4.460 
assign (resid 167 and name N) (resid 167 and name HN) -6.271 2.000 
assign (resid 168 and name N) (resid 168 and name RN) -3.228 2.000 
assign (resid 169 and name CA) (resid 169 and name C) -6.890 8.465 
assign (resid 169 and name N) (resid 169 and name RN) -4.492 2.000 
assign (resid 170 and name N) (resid 170 and name HN) -4.291 2.000 
assign (resid 171 and name CA) (resid 171 and name C) 13.233 8.465 
assign (resid 171 and name CA) (resid 171 and name HA) 3.468 4.460 
assign (resid 172 and name CA) (resid 172 and name C) -8.904 8.465 
assign (resid 172 and name N) (resid 172 and name RN) -5.777 2.000 
assign (resid 174 and name N) (resid 174 and name RN) -6.518 2.000 
assign (resid 176 and name N) (resid 176 and name RN) 1.655 2.000 
assign (resid 177 and name CA) (resid 177 and name C) 12.115 8.465 
assign (resid 177 and name CA) (resid 177 and name HA) -7.623 4.460 
assign (resid 178 and name CA) (resid 178 and name HA) -2.473 4.460 
assign (resid 178 and name N) (resid 178 and name HN) -6.220 2.000 
assign (resid 179 and name CA) (resid 179 and name C) -5.595 8.465 
assign (resid 179 and name CA) (resid 179 and name HA) -0.824 4.460 
assign (resid 179 and name N) (resid 179 and name RN) -0.992 2.000 
assign (resid 180 and name CA) (resid 180 and name C) 29.784 8.465 
assign (resid 180 and name N) (resid 180 and name RN) -0.643 2.000 
assign (resid 181 and name N) (resid 181 and name RN) -3.293 2.000 
assign (resid 182 and name CA) (resid 182 and name C) -5.987 8.465 
assign (resid 182 and name CA) (resid 182 and name HA) 5.288 4.460 
assign (resid 183 and name N) (resid 183 and name RN) -3.056 2.000 
assign (resid 185 and name CA) (resid 185 and name C) -5.678 8.465 
assign (resid 185 and name CA) (resid 185 and name HA) -5.199 4.460 
assign (resid 186 and name CA) (resid 186 and name C) 13.651 8.465 
assign (resid 186 and name CA) (resid 186 and name HA) -4.024 4.460 
assign (resid 186 and name N) (resid 186 and name RN) -4.804 2.000 
assign (resid 187 and name CA) (resid 187 and name C) 4.698 8.465 
assign (resid 187 and name CA) (resid 187 and name HA) -8.075 4.460 
assign (resid 187 and name N) (resid 187 and name RN) -5.745 2.000 
assign (resid 188 and name CA) (resid 188 and name C) -0.522 8.465 
assign (resid 188 and name N) (resid 188 and name HN) -4.564 2.000 
Conformer two 
assign (resid 64 and name CA) (resid 64 and name C) 7.281 8.465 
assign (resid 64 and name CA) (resid 64 and name HA) -0.879 4.460 
assign (resid 65 and name CA) (resid 65 and name C) -11.116 8.465 
assign (resid 65 and name CA) (resid 65 and name HA) -3.751 4.460 
assign (resid 65 and name N) (resid 65 and name HN) -7.665 2.000 
assign (resid 66 and name N) (resid 66 and name HN) -4.896 2.000 
assign (resid 67 and name CA) (resid 67 and name C) 4.304 8.465 
assign (resid 67 and name CA) (resid 67 and name HA) 3.471 4.460 
assign (resid 73 and name CA) (resid 73 and name C) -8.842 8.465 
assign (resid 73 and name CA) (resid 73 and name HA) -2.259 4.460 
assign (resid 73 and name N) (resid 73 and name HN) -3.519 2.000 
assign (resid 74 and name CA) (resid 74 and name C) 6.492 8.465 
assign (resid 74 and name N) (resid 74 and name HN) -4.913 2.000 
assign (resid 75 and name N) (resid 75 and name HN) -4.254 2.000 
assign (resid 76 and name CA) (resid 76 and name C) -6.526 8.465 
assign (resid 78 and name CA) (resid 78 and name C) -12.873 8.465 
assign (resid 78 and name CA) (resid 78 and name HA) 6.667 4.460 
assign (resid 79 and name CA) (resid 79 and name C) -1.175 8.465 
assign (resid 79 and name N) (resid 79 and name RN) -4.853 2.000 
assign (resid 80 and name CA) (resid 80 and name C) -0.493 8.465 
assign (resid 80 and name CA) (resid 80 and name HA) -7.316 4.460 
assign (resid 80 and name N) (resid 80 and name RN) -2.363 2.000 
assign (resid 81 and name CA) (resid 81 and name C) 10.299 8.465 
assign (resid 81 and name CA) (resid 81 and name HA) 0.243 4.460 
assign (resid 81 and name N) (resid 81 and name HN) -3.303 2.000 
assign (resid 83 and name CA) (resid 83 and name C) 6.208 8.465 
assign (resid 83 and name CA) (resid 83 and name HA) -0.796 4.460 
assign (resid 83 and name N) (resid 83 and name RN) 0.079 2.000 
assign (resid 85 and name N) (resid 85 and name RN) -4.261 2.000 
assign (resid 88 and name N) (resid 88 and name RN) 1.503 2.000 
assign (resid 89 and name N) (resid 89 and name HN) -5.992 2.000 
assign (resid 90 and name CA) (resid 90 and name C) -5.724 8.465 
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assign (resid 90 and name N) (resid 90 and name RN) -2.967 2.000 
assign (resid 91 and name CA) (resid 91 and name C) -10.482 8.465 
assign (resid 92 and name N) (resid 92 and name HN) -8.351 2.000 
assign (resid 94 and name N) (resid 94 and name HN) -4.658 2.000 
assign (resid 96 and name N) (resid 96 and name RN) -6.430 2.000 
assign (resid 99 and name CA) (resid 99 and name RA) -17.306 4.460 
assign (resid 100 and name CA) (resid 100 and name C) 13.643 8.465 
assign (resid 100 and name CA) (resid 100 and name HA) -9.366 4.460 
assign (resid 100 and name N) (resid 100 and name RN) -5.979 2.000 
assign (resid 101 and name CA) (resid 101 and name C) -14.685 8.465 
assign (resid 101 and name CA) (resid 101 and name HA) -0.874 4.460 
assign (resid 101 and name N) (resid 101 and name RN) -4.598 2.000 
assign (resid 102 and name N) (resid 102 and name RN) -2.095 2.000 
assign (resid 103 and name CA) (resid 103 and name C) 0.380 8.465 
assign (resid 103 and name CA) (resid 103 and name HA) -2.018 4.460 
assign (resid 107 and name CA) (resid 107 and name C) 1.518 8.465 
assign (resid 107 and name CA) (resid 107 and name HA) -2.155 4.460 
assign (resid 110 and name CA) (resid 110 and name C) 2.332 8.465 
assign (resid 110 and name CA) (resid 110 and name RA) -4.867 4.460 
assign (resid 110 and name N) (resid 110 and name RN) -7.811 2.000 
assign (resid 111 and name CA) (resid 111 and name C) 15.090 8.465 
assign (resid 111 and name CA) (resid 111 and name HA) 0.605 4.460 
assign (resid 111 and name N) (resid 111 and name RN) -4.629 2.000 
assign (resid 114 and name CA) (resid 114 and name C) -0.502 8.465 
assign (resid 114 and name N) (resid 114 and name RN) 0.848 2.000 
assign (resid 115 and name CA) (resid 115 and name C) 17.798 8.465 
assign (resid 115 and name CA) (resid 115 and name HA) -1.881 4.460 
assign (resid 115 and name N) (resid 115 and name HN) -2.140 2.000 
assign (resid 116 and name CA) (resid 116 and name C) -0.139 8.465 
assign (resid 116 and name CA) (resid 116 and name HA) -0.899 4.460 
assign (resid 116 and name N) (resid 116 and name RN) 2.162 2.000 
assign (resid 117 and name CA) (resid 117 and name C) -11.329 8.465 
assign (resid 117 and name N) (resid 117 and name RN) 3.457 2.000 
assign (resid 118 and name CA) (resid 118 and name C) 14.458 8.465 
assign (resid 118 and name N) (resid 118 and name 1-IN) -3.037 2.000 
assign (resid 123 and name CA) (resid 123 and name C) 15.510 8.465 
assign (resid 123 and name CA) (resid 123 and name HA) -4.017 4.460 
assign (resid 123 and name N) (resid 123 and name HN) -1.998 2.000 
assign (resid 124 and name CA) (resid 124 and name C) -2.907 8.465 
assign (resid 124 and name N) (resid 124 and name RN) -4.511 2.000 
assign (resid 125 and name CA) (resid 125 and name C) -8.934 8.465 
assign (resid 125 and name CA) (resid 125 and name HA) -8.728 4.460 
assign (resid 125 and name N) (resid 125 and name HN) -3.980 2.000 
assign (resid 126 and name CA) (resid 126 and name C) -23.956 8.465 
assign (resid 126 and name CA) (resid 126 and name HA) -1.516 4.460 
assign (resid 126 and name N) (resid 126 and name RN) -4.668 2.000 
assign (resid 127 and name CA) (resid 127 and name C) -2.085 8.465 
assign (resid 127 and name CA) (resid 127 and name HA) -4.641 4.460 
assign (resid 127 and name N) (resid 127 and name HN) -9.812 2.000 
assign (resid 128 and name N) (resid 128 and name HN) -1.692 2.000 
assign (resid 129 and name N) (resid 129 and name RN) -4.645 2.000 
assign (resid 130 and name CA) (resid 130 and name C) -4.159 8.465 
assign (resid 130 and name CA) (resid 130 and name HA) 3.520 4.460 
assign (resid 131 and name N) (resid 131 and name RN) -2.277 2.000 
assign (resid 132 and name CA) (resid 132 and name C) 15.604 8.465 
assign (resid 132 and name CA) (resid 132 and name HA) -7.212 4.460 
assign (resid 135 and name N) (resid 135 and name HN) -4.303 2.000 
assign (resid 136 and name CA) (resid 136 and name C) 3.124 8.465 
assign (resid 136 and name CA) (resid 136 and name HA) -4.599 4.460 
assign (resid 137 and name CA) (resid 137 and name C) 0.057 8.465 
assign (resid 137 and name CA) (resid 137 and name HA) -9.979 4.460 
assign (resid 137 and name N) (resid 137 and name RN) -5.549 2.000 
assign (resid 138 and name CA) (resid 138 and name C) 16.564 8.465 
assign (resid 138 and name N) (resid 138 and name RN) -0.612 2.000 
assign (resid 140 and name CA) (resid 140 and name C) 11.866 8.465 
assign (resid 140 and name CA) (resid 140 and name HA) -12.979 4.460 
assign (resid 140 and name N) (resid 140 and name RN) -7.637 2.000 
assign (resid 141 and name N) (resid 141 and name RN) -6.446 2.000 
assign (resid 142 and name N) (resid 142 and name RN) -7.500 2.000 
assign (resid 143 and name CA) (resid 143 and name C) 12.779 8.465 
assign (resid 143 and name CA) (resid 143 and name HA) -6.247 4.460 
assign (resid 146 and name CA) (resid 146 and name C) -18.593 8.465 
assign (resid 146 and name CA) (resid 146 and name RA) 2.075 4.460 
assign (resid 146 and name N) (resid 146 and name HN) 2.715 2.000 
assign (resid 147 and name N) (resid 147 and name RN) -5.152 2.000 
assign (resid 149 and name CA) (resid 149 and name C) -8.881 8.465 
assign (resid 150 and name N) (resid 150 and name RN) -1.902 2.000 
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assign (resid 152 and name N) (resid 152 and name HN) -5.578 2.000 
assign (resid 154 and name CA) (resid 154 and name C) -5.779 8.465 
assign (resid 154 and name N) (resid 154 and name HN) -7.935 2.000 
assign (resid 155 and name CA) (resid 155 and name C) -3.151 8.465 
assign (resid 155 and name CA) (resid 155 and name HA) 7.685 4.460 
assign (resid 155 and name N) (resid 155 and name HN) -4.258 2.000 
assign (resid 156 and name CA) (resid 156 and name C) -11.316 8.465 
assign (resid 156 and name CA) (resid 156 and name HA) -2.013 4.460 
assign (resid 156 and name N) (resid 156 and name HN) -3.328 2.000 
assign (resid 157 and name CA) (resid 157 and name C) 21.108 8.465 
assign (resid 157 and name CA) (resid 157 and name HA) 1.449 4.460 
assign (resid 157 and name N) (resid 157 and name HN) -4.864 2.000 
assign (resid 158 and name CA) (resid 158 and name C) 1.408 8.465 
assign (resid 158 and name CA) (resid 158 and name HA) -12.377 4.460 
assign (resid 158 and name N) (resid 158 and name HN) -1.138 2.000 
assign (resid 159 and name CA) (resid 159 and name C) 6.780 8.465 
assign (resid 159 and name N) (resid 159 and name HN) -6.183 2.000 
assign (resid 160 and name CA) (resid 160 and name C) 0.464 8.465 
assign (resid 160 and name CA)- (resid 160 and name HA) 3.388 4.460 
assign (resid 160 and name N) (resid 160 and name HN) 3.786 2.000 
assign (resid 161 and name CA) (resid 161 and name HA) -4.999 4.460 
assign (resid 161 and name N) (resid 161 and name HN) -1.899 2.000 
assign (resid 163 and name CA) (resid 163 and name C) -2.491 8.465 
assign (resid 163 and name CA) (resid 163 and name HA) -5.171 4.460 
assign (resid 163 and name N) (resid 163 and name HN) -5.210 2.000 
assign (resid 164 and name N) (resid 164 and name HN) -1.368 2.000 
assign (resid 165 and name CA) (resid 165 and name C) -5.320 8.465 
assign (resid 165 and name CA) (resid 165 and name HA) -2.654 4.460 
assign (resid 166 and name CA) (resid 166 and name C) 24.730 8.465 
assign (resid 166 and name CA) (resid 166 and name HA) -5.018 4.460 
assign (resid 166 and name N) (resid 166 and name HN) -7.552 2.000 
assign (resid 167 and name CA) (resid 167 and name C) -1.177 8.465 
assign (resid 167 and name CA) (resid 167 and name HA) -7.786 4.460 
assign (resid 167 and name N) (resid 167 and name HN) -6.271 2.000 
assign (resid 168 and name CA) (resid 168 and name C) 6.290 8.465 
assign (resid 168 and name N) (resid 168 and name HN) -3.228 2.000' 
assign (resid 169 and name CA) (resid 169 and name C) -6.890 8.465 
assign (resid 169 and name N) (resid 169 and name HN) -4.492 2.000 
assign (resid 170 and name N) (resid 170 and name HN) -4.291 2.000 
assign (resid 171 and name CA) (resid 171 and name C) 13.233 8.465 
assign (resid 171 and name CA) (resid 171 and name HA) 3.468 4.460 
assign (resid 172 and name CA) (resid 172 and name C) -8.904 8.465 
assign (resid 172 and name N) (resid 172 and name HN) -5.777 2.000 
assign (resid 174 and name N) (resid 174 and name HN) -6.518 2.000 
assign (resid 17,6 and name N) (resid 176 and name RN) 1.655 2.000 
assign (resid 177 and name CA) (resid 177 and name C) 12.115 8.465 
assign (resid 177 and name CA) (resid 177 and name HA) -7.623 4.460 
assign (resid 178 and name CA) (resid 178 and name HA) -2.473 4.460 
assign (resid 178 and name N) (resid 178 and name HN) -6.220 2.000 
assign (resid 179 and name CA) (resid 179 and name C) -5.595 8.465 
assign (resid 179 and name CA) (resid 179 and name HA) -0.824 4.460 
assign (resid 179 and name N) (resid 179 and name RN) -0.992 2.000 
assign (resid 179 and name N) (resid 179 and name HN) -0.992 2.000 
assign (resid 180 and name CA) (resid 180 and name C) 29.784 8.465 
assign (resid 180 and name N) (resid 180 and name HN) -0.643 2.000 
assign (resid 181 and name N) (resid 181 and name RN) -3.293 2.000 
assign (resid 182 and name CA) (resid 182 and name C) -5.987 8.465 
assign (resid 182 and name CA) (resid 182 and name HA) 5.288 4.460 
assign (resid 183 and name N) (resid 183 and name HN) -3.056 2.000 
assign (resid 185 and name CA) (resid 185 and name C) -5.678 8.465 
assign (resid 185 and name CA) (resid 185 and name HA) -5.199 4.460 
assign (resid 186 and name CA) (resid 186 and name C) 13.651 8.465 
assign (resid 186 and name CA) (resid 186 and name HA) -4.024 4.460 
assign (resid 186 and name N) (resid 186 and name HN) -4.804 2.000 
assign (resid 187 and name CA) (resid 187 and name C) 4.698 8.465 
assign (resid 187 and name CA) (resid 187 and name HA) -8.075 4.460 
assign (resid 187 and name N) (resid 187 and name RN) -5.745 2.000 
assign (resid 188 and name CA) (resid 188 and name C) -0.522 8.465 




TENSO REFINEMENT SCRIPT USED FOR RDC INPUT 
IN CNS 
REMARK refine partial.inp 
REMARK refinement protocol with ambiguous restraints 
REMARK essentially as published in 
REMARK Nilges, N. (1993), A calculation strategy for the structure 
REMARK determination of symmetric dimers by 18 NMR. 
REMARK 	Proteins 17, 297-309. 
REMARK Nilges, M. (1994) 
REMARK Calculation of three-dimensional structures of proteins from 
REMARK 	ambiguous distance restraints. 3MB in press 
Doesn't adjust the scale factor for dihedral restraints 
if ($exist_start_count = FALSE) then 
(====>) evaluate ($startcount=O) 
end if 
if (Sexist—end—count = FALSE) then 
{====>) evaluate ($endcount=5) 
end if 
if ($existseed= FALSE) then 
evaluate ($seed = 8764) 
end if 
(* number of structures *) 
{* number of structures *) 
evaluate ($seed = $seed * ($start count + 1)) 
{* Doubled high steps and cool_steps 21/8/95 *} 
evaluate ($high steps 	= 10000) 
evaluate ($coolstepsl = 10000) 
evaluate ($coolsteps2 = 4000) 
evaluate ($initt = 2000.01) 
set the weights for the experimental energy terms 
evaluate ($knoe = 25.0) 	noes 
evaluate ($asym = 0.1) slope of NOE potential 
evaluate ($kcdi = 0.0) 	torsion angles 
noe 
averaging * sum 
potential * soft 
scale 	* 25 
sqconstant * 1.0 
sqexponent * 2 
soexponent * 1 
rswitch 	* 0.5 
sqoffset * 0.0 
asymptote * 0.1 
end 
phi angle restraints 
restraints dihedral 
scale = 25.0 
end 






Scale factor for the dihedrals. 
at high temp. almost no weight 
310 




evaluate ($rcon = 0.003) 
flags 
exclude * 
include angi bond impr vdw noe coup cdih dihe 
end 
evaluate ($count = $start_count) 
while ($count <= $end count) loop stru 
evaluate ($filename="rrsa" + $fileroot + 	+ encode($count)+".pdb") 
coor mit end 
coor @@$filename 
evaluate ($bath = $initt) 
do (mass = 100.0) (all) 
do (fbeta = 10.0) (all) 
define prochiral centres to be swapped & floated 
store2 is set AND ids are stored in bcomp & qcomp) 
@PROTOCOLS : setupswap. cns 
swap_sel=&swap_sel; 
@PROTOCOLS: float prochirals . cns 
high temperature stage (reduced non-bonded) * 
evaluate ($knoe = 25.0) 	noes 
evaluate ($asym = 0.1) slope of NOE potential 
noe 
averaging * sum 
potential * soft 
scale 	* $knoe 
sqconstant * 1.0 
sqexponent * 2 
soexponent * 1 
rswitch 	* 0.5 
sqoffset * 0.0 





wmin 	= 0.01 warning off 
cutnb 	= 100 nonbonded cutoff 
tolerance 45 
repel 	= 1.54 ! 	scale factor for vdW radii = 1 	( L-J radii) 
rexp = 4 ! 	exponents in 	(rirex - R0irex)rexp 
irex 	= 1 
rcon = 4.0 ! 	actually set the vdW weight 
end 
end 
inline @PROTOCOLS : setupreduced. cns 
igroup 
interaction (not storel) (all) 
weights * 1 angl 0.4 irnpr 0.1 dihe 0.1 vdw 0 elec 0 end 
interaction (storel) (storel) 





tcoupling = true 
temperature = $bath 
nprint50 
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ntrfr = 99999999 
end 




wmin 	= 0.01 warning off 
cutnb 	= 7.0 nonbonded cutoff 
tolerance 0.5 
repel 	= 1.28 scale factor for vdw radii = 1 	( L-J radii) 
rexp = 4 exponents in (rirex - ROirex)rexp 
irex 	= 1 
rcon = 4.0 actually set the vdW weight 
end 
end 
* =========================== 	== == 	===== first cooling stage * 
evaluate($redf = 5) 	(fr reduction factor for temp step ***) 
evaluate ($finalt = 1000) ( 	K 
evaluate ($tempstep = 	50) ( 	K 
evaluate ($tempstep = 	int(50/$redf)) 	{ 	K 
evaluate ($ncycle = ($initt-$finalt)/$teinpstep) 
evaluate ($nstep = int($cool steps l/$ncycle)) 
evaluate ($nstep = int(($coolstepsl*$redf)/$ncycle)) 
evaluate ($ini tad = 1.28) evaluate 	($finrad = 1.0) 
evaluate ($ini con = 0.012) evaluate 	($fin con = 11.0) 
evaluate ($ini_ang = 0.25) evaluate 	($finang = 1.0) 
evaluate ($ini imp = 0.1) evaluate 	($fin imp = 1.0) 
evaluate ($ini_dihe = 	0.1) evaluate 	($fin_dihe = 	1.0) 
evaluate ($iniasy = 0.1) evaluate 	($finasy = 1.0) 
evaluate ($iniflt = 25.0) evaluate 	($finflt = 500.0) 
evaluate ($initenso = 0.001) evaluate 	($fin_tenso = 1 
evaluate ($kvdw = $ini con) 
evaluate ($k_vdwfact = ($fincon/$inicon)'(1/$ncycle)) 
evaluate ($radius= 	$ini_rad) 
evaluate ($radfact = ($finrad/$inirad)'(l/$ncycle)) 
evaluate ($k_ang = $iniang) 
evaluate (sang fac = ($finang/$iniang)'(1/$ncycle)) 
evaluate (Skimp = $ini imp) 
evaluate ($imp_fac = ($finimp/$iniimp)"(l/$ncycle)) 
evaluate ($kdihe = $inidihe) 
evaluate ($dihefac = ($findihe/$inidihe)"(l/$ncycle)) 
evaluate ($asym = $iniasy) 
evaluate ($asyfac = ($finasy/$iniasy)'(l/$ncycle)) 
evaluate ($kflt = $iniflt) 
evaluate ($fltfac = ($finflt/$iriiflt)"(l/$ncycle)) 
evaluate ($ktenso = $initenso) 
evaluate ($tensofac = ($fintenso/$initenso)"(l/$ncycle)) 
do (vx = maxwell($bath)) (all) 
do (vy = maxwell($bath)) (all) 
do (vz = maxwell($bath)) (all) 
evaluate ($icool = 1) 
while (Si_cool < $ncycle) loop cooll 
evaluate ($icool=$icool+l) 
evaluate ($bath = $bath - $tempstep) 
evaluate ($kvdw=min ($fin con, $kvdw*$kvdwfact)) 
evaluate ($ radi us=max ($finrad,$radius*$radfact)) 
evaluate ($kang = $kang*$angac) 
evaluate (Skimp = $kimp*$impfac) 
evaluate ($k_dihe = $k_dihe*$dihe_fac) 
evaluate ($asym = $asym*$asy_fac) 
evaluate ($kflt = $kflt*$fltfac) 
evaluate ($ktenso = $ktenso*$tenso_fac) 
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igroup interaction (all) (all) weights 
* 1 angles $k_ang improper $k—imp dihedral $k_dihe 
end end 
parameter nbonds 
cutnb=7.0 rcon=$k_vdw nbxmod=5 repel=$radius 
end 	end 
parameter 
angle (store3) (all) (store3) $k_flt TOKEN 
	
angle (all) 	(all) (store3) $k fit TOKEN 
end 
noe 
asymptote * $asym 
end 
Do swaps I 
@PROTOCOLS: swap_metropolis. cns 
toswap = methyl amido methylene; 
swap sei=&swap_sel; 








tcoupling = true temperature = $bath nprint=$nstep 
ntrfr = 99999999 
end 
end loop cooll 
* ==========-========= 	==== ==== ========== ===== second cooling stage * 
evaluate ($finalt = 100) 	1 K 
evaluate ($tempstep = 50) ( K 
evaluate ($ncycie = ($bath-$finait)/$tempstep) 
evaluate ($nstep = int($coolsteps_2/$ncycle)) 
evaluate ($i cool = 1) 
while ($i—cool < $ncycle) loop coo12 
evaluate (Sicooi=$icool+i) 
evaluate ($bath = Sbath - $tempstep) 
Do swaps 
@PROTOCOLS: swap_metropolis. cns 
toswap = methyl amido methylene; 
swap sel=&swap sel; 








tcoupling = true temperature = $bath nprint=$nstep 
ntrfr = 99999999 
end 
end loop coo12 
evaluate ($stats = 2 * $nstep) 
dynamics cartesian 
nstep=$stats timestep=0.003 
tcoupling = true temperature = $bath nprint=$nstep 
ntrfr = 99999999 
end 
(* ============= Powell energy minimization 	 * 
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Do swaps 
@PROTOCOLS: swap_downhill. cns 
toswap = methyl amido methylene; 
swap_sel=&swap_sel; 




include angl bond impr vdw moe coup cdih dihe tenso 
end 
mini powell nstep= 500 nprint= 50 end 
Do swaps 
@PROTOCOLS: swapdownhill. cns 
toswap = methyl amido methylene; 
swapsel=&swapsel; 




include angl bond impr vdw noe coup cdih dihe tenso 
end 
mini powell nstep= 500 nprint= 50 end 
Do swaps 
@PROTOCOLS: swapdownhill. cns 
toswap = methyl amido methylene; 
swap sel=&swap sel; 
bath=$bath; 	(needs $bath} 
swap stats=$swap stats; 
flags 
exclude * 
include angl bond inpr vdw noe coup cdih dihe tenso 
end 
mini powell nstep= 500 nprint= 50 end 
lash up to avoid ids overflowing b & q fields of pdb and producing havoc in PROCHECK 
with q=0.01 
do (b = 0.0) (all) 
do (q = 1.0) (all) 
evaluate ($vjo].file = $fileroot + encode($count) + ".violrdc") 
set print $violfile end 








print threshold=5. cdih 
evaluate ($rmscdih=$result) 
evaluate ($violationscdih=$violations) 
print thres=0.018 bonds 	(6*sigma Engh & Huber) 
evaluate ($rmsbond=$result) 
print thres=3.04 angles 	(6*sigma Engh & Huber) 
evaluate ($rmsangl$result) 
print thres=5. impropers 
evaluate ($rmsimpr=$result) 
print thres=5. dihedrals 
evaluate ($rmsdihe=$result) 
tenso print threshold=l class dipolar end 
evaluate ($rmstenso=$result) 
evaluate ($violtenso=$violations) 
close $violfile end 
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set print_f ile=OUTPUT end 
remarks 
remarks 	 overall,bonds,angles,improper,vdw,noe,cdih,dihe,tenso 
remarks energies: Sener, $bond, $angl, $impr, $vdw, $noe, $cdih, $dihe, $tens 
remarks 
remarks 	. 	bonds,angles,impropers,noe,cdih,dihe,tenso 
remarks rms-d: 
$rms_bond, $rms_angl, $rms impr, $rms noe, $rms cdih, $rms dihe, $rmstenso 
remarks 
remarks 	 noe, cdih, tenso 
remarks violations.: $violationsnoe, $violationscdih, $violtenso 
remarks 
remarks seed = $seed 
evaluate ($file = "refine rdc " + $fileroot + 	+ encode($count) + ".pdb") 
write coor output= $file end 
evaluate ($count = $count + 1) 




BACK-CALCULATED NOE INTERACTIONS FROM 
CRYSTAL STRUCTURES 
Back-calculated linker- No. of Seen in current Seen in Uhrinova et al. 
module 2 NOE interaction models NOESY assignments NOESY assignments 
G98Hct1-K127H2 2 N N 
G98Ha1-K127H81 3 N N 
G98Ha1-K127H2 5 N N 
G98 Hal -K127H# 2 N N 
G98Hct2-K127H2 6 N N 
G98Ha2-K127H# 2 - - 
Y99Hn-K127H2 2 N(P) N 
Y99 Hn - K127 Hç# 1 - - 
Y99Ha-KI26Ha 8 Y Y 
Y99Ha-K127Hn 8 Y N 
Y99Ha-K127Hy1 8 N(P) N 
Y99 Ha - K127 H2 2 N (P) N 
Y99H5I-K125Ha 4 Y -N 
Y99H81-K126Hn 1 N(P) N 
Y99H1-K126Ha 8 Y Y 
Y99H51-K126Hy1 4 N(P) N 
Y99HcI-K126Hyl 8 Y N 
Y99Hc1-K126Hy2 4 Y N 
Y99Hc1-K126H2 1 N(P) N 
Y99HE1-K126HE1 3 Y N 
Y99H1-K126Hy2 2 - - 
Y99Hi-K126Hc1 2 - - 
R100 Hn - K125 Hn 8 Y N 
R100Hn-K125Hy1 2 N(P) N 
R100 Hn - K125 Hy2 1 N N 
R100Hn-K127H'yl 2 N N 
R100 Hoc -K127Hc1 I N(P) N 
RI00HI31-K125Hy1 1 N(P) N 
R100H31-K125H'y2 1 N(P) N 
R100H31-K125H1 1 N N 
R100HI31-K125H4 1 - N 
R100H31-K127Hy1 7 N N 
R100HI31-K127Hy2 5 N N 
RI00HI31-K127HCI 5 N(P) N 
R100H32-K125Hy1 1 N(P) N 
R100H32-K125Hy2 1 N(P) N 
R100H32-K125Hc1 1 N(P) N 
R100HT1-K125Hn 1 Y N 
R100H'y1-K125H132 4 N(P) N 
R100Hy1-K125Hyl 2 N(P) N 
R100H'yl-K125Hy2 3 N N 
R100Hy1-K125H82 2 N(P) N 
R100Hy2-KI25Hn 2 Y I 	N 
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RI00Hy2—K125H131 2 N(P) N 
R100Hy2—K125H32 2 N(P) N 
RI00Hy2—K125Hy1 1 N(P) N 
R100 Hy2 — K125 Hy2 1 N N 
R100Hy2—K125H62 2 N(P) N 
R100Hy2—K127Hoc 4 y N 
R100Hy2—KI27Hy1 3 N N 
R100H1—K127Ha 4 N N 
R100H1—K127Hy1 3 N N 
R100H1—K127Hy2 3 N N 
R100H61—K127Hc1 1 N N 
R100H81—S128Hn 2 N N 
R100H52—K127Hy2 1 N N 
R100H—K125Hy1 2 N N 
R100Hc—K125H2 2 N N 
R100Hc—KI25Hc1 2 N N 
R100He—K125Hc2 2 N N 
R100Hc—K127Hoc 1 N N 
R100H111—K125Hg1 2 - - 
R100H111—K125Hc2 2 - - 




R100H112—K127Hy2 2 - - 
R100H112—S128Hn 2 - - 
R100Hr121—K125H8I 2 - - 











EI02Ha—K125H61 2 N N 
E102Ha—K125Hc1 1 N N 
ElO2 Hoc —K125Hc2 1 N N 
E102H32—K125H1 2 N(P) N 
E102H2—K125Hy1 2 Y N 
E102HJ32—K125Hy2 4 y N 
E102142—K125H61 2 N(P) N 
E102H2—K125H2 1 N(P) N 
E122Hf31—K125H81 2 N(P) N 
E122Hl31—K125H2 2 N(P) N 
E122H31—K125H2 1 Y N 
Cl24 Hot —K125Hn 8 Y y 
Table 9.1: Table of back-calculated linker to module three NOEs the from X-ray crystal structures of 
DAF23 . 
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Back-calculated linker- No. of Seen in current Seen in original 
module 3 NOE interaction models NOESY assignments NOESY assignments 
K126H1—L147H31 8 N(P) N 
K126141—L147H81# 1 N(P) N 
K126Hf1—F148Hn 8 N N 
K126H31-F148HI31 6 Y N 
K126H32—L147HI31 3 N(P) N 
K126H2—L147H81# 3 N(P) N 
K126Hy1—FI48H81 3 N N 
K126Hy2—L147H131 1 N(P) N 
K126Hy2—F148Hn 1 N N 
K126Hy2—F148H31 8 N(P) N 
K126H72—F148H8I 5 N(P) N 
K126Hy2—F148H82 2 N(P) N 
K126H1—L147H1 4 N(P) N 
K126H61—F148HI31 5 N(P) N 
K126H2—L147H31 1 N(P) N 
K126H2- L147 H132 1 N N 
K126 Hcl - F148 Höl 3 Y N 
K126Hc1—G149Hal 1 N(P) N 
K127Hn—F148HfH 7 N N 
K127Hn—F148H2 4 N N 
K127H131—V177Hy1# 2 N(P) Y 
K127H131—V177H72# 8 N(P) Y 
K127 H32 - F148 H32 7 Y N 
K127H2—V177Hy1# 7 N(P) Y 
K127H32—V177Hy2# 3 N(P) Y 
K127H1—S176 Hot 6 Y N 
K127H1—S176Hf32 2 N Y 
K127H1—V177Hn 2 N Y 
K127H62—S176Ha 2 Y N 
K127H52—V177Hn 1 N N 
K127H82—V177H'yl# 1 N(P) Y 
K127H#-S176Hoc 5 - - 
K127H#-S176Hy 1 - - 
S128Hct—C129Hn 8 N(P) N 
S128 Hoc —L147Hc 8 N 
S128Ha—L147H131 1 N(P) N 
S128 Hoc —L147H2# 8 N(P) Y 
S128 Ha — F148 Hn 4 N(P) N 
S128H32—I146Hy11 2 N N 
S128H132—L147Ha 2 N(P) N 
S128Hl32—L147H2# 8 Y y 
S128 Hy — C129 Hn 3 - - 
S128Hy-1146Hyl1 4 - - 
S128Hy—I146H1 3 - - 
S128Hy—L147Hot 1 - - 
S128Hy—L147H62 2 - - 
Table 9.2: Table of back-calculated linker to module three NOEs the from X-ray crystal structures of 
DAF23 . 
Those shown are between protons less than 3.3 A apart. * Both Hoc not assigned in 13 C-NOESY due to 
overlap. Where one of the protons involved in the interaction has not been assigned, a dash is inserted. 
Where the NOE interaction could possibly be represented by a NOESY cross-peak, but it is too 
overlapped for that restraint to be resolved, (P) is inserted. 
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DIFFUSION TENSOR ESTIMATION USING 'quadratic-diffusion' 
PDB 
ISOTROPIC  AXIALLY SYMMETRIC ANISOTROPIC (PROLATE)  
D10 (1 	
-7/S) D iso (10IS) Dpar/Dper Theta (it/i 80 0) Phi (m/180 0) F statistic P 
Ctm 1.95761 1.93312 1.28986 0.42170 5.83439 2.80828 0.04570 
Ctm2 1.95761 1.93671 1.24080 0.35941 3.56232 2.59160 0.05940 
Ctm3 1.95761 1.93159 1.27285 0.25994 5.60154 2.66712 0.05420 
Ctm4Ie5 1.95761 1.93179 1.27080 0.29084 2.27629 2.81656 0.04520 
Ctm5 1.95761 1.93731 1.25724 0.27261 1.59717 3.37654 0.02300 
Le 1.95761 1.93618 1.25846 0.46934 1.43753 3.09007 0.03250 
Le2 1.95761 1.93387 1.26494 1 	0.25323 5.90473 3.08070 0.03280 
Le3 1.95761 1.93124 1.24185 0.10647 0.85459 2.56011 0.06170 
Le4 1.95761 1.92202 1.31829 1 0.24773 0.71951 3.73399 0.01490 
PDB 
FULLY AN ISOTROPIC  
D0 (10 7/s) 2D/(D,+D) DID, Theta (it/I 80 
0) Phi (it/i 80 0) Psi (ic/i 80 0) F statistic P 
Ctm 1.94007 1.34827 0.85215 0.38142 -0.56020 0.85170 1.66419220 0.1969 
Ctm2 1.93798 1.24142 0.96135 0.34747 -2.65587 1.07430 0.12964074 0.8786 
Ctm3 1.94063 1.27858 0.87206 0.29119 -0.83907 0.51912 1.85557950 0.1641 
Ctm4Ie5 1.94406 1.35347 0.81844 0.29440 2.06108 -0.30439 2.60633111 0.0811 
CtmS 11.94039 1.29214 0.86805 0.27980 1.61890 0.15067 1.86492431 0.1626 
Le 1.93643 1.28490 0.92838 0.47668 1.46115 0.42983 0.42364711 0.6563 
Le2 1.94383 1.32107 0.85749 0.26043 -0.47653 1.44787 2.23854852 0.1143 
Le3 1 	1.93962 1 	1.31187 1 	0.85125 1 	0.09918 1.09081 1 	0.40359 1 	1.94831586 1 	0.1503 
Le4 1 1.92291 1 1.33979 1 0.92946 1 0.26818 0.69384 1 0.63249 1 0.43117988 1 0.4312 
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PDB 
ISOTROPIC  AXIALLY SYMMETRIC ANISOTROPIC (OBLATE)  
D10 (10Is) D 0 (10 71s) Dpar/Dpe r Theta (ic/I 80 
0) Phi (ic/I 80 0) F statistic P 
Ctm 1.95761 1.96658 0.84052 1.27326 1.64533 1.59381 0.19850 
Ctm2 1.95761 1.95773 0.90789 1.37930 1.64187 0.72195 0.54220 
Ctm3 1.95761 1.96193 0.83972 1.28703 1.58844 2.54932 0.06250 
Ctm4Ie5 1.95761 1.97064 0.81717 1.27640 4.79087 2.03748 0.11640 
Ctm5 1.95761 1.95886 0.84350 1.31988 4.80811 2.27361 0.08740 
Le 1.95761 1.95749 0.90434 1.06477 4.94488 0.61118 0.61000 
Le2 1.95761 1.96370 0.84996 1.57538 4.20236 1.99890 0.12190 - 
Le3 1.95761 1.96539 0.85105 1.63857 1.52525- 1.49239 0.22400 
Le4 1.95761 1.95775 0.89730 1.34451 4.56258 0.76551 0.51710 
PDB 
FULLY ANISOTROPIC  
Diso (10 7/s) 2Dzz/(Dxx+Dyy) Dxx/Dyy Theta (it/180 0) Phi (ic/I 80 0) Psi (ic/I 80 
0) F P 
Ctm 1.94007 1.34827 0.85215 0.38142 -0.56020 0.85170 3.40288758 0.0390 
Ctm2 1.93798 1.24142 0.96135 0.34747 -2.65587 1.07430 2.78438091 0.0687 
Ctm3 1.94063 1.27858 0.87206 1 	0.29119 -0.83907 0.51912 2.01895261 0.1406 
Ctm4Ie5 1.94406 1.35347 0.81844 0.29440 2.06108 -0.30439 3.73100877 0.0289 
Ctm5 1.94039 1.29214 0.86805 0.27980 1.61890 0.15067 3.41109514 0.0387 
Le 1.93643 1.28490 0.92838 0.47668 1.46115 0.42983 3.98952508 0.0229 
Le2 1.94383 1.32107 1 0.85749 0.26043 -0.47653 1.44787 3.78707409 0.0275 
Le3 1.93962 1.31187 0.85125 1 	0.09918 1.09081 1 	0.40359 1 	3.49513912 0.0358 
Le4 1.92291 1.33979 0.92946 1 0.26818 0.69384 1 0.63249 1 	4.67528725 0.0125 




RELAXATION DATA AND MODELFREE DATA 
600 MHz relaxation data 
Residue Number R 1 (ifs) R1 error R2 (ifs) R2 error NOE NOE error 
62 1.501 0.075 6.077 0.304 - - 
63 1.299 0.065 10.44 0.522 0.557 0.028 
64 1.443 0.072 12.926 0.646 0.741 0.037 
65 1.503 0.075 11.523 0.576 0.735 0.037 
66 1.372 0.069 9.125 0.456 0.684 0.034 
68 1.254 0.063 11.573 0.579 0.643 0.032 
69 1.482 0.074 12.223 0.611 0.648 0.032 
70 1.316 0.066 9.534 0.477 0.67 0.034 
71 1.048 0.09 15.372 0.769 0.759 0.054 
72 1.402 0.07 14.912 0.746 0.75 0.038 
73 1.45 0.073 14.023 0.701 0.785 0.039 
74 1.501 0.075 11.302 0.565 0.732 0.037 
75 1.324 0.066 10.79 0.54 0.701 0.035 
77 1.159 0.058 14.286 0.714 0.67 0.034 
79 1.391 0.07 12.779 0.639 0.741 0.037 
80 1.486 0.074 13.071 0.654 0.705 0.035 
81 1.522 0.076 11.488 1.414 0.68 0.034 
82 1.107 0.055 14.083 0.704 0.677 0.034 
84 1.268 0.063 8.561 0.428 0.644 0.032 
85 1.47 0.074 9.925 0.496 0.689 0.034 
87 - - - - - - 
88 1.237 0.062 11.138 0.557 0.742 0.037 
89 1.442 0.072 - - 0.718 0.036 
90 1.177 0.059 11.513 0.576 0.7 0.035 
91 1.434 0.072 9.579 0.527 0.761 0.038 
92 1.431 0.148 12.137 0.607 0.82 0.082 
93 1.38 0.069 11.904 0.595 - - 
94 1.499 0.093 11.225 0.561 0.73 0.037 
95 1.436 0.072 12.47 0.624 0.708 0.035 
96 1.552 0.078 13.318 0.666 0.727 0.036 
98 1.532 0.077 - - 0.715 0.036 
99 1.323 0.066 12.381 0.619 0.774 0.039 
100 1.438 0.072 11.621 0.581 0.768 0.038 
101 1.438 0.072 12.233 0.612 0.722 0.036 
102 1.284 0.064 12.588 0.629 0.738 0.037 
104 1.055 0.053 13.446 1.095 0.549 0.027 
105 1.075 0.054 15.018 0.751 0.701 0.035 
108 1.351 0.068 12.044 0.602 0.68 0.034 
109 1.447 0.072 11.184 0.559 0.647 0.032 
110 1.255 0.063 10.643 0.532 0.763 0.038 
ill 1.439 0.072 10.824 0.541 0.743 0.037 
112 1.22 0.061 15.789 0.789 0.753 0.038 
113 1.384 0.069 10.918 0.546 0.602 0.03 
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114 1.236 0.062 13.415 0.671 0.729 0.036 
115 1.575 0.079 9.788 0.489 0.723 0.036 
116 1.262 0.063 12.203 0.61 0.696 0.035 
117 1.256 0.063 12.068 0.603 0.709 0.035 
118 1.406 . 	 0.07 10.267 0.513 0.734 0.037 
119 1.211 0.061 13.109 0.655 0.726 0.036 
120 1.224 0.061 11.252 0.563 0.554 0.028 
121 1.21 0.061 8.572 0.429 0.509 0.025 
122 1.368 0.068 11.485 0.574 0.482 0.024 
123 1.18 0.059 10.791 0.54 0.696 0.035 
124 1.475 0.074 13.706 0.685 0.718 0.036 
125 1.279 0.064 11.985 0.599 0.741 0.037 
126 1.363 0.068 11.11 0.556 0.756 0.038 
127 1.443 0.072 11.876 0.594 0.737 0.037 
128 1.265 0.063 10.736 0.537 0.728 0.036 
129 1.482 0.074 14.903 0.745 0.728 0.036 
131 1.345 0.067 10.924 0.546 0.743 0.037 
133 1.051 0.053 14.59 0.73 0.65 0.033 
134 1.13 0.057 10.548 0.527 0.57 0.029 
135 1.308 0.065 11.179 0.559 0.664 0.033 
136 1.25 0.063 - - 0.707 0.035 
137 1.459 0.073 11.854 0.593 0.726 0.036 
138 1.415 0.071 13.511 0.676 0.713 0.036 
140 1.318 0.066 12.244 0.612 0.712 0.036 
141 1.479 0.074 11.838 0.592 0.744 0.037 
142 1.237 0.062 10.148 0.507 0.694 0.035 
144 1.187 0.059 15.704 0.785 0.702 0.035 
145 1.016 0.051 14.315 0.716 0.63 0.032 
146 1.331 0.067 12.36 0.618 0.761 0.038 
147 1.494 0.075 12.241 0.612 0.755 0.038 
150 1.478 0.074 13.061 0.653 0.752 0.038 
152 1.494 0.075 11.945 0.597 0.73 0.037 
153 1.43 0.072 10.805 0.54 0.673 0.034 
154 1.359 0.068 9.882 0.632 0.699 0.035 
155 1.425 0.071 10.637 0.532 0.757 0.038 
156 1.285 0.064 11.969 0.598 0.743 0.037 
157 1.455 0.073 8.295 0.415 0.742 0.037 
158 1.265 0.063 10.998 0.55 0.745 0.037 
159 1.581 0.079 12.403 0.62 0.706 0.035 
160 1.29 0.065 12.62 0.631 0.713 0.036 
161 1.291 0.065 11.875 0.594 0.715 0.036 
162 1.351 0.068 11.534 0.577 0.7 0.035 
163 1.395 0.07 10.524 0.526 0.757 0.038 
164 1.208 0.06 12.603 0.63 0.728 0.036 
166 1.386 0.069 11.803 0.59 0.65 0.033 
167 1.454 0.073 12.36 0.618 0.699 0.035 
168 1.385 0.069 11.438 0.572 0.726 0.036 
• 169 1.307 0.065 13.442 0.672 0.748 0.037 
170 1.497 0.075 13.338 0.667 0.763 0.038 
171 - - - - - - 
172 - 	 1.362 0.068 11.889 0.594 0.721 0.036 
173 - 	 1.438 0.072 10.333 0.517 0.644 0.032 
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174 1.531 	
° 
0.077 11.12 0.556 0.682 0.034 
175 1.321 0.066 11.772 0.589 0.657 0.033 
176 1.339 0.067 - - 0.696 0.035 
178 1.353 0.068 12.81 0.641 0.726 0.036 
179 1.266 0.063 12.307 0.615 0.697 0.035 
180 1.427 0.071 12.394 0.62 0.771 0.039 
181 1.348 0.067 11.386 0.569 0.693 0.035 
183 1.379 0.069 11.636 0.582 0.708 0.035 
186 1.359 0.068 10.729 0.536 0.718 0.036 
187 1.238 0.062 12.33 0.617 0.697 0.035 
188 1.415 0.071 10.336 0.517 0.652 0.033 
189 1.546 0.077 10.767 0.538 0.517 0.026 
800 MHz relaxation data 
Residue Number R1 (us) R1 error R2 (ifs) R2 error NOE NQE error 
62 1.449 0.072 - - 0.243 0.012 
63 1.052 0.053 12.384 0.619 0.643 0.034 
64 1.042 0.073 19.886 2.473 0.764 0.044 
65 1.036 0.052 13.51 0.676 0.711 0.036 
66 0.985 0.049 11.875 0.594 0.677 0.044 
68 0.917 0.046 11.467 0.573 0.686 0.037 
69 1.24 0.062 14.038 0.702 0.691 0.035 
70 0.999 0.05 10.009 0.581 0.661 0.036 
71 0.93 0.11 15.136 1.11 0.768 0.113 
72 1.019 0.051 16.191 0.861 0.665 0.049 
73 1.13 0.057 16.523 0.826 0.745 0.037 
74 1.014 0.058 11.78 0.589 0.757 0.038 
75 0.862 0.043 12.523 0.626 0.725 0.044 
77 0.91 0.046 17.153 0.858 0.645 0.037 
79 1.145 0.057 13.244 0.662 0.699 0.035 
80 1.095 0.07 15.169 0.758 0.74 0.046 
81 1.044 0.057 13.362 0.668 0.671 0.036 
82 0.851 0.043 15.998 0.8 0.698 0.042 
84 0.902 0.045 11.777 0.589 0.644 0.033 
85 1.031 0.057 - - 0.732 0.037 
87 0.925 0.046 16.593 0.83 0.726 0.036 
88 1.111 0.106 10.001 0.575 0.785 0.058 
89 1.074 0.054 14.438 0.722 0.719 0.036 
90 0.892 0.045 11.636 0.961 0.698 0.049 
91 1.302 0.065 15.629 0.781 0.755 0.053 
92 0.914 0.076 11.957 0.598 - - 
93 1.201 0.084 14.641 1.232 0.698 0.057 
94 0.934 0.068 11.603 0.58 0.697 0.035 
95 1.26 0.099 16.425 0.821 0.781 0.041 
96 1.172 0.064 10.907 0.961 0.727 0.042 
98 1.257 0.158 - - 0.709 0.06 
99 0.993 0.05 16.207 0.81 0.778 0.039 
100 0.971 0.049 13.713 0.686 0.734 0.037 
101 1.048 0.052 14.919 0.808 0.765 0.038 
102 1.049 0.052 11.378 0.798 0.735 0.037 
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104 0.926 0.052 20.667 1.033 0.587 0.029 
105 0.771 0.039 16.937 0.847 0.71 0.036 
108 1.197 0.123 14.911 0.746 0.653 0.033 
109 1.023 0.051 13.642 0.682 0.601 0.036 
110 0.745 0.037 11.112 0.556 0.7 0.043 
111 1.108 0.059 11.422 0.885 0.719 0.044 
112 0.89 	1 0.09 18.551 0.928 0.753 0.038 
113 1.076 0.054 9.501 0.947 0.65 0.033 
114 1.028 0.051 13.818 0.691 0.785 0.039 
115 1.209 0.06 14.485 0.724 0.791 0.04 
116 0.926 0.046 15.152 0.758 0.666 0.033 
117 0.99 0.05 14.703 0.735 0.744 0.037 
118 1.192 0.06 14.674 0.894 0.743 0.041 
119 0.91 0.046 13.145 0.657 0.67 0.034 
120 1.003 0.05 11.558 0.578 0.611 0.031 
121 0.959 0.05 8.475 0.694 0.542 0.036 
122 1.105 0.055 13.377 0.804 0.595 0.03 
123 0.979 0.077 13.8 0.924 0.677 0.051 
124 1.2 0.06 17.073 0.854 0.758 0.038 
125 0.925 0.046 14.152 0.708 0.734 0.037 
126 0.948 0.047 14.952 0.748 0.763 0.038 
127 1.031 0.052 14.118 0.706 0.743 0.037 
128 0.957 0.048 12.405 1.022 0.745 0037 
129 0.983 0.049 13.688 0.684 0.732 0.037 
131 1.012 0.051 13.016 0.651 0.731 0.037 
133 0.757 0.04 9.938 0.497 0.66 0.033 
134 0.797 0.04 13.559 0.678 0.597 0.03 
135 0.963 0.048 12.394 0.62 0.668 0.033 
136 1.006 0.062 15.091 0.755 0.692 0.035 
137 1.131 0.057 13.327 0.666 0.695 0.035 
138 1.171 0.059 12.564 0.628 0.766 0.038 
140 0.892 0.045 13.986 0.699 0.718 0.036 
141 1.061 0.053 13.364 0.668 0.718 0.036 
142 0.824 0.041 11.62 0.581 0.714 0.036 
144 0.835 0.042 15.413 0.771 0.69 0.035 
145 0.748 0.037 15.93 0.797 0.62 0.031 
146 0.961 0.048 14.171 0.709 0.76 0.038 
147 1.111 0.056 16.296 0.815 0.741 0.037 
150 1.733 0.129 13.757 0.688 0.77 0.039 
152 1.015 0.065 14.49 0.725 0.693 0.035 
153 1.139 0.057 13.902 0.695 0.681 0.034 
154 1.127 0.056 12.625 0.631 0.745 0.037 
155 1.134 0.057 12.313 0.616 0.772 0.039 
156 0.925 0.046 9.699 0.591 0.724 0.036 
157 - - 13.379 0.669 0.736 0.037 
158 0.953 0.048 10.635 0.532 0.733 0.037 
159 0.995 0.052 12.043 0.602 0.719 0.036 
160 1 0.05 14.833 0.742 0.717 0.036 
161 1.004 0.05 11.131 0.557 0.726 0.036 
162 0.972 0.049 16.998 0.85 0.704 0.035 
163 1.213 0.061 14.397 0.72 0.742 0.037 
164 0.819 0.041 12.274 0.614 0.695 0.035 
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166 0.974 0.049 11.874 0.594 0.703 0.035 
167 1.083 0.054 13.578 0.679 0.723 0.036 
168 1.03 0.052 11.553 0.578 0.719 0.036 
169 1.024 0.051 14.632 0.732 0.768 0.038 
170 1.168 0.058 12.369 0.618 0.742 0.037 
171 0.88 0.044 15.61 0.781 0.753 0.038 
172 0.969 0.048 14.451 0.723 0.697 0.035 
173 1.126 0.056 11.079 0.554 0.677 0.034 
174 1.257 0.063 12.768 0.638 0.665 0.033 
175 1.146 0.057 13.768 0.688 0.685 0.034 
176 1.049 0.052 12.844 0.642 0.681 0.034 
178 1.022 0.051 17.272 0.864 0.697 0.035 
179 0.938 0.047 16.501 0.825 0.696 0.035 
180 1.046 0.052 14.443 0.722 0.764 0.038 
181 0.994 0.05 14.491 0.725 0.666 0.033 
183 0.988 0.049 14.311 0.716 0.722 0.036 
186 1.019 0.051 12.168 0.608 0.705 0.035 
187 1.034 0.052 8.601 1.122 0.71 0.036 
188 1.201 0.06 12.539 0.627 0.699 0.035 
189 1.281 0.064 7.551 0.877 0.571 0.029 
Fitted model-free parameters 
Residue Model No S S' Del PS Rex / S 
62 5 0.381 0.408 0.934 716.823 0.000 
63 5 0.773 0.879 0.880 481.16 0.000 
64 2 0.953 0.953 1.000 119.86 0.000 
65 2 0.885 0.885 1.000 55.607 0.000 
66 5 0.721 0.881 0.818 855.083 0.000 
68 5 0.764 0.919 0.831 430.257 0.000 
69 2 0.904 0.904 1.000 574.186 0.000 
70 5 0.642 0.819 0.785 1123.099 0.000 
71 4 0.741 0.741 1.000 11.792 3.350 
72 4 0.931 0.931 1.000 104.62 0.801 
73 4 0947 0.947 1.000 90.684 1.094 
74 5 0.774 0.890 0.869 1227.755 0.000 
75 2 0.793 0.793 1.000 27.061 0.000 
77 4 0.744 0.744 1.000 30.537 3.505 
79 2 0.903 0.903 1.000 71.729 0.000 
80 2 0.951 0.951 1.000 208.94 0.000 
81 2 0.892 0.892 1.000 . 	86.613 0.000 
82 4 0.751 0.751 1.000 25.124 2.460 
84 5 0.701 0.899 0.780 502.133 0.000 
85 5 0.753 0.880 0.856 988.696 0.000 
87 4 0.875 0.875 1.000 42.46 0.984 
88 5 0.694 0.889 0.780 1478.537 0.000 
89 2 0.912 0.912 1.000 77.753 0.000 
90 4 0.761 0.761 1.000 25.45 0.506 
91 5 0.807 0.877 0.920 1570.651 0.000 
92 2 0.841 0.841 1.000 0.711 0.000 
93 2 0.901 0.901 1.000 78.77 0.000 
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94 2 0.817 0.817 1.000 33.762 0.000 
95 2 0.892 0.892 1.000 1161.433 0.000 
96 2 0.923 0.923 1.000 697.405 0.000 
98 4 0.944 0.944 1.000 174.298 0.000 
99 4 0.842 0.842 1.000 20.173 1.607 
100 2 0.875 0.875 1.000 36.527 0.000 
101 2 0.922 0.922 1.000 66.954 0.000 
102 5 0.802 0.919 0.873 872.387 0.000 
104 4 0.681 0.681 1.000 33.77 5.324 
105 4 0.735 0.735 1.000 19.213 3.004 
108 4 0.843 0.843 1.000 56.406 1.016 
109 2 0.895 0.895 1.000 153.061 0.000 
110 4 0.710 0.710 1.000 14.479 0.341 
111 5 0.771 0.882 0.875 1244.697 0.000 
112 4 0.788 0.788 1.000 17.95 3.939 
113 5 0.755 0.863 0.875 670.176 0.000 
114 2 0.882 0.882 1.000 33.733 0.000 
115 5 0.780 0.850 0.917 1647.021 0.000 
116 4 0.803 0.803 1.000 36.967 1.289 
117 4 0.832 0.832 1.000 31.38 0.821 
118 5 0.797 0.882 0.904 1243.136 0.000 
119 4 0.793 0.793 1.000 31.279 0.773 
120 5 0.732 0.859 0.852 582.815 0.000 
121 5 0.564 0.756 0.745 877.365 0.000 
122 5 0.818 0.859 0.952 413.183 0.000 
123 2 0.793 0.793 1.000 32.605 0.000 
124 4 0.908 0.908 1.000 971.162 1.121 
125 4 0.806 0.806 1.000 24.117 0.999 
126 2 0.865 0.865 1.000 28.272 0.000 
127 2 0.900 0.900 1.000 52.522 0.000 
128 2 0.808 0.808 1.000 24.724 0.000 
129 4 0.894 0.894 1.000 52.911 0.646 
131 2 0.843 0.843 1.000 32.612 0.000 
133 2 0.688 0.688 1.000 22.131 0.000 
134 4 0.705 0.705 1.000 33.64 0.954 
135 2 0.814 0.814 1.000 43.987 0.000 
136 4 0.795 0.795 1.000 31.749 1.579 
137 5 0.824 0.882 0.935 1006.777 0.000 
138 2 0.912 0.912 1.000 64.977 0.000 
140 4 	. 0.790 0.790 1.000 26.381 1.279 
141 2 0.896 0.896 1.000 57.995 0.000 
142 2 0.745 0.745 1.000 21.772 0.000 
144 4 0.797 0.797 1.000 29.735 1.861 
145 4 0.627 0.627 1.000 20.52 4.206 
146 2 0.878 0.878 1.000 31.261 0.000 
147 4 0.929 0.929 1.000 76.942 0.738 
150 2 0.896 0.896 1.000 1297.167 0.000 
152 2 0.909 0.909 1.000 80.874 0.000 
153 2 0.883 0.883 1.000 79.072 0.000 
154 5 0.769 0.885 0.869 1030.843 0.000 
155 5 0.781 0.892 0.876 1439.476 0.000 
156 2 0.770 0.770 1.000 21.347 0.000 
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157 5 0.686 0.831 0.825 1619.706 0.000 
158 5 0.732 0.917 0.798 896.393 0.000 
159 2 0.874 0.874 1.000 52.978 0.000 
160 4 0.841 0.841 1.000 37.733 1.026 
161 2 0.807 0.807 1.000 29.213 0.000 
162 4 0.814 0.814 1.000 35.204 1.839 
163 5 0.831 0.904 0.920 1123.187 0.000 
164 2 0.781 0.781 1.000 24.511 0.000 
166 2 0.829 0.829 1.000 46.039 0.000 
167 2 0.908 0.908 1.000 79.82 0.000 
168 2 0.829 0.829 1.000 34.488 0.000 
169 4 0.865 0.865 1.000 29.624 0.984 
170 5 0.870 0.918 0.947 1006.463 0.000 
171 2 0.879 0.879 1.000 32.563 0.000 
172 4 0.835 0.835 1.000 38.86 0.838 
173 5 0.728 0.835 0.872 972.425 0.000 
174 5 0.820 0.854 0.960 930.935 0.000 
175 5 0.811 0.875 0.927 829.944 0.000 
176 2 0.850 0.850 1.000 50.777 0.000 
178 4 0.856 0.856 1.000 45.418 1.897 
179 4 0.789 0.789 1.000 30.642 2.192 
180 2 0.918 0.918 1.000 47.754 0.000 
181 4 0.841 0.841 1.000 50.031 0.508 
183 2 0.875 0.875 1.000 49.689 0.000 
186 2 0.825 0.825 1.000 36.155 0.000 
187 2 0.819 0.819 1.000 35.528 0.000 
188 5 0.736 0.819 0.898 1148.04 0.000 
189 5 0.645 0.706 0.914 1025.434 0.000 
